Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:nitroso group
go back to main search page
Accession:CHEBI:35801 term browser browse the term
Synonyms:related_synonym: -N=O;   nitroso
 chemrof_smiles: *N=O
 chemrof_formula: NO


show annotations for term's descendants           Sort by:
1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Angpt1 angiopoietin 1 increases expression EXP
ISO 		2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of ANGPT1 mRNA; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of ANGPT1 protein CTD PMID:16735674 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Bach1 BTB domain and CNC homolog 1 multiple interactions ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [alpha-pyrrolidinononanophenone analog results in increased expression of BACH1 protein] CTD PMID:38040126 NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277 		JBrowse link
G Bmp4 bone morphogenetic protein 4 increases expression EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of BMP4 mRNA CTD PMID:15991191 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Cav1 caveolin 1 multiple interactions
increases expression 		ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased metabolism of and results in increased stability of CAV1 protein
2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CAV1 protein 		CTD PMID:19706615 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Ccn4 cellular communication network factor 4 multiple interactions
increases expression 		ISO CREB1 mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA]; CTNNB1 mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA]; Cycloheximide inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA]; Dactinomycin inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA]
2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 protein 		CTD PMID:19238344 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Cdh2 cadherin 2 increases expression
multiple interactions
affects response to substance 		ISO
EXP 		2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CDH2 mRNA
CDH2 protein affects the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA]
CDH2 protein affects the susceptibility to 2,2'-(hydroxynitrosohydrazono)bis-ethanamine 		CTD PMID:16580782 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cldn5 claudin 5 multiple interactions ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine promotes the reaction [9,10-phenanthrenequinone results in decreased expression of CLDN5 protein] CTD PMID:34391839 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases phosphorylation
multiple interactions 		ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased phosphorylation of CREB1 protein
CREB1 mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA] 		CTD PMID:19238344 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression
increases activity
multiple interactions 		ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA
2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased activity of CTNNB1 protein
CDH2 protein affects the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA]; CTNNB1 mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA] 		CTD PMID:16580782 PMID:19238344 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A1 protein CTD PMID:15542068 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A2 protein CTD PMID:15542068 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Gfap glial fibrillary acidic protein decreases expression ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased expression of GFAP mRNA CTD PMID:16580782 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine affects the reaction [alpha-pyrrolidinononanophenone analog affects the expression of HMOX1 protein] CTD PMID:38040126 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D multiple interactions
increases expression 		EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine promotes the reaction [HNRNPD protein binds to MMP9 3' UTR]; HNRNPD mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]]
2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of HNRNPD protein 		CTD PMID:16683234 NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Fructose results in increased expression of ICAM1 protein] CTD PMID:18508964 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA] CTD PMID:16378139 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine promotes the reaction [HNRNPD protein binds to MMP9 3' UTR]; HNRNPD mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]] CTD PMID:16378139 PMID:16683234 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 increases metabolic processing ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased metabolism of NCF1 protein CTD PMID:17568572 NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Neurog1 neurogenin 1 increases expression ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of NEUROG1 mRNA CTD PMID:16580782 NCBI chr17:8,368,096...8,369,615
Ensembl chr17:8,368,096...8,369,615 		JBrowse link
G Ocln occludin increases expression EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of OCLN protein CTD PMID:16735674 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Rasd1 ras related dexamethasone induced 1 multiple interactions EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased nitrosation of and results in increased activity of RASD1 protein CTD PMID:16908409 NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710 		JBrowse link
G Slc26a4 solute carrier family 26 member 4 decreases expression ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased expression of SLC26A4 protein CTD PMID:22811483 NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:53,835,110...53,873,216 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
increases response to substance 		EXP
ISO 		1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA]; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Doxorubicin results in increased expression of SOD2 protein]; [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein; [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA; Dactinomycin inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA]
SOD2 protein results in increased susceptibility to 2,2'-(hydroxynitrosohydrazono)bis-ethanamine 		CTD PMID:10511315 PMID:14996425 PMID:19286953 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Tek TEK receptor tyrosine kinase increases expression EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of TEK mRNA; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of TEK protein CTD PMID:16735674 NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of TGFB1 mRNA; 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of TGFB1 protein CTD PMID:12798441 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [TNF protein results in increased secretion of VWF protein] CTD PMID:34678311 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Vamp2 vesicle-associated membrane protein 2 multiple interactions EXP 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [lead acetate affects the localization of VAMP2 protein] CTD PMID:22265330 NCBI chr10:54,292,423...54,296,657
Ensembl chr10:54,292,806...54,296,654 		JBrowse link
G Vwf von Willebrand factor multiple interactions ISO 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [TNF protein results in increased secretion of VWF protein] CTD PMID:34678311 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ABCB1B mRNA CTD PMID:14600272 PMID:23052194 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 affects abundance EXP ABCC2 protein affects the abundance of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone metabolite CTD PMID:17724374 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Aco1 aconitase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ACO1 mRNA CTD PMID:15890375 NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of ACSL1 mRNA CTD PMID:20146248 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Agpat1 1-acylglycerol-3-phosphate O-acyltransferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of AGPAT1 mRNA CTD PMID:20146248 NCBI chr20:4,140,565...4,149,531
Ensembl chr20:4,140,565...4,150,445 		JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of AIF1 mRNA CTD PMID:14600272 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases metabolic processing ISO AKR1C1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases metabolic processing ISO AKR1C2 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of AKR7A3 mRNA CTD PMID:14600272 PMID:23052194 NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation 		ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein]; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein; [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of EIF4EBP1 protein; [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3A protein; [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein; Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein]; GSK690693 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of AKT1 protein]; Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein]; methyllycaconitine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] CTD PMID:12511591 PMID:34784199 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ALDH1A1 mRNA CTD PMID:14600272 PMID:22484513 PMID:23052194 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ALDH7A1 mRNA CTD PMID:19038236 NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467 		JBrowse link
G Anxa2 annexin A2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ANXA2 mRNA CTD PMID:14600272 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of APEX1 mRNA CTD PMID:15890375 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Aph1b aph-1 homolog B, gamma secretase subunit increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of APH1B mRNA CTD PMID:22484513 NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:76,310,380...76,331,428 		JBrowse link
G Arid4b AT-rich interaction domain 4B multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of ARID4B mRNA CTD PMID:20146248 NCBI chr17:55,833,908...55,958,382
Ensembl chr17:55,833,908...55,958,382 		JBrowse link
G Asl argininosuccinate lyase increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ASL mRNA CTD PMID:19038236 NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261 		JBrowse link
G Atf1 activating transcription factor 1 increases phosphorylation
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of ATF1 protein
Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of ATF1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of ATF1 protein]; RTKI cpd inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of ATF1 protein] 		CTD PMID:16671086 NCBI chr 7:133,240,774...133,283,488
Ensembl chr 7:133,241,197...133,283,485 		JBrowse link
G Atf3 activating transcription factor 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ATF3 mRNA CTD PMID:15890375 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atm ATM serine/threonine kinase multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of ATM mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of ATM mRNA] CTD PMID:21882252 NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629 		JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of ATP5MC1 mRNA CTD PMID:14600272 NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363 		JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ATP6V1D mRNA CTD PMID:14600272 PMID:22484513 PMID:23052194 NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346 		JBrowse link
G B4galt1 beta-1,4-galactosyltransferase 1 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA] CTD PMID:21882252 NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445 		JBrowse link
G Bad BCL2-associated agonist of cell death decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BAD protein
SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BAD protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BAD protein] 		CTD PMID:18508827 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Barhl1 BarH-like homeobox 1 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BARHL1 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BARHL1 mRNA] CTD PMID:21882252 NCBI chr 3:32,639,283...32,646,605
Ensembl chr 3:32,638,644...32,646,605 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
decreases expression
increases expression 		ISO
EXP 		[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BAX mRNA; [Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of BAX protein; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BAX mRNA]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BAX protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX mRNA 		CTD PMID:14600272 PMID:15890375 PMID:21882252 PMID:22484513 PMID:23052194 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression 		ISO Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA]; SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein 		CTD PMID:16582591 PMID:16835749 PMID:18508827 PMID:21776270 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BHMT mRNA CTD PMID:14600272 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 increases expression
increases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BIRC3 protein
NNK increases expression of BIRC3 protein in nonsmall cell lung cancer cells
SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BIRC3 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BIRC3 protein]; zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BIRC3 protein] 		CTD
RGD		 PMID:18508827 PMID:18508827 RGD:152998973 NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BIRC5 mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of and results in increased expression of BIRC5 protein 		CTD PMID:21167638 PMID:21776270 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bola3 bolA family member 3 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA] CTD PMID:21882252 NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:117,410,680...117,420,491 		JBrowse link
G Brca1 BRCA1, DNA repair associated increases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BRCA1 mRNA
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of BRCA1 mRNA 		CTD PMID:21167638 NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BTG2 mRNA CTD PMID:14600272 PMID:15890375 PMID:22484513 PMID:23052194 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BTG3 mRNA CTD PMID:22484513 PMID:23052194 NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082 		JBrowse link
G Casp8 caspase 8 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CASP8 mRNA CTD PMID:21167638 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Cbr1 carbonyl reductase 1 increases metabolic processing
multiple interactions 		ISO CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Quercetin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] 		CTD PMID:11306090 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein CTD PMID:15762874 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccnb1 cyclin B1 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCNB1 mRNA CTD PMID:15890375 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression 		ISO
EXP 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone promotes the reaction [CDK4 protein binds to CCND1 protein]; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone promotes the reaction [CDK6 protein binds to CCND1 protein]; Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA]; Benzamides analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA]; diphenyleneiodonium inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA]; wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 protein 		CTD PMID:14600272 PMID:15890375 PMID:18805435 PMID:22484513 PMID:28321046 More... NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccne1 cyclin E1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCNE1 protein CTD PMID:30236600 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccng1 cyclin G1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCNG1 mRNA CTD PMID:14600272 PMID:15890375 PMID:22484513 PMID:23052194 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Cct3 chaperonin containing TCP1 subunit 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCT3 mRNA CTD PMID:15890375 NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925 		JBrowse link
G Cdc20 cell division cycle 20 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDC20 mRNA CTD PMID:15890375 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdh1 cadherin 1 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDH1 protein CTD PMID:30236600 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh2 cadherin 2 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDH2 protein CTD PMID:30236600 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDK1 mRNA CTD PMID:15890375 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk16 cyclin-dependent kinase 16 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDK16 mRNA CTD PMID:15890375 NCBI chr  X:4,046,330...4,057,825
Ensembl chr  X:4,026,866...4,057,380 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions
increases expression 		ISO
EXP 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone promotes the reaction [CDK4 protein binds to CCND1 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDK4 mRNA 		CTD PMID:15890375 PMID:18805435 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 multiple interactions ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone promotes the reaction [CDK6 protein binds to CCND1 protein] CTD PMID:18805435 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions 		ISO
EXP 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1A mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1A protein
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1A protein]; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CDKN1A protein; SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein]; zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CDKN1A protein] 		CTD PMID:14600272 PMID:15890375 PMID:18508827 PMID:18805435 PMID:20421341 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein] 		CTD PMID:18805435 PMID:30236600 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions ISO [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of CDKN2A mRNA; [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of CDKN2A protein CTD PMID:21167638 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Ces2c carboxylesterase 2C increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CES2C mRNA CTD PMID:23052194 NCBI chr 1:270,377,201...270,384,768
Ensembl chr 1:270,374,913...270,384,801 		JBrowse link
G Ces2h carboxylesterase 2H increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CES2 mRNA CTD PMID:14600272 PMID:22484513 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CGREF1 mRNA CTD PMID:14600272 PMID:15890375 PMID:22484513 PMID:23052194 NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800 		JBrowse link
G Cgrrf1 cell growth regulator with ring finger domain 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CGRRF1 mRNA CTD PMID:15890375 NCBI chr15:22,560,902...22,588,815
Ensembl chr15:22,568,332...22,588,811 		JBrowse link
G Chd1l chromodomain helicase DNA binding protein 1-like increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CHD1L mRNA CTD PMID:19038236 NCBI chr 2:187,819,869...187,906,359
Ensembl chr 2:187,811,954...187,890,477 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit increases expression
increases activity
affects binding 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CHRNA7 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of CHRNA7 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone binds to CHRNA7 protein 		CTD PMID:16835749 PMID:17459420 PMID:19027725 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858 		JBrowse link
G Chrna9 cholinergic receptor nicotinic alpha 9 subunit multiple interactions ISO [Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of CHRNA9 protein CTD PMID:30259641 NCBI chr14:42,588,948...42,595,669
Ensembl chr14:42,588,948...42,595,669 		JBrowse link
G Cntn1 contactin 1 increases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CNTN1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CNTN1 mRNA]; Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CNTN1 mRNA] 		CTD PMID:19027725 NCBI chr 7:125,142,638...125,440,397
Ensembl chr 7:125,142,696...125,440,391 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of COL6A1 protein CTD PMID:23692979 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Commd1 copper metabolism domain containing 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of COMMD1 mRNA CTD PMID:19038236 NCBI chr14:101,081,667...101,185,738
Ensembl chr14:101,081,667...101,185,639 		JBrowse link
G Cox17 cytochrome c oxidase copper chaperone COX17 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of COX17 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of COX17 mRNA] CTD PMID:21882252 NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019 		JBrowse link
G Cr1l complement C3b/C4b receptor 1 like increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CR1L mRNA CTD PMID:15890375 NCBI chr13:109,138,132...109,189,068
Ensembl chr13:109,103,235...109,188,869 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases phosphorylation
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of CREB1 protein
Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of CREB1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of CREB1 protein]; RTKI cpd inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of CREB1 protein] 		CTD PMID:16671086 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Cryab crystallin, alpha B increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CRYAB mRNA CTD PMID:14600272 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Cstb cystatin B increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CSTB mRNA CTD PMID:15890375 NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein; Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein]; wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTNNB1 protein] CTD PMID:28321046 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctsd cathepsin D increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTSD mRNA CTD PMID:15890375 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Ctss cathepsin S increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTSS mRNA CTD PMID:14600272 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CXCL10 mRNA CTD PMID:14600272 PMID:15890375 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cyb5a cytochrome b5 type A multiple interactions ISO CYB5A protein promotes the reaction [CYP2A6 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:15728263 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CYB5R3 mRNA CTD PMID:14600272 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO
EXP 		[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of CYP1A1 mRNA; CYP1A1 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; Grape Seed Proanthocyanidins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CYP1A1 mRNA]; Grape Seed Proanthocyanidins inhibits the reaction [[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of CYP1A1 mRNA] CTD PMID:11774366 PMID:20146248 PMID:23052194 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases activity 		ISO CYP1A2 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP1A2 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 		CTD PMID:11774366 PMID:15728263 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO CYP1B1 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; Grape Seed Proanthocyanidins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CYP1B1 mRNA] CTD PMID:11774366 PMID:20146248 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 multiple interactions
increases hydroxylation
decreases metabolic processing
increases activity
increases metabolic processing
decreases hydroxylation
affects metabolic processing 		ISO [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] which results in increased abundance of 4-hydroxy-1-(3-pyridyl)-1-butanone; [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] which results in increased abundance of 4-oxo-4-(3-pyridinebutanal); [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] which results in increased abundance of 4-oxo-4-(3-pyridyl)butanoic acid; CYP2A13 gene polymorphism inhibits the reaction [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; CYP2A13 protein promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AX protein]; CYP2A13 protein results in increased metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; CYP2A13 protein results in increased metabolism of and results in increased susceptibility to 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; Methoxsalen inhibits the reaction [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Methoxsalen inhibits the reaction [CYP2A13 protein results in increased metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Metyrapone inhibits the reaction [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Miconazole inhibits the reaction [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Tranylcypromine inhibits the reaction [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]
CYP2A13 protein results in increased hydroxylation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; CYP2A13 results in increased hydroxylation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP2A13 protein SNP results in decreased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP2A13 results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP2A13 gene polymorphism results in decreased hydroxylation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP2A13 protein affects the metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 		CTD PMID:12920169 PMID:14633739 PMID:15608128 PMID:16917071 PMID:17671098 More... NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases activity EXP CYP2B1 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:10799646 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 affects metabolic processing
multiple interactions
increases activity 		ISO CYP2B6 protein affects the metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
[CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP2B6 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 		CTD PMID:10799646 PMID:12920169 PMID:32672941 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c12 cytochrome P450, family 2, subfamily c, polypeptide 12 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CYP2C12 mRNA CTD PMID:22484513 PMID:23052194 NCBI chr 1:248,619,887...248,681,945
Ensembl chr 1:248,619,882...248,677,042 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions ISO CYP2C19 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11774366 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases metabolic processing ISO CYP2D6 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:2070484 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects metabolic processing
increases metabolic processing
increases activity 		ISO
EXP 		CYP2E1 protein affects the metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP2E1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of CYP2E1 protein 		CTD PMID:9774145 PMID:12115524 PMID:12920169 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases metabolic processing 		ISO CYP3A4 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
CYP3A4 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 		CTD PMID:9029045 PMID:11774366 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Dapk1 death associated protein kinase 1 increases methylation ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased methylation of DAPK1 promoter CTD PMID:15172992 NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581 		JBrowse link
G Dcn decorin increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DCN mRNA CTD PMID:14600272 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DDAH1 mRNA CTD PMID:15890375 NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626 		JBrowse link
G Ddx21 DExD-box helicase 21 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DDX21 mRNA CTD PMID:15890375 NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 increases metabolic processing ISO DHRS3 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:25451588 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Dhrs7 dehydrogenase/reductase 7 increases reduction ISO DHRS7 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:24246760 NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744 		JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKC1 mRNA CTD PMID:15890375 NCBI chr  X:157,751,651...157,757,796
Ensembl chr  Y:380,743...385,405
Ensembl chr  X:380,743...385,405 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA]; Benzamides analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA]; diphenyleneiodonium inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA]; Wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA] CTD PMID:28321046 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DMBT1 mRNA CTD PMID:23052194 NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:195,047,713...195,126,704 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of DPYD mRNA CTD PMID:15890375 NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778 		JBrowse link
G Dusp6 dual specificity phosphatase 6 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of DUSP6 mRNA CTD PMID:15890375 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dut deoxyuridine triphosphatase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DUT mRNA CTD PMID:15890375 NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956 		JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EEF1G mRNA CTD PMID:15890375 NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EEF2 mRNA CTD PMID:15890375 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Egfr epidermal growth factor receptor increases phosphorylation
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of EGFR protein
Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of EGFR protein] 		CTD PMID:16671086 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 increases expression
multiple interactions 		EXP
ISO 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EIF4EBP1 mRNA
[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of EIF4EBP1 protein 		CTD PMID:12511591 PMID:15890375 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EPHX1 mRNA CTD PMID:14600272 PMID:15890375 PMID:22484513 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Fam162a family with sequence similarity 162, member A increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FAM162A mRNA CTD PMID:15890375 NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560 		JBrowse link
G Fasn fatty acid synthase increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FASN protein CTD PMID:18413838 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FEN1 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FEN1 protein
NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FEN1 protein] 		CTD PMID:35435490 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fkbp4 FKBP prolyl isomerase 4 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FKBP4 mRNA CTD PMID:15890375 NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918 		JBrowse link
G Fn1 fibronectin 1 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FN1 mRNA CTD PMID:15890375 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FOS mRNA
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of FOS mRNA 		CTD PMID:21167638 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Foxp1 forkhead box P1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FOXP1 mRNA alternative form CTD PMID:35435490 NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of FTH1 mRNA CTD PMID:20146248 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of FXYD3 mRNA CTD PMID:20146248 NCBI chr 1:95,432,918...95,440,129
Ensembl chr 1:95,432,919...95,439,702 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GADD45A mRNA CTD PMID:15890375 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gas6 growth arrest specific 6 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GAS6 mRNA CTD PMID:14600272 PMID:15890375 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gata3 GATA binding protein 3 multiple interactions
increases expression
increases activity 		ISO Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein]; Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GATA3 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GATA3 mRNA 		CTD PMID:16582591 PMID:16835749 NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GCLC mRNA CTD PMID:15890375 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GDF15 mRNA CTD PMID:14600272 PMID:15890375 PMID:23052194 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gls2 glutaminase 2 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GLS2 mRNA CTD PMID:14600272 NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013 		JBrowse link
G Gnmt glycine N-methyltransferase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GNMT mRNA CTD PMID:14600272 NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692 		JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GRIA3 mRNA CTD PMID:22484513 NCBI chr  X:125,103,975...125,369,690
Ensembl chr  X:125,103,782...125,369,679 		JBrowse link
G Grpel1 GrpE-like 1, mitochondrial increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GRPEL1 mRNA CTD PMID:15890375 NCBI chr14:78,517,049...78,522,868
Ensembl chr14:78,517,052...78,522,861 		JBrowse link
G Gsk3a glycogen synthase kinase 3 alpha multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3A protein CTD PMID:12511591 NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein CTD PMID:12511591 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GSR mRNA CTD PMID:15890375 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gss glutathione synthetase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GSS mRNA CTD PMID:15890375 NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GSTA2 mRNA CTD PMID:15890375 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092 		JBrowse link
G Gsta4 glutathione S-transferase alpha 4 decreases expression
increases expression
increases activity 		EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GSTA4 mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GSTA4 mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GSTA4 protein 		CTD PMID:9774145 NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488 		JBrowse link
G Gsta5 glutathione S-transferase alpha 5 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GSTA5 mRNA CTD PMID:14600272 NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765 		JBrowse link
G Gtpbp1 GTP binding protein 1 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GTPBP1 mRNA CTD PMID:19038236 NCBI chr 7:113,128,645...113,153,094
Ensembl chr 7:113,128,670...113,154,621 		JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression
increases phosphorylation 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AX protein]; [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AX protein; Caffeine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AX protein]; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AX protein]; CYP2A13 protein promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AX protein]; GSK690693 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein]; methyllycaconitine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein]; NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein modified form]; Wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein modified form
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX mRNA 		CTD PMID:15890375 PMID:21882252 PMID:26231820 PMID:34784199 PMID:35435490 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2az1 H2A.Z variant histone 1 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of H2AZ1 mRNA CTD PMID:15890375 NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411 		JBrowse link
G H3f4 H3.4 histone, cluster member increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H3-4 mRNA CTD PMID:19038236 NCBI chr10:44,240,282...44,240,842 JBrowse link
G Hba-a3 hemoglobin alpha, adult chain 3 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of HBA2 mRNA CTD PMID:20146248 NCBI chr10:15,816,099...15,816,943
Ensembl chr10:15,816,096...15,817,167 		JBrowse link
G Hcrtr2 hypocretin receptor 2 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HCRTR2 mRNA CTD PMID:19038236 NCBI chr 8:85,870,279...85,986,405
Ensembl chr 8:85,870,279...85,986,405 		JBrowse link
G Hdc histidine decarboxylase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HDC mRNA CTD PMID:15890375 NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions
increases expression 		ISO 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HES1 mRNA] CTD PMID:28321046 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hmgb2 high mobility group box 2 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of HMGB2 mRNA CTD PMID:15890375 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression 		ISO
EXP 		SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HMOX1 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HMOX1 protein]; zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HMOX1 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HMOX1 mRNA 		CTD PMID:15890375 PMID:18508827 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 multiple interactions
increases mutagenesis 		ISO [Ozone co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of HPRT1 gene; Dibutyl Phthalate promotes the reaction [[Ozone co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of HPRT1 gene]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of HPRT1 gene 		CTD PMID:15613823 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions
increases reduction 		ISO drospirenone inhibits the reaction [HSD11B1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Ethinyl Estradiol inhibits the reaction [HSD11B1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Progesterone inhibits the reaction [HSD11B1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Testosterone inhibits the reaction [HSD11B1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:28257955 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of HSD11B2 mRNA; Grape Seed Proanthocyanidins inhibits the reaction [[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of HSD11B2 mRNA] CTD PMID:20146248 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsf1 heat shock transcription factor 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSF1 mRNA CTD PMID:15890375 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSPA9 mRNA CTD PMID:15890375 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSPB1 mRNA CTD PMID:15890375 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSPE1 mRNA CTD PMID:15890375 NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSPH1 mRNA CTD PMID:15890375 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891 		JBrowse link
G Ide insulin degrading enzyme increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IDE mRNA CTD PMID:15890375 NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP1 mRNA CTD PMID:15890375 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP2 mRNA CTD PMID:22484513 PMID:23052194 NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of IGFBP3 mRNA CTD PMID:15890375 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Il6 interleukin 6 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of IL6 protein CTD PMID:15762874 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Inmt indolethylamine N-methyltransferase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of INMT mRNA CTD PMID:22484513 NCBI chr 4:85,648,459...85,652,755
Ensembl chr 4:85,648,459...85,652,755 		JBrowse link
G Ints4 integrator complex subunit 4 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of INTS4 mRNA CTD PMID:22484513 NCBI chr 1:161,201,284...161,265,042
Ensembl chr 1:161,197,708...161,269,124 		JBrowse link
G Irf1 interferon regulatory factor 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IRF1 mRNA CTD PMID:14600272 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of JUN mRNA
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of JUN mRNA 		CTD PMID:21167638 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kras KRAS proto-oncogene, GTPase increases mutagenesis
multiple interactions 		EXP
ISO 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of KRAS gene
[Lipopolysaccharides co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of KRAS gene 		CTD PMID:18271921 PMID:21868532 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320 		JBrowse link
G Krt15 keratin 15 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of KRT15 mRNA CTD PMID:20146248 NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142 		JBrowse link
G Lama5 laminin subunit alpha 5 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LAMA5 mRNA CTD PMID:22484513 NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173 		JBrowse link
G Lgals3 galectin 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA CTD PMID:15890375 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Ltb4r leukotriene B4 receptor decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of LTB4R mRNA CTD PMID:19038236 NCBI chr15:33,233,120...33,235,636
Ensembl chr15:33,232,820...33,235,637 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein] CTD PMID:21882252 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184 		JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K2 protein; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K2 protein] CTD PMID:21882252 NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation
increases activity
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of MAPK1 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of MAPK1 protein; [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAPK1 protein; [Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased phosphorylation of MAPK1 protein; Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein]; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAPK1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein] 		CTD PMID:15603589 PMID:16671086 PMID:17459420 PMID:18508827 PMID:21882252 More... NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases activity
multiple interactions
increases phosphorylation 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of MAPK3 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of MAPK3 protein; [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAPK3 protein; [Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased phosphorylation of MAPK3 protein; Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK3 protein]; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAPK3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK3 protein] 		CTD PMID:15603589 PMID:16671086 PMID:17459420 PMID:18508827 PMID:21882252 More... NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mat1a methionine adenosyltransferase 1A decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MAT1A mRNA CTD PMID:14600272 NCBI chr16:17,017,168...17,035,368
Ensembl chr16:17,016,030...17,035,367 		JBrowse link
G Mcam melanoma cell adhesion molecule decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MCAM mRNA CTD PMID:21167638 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MCM6 mRNA CTD PMID:15890375 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MDM2 mRNA CTD PMID:14600272 PMID:15890375 PMID:22484513 PMID:23052194 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MGMT mRNA CTD PMID:14600272 PMID:15890375 PMID:22484513 PMID:23052194 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mir155 microRNA 155 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MIR155 mRNA CTD PMID:32326378 NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178 		JBrowse link
G Mir21 microRNA 21 multiple interactions
increases expression 		ISO MIR21 mRNA affects the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MSH2 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MIR21 mRNA 		CTD PMID:32326378 NCBI chr10:71,902,600...71,902,691 JBrowse link
G Mis18a MIS18 kinetochore protein A increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MIS18A mRNA CTD PMID:19038236 NCBI chr11:43,454,129...43,467,157
Ensembl chr11:43,454,161...43,476,264 		JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MKI67 protein CTD PMID:21776270 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mlh1 mutL homolog 1 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MLH1 mRNA CTD PMID:32326378 NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011 		JBrowse link
G Mmp9 matrix metallopeptidase 9 decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MMP9 mRNA
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA 		CTD PMID:21167638 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mrpl41 mitochondrial ribosomal protein L41 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of MRPL41 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of MRPL41 mRNA] CTD PMID:21882252 NCBI chr 3:28,178,837...28,179,755
Ensembl chr 3:28,162,197...28,181,250 		JBrowse link
G Msh2 mutS homolog 2 multiple interactions
decreases expression 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of and affects the localization of MSH2 protein; MIR21 mRNA affects the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MSH2 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MSH2 mRNA 		CTD PMID:32326378 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of MT1E mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of MT1E mRNA] CTD PMID:21882252 NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200 		JBrowse link
G Mt1a metallothionein 1A decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT1A mRNA CTD PMID:14600272 PMID:15890375 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT2 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT2A mRNA CTD PMID:14600272 PMID:15890375 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mta2 metastasis associated 1 family, member 2 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MTA2 mRNA CTD PMID:21167638 NCBI chr 1:215,267,286...215,276,008
Ensembl chr 1:215,267,046...215,276,062 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases activity
increases expression 		ISO
EXP 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of MYC protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MYC mRNA 		CTD PMID:15890375 PMID:17459420 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Nanog Nanog homeobox increases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NANOG protein
[Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of NANOG protein 		CTD PMID:30259641 NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061 		JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NAP1L1 mRNA CTD PMID:15890375 NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 increases activity
multiple interactions
increases expression 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein
Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA]; Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA]; SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein] 		CTD PMID:16582591 PMID:16835749 PMID:18508827 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha increases phosphorylation ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of NFKBIA protein CTD PMID:18508827 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nhej1 nonhomologous end-joining factor 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NHEJ1 mRNA CTD PMID:22484513 NCBI chr 9:83,974,995...84,071,161
Ensembl chr 9:83,974,997...84,070,594 		JBrowse link
G Nipbl NIPBL, cohesin loading factor multiple interactions
increases expression
increases response to substance 		ISO NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FEN1 protein]; NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 protein]; NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PCNA protein]; NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XRCC1 protein]; NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein modified form]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NIPBL mRNA alternative form
NIPBL mRNA alternative form results in increased susceptibility to 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 		CTD PMID:35435490 NCBI chr 2:59,126,676...59,314,841
Ensembl chr 2:59,126,676...59,293,277 		JBrowse link
G Npc1 NPC intracellular cholesterol transporter 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NPC1 mRNA CTD PMID:19038236 NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800 		JBrowse link
G Npm1 nucleophosmin 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NPM1 mRNA CTD PMID:15890375 NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024
Ensembl chr  X:18,245,740...18,256,024 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NQO1 mRNA CTD PMID:14600272 PMID:15890375 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nrcam neuronal cell adhesion molecule increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NRCAM mRNA CTD PMID:22484513 NCBI chr 6:67,129,723...67,425,510
Ensembl chr 6:67,129,801...67,430,539 		JBrowse link
G Nrg1 neuregulin 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NRG1 mRNA CTD PMID:14600272 PMID:15890375 PMID:23052194 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Nubpl NUBP iron-sulfur cluster assembly factor, mitochondrial decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of NUBPL mRNA CTD PMID:22484513 NCBI chr 6:75,294,609...75,516,603
Ensembl chr 6:75,294,632...75,516,601 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of NUPR1 mRNA CTD PMID:15890375 PMID:23052194 NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901 		JBrowse link
G Oat ornithine aminotransferase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of OAT mRNA CTD PMID:14600272 PMID:22484513 NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754 		JBrowse link
G Obp1f odorant binding protein I f increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of OBP1F mRNA CTD PMID:22484513 NCBI chr  X:45,833,861...45,839,070 JBrowse link
G Obp3 alpha-2u globulin PGCL4 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of OBP3 mRNA CTD PMID:15890375 NCBI chr 5:79,637,234...79,640,810
Ensembl chr 5:79,637,234...79,640,675 		JBrowse link
G Ocln occludin decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of OCLN protein CTD PMID:30236600 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Odc1 ornithine decarboxylase 1 increases activity
increases expression
multiple interactions 		ISO
EXP 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of ODC1 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ODC1 mRNA
tocopheryloxybutyric acid inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of ODC1 protein]; tocopheryloxybutyric acid inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ODC1 mRNA] 		CTD PMID:11301052 PMID:15890375 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
decreases expression 		ISO NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 protein 		CTD PMID:35435490 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
decreases expression
increases expression 		ISO
EXP 		Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PCNA mRNA]; NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PCNA protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PCNA mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PCNA protein 		CTD PMID:15890375 PMID:16582591 PMID:16835749 PMID:35435490 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcsk2 proprotein convertase subtilisin/kexin type 2 multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of PCSK2 mRNA CTD PMID:20146248 NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:151,333,234...151,638,849 		JBrowse link
G Pdcd4 programmed cell death 4 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PDCD4 mRNA CTD PMID:21873647 NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189 		JBrowse link
G Per1 period circadian regulator 1 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of PER1 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of PER1 mRNA] CTD PMID:21882252 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211 		JBrowse link
G Pgd phosphogluconate dehydrogenase decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PGD mRNA CTD PMID:19038236 NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PHGDH mRNA CTD PMID:15890375 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PHLDA3 mRNA CTD PMID:22484513 PMID:23052194 NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621 		JBrowse link
G Pla2g2a phospholipase A2 group IIA increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLA2G2A mRNA CTD PMID:24835565 NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297 		JBrowse link
G Pla2g4a phospholipase A2 group 4A increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLA2G4A mRNA CTD PMID:24835565 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Plau plasminogen activator, urokinase decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PLAU mRNA
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of PLAU mRNA 		CTD PMID:21167638 NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Plk2 polo-like kinase 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLK2 mRNA CTD PMID:23052194 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Pln phospholamban increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLN mRNA CTD PMID:22484513 NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241 		JBrowse link
G Por cytochrome p450 oxidoreductase affects response to substance ISO POR affects the susceptibility to 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:22710403 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809 		JBrowse link
G Prdx6 peroxiredoxin 6 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PRDX6 protein CTD PMID:23692979 NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657 		JBrowse link
G Psma1 proteasome 20S subunit alpha 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMA1 mRNA CTD PMID:15890375 NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949 		JBrowse link
G Psma2 proteasome 20S subunit alpha 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMA2 mRNA CTD PMID:15890375 NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673 		JBrowse link
G Psma4 proteasome 20S subunit alpha 4 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMA4 mRNA CTD PMID:15890375 NCBI chr 8:64,236,520...64,243,980
Ensembl chr 8:64,236,783...64,243,979 		JBrowse link
G Psma5 proteasome 20S subunit alpha 5 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PSMA5 mRNA CTD PMID:15890375 NCBI chr 2:198,584,502...198,607,867
Ensembl chr 2:198,584,505...198,607,867 		JBrowse link
G Psma7 proteasome 20S subunit alpha 7 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMA7 mRNA CTD PMID:15890375 NCBI chr 3:187,514,901...187,521,289
Ensembl chr 3:187,513,441...187,521,253 		JBrowse link
G Psmb1 proteasome 20S subunit beta 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB1 mRNA CTD PMID:15890375 NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640 		JBrowse link
G Psmb3 proteasome 20S subunit beta 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB3 mRNA CTD PMID:15890375 NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883 		JBrowse link
G Psmb4 proteasome 20S subunit beta 4 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB4 mRNA CTD PMID:15890375 NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287 		JBrowse link
G Psmb5 proteasome 20S subunit beta 5 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB5 mRNA CTD PMID:15890375 NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379 		JBrowse link
G Psmc1 proteasome 26S subunit, ATPase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMC1 mRNA CTD PMID:15890375 NCBI chr 6:125,122,497...125,134,859
Ensembl chr 6:125,122,490...125,134,858 		JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMC2 mRNA CTD PMID:15890375 NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390 		JBrowse link
G Psmc4 proteasome 26S subunit, ATPase 4 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMC4 mRNA CTD PMID:15890375 NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060 		JBrowse link
G Psmc5 proteasome 26S subunit, ATPase 5 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMC5 mRNA CTD PMID:15890375 NCBI chr10:91,687,553...91,693,487
Ensembl chr10:91,686,295...91,695,921 		JBrowse link
G Psmd1 proteasome 26S subunit, non-ATPase 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMD1 mRNA CTD PMID:15890375 NCBI chr 9:94,157,971...94,233,218
Ensembl chr 9:94,157,971...94,233,218 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases activity 		ISO [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased abundance of Dinoprostone]; Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein]; Propranolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein]; SB 203580 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein]; U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein] CTD PMID:15762874 PMID:18805435 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptk2 protein tyrosine kinase 2 multiple interactions ISO [Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of PTK2 protein CTD PMID:30259641 NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PTP4A1 mRNA CTD PMID:15890375 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptprv protein tyrosine phosphatase, receptor type, V increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PTPRV mRNA CTD PMID:22484513 NCBI chr13:49,099,922...49,120,247
Ensembl chr13:49,099,925...49,120,121 		JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PTTG1 mRNA CTD PMID:15890375 NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309 		JBrowse link
G R3hdm2 R3H domain containing 2 decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of R3HDM2 mRNA CTD PMID:22484513 NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:65,097,923...65,225,862 		JBrowse link
G Rad23b RAD23 homolog B, nucleotide excision repair protein decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of RAD23B mRNA CTD PMID:19038236 NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:74,885,516...74,962,426 		JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase increases activity ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of RAF1 protein CTD PMID:17459420 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813 		JBrowse link
G Rarb retinoic acid receptor, beta increases methylation ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased methylation of RARB promoter CTD PMID:14656941 NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040 		JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions
decreases expression
increases phosphorylation 		ISO
EXP 		4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of RB1 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of RB1 mRNA 		CTD PMID:15890375 PMID:18805435 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of RELA protein CTD PMID:18508827 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rfx1 regulatory factor X1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RFX1 mRNA CTD PMID:19038236 NCBI chr19:40,966,102...40,996,809
Ensembl chr19:40,966,102...40,996,809 		JBrowse link
G Rgmb repulsive guidance molecule BMP co-receptor b multiple interactions ISO [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of RGMB mRNA CTD PMID:20146248 NCBI chr 1:65,439,748...65,465,149
Ensembl chr 1:65,441,410...65,465,098 		JBrowse link
G Rhcg Rh family, C glycoprotein decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of RHCG mRNA CTD PMID:19038236 NCBI chr 1:142,941,046...142,965,242
Ensembl chr 1:142,941,048...142,965,376 		JBrowse link
G Rheb Ras homolog, mTORC1 binding increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RHEB mRNA CTD PMID:15890375 NCBI chr 4:11,012,173...11,053,860
Ensembl chr 4:11,012,643...11,053,931 		JBrowse link
G Rhob ras homolog family member B increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RHOB mRNA CTD PMID:14600272 PMID:22484513 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Rpl10 ribosomal protein L10 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL10 mRNA CTD PMID:15890375 NCBI chr  X:157,205,850...157,208,057
Ensembl chr  X:157,205,836...157,208,049 		JBrowse link
G Rpl10a ribosomal protein L10A increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL10A mRNA CTD PMID:15890375 NCBI chr20:6,390,533...6,393,091
Ensembl chr20:6,390,179...6,393,091 		JBrowse link
G Rpl13 ribosomal protein L13 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL13 mRNA CTD PMID:15890375 NCBI chr19:68,062,442...68,065,065
Ensembl chr19:68,062,493...68,065,059 		JBrowse link
G Rpl15 ribosomal protein L15 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL15 mRNA CTD PMID:15890375 NCBI chr15:9,934,663...9,937,946
Ensembl chr15:9,934,679...9,938,308 		JBrowse link
G Rpl17 ribosomal protein L17 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL17 mRNA CTD PMID:15890375 NCBI chr18:70,856,275...70,859,388
Ensembl chr 3:111,722,010...111,722,638
Ensembl chr18:111,722,010...111,722,638 		JBrowse link
G Rpl23 ribosomal protein L23 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL23 mRNA CTD PMID:15890375 NCBI chr10:83,268,223...83,272,184
Ensembl chr10:83,262,592...83,272,214 		JBrowse link
G Rpl6 ribosomal protein L6 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL6 mRNA CTD PMID:15890375 NCBI chr12:41,008,142...41,012,756
Ensembl chr12:41,008,142...41,025,733 		JBrowse link
G Rpl7a ribosomal protein L7A increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL7A mRNA CTD PMID:15890375 NCBI chr 3:30,637,136...30,639,778
Ensembl chr 3:30,637,059...30,639,791
Ensembl chr18:30,637,059...30,639,791 		JBrowse link
G Rpl8 ribosomal protein L8 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL8 mRNA CTD PMID:15890375 NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103
Ensembl chr 3:110,506,800...110,509,103 		JBrowse link
G Rps15a ribosomal protein S15a increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS15A mRNA CTD PMID:15890375 NCBI chr 1:181,854,396...181,861,330
Ensembl chr 1:181,854,396...181,861,201 		JBrowse link
G Rps19 ribosomal protein S19 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS19 mRNA CTD PMID:14600272 PMID:15890375 NCBI chr 1:89,608,408...89,614,390
Ensembl chr 7:104,324,520...104,325,132
Ensembl chr 1:104,324,520...104,325,132 		JBrowse link
G Rps24 ribosomal protein S24 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS24 mRNA CTD PMID:15890375 NCBI chr16:95,429...101,146
Ensembl chr16:96,484...101,144 		JBrowse link
G Rps27l ribosomal protein S27-like increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS27L mRNA CTD PMID:15890375 NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130
Ensembl chr 8:33,713,661...33,714,130 		JBrowse link
G Rps3 ribosomal protein S3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS3 mRNA CTD PMID:15890375 NCBI chr 1:163,190,476...163,195,885
Ensembl chr 1:163,189,842...163,195,776 		JBrowse link
G Rps4x ribosomal protein S4, X-linked increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS4X mRNA CTD PMID:15890375 NCBI chr  X:71,338,478...71,342,921
Ensembl chr  X:71,338,479...71,342,921
Ensembl chr 4:71,338,479...71,342,921 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions
increases phosphorylation 		ISO [Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased phosphorylation of RPS6KB1 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of RPS6KB1 protein 		CTD PMID:30259641 NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238 		JBrowse link
G Rps7 ribosomal protein S7 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPS7 mRNA CTD PMID:15890375 NCBI chr 6:50,994,581...50,999,447 JBrowse link
G Rpsa ribosomal protein SA increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPSA mRNA CTD PMID:15890375 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G RT1-Bb RT1 class II, locus Bb increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RT1-BB mRNA CTD PMID:14600272 NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118 		JBrowse link
G S100a4 S100 calcium-binding protein A4 decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of S100A4 mRNA
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of S100A4 mRNA 		CTD PMID:21167638 NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837 		JBrowse link
G Sds serine dehydratase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SDS mRNA CTD PMID:14600272 NCBI chr12:41,743,796...41,751,108
Ensembl chr12:41,743,799...41,748,773 		JBrowse link
G Selenoo selenoprotein O increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SELENOO mRNA CTD PMID:19038236 NCBI chr 7:122,047,555...122,058,448
Ensembl chr 7:122,047,555...122,058,447 		JBrowse link
G Selenow selenoprotein W increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SELENOW mRNA CTD PMID:15890375 NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703 		JBrowse link
G Serpina7 serpin family A member 7 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SERPINA7 mRNA CTD PMID:14600272 NCBI chr  X:107,452,044...107,510,958
Ensembl chr  X:107,452,044...107,457,681 		JBrowse link
G Slc19a2 solute carrier family 19 member 2 decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 protein
[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 protein] which results in decreased uptake of Thiamine 		CTD PMID:24244374 NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315 		JBrowse link
G Slc19a3 solute carrier family 19 member 3 multiple interactions
decreases expression 		ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A3 protein] which results in decreased uptake of Thiamine
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A3 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A3 protein 		CTD PMID:24244374 NCBI chr 9:91,723,799...91,747,499
Ensembl chr 9:91,724,718...91,754,991 		JBrowse link
G Slc9a9 solute carrier family 9 member A9 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC9A9 mRNA CTD PMID:19038236 NCBI chr 8:104,112,279...104,675,944
Ensembl chr 8:104,112,559...104,676,891 		JBrowse link
G Smg1 SMG1, nonsense mediated mRNA decay associated PI3K related kinase increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SMG1 mRNA CTD PMID:19038236 NCBI chr 1:181,876,134...181,977,894
Ensembl chr 1:181,876,134...181,977,894 		JBrowse link
G Smoc1 SPARC related modular calcium binding 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SMOC1 mRNA CTD PMID:19038236 NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:106,432,603...106,593,956 		JBrowse link
G Snai2 snail family transcriptional repressor 2 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SNAI2 protein CTD PMID:30236600 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349 		JBrowse link
G Soat2 sterol O-acyltransferase 2 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SOAT2 mRNA CTD PMID:19038236 NCBI chr 7:135,160,424...135,173,521
Ensembl chr 7:135,160,402...135,173,513 		JBrowse link
G Sprr1b small proline-rich protein 1B multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of SPRR1B mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of SPRR1B mRNA] CTD PMID:21882252 NCBI chr 2:180,704,457...180,706,355
Ensembl chr 2:180,704,457...180,706,355 		JBrowse link
G Sptan1 spectrin, alpha, non-erythrocytic 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SPTAN1 mRNA CTD PMID:14600272 NCBI chr 3:33,639,020...33,703,890
Ensembl chr 3:33,607,210...33,703,889 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 increases activity
multiple interactions
increases expression 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of STAT1 protein
Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of STAT1 protein]; Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of STAT1 mRNA]; Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of STAT1 protein] 		CTD PMID:16582591 PMID:16835749 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stmn1 stathmin 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of STMN1 mRNA CTD PMID:15890375 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Tap1 transporter 1, ATP binding cassette subfamily B member increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TAP1 mRNA CTD PMID:14600272 NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810 		JBrowse link
G Tars1 threonyl-tRNA synthetase 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TARS1 mRNA CTD PMID:19038236 NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802 		JBrowse link
G Tat tyrosine aminotransferase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TAT mRNA CTD PMID:15890375 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tbrg4 transforming growth factor beta regulator 4 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TBRG4 mRNA CTD PMID:19038236 NCBI chr14:85,696,738...85,704,691
Ensembl chr14:85,695,893...85,704,659 		JBrowse link
G Timm10b translocase of inner mitochondrial membrane 10B increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TIMM10B mRNA CTD PMID:15890375 NCBI chr 1:169,392,355...169,395,201
Ensembl chr 1:169,392,177...169,395,205 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TIMP1 mRNA CTD PMID:14600272 PMID:15890375 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tmsb10 thymosin, beta 10 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TMSB10 mRNA CTD PMID:14600272 NCBI chr 4:106,568,080...106,569,210 JBrowse link
G Tnfaip3 TNF alpha induced protein 3 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TNFAIP3 mRNA CTD PMID:21873647 NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979 		JBrowse link
G Tnfrsf8 TNF receptor superfamily member 8 multiple interactions ISO [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in decreased expression of TNFRSF8 mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in decreased expression of TNFRSF8 mRNA] CTD PMID:21882252 NCBI chr 5:162,406,387...162,451,620
Ensembl chr 5:162,406,387...162,451,620 		JBrowse link
G Top2a DNA topoisomerase II alpha decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TOP2A mRNA CTD PMID:15890375 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
increases ADP-ribosylation
increases phosphorylation
decreases expression
affects localization 		ISO 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TP53 protein]; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone inhibits the reaction [sodium arsenite affects the localization of TP53 protein]; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone inhibits the reaction [sodium arsenite results in increased activity of TP53 protein]
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53 protein
[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of TRP53 mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased ADP-ribosylation of TP53 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of TP53 protein
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of TP53 protein 		CTD PMID:18805435 PMID:19931552 PMID:20421341 PMID:21167638 PMID:21776270 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp53bp1 tumor protein p53 binding protein 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53BP1 protein CTD PMID:26231820 NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747 		JBrowse link
G Tpd52 tumor protein D52 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TPD52 mRNA CTD PMID:21873647 NCBI chr 2:94,642,514...94,723,442
Ensembl chr 2:94,642,585...94,724,241 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 decreases expression EXP
ISO 		4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TSC22D1 mRNA
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TSC22 mRNA 		CTD PMID:15890375 PMID:19038236 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tuba1c tubulin, alpha 1C increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TUBA1C mRNA CTD PMID:15890375 NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311 		JBrowse link
G Tubb5 tubulin, beta 5 class I increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TUBB5 mRNA CTD PMID:15890375 NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TWIST1 mRNA CTD PMID:21167638 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Tyms thymidylate synthetase increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TYMS mRNA CTD PMID:14600272 PMID:15890375 PMID:23052194 NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:120,763,386...120,776,097 		JBrowse link
G Uba52 ubiquitin A-52 residue ribosomal protein fusion product 1 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of UBA52 mRNA CTD PMID:19038236 NCBI chr16:18,952,583...18,954,780 JBrowse link
G Ube2r2 ubiquitin-conjugating enzyme E2R 2 increases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of UBE2R2 mRNA CTD PMID:19038236 NCBI chr 5:61,082,552...61,141,099
Ensembl chr 5:61,082,552...61,141,452 		JBrowse link
G Ugt1a5 UDP glucuronosyltransferase family 1 member A5 increases glucuronidation ISO UGT1A4 gene polymorphism results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; UGT1A4 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:14871856 PMID:31307193 NCBI chr 9:96,210,053...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a7c UDP glucuronosyltransferase 1 family, polypeptide A7C increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of UGT1A7 mRNA CTD PMID:14600272 NCBI chr 9:96,187,382...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 increases glucuronidation ISO UGT1A9 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt2b1 UDP glucuronosyltransferase 2 family, polypeptide B1 increases glucuronidation ISO UGT2B17 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 decreases glucuronidation
increases glucuronidation 		ISO UGT2B7 gene polymorphism results in decreased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
UGT2B7 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 		CTD PMID:14871856 PMID:31307193 NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of VEGFA mRNA CTD PMID:15890375 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vim vimentin increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of VIM mRNA CTD PMID:14600272 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Xdh xanthine dehydrogenase decreases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XDH mRNA CTD PMID:15890375 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350 		JBrowse link
G Xiap X-linked inhibitor of apoptosis increases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of XIAP protein
[Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of XIAP protein 		CTD PMID:30259641 NCBI chr  X:125,756,107...125,803,979
Ensembl chr  X:125,737,971...125,803,978 		JBrowse link
G Xpo1 exportin 1 decreases expression ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XPO1 protein CTD PMID:20421341 NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714 		JBrowse link
G Xrcc1 X-ray repair cross complementing 1 decreases expression
multiple interactions 		ISO 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XRCC1 mRNA; 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XRCC1 protein
NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XRCC1 protein] 		CTD PMID:35435490 NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613 		JBrowse link
G Zmat3 zinc finger, matrin type 3 increases expression EXP 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ZMAT3 mRNA CTD PMID:14600272 PMID:15890375 NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294 		JBrowse link
6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atr ATR serine/threonine kinase multiple interactions
decreases activity 		ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Cisplatin; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Hydroxyurea; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Temozolomide CTD PMID:21730979 PMID:25748550 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Casp7 caspase 7 multiple interactions ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP7 protein] CTD PMID:26208482 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 multiple interactions ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP8 protein] CTD PMID:26208482 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 multiple interactions ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein] CTD PMID:26208482 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased phosphorylation of CHEK1 protein] CTD PMID:26208482 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased phosphorylation of CHEK2 protein] CTD PMID:26208482 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine co-treated with 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea] results in increased cleavage of PARP1 protein CTD PMID:26208482 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased expression of and results in increased stability of TNF mRNA]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased expression of TNF protein]
4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein] 		CTD PMID:24817034 PMID:25748550 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
carmustine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
multiple interactions 		ISO Carmustine results in increased expression of ABCB1 protein
[MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Carmustine 		CTD PMID:11792417 PMID:15239124 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 affects response to substance ISO ABCC2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 affects response to substance ISO ABCG5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376 		JBrowse link
G Acer2 alkaline ceramidase 2 increases expression EXP Carmustine results in increased expression of ACER2 mRNA CTD PMID:16005536 NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583 		JBrowse link
G Acp3 acid phosphatase 3 decreases expression EXP Carmustine results in decreased expression of ACP3 mRNA CTD PMID:16005536 NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033 		JBrowse link
G Actc1 actin, alpha, cardiac muscle 1 decreases expression ISO Carmustine results in decreased expression of ACTC1 mRNA CTD PMID:15980968 NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827 		JBrowse link
G Actg2 actin gamma 2, smooth muscle decreases expression ISO Carmustine results in decreased expression of ACTG2 mRNA CTD PMID:15980968 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn1 actinin, alpha 1 decreases expression ISO Carmustine results in decreased expression of ACTN1 mRNA CTD PMID:15980968 NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172 		JBrowse link
G Adam15 ADAM metallopeptidase domain 15 decreases expression ISO Carmustine results in decreased expression of ADAM15 mRNA CTD PMID:15980968 NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:177,052,363...177,062,849 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 decreases expression ISO Carmustine results in decreased expression of ADAMTS4 mRNA CTD PMID:15980968 NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514 		JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 decreases expression ISO Carmustine results in decreased expression of ADCYAP1 mRNA CTD PMID:15980968 NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:120,550,328...120,556,383 		JBrowse link
G Adra1b adrenoceptor alpha 1B decreases expression ISO Carmustine results in decreased expression of ADRA1B mRNA CTD PMID:15980968 NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347 		JBrowse link
G Agr3 anterior gradient 3, protein disulphide isomerase family member affects response to substance ISO AGR3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:58,370,701...58,393,944
Ensembl chr 6:58,370,701...58,399,859 		JBrowse link
G Agt angiotensinogen decreases response to substance ISO AGT protein mutant form results in decreased susceptibility to Carmustine; AGT protein results in decreased susceptibility to Carmustine CTD PMID:11034089 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 affects response to substance ISO AKR1B1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 affects response to substance ISO AKR1C1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases phosphorylation
multiple interactions
affects response to substance 		EXP
ISO 		Carmustine results in decreased phosphorylation of AKT1 protein
LCN2 protein promotes the reaction [Carmustine results in decreased phosphorylation of AKT1 protein]
AKT1 protein affects the susceptibility to Carmustine 		CTD PMID:18430789 PMID:19860839 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 decreases expression ISO Carmustine results in decreased expression of AKT2 mRNA CTD PMID:15980968 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Alad aminolevulinate dehydratase decreases expression
multiple interactions 		ISO Carmustine results in decreased expression of ALAD mRNA
[Cyclophosphamide co-treated with Carmustine co-treated with Etoposide] results in decreased activity of ALAD protein 		CTD PMID:15980968 PMID:19162187 NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041 		JBrowse link
G Alas2 5'-aminolevulinate synthase 2 decreases expression EXP Carmustine results in decreased expression of ALAS2 mRNA CTD PMID:16005536 NCBI chr  X:22,890,650...22,914,046
Ensembl chr  X:22,890,689...22,914,043 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 affects response to substance ISO ALDH1A3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 increases expression EXP Carmustine results in increased expression of ALDH1A7 mRNA CTD PMID:16005536 NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:227,627,448...227,672,523 		JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type affects response to substance
decreases expression 		ISO
EXP 		ALOX12 protein affects the susceptibility to Carmustine
Carmustine results in decreased expression of ALOX12 mRNA 		CTD PMID:16005536 PMID:19373248 NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199 		JBrowse link
G Alox15b arachidonate 15-lipoxygenase, type B decreases expression ISO Carmustine results in decreased expression of ALOX15B mRNA CTD PMID:15980968 NCBI chr10:54,391,331...54,400,648
Ensembl chr10:54,391,302...54,400,648 		JBrowse link
G Amh anti-Mullerian hormone decreases expression ISO Carmustine results in decreased expression of AMH mRNA CTD PMID:15980968 NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867 		JBrowse link
G Ank2 ankyrin 2 affects response to substance ISO ANK2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 affects response to substance ISO ANKRD1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751 		JBrowse link
G Ap1s2 adaptor related protein complex 1 subunit sigma 2 affects response to substance ISO AP1S2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr  X:34,204,601...34,230,819
Ensembl chr  X:34,204,603...34,228,529 		JBrowse link
G Apc APC regulator of WNT signaling pathway affects response to substance ISO APC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apc2 APC regulator of WNT signaling pathway 2 decreases expression ISO Carmustine results in decreased expression of APC2 mRNA CTD PMID:15980968 NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:10,043,010...10,065,210 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases response to substance
decreases response to substance 		ISO APEX1 protein mutant form results in increased susceptibility to Carmustine
APEX1 protein results in decreased susceptibility to Carmustine 		CTD PMID:12231548 PMID:16243814 PMID:17259346 PMID:19470598 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Aplnr apelin receptor decreases expression ISO Carmustine results in decreased expression of APLNR mRNA CTD PMID:15980968 NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908 		JBrowse link
G Aqp8 aquaporin 8 decreases expression ISO Carmustine results in decreased expression of AQP8 mRNA CTD PMID:15980968 NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242 		JBrowse link
G Arf1 ARF GTPase 1 affects response to substance ISO ARF1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:44,497,543...44,513,994 JBrowse link
G Arpc2 actin related protein 2/3 complex, subunit 2 decreases expression ISO Carmustine results in decreased expression of ARPC2 mRNA CTD PMID:15980968 NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:83,269,932...83,305,409 		JBrowse link
G Arrdc2 arrestin domain containing 2 affects response to substance ISO ARRDC2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158 		JBrowse link
G Artn artemin decreases expression ISO Carmustine results in decreased expression of ARTN mRNA CTD PMID:15980968 NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457 		JBrowse link
G Asmtl acetylserotonin O-methyltransferase-like decreases expression ISO Carmustine results in decreased expression of ASMTL mRNA CTD PMID:15980968 NCBI chr12:21,429,119...21,431,847
Ensembl chr12:21,429,171...21,431,847 		JBrowse link
G Atp1a3 ATPase Na+/K+ transporting subunit alpha 3 decreases expression ISO Carmustine results in decreased expression of ATP1A3 mRNA CTD PMID:15980968 NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825 		JBrowse link
G Atp4b ATPase H+/K+ transporting subunit beta decreases expression ISO Carmustine results in decreased expression of ATP4B mRNA CTD PMID:15980968 NCBI chr16:82,846,329...82,855,242
Ensembl chr16:82,846,329...82,855,242 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta decreases expression ISO Carmustine results in decreased expression of ATP5F1D mRNA CTD PMID:15980968 NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583 		JBrowse link
G Atp6v0c ATPase H+ transporting V0 subunit C decreases expression ISO Carmustine results in decreased expression of ATP6V0C mRNA CTD PMID:15980968 NCBI chr10:13,700,764...13,707,147
Ensembl chr10:13,700,764...13,706,245 		JBrowse link
G Atr ATR serine/threonine kinase multiple interactions ISO ATR protein affects the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein] CTD PMID:19261750 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Atxn2l ataxin 2-like decreases expression ISO Carmustine results in decreased expression of ATXN2L mRNA CTD PMID:15980968 NCBI chr 1:190,508,878...190,526,263
Ensembl chr 1:190,508,878...190,520,579 		JBrowse link
G Avpr1a arginine vasopressin receptor 1A increases expression ISO Carmustine results in increased expression of AVPR1A mRNA CTD PMID:15980968 NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837 		JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 decreases expression ISO Carmustine results in decreased expression of B4GALT5 mRNA CTD PMID:15980968 NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:176,437,073...176,488,978 		JBrowse link
G Baiap2 BAR/IMD domain containing adaptor protein 2 decreases expression ISO Carmustine results in decreased expression of BAIAP2 mRNA CTD PMID:15980968 NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549 		JBrowse link
G Baiap3 BAI1-associated protein 3 decreases expression ISO Carmustine results in decreased expression of BAIAP3 mRNA CTD PMID:15980968 NCBI chr10:14,764,768...14,777,516
Ensembl chr10:14,756,693...14,777,516 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Carmustine results in increased expression of BAX protein CTD PMID:20920327 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl10 BCL10, immune signaling adaptor increases expression ISO Carmustine results in increased expression of BCL10 mRNA CTD PMID:15980968 NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
affects response to substance
decreases expression 		ISO [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein
BCL2 protein affects the susceptibility to Carmustine
Carmustine results in decreased expression of BCL2 protein 		CTD PMID:15332326 PMID:16187019 PMID:18430789 PMID:20920327 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 affects response to substance
decreases expression
multiple interactions 		ISO
EXP 		BCL2L1 protein affects the susceptibility to Carmustine
Carmustine results in decreased expression of BCL2L1 protein
[Fenretinide co-treated with Carmustine] results in decreased expression of BCL2L1 protein
Carmustine results in decreased expression of BCL2L1 mRNA; Carmustine results in decreased expression of BCL2L1 protein 		CTD PMID:15332326 PMID:16187019 PMID:19860839 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Becn1 beclin 1 decreases expression ISO Carmustine results in decreased expression of BECN1 mRNA CTD PMID:15980968 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bicd1 BICD cargo adaptor 1 decreases expression ISO Carmustine results in decreased expression of BICD1 mRNA CTD PMID:15980968 NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:184,210,363...184,357,391 		JBrowse link
G Blk BLK proto-oncogene, Src family tyrosine kinase decreases expression ISO Carmustine results in decreased expression of BLK mRNA CTD PMID:15980968 NCBI chr15:41,802,701...41,841,004
Ensembl chr15:41,802,994...41,840,982 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression EXP Carmustine results in decreased expression of BMAL1 mRNA CTD PMID:16005536 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmp5 bone morphogenetic protein 5 affects response to substance ISO BMP5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bmp7 bone morphogenetic protein 7 decreases expression ISO Carmustine results in decreased expression of BMP7 mRNA CTD PMID:15980968 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Brf1 BRF1 general transcription factor IIIB subunit decreases expression ISO Carmustine results in decreased expression of BRF1 mRNA CTD PMID:15980968 NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386 		JBrowse link
G Ca6 carbonic anhydrase 6 decreases expression ISO Carmustine results in decreased expression of CA6 mRNA CTD PMID:15980968 NCBI chr 5:165,941,028...165,959,566
Ensembl chr 5:165,941,029...165,959,566 		JBrowse link
G Cadm1 cell adhesion molecule 1 affects response to substance ISO CADM1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192 		JBrowse link
G Calb2 calbindin 2 decreases expression ISO Carmustine results in decreased expression of CALB2 mRNA CTD PMID:15980968 NCBI chr19:55,023,849...55,050,858
Ensembl chr19:55,023,838...55,057,952 		JBrowse link
G Casp3 caspase 3 increases activity
multiple interactions
increases cleavage
increases expression 		EXP
ISO 		Carmustine results in increased activity of CASP3 protein
[Carmustine co-treated with 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid] results in increased activity of CASP3 protein; Disulfiram promotes the reaction [Carmustine results in increased cleavage of CASP3 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Carmustine results in increased activity of and results in increased cleavage of CASP3 protein]; [LCN2 protein co-treated with Carmustine] results in increased cleavage of and results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [Carmustine results in increased activity of and results in increased cleavage of CASP3 protein]; Carmustine results in increased activity of and results in increased cleavage of CASP3 protein; pyrazolanthrone inhibits the reaction [Carmustine results in increased activity of and results in increased cleavage of CASP3 protein]; Zinc Sulfate inhibits the reaction [Carmustine results in increased activity of CASP3 protein]
Carmustine results in increased expression of CASP3 protein 		CTD PMID:18590702 PMID:19860839 PMID:20046642 PMID:20920327 PMID:21600974 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Cat catalase decreases activity
multiple interactions 		EXP Carmustine results in decreased activity of CAT protein
Acetylcysteine inhibits the reaction [Carmustine results in decreased activity of CAT protein] 		CTD PMID:20332008 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 affects activity
affects response to substance
increases expression
decreases expression 		ISO Carmustine affects the activity of CCL2 protein
CCL2 mRNA affects the susceptibility to Carmustine
Carmustine results in increased expression of CCL2 mRNA
Carmustine results in decreased expression of CCL2 protein 		CTD PMID:15980968 PMID:16365179 PMID:17522861 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccn4 cellular communication network factor 4 affects response to substance ISO CCN4 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Ccnd1 cyclin D1 affects response to substance ISO CCND1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccne1 cyclin E1 increases expression EXP Carmustine results in increased expression of CCNE1 mRNA CTD PMID:16005536 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) decreases expression ISO Carmustine results in decreased expression of CD151 mRNA CTD PMID:15980968 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd44 CD44 molecule affects response to substance ISO CD44 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd68 Cd68 molecule decreases expression ISO Carmustine results in decreased expression of CD68 mRNA CTD PMID:15980968 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cd79a CD79a molecule decreases expression ISO Carmustine results in decreased expression of CD79A mRNA CTD PMID:15980968 NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812 		JBrowse link
G Cd80 Cd80 molecule increases expression ISO Carmustine results in increased expression of CD80 mRNA CTD PMID:15980968 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cdc25b cell division cycle 25B decreases expression EXP Carmustine results in decreased expression of CDC25B mRNA CTD PMID:16005536 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492 		JBrowse link
G Cdh13 cadherin 13 affects response to substance ISO CDH13 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdk8 cyclin-dependent kinase 8 decreases expression ISO Carmustine results in decreased expression of CDK8 mRNA CTD PMID:15980968 NCBI chr12:13,851,024...13,919,017
Ensembl chr12:13,851,024...13,917,992 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression 		ISO [Carmustine co-treated with O(6)-benzylguanine] results in increased expression of CDKN1A protein; MDM4 protein promotes the reaction [Carmustine results in increased expression of CDKN1A protein] CTD PMID:15735757 PMID:16193384 PMID:18632648 PMID:20472715 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C affects response to substance ISO CDKN1C mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases response to substance ISO CDKN2A protein results in increased susceptibility to Carmustine CTD PMID:16786135 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression EXP Carmustine results in decreased expression of CDKN3 mRNA CTD PMID:16005536 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdx4 caudal type homeo box 4 decreases expression ISO Carmustine results in decreased expression of CDX4 mRNA CTD PMID:15980968 NCBI chr  X:72,392,653...72,401,239
Ensembl chr  X:72,392,653...72,401,239 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta decreases expression ISO Carmustine results in decreased expression of CEBPB mRNA CTD PMID:15980968 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression EXP Carmustine results in increased expression of CGREF1 mRNA CTD PMID:16005536 NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 affects response to substance ISO CHD2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO ATR protein affects the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein]; Caffeine inhibits the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein]; Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein; O(6)-benzylguanine promotes the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein]; wortmannin inhibits the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein] CTD PMID:19261750 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 decreases expression ISO Carmustine results in decreased expression of CHRM4 mRNA CTD PMID:15980968 NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771 		JBrowse link
G Chrnb3 cholinergic receptor nicotinic beta 3 subunit decreases expression ISO Carmustine results in decreased expression of CHRNB3 mRNA CTD PMID:15980968 NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225 		JBrowse link
G Chrng cholinergic receptor nicotinic gamma subunit decreases expression ISO Carmustine results in decreased expression of CHRNG mRNA CTD PMID:15980968 NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092 		JBrowse link
G Ckm creatine kinase, M-type decreases expression ISO Carmustine results in decreased expression of CKM mRNA CTD PMID:15980968 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719 		JBrowse link
G Clic1 chloride intracellular channel 1 multiple interactions
decreases response to substance 		ISO [4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of CLIC1 protein] which results in increased susceptibility to Carmustine
CLIC1 protein results in decreased susceptibility to Carmustine 		CTD PMID:18590702 NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367 		JBrowse link
G Cntnap1 contactin associated protein 1 increases expression ISO Carmustine results in increased expression of CNTNAP1 mRNA CTD PMID:15980968 NCBI chr10:86,610,140...86,625,896
Ensembl chr10:86,611,890...86,631,730 		JBrowse link
G Col1a1 collagen type I alpha 1 chain affects response to substance ISO COL1A1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression EXP Carmustine results in decreased expression of COL5A3 mRNA CTD PMID:16005536 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Col9a1 collagen type IX alpha 1 chain decreases expression ISO Carmustine results in decreased expression of COL9A1 mRNA CTD PMID:15980968 NCBI chr 9:34,081,364...34,164,552
Ensembl chr 9:34,003,905...34,164,543 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 decreases expression ISO Carmustine results in decreased expression of COX6A2 mRNA CTD PMID:15980968 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 decreases expression ISO Carmustine results in decreased expression of CRABP1 mRNA CTD PMID:15980968 NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470 		JBrowse link
G Crat carnitine O-acetyltransferase decreases expression ISO Carmustine results in decreased expression of CRAT mRNA CTD PMID:15980968 NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099 		JBrowse link
G Crybb1 crystallin, beta B1 decreases expression ISO Carmustine results in decreased expression of CRYBB1 mRNA CTD PMID:15980968 NCBI chr12:50,030,146...50,043,756
Ensembl chr12:50,030,146...50,043,756 		JBrowse link
G Csf2 colony stimulating factor 2 affects response to substance ISO CSF2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 affects response to substance ISO CSGALNACT1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:25,761,946...26,097,306
Ensembl chr16:26,002,530...26,096,065 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 affects response to substance ISO CSRP3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Cst5 cystatin D decreases expression ISO Carmustine results in decreased expression of CST5 mRNA CTD PMID:15980968 NCBI chr 3:158,033,791...158,038,345
Ensembl chr 3:158,033,791...158,038,345 		JBrowse link
G Ctf1 cardiotrophin 1 decreases expression ISO Carmustine results in decreased expression of CTF1 mRNA CTD PMID:15980968 NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:191,757,477...191,776,395 		JBrowse link
G Ctnnal1 catenin alpha-like 1 increases expression ISO Carmustine results in increased expression of CTNNAL1 mRNA CTD PMID:15980968 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637 		JBrowse link
G Ctsl cathepsin L increases expression EXP Carmustine results in increased expression of CTSL mRNA CTD PMID:16005536 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Cux2 cut-like homeobox 2 affects expression EXP Carmustine affects the expression of CUX2 mRNA CTD PMID:19174181 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 affects response to substance ISO CXCL1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 affects response to substance ISO CXCL2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 affects response to substance ISO CXCL1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases expression ISO Carmustine results in decreased expression of CYP19A1 mRNA CTD PMID:15980968 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO CYP3A4 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] CTD PMID:16087946 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO CYP3A5 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] CTD PMID:16087946 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyth1 cytohesin 1 increases expression ISO Carmustine results in increased expression of CYTH1 mRNA CTD PMID:15980968 NCBI chr10:103,901,376...103,984,496
Ensembl chr10:103,864,804...103,984,383 		JBrowse link
G Def6 DEF6 guanine nucleotide exchange factor affects response to substance ISO DEF6 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr20:6,270,323...6,291,724
Ensembl chr20:6,269,357...6,291,771 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 affects response to substance ISO DHRS3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Dhx16 DEAH-box helicase 16 decreases expression ISO Carmustine results in decreased expression of DHX16 mRNA CTD PMID:15980968 NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,866,804...2,879,751 		JBrowse link
G Dhx37 DEAH-box helicase 37 affects response to substance ISO DHX37 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr12:36,856,119...36,876,245
Ensembl chr12:36,849,701...36,876,240 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 increases response to substance ISO DKK1 protein results in increased susceptibility to Carmustine CTD PMID:20920327 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dmrtc2 DMRT-like family C2 affects response to substance ISO DMRTC2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:89,594,120...89,601,761
Ensembl chr 1:89,594,215...89,601,762 		JBrowse link
G Dnase1l2 deoxyribonuclease 1 like 2 decreases expression ISO Carmustine results in decreased expression of DNASE1L2 mRNA CTD PMID:15980968 NCBI chr10:13,976,012...13,978,574
Ensembl chr10:13,976,012...13,978,366 		JBrowse link
G Dvl1 dishevelled segment polarity protein 1 decreases expression ISO Carmustine results in decreased expression of DVL1 mRNA CTD PMID:15980968 NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966 		JBrowse link
G Dyrk1b dual specificity tyrosine phosphorylation regulated kinase 1B affects response to substance ISO DYRK1B mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:92,606,743...92,624,089
Ensembl chr 1:92,607,303...92,614,744 		JBrowse link
G E2f1 E2F transcription factor 1 increases expression ISO Carmustine results in increased expression of E2F1 protein CTD PMID:18632648 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563 		JBrowse link
G Ecm2 extracellular matrix protein 2 increases expression ISO Carmustine results in increased expression of ECM2 mRNA CTD PMID:15980968 NCBI chr17:15,326,359...15,358,938
Ensembl chr17:15,326,359...15,358,855 		JBrowse link
G Ednra endothelin receptor type A affects response to substance ISO EDNRA mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma increases expression ISO Carmustine results in increased expression of EEF1G mRNA CTD PMID:15980968 NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479 		JBrowse link
G Eif2b1 eukaryotic translation initiation factor 2B subunit alpha increases expression ISO Carmustine results in increased expression of EIF2B1 mRNA CTD PMID:15980968 NCBI chr12:37,686,149...37,694,830
Ensembl chr12:37,686,559...37,708,078 		JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 affects response to substance ISO EIF4A2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323 		JBrowse link
G Eif6 eukaryotic translation initiation factor 6 decreases expression ISO Carmustine results in decreased expression of EIF6 mRNA CTD PMID:15980968 NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525 		JBrowse link
G Elmo1 engulfment and cell motility 1 affects response to substance ISO ELMO1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:48,982,188...49,518,525
Ensembl chr17:48,982,188...49,518,159 		JBrowse link
G Enc1 ectodermal-neural cortex 1 increases expression EXP Carmustine results in increased expression of ENC1 mRNA CTD PMID:16005536 NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Ephx1 epoxide hydrolase 1 decreases expression ISO Carmustine results in decreased expression of EPHX1 mRNA CTD PMID:15980968 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Espn espin increases expression EXP Carmustine results in increased expression of ESPN mRNA CTD PMID:16005536 NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984 		JBrowse link
G Esrra estrogen related receptor, alpha increases expression ISO Carmustine results in increased expression of ESRRA mRNA CTD PMID:15980968 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Etv1 ETS variant transcription factor 1 affects response to substance
affects expression 		ISO
EXP 		ETV1 mRNA affects the susceptibility to Carmustine
Carmustine affects the expression of ETV1 mRNA 		CTD PMID:16365179 PMID:19174181 NCBI chr 6:61,316,836...61,408,985
Ensembl chr 6:61,317,429...61,408,959 		JBrowse link
G Extl1 exostosin-like glycosyltransferase 1 affects response to substance ISO EXTL1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:151,857,629...151,872,830
Ensembl chr 5:151,857,629...151,872,830 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression ISO Carmustine results in decreased expression of EZH2 mRNA CTD PMID:15980968 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression EXP Carmustine results in increased expression of F3 mRNA CTD PMID:16005536 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Fancc FA complementation group C affects response to substance ISO FANCC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096 		JBrowse link
G Fancd2 FA complementation group D2 increases ubiquitination
affects localization 		ISO Carmustine results in increased ubiquitination of FANCD2 protein
Carmustine affects the localization of FANCD2 protein 		CTD PMID:17221219 NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035 		JBrowse link
G Fbln5 fibulin 5 decreases expression EXP Carmustine results in decreased expression of FBLN5 mRNA CTD PMID:16005536 NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296 		JBrowse link
G Fbn1 fibrillin 1 decreases expression ISO Carmustine results in decreased expression of FBN1 mRNA CTD PMID:15980968 NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283 		JBrowse link
G Fbxo32 F-box protein 32 affects response to substance ISO FBXO32 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fech ferrochelatase multiple interactions ISO [MGMT protein mutant form co-treated with FECH protein] results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] CTD PMID:12950064 NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546 		JBrowse link
G Fgf2 fibroblast growth factor 2 decreases response to substance ISO FGF2 protein results in decreased susceptibility to Carmustine CTD PMID:20221717 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fhl2 four and a half LIM domains 2 affects response to substance ISO FHL2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326 		JBrowse link
G Fkbp1a FKBP prolyl isomerase 1A decreases expression ISO Carmustine results in decreased expression of FKBP1A mRNA CTD PMID:15980968 NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression EXP Carmustine results in increased expression of FKBP5 mRNA CTD PMID:16005536 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Fnta farnesyltransferase, CAAX box, subunit alpha decreases expression
increases expression 		ISO Carmustine results in decreased expression of FNTA mRNA
Carmustine results in increased expression of FNTA mRNA 		CTD PMID:15980968 NCBI chr16:72,767,864...72,786,193
Ensembl chr16:72,767,627...72,788,229 		JBrowse link
G Foxf2 forkhead box F2 affects response to substance ISO FOXF2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259 		JBrowse link
G Foxj1 forkhead box J1 decreases expression ISO Carmustine results in decreased expression of FOXJ1 mRNA CTD PMID:15980968 NCBI chr10:102,065,163...102,069,945
Ensembl chr10:102,065,170...102,069,241 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions
decreases response to substance
decreases expression 		ISO Carmustine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of FTH1 mRNA]
FTH1 results in decreased susceptibility to Carmustine
Carmustine results in decreased expression of FTH1 mRNA 		CTD PMID:15980968 PMID:16631525 PMID:21385903 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Ftl1 ferritin light chain 1 decreases expression ISO Carmustine results in decreased expression of FTL mRNA CTD PMID:15980968 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G Fut8 fucosyltransferase 8 affects response to substance ISO FUT8 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:101,682,354...101,909,784
Ensembl chr 6:101,683,007...101,909,775 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase decreases expression ISO Carmustine results in decreased expression of FYN mRNA CTD PMID:15980968 NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479 		JBrowse link
G Gabra2 gamma-aminobutyric acid type A receptor subunit alpha 2 decreases expression
affects response to substance 		ISO Carmustine results in decreased expression of GABRA2 mRNA
GABRA2 mRNA affects the susceptibility to Carmustine 		CTD PMID:15980968 PMID:16365179 NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457 		JBrowse link
G Gabra6 gamma-aminobutyric acid type A receptor subunit alpha6 decreases expression ISO Carmustine results in decreased expression of GABRA6 mRNA CTD PMID:15980968 NCBI chr10:27,311,965...27,327,337
Ensembl chr10:27,311,979...27,327,234 		JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 affects response to substance ISO GALNT15 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285 		JBrowse link
G Gamt guanidinoacetate N-methyltransferase decreases expression ISO Carmustine results in decreased expression of GAMT mRNA CTD PMID:15980968 NCBI chr 7:10,099,267...10,102,083
Ensembl chr 7:10,098,571...10,102,083 		JBrowse link
G Garnl3 GTPase activating Rap/RanGAP domain-like 3 affects response to substance ISO GARNL3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:36,686,388...36,830,011
Ensembl chr 3:36,686,389...36,830,020 		JBrowse link
G Gast gastrin decreases expression ISO Carmustine results in decreased expression of GAST mRNA CTD PMID:15980968 NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions EXP [Buthionine Sulfoximine co-treated with Carmustine] results in decreased activity of GCLC protein; [Carmustine co-treated with Buthionine Sulfoximine] results in decreased activity of GCLC protein CTD PMID:12967637 PMID:16288907 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gcm1 glial cells missing transcription factor 1 increases expression ISO Carmustine results in increased expression of GCM1 mRNA CTD PMID:15980968 NCBI chr 8:87,805,993...87,819,229
Ensembl chr 8:87,805,993...87,819,229 		JBrowse link
G Gdi1 GDP dissociation inhibitor 1 increases expression ISO Carmustine results in increased expression of GDI1 mRNA CTD PMID:15980968 NCBI chr  X:157,238,900...157,245,562
Ensembl chr  X:157,238,892...157,245,560 		JBrowse link
G Gdi2 GDP dissociation inhibitor 2 increases expression ISO Carmustine results in increased expression of GDI2 mRNA CTD PMID:15980968 NCBI chr17:71,559,460...71,586,147
Ensembl chr17:71,559,461...71,586,147 		JBrowse link
G Gdnf glial cell derived neurotrophic factor decreases response to substance ISO GDNF protein results in decreased susceptibility to Carmustine CTD PMID:19138852 NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240 		JBrowse link
G Gfap glial fibrillary acidic protein decreases expression
multiple interactions 		ISO
EXP 		Carmustine results in decreased expression of GFAP mRNA
Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein] 		CTD PMID:15980968 PMID:17572393 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Ghsr growth hormone secretagogue receptor decreases expression ISO Carmustine results in decreased expression of GHSR mRNA CTD PMID:15980968 NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:112,196,767...112,201,181 		JBrowse link
G Glrb glycine receptor, beta affects response to substance ISO GLRB mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:168,432,736...168,505,614
Ensembl chr 2:168,432,736...168,505,614 		JBrowse link
G Gnrhr gonadotropin releasing hormone receptor increases expression ISO Carmustine results in increased expression of GNRHR mRNA CTD PMID:15980968 NCBI chr14:22,211,666...22,229,654 JBrowse link
G Golga2 golgin A2 decreases expression ISO Carmustine results in decreased expression of GOLGA2 mRNA CTD PMID:15980968 NCBI chr 3:35,981,783...36,002,023
Ensembl chr 3:35,981,499...36,002,022 		JBrowse link
G Golga4 golgin A4 increases expression ISO Carmustine results in increased expression of GOLGA4 mRNA CTD PMID:15980968 NCBI chr 8:127,085,830...127,163,227
Ensembl chr 8:127,085,848...127,163,603 		JBrowse link
G Gp1bb glycoprotein Ib platelet subunit beta decreases expression ISO Carmustine results in decreased expression of GP1BB mRNA CTD PMID:15980968 NCBI chr11:95,882,561...95,883,738 JBrowse link
G Gpr25 G protein-coupled receptor 25 decreases expression ISO Carmustine results in decreased expression of GPR25 mRNA CTD PMID:15980968 NCBI chr13:50,264,516...50,266,422
Ensembl chr13:50,264,518...50,267,692 		JBrowse link
G Gpr32 G protein-coupled receptor 32 decreases expression ISO Carmustine results in decreased expression of GPR32 mRNA CTD PMID:15980968 NCBI chr 1:103,893,405...103,894,667 JBrowse link
G Gpr37 G protein-coupled receptor 37 decreases expression ISO Carmustine results in decreased expression of GPR37 mRNA CTD PMID:15980968 NCBI chr 4:55,104,355...55,126,420
Ensembl chr 4:55,104,365...55,126,494 		JBrowse link
G Gpr65 G-protein coupled receptor 65 increases expression ISO Carmustine results in increased expression of GPR65 mRNA CTD PMID:15980968 NCBI chr 6:123,245,534...123,262,758
Ensembl chr 6:123,219,633...123,266,285 		JBrowse link
G Grb7 growth factor receptor bound protein 7 decreases expression ISO Carmustine results in decreased expression of GRB7 mRNA CTD PMID:15980968 NCBI chr10:83,936,538...83,949,344
Ensembl chr10:83,939,299...83,949,382 		JBrowse link
G Grn granulin precursor decreases expression ISO Carmustine results in decreased expression of GRN mRNA CTD PMID:15980968 NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases activity 		ISO
EXP 		[Carmustine results in decreased activity of GSR protein] which results in increased susceptibility to Doxorubicin; [Carmustine results in decreased activity of GSR protein] which results in increased susceptibility to zinc chloride; Glutathione Disulfide inhibits the reaction [Carmustine results in decreased activity of GSR protein]; NADP affects the reaction [Carmustine results in decreased activity of GSR protein]
[Buthionine Sulfoximine co-treated with Carmustine] results in decreased activity of GSR protein; [Carmustine co-treated with Buthionine Sulfoximine] results in decreased activity of GSR protein; [Carmustine results in decreased activity of GSR protein] which results in increased susceptibility to Streptozocin; [Carmustine results in decreased activity of GSR protein] which results in increased uptake of Calcium; MT2 protein inhibits the reaction [Carmustine results in decreased activity of GSR protein]; Zinc Sulfate inhibits the reaction [Carmustine results in decreased activity of GSR protein]
[[Carmustine results in decreased activity of GSR protein] which co-treated with Oligodeoxyribonucleotides analog] results in increased abundance of Glutathione Disulfide; [[Cyclophosphamide co-treated with Cisplatin co-treated with Carmustine] results in decreased activity of GSR protein] which results in increased abundance of Glutathione Disulfide; [Carmustine results in decreased activity of GSR protein] which results in decreased susceptibility to chromium hexavalent ion; [Cyclophosphamide co-treated with Cisplatin co-treated with Carmustine] results in decreased activity of GSR protein 		CTD PMID:2116959 PMID:12114195 PMID:12433058 PMID:12477282 PMID:12632252 More... NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 affects response to substance
decreases response to substance
multiple interactions 		ISO GSTM1 gene affects the susceptibility to Carmustine
GSTM1 protein results in decreased susceptibility to Carmustine
GSTM1 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] 		CTD PMID:16087946 PMID:20067466 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 decreases nitrosation ISO GSTM2 protein results in decreased nitrosation of Carmustine CTD PMID:11841793 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G Gstm5 glutathione S-transferase, mu 5 multiple interactions
affects metabolic processing
decreases nitrosation 		ISO GSTM3 protein results in decreased nitrosation of and results in decreased activity of Carmustine
GSTM3 protein affects the metabolism of Carmustine
GSTM3 protein results in decreased nitrosation of Carmustine 		CTD PMID:8395980 PMID:11841793 PMID:15247628 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions
decreases response to substance 		ISO GSTP1 gene SNP results in increased susceptibility to [Carmustine co-treated with Doxorubicin co-treated with Cyclophosphamide co-treated with Melphalan]
GSTP1 protein results in decreased susceptibility to Carmustine 		CTD PMID:12791655 PMID:16899598 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 affects response to substance
affects metabolic processing
decreases nitrosation 		ISO GSTT1 protein affects the susceptibility to Carmustine
GSTT1 protein affects the metabolism of Carmustine
GSTT1 protein results in decreased nitrosation of Carmustine 		CTD PMID:11841793 PMID:16874663 PMID:17827337 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Gtf2f1 general transcription factor IIF subunit 1 decreases expression ISO Carmustine results in decreased expression of GTF2F1 mRNA CTD PMID:15980968 NCBI chr 9:1,931,033...1,940,197
Ensembl chr 9:1,930,055...1,940,197 		JBrowse link
G Gucy1b2 guanylate cyclase 1 soluble subunit beta 2 decreases expression EXP Carmustine results in decreased expression of GUCY1B2 mRNA CTD PMID:16005536 NCBI chr15:40,774,907...40,845,463
Ensembl chr15:40,774,906...40,845,463 		JBrowse link
G H2ax H2A.X variant histone decreases expression
increases phosphorylation
multiple interactions
affects localization 		ISO Carmustine results in decreased expression of H2AX mRNA
Carmustine results in increased phosphorylation of H2AX protein
MDM4 protein promotes the reaction [Carmustine affects the localization of H2AX protein]; MDM4 protein promotes the reaction [Carmustine results in increased phosphorylation of H2AX protein] 		CTD PMID:15980968 PMID:20472715 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hacl1 2-hydroxyacyl-CoA lyase 1 decreases expression EXP Carmustine results in decreased expression of HACL1 mRNA CTD PMID:16005536 NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase decreases expression ISO Carmustine results in decreased expression of HADH mRNA CTD PMID:15980968 NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446 		JBrowse link
G Hagh hydroxyacyl glutathione hydrolase decreases expression ISO Carmustine results in decreased expression of HAGH mRNA CTD PMID:15980968 NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043 		JBrowse link
G Hcfc1 host cell factor C1 decreases expression ISO Carmustine results in decreased expression of HCFC1 mRNA CTD PMID:15980968 NCBI chr  X:156,839,100...156,864,132
Ensembl chr  X:156,839,100...156,863,813 		JBrowse link
G Hhat hedgehog acyltransferase affects response to substance ISO HHAT mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr13:106,558,635...106,814,723
Ensembl chr13:106,541,866...106,811,563 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha decreases response to substance
multiple interactions 		EXP HIF1A protein results in decreased susceptibility to Carmustine
[cobaltous chloride results in increased activity of HIF1A protein] which results in decreased susceptibility to Carmustine; [Deferoxamine results in increased activity of HIF1A protein] which results in decreased susceptibility to Carmustine 		CTD PMID:14980978 PMID:15965067 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hmgn2 high mobility group nucleosomal binding domain 2 decreases expression ISO Carmustine results in decreased expression of HMGN2 mRNA CTD PMID:15980968 NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO Carmustine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA] CTD PMID:16631525 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnf1a HNF1 homeobox A decreases expression ISO Carmustine results in decreased expression of HNF1A mRNA CTD PMID:15980968 NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755 		JBrowse link
G Hoxa4 homeo box A4 decreases expression ISO Carmustine results in decreased expression of HOXA4 mRNA CTD PMID:15980968 NCBI chr 4:82,620,294...82,622,302
Ensembl chr 4:82,620,299...82,622,302 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases mutagenesis ISO Carmustine results in increased mutagenesis of HPRT1 gene CTD PMID:17116724 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Icam5 intercellular adhesion molecule 5 decreases expression ISO Carmustine results in decreased expression of ICAM5 mRNA CTD PMID:15980968 NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104 		JBrowse link
G Ids iduronate 2-sulfatase decreases expression ISO Carmustine results in decreased expression of IDS mRNA CTD PMID:15980968 NCBI chr  X:154,070,781...154,093,681
Ensembl chr  X:154,070,781...154,091,444 		JBrowse link
G Ier3 immediate early response 3 decreases expression ISO Carmustine results in decreased expression of IER3 mRNA CTD PMID:15980968 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression
increases expression 		ISO Carmustine results in decreased expression of IGF1 protein
Carmustine results in increased expression of IGF1 protein 		CTD PMID:15286697 PMID:18443378 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf2 insulin-like growth factor 2 affects response to substance ISO IGF2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 decreases expression EXP Carmustine results in decreased expression of IGFBP3 mRNA CTD PMID:16005536 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Ikbkg inhibitor of nuclear factor kappa B kinase regulatory subunit gamma decreases expression ISO Carmustine results in decreased expression of IKBKG mRNA CTD PMID:15980968 NCBI chr  X:157,358,279...157,397,563
Ensembl chr  X:157,367,639...157,392,757 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO Carmustine promotes the reaction [Lipopolysaccharides results in increased expression of IL12B protein] CTD PMID:12688424 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP Carmustine promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] CTD PMID:11970852 PMID:12433058 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1r1 interleukin 1 receptor type 1 affects response to substance ISO IL1R1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579 		JBrowse link
G Il6 interleukin 6 affects response to substance
multiple interactions 		ISO
EXP 		IL6 mRNA affects the susceptibility to Carmustine
Carmustine promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
Carmustine promotes the reaction [Oligodeoxyribonucleotides analog results in increased secretion of IL6 protein] 		CTD PMID:11970852 PMID:12433058 PMID:12477282 PMID:16365179 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Inhba inhibin subunit beta A affects response to substance ISO INHBA mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508 		JBrowse link
G Inppl1 inositol polyphosphate phosphatase-like 1 decreases expression ISO Carmustine results in decreased expression of INPPL1 mRNA CTD PMID:15980968 NCBI chr 1:165,595,047...165,609,503
Ensembl chr 1:165,595,063...165,609,503 		JBrowse link
G Insig1 insulin induced gene 1 decreases expression ISO Carmustine results in decreased expression of INSIG1 mRNA CTD PMID:15980968 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Insl3 insulin-like 3 decreases expression ISO Carmustine results in decreased expression of INSL3 mRNA CTD PMID:15980968 NCBI chr16:18,432,668...18,434,539 JBrowse link
G Ipo4 importin 4 affects response to substance ISO IPO4 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr15:33,087,321...33,097,241
Ensembl chr15:33,087,321...33,097,241 		JBrowse link
G Irag2 inositol 1,4,5-triphosphate receptor associated 2 decreases expression ISO Carmustine results in decreased expression of IRAG2 mRNA CTD PMID:15980968 NCBI chr 4:179,819,526...179,874,408
Ensembl chr 4:179,820,188...179,874,406 		JBrowse link
G Irs1 insulin receptor substrate 1 decreases expression ISO Carmustine results in decreased expression of IRS1 mRNA CTD PMID:15980968 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Islr immunoglobulin superfamily containing leucine-rich repeat decreases expression ISO
EXP 		Carmustine results in decreased expression of ISLR mRNA CTD PMID:15980968 PMID:16005536 NCBI chr 8:67,467,013...67,469,989
Ensembl chr 8:67,444,536...67,487,493 		JBrowse link
G Itga3 integrin subunit alpha 3 decreases expression ISO Carmustine results in decreased expression of ITGA3 mRNA CTD PMID:15980968 NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901 		JBrowse link
G Itgb1 integrin subunit beta 1 decreases expression ISO Carmustine results in decreased expression of ITGB1 protein CTD PMID:18443378 NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269 		JBrowse link
G Itgb3 integrin subunit beta 3 increases response to substance
multiple interactions 		ISO
EXP 		ITGB3 protein results in increased susceptibility to Carmustine
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ITGB3 protein results in increased susceptibility to Carmustine] 		CTD PMID:21332719 NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800 		JBrowse link
G Itih1 inter-alpha trypsin inhibitor, heavy chain 1 decreases expression ISO Carmustine results in decreased expression of ITIH1 mRNA CTD PMID:15980968 NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853 		JBrowse link
G Kcna4 potassium voltage-gated channel subfamily A member 4 multiple interactions EXP [Carmustine co-treated with Buthionine Sulfoximine] results in decreased expression of KCNA4 protein CTD PMID:16288907 NCBI chr 3:114,211,091...114,218,545
Ensembl chr 3:114,210,998...114,344,932 		JBrowse link
G Kcnab2 potassium voltage-gated channel subfamily A regulatory beta subunit 2 affects response to substance ISO KCNAB2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:168,182,228...168,270,760
Ensembl chr 5:168,184,613...168,270,760 		JBrowse link
G Kcnd2 potassium voltage-gated channel subfamily D member 2 multiple interactions EXP [Carmustine co-treated with Buthionine Sulfoximine] results in decreased expression of KCND2 mRNA; [Carmustine co-treated with Buthionine Sulfoximine] results in decreased expression of KCND2 protein CTD PMID:16288907 NCBI chr 4:50,741,595...51,243,540
Ensembl chr 4:50,742,839...51,243,522 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases expression ISO Carmustine results in decreased expression of KCNH2 mRNA CTD PMID:15980968 NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421 		JBrowse link
G Kif2c kinesin family member 2C decreases expression EXP Carmustine results in decreased expression of KIF2C mRNA CTD PMID:16005536 NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:135,873,925...135,899,212 		JBrowse link
G Kif5a kinesin family member 5A decreases expression ISO Carmustine results in decreased expression of KIF5A mRNA CTD PMID:15980968 NCBI chr 7:64,937,210...64,974,339
Ensembl chr 7:64,934,740...64,978,272 		JBrowse link
G Krt17 keratin 17 decreases expression ISO Carmustine results in decreased expression of KRT17 mRNA CTD PMID:15980968 NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787 		JBrowse link
G Krt31 keratin 31 decreases expression ISO Carmustine results in decreased expression of KRT31 mRNA CTD PMID:15980968 NCBI chr10:85,479,533...85,483,300
Ensembl chr10:85,479,796...85,483,300 		JBrowse link
G Krt8 keratin 8 affects response to substance ISO KRT8 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Lad1 ladinin 1 decreases expression ISO Carmustine results in decreased expression of LAD1 mRNA CTD PMID:15980968 NCBI chr13:49,801,347...49,815,709
Ensembl chr13:49,800,472...49,815,709 		JBrowse link
G Lair1 leukocyte-associated immunoglobulin-like receptor 1 increases expression ISO Carmustine results in increased expression of LAIR1 mRNA CTD PMID:15980968 NCBI chr 1:79,140,850...79,261,546
Ensembl chr 1:79,198,311...79,258,037 		JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression ISO Carmustine results in decreased expression of LAMB3 mRNA CTD PMID:15980968 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lbp lipopolysaccharide binding protein affects response to substance ISO LBP mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518 		JBrowse link
G Lcn2 lipocalin 2 increases response to substance
multiple interactions 		ISO
EXP 		LCN2 protein results in increased susceptibility to Carmustine
[LCN2 protein co-treated with Carmustine] results in increased cleavage of and results in increased activity of CASP3 protein; LCN2 protein promotes the reaction [Carmustine results in decreased phosphorylation of AKT1 protein] 		CTD PMID:19860839 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Ldlr low density lipoprotein receptor affects uptake ISO LDLR protein affects the uptake of Carmustine analog CTD PMID:12107554 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Lif LIF, interleukin 6 family cytokine increases response to substance ISO LIF mRNA results in increased susceptibility to Carmustine CTD PMID:16365179 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053 		JBrowse link
G Lig1 DNA ligase 1 decreases expression EXP Carmustine results in decreased expression of LIG1 mRNA CTD PMID:16005536 NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708 		JBrowse link
G Lins1 lines homolog 1 affects response to substance ISO LINS1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:129,677,815...129,705,399
Ensembl chr 1:129,692,225...129,703,826 		JBrowse link
G Lman1l lectin, mannose-binding, 1 like affects response to substance ISO LMAN1L mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 8:66,906,684...66,925,512
Ensembl chr 8:66,906,624...66,919,584 		JBrowse link
G Lmtk2 lemur tyrosine kinase 2 affects response to substance ISO LMTK2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr12:15,540,428...15,622,392
Ensembl chr12:15,540,428...15,622,392 		JBrowse link
G Lmx1b LIM homeobox transcription factor 1 beta decreases expression ISO Carmustine results in decreased expression of LMX1B mRNA CTD PMID:15980968 NCBI chr 3:37,257,025...37,338,675
Ensembl chr 3:37,259,855...37,338,557 		JBrowse link
G Loxl1 lysyl oxidase-like 1 decreases expression ISO Carmustine results in decreased expression of LOXL1 mRNA CTD PMID:15980968 NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224 		JBrowse link
G Lrch4 leucine rich repeats and calponin homology domain containing 4 decreases expression ISO Carmustine results in decreased expression of LRCH4 mRNA CTD PMID:15980968 NCBI chr12:24,694,364...24,709,354
Ensembl chr12:24,694,370...24,706,412 		JBrowse link
G Lsp1 lymphocyte-specific protein 1 decreases expression EXP Carmustine results in decreased expression of LSP1 mRNA CTD PMID:16005536 NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893 		JBrowse link
G Mad1l1 mitotic arrest deficient 1 like 1 decreases expression ISO Carmustine results in decreased expression of MAD1L1 mRNA CTD PMID:15980968 NCBI chr12:19,434,782...19,744,574
Ensembl chr12:19,434,746...19,744,567 		JBrowse link
G Map4k2 mitogen activated protein kinase kinase kinase kinase 2 decreases expression ISO Carmustine results in decreased expression of MAP4K2 mRNA CTD PMID:15980968 NCBI chr 1:213,074,360...213,090,042
Ensembl chr 1:213,074,377...213,096,987 		JBrowse link
G Mapk10 mitogen activated protein kinase 10 decreases expression ISO Carmustine results in decreased expression of MAPK10 mRNA CTD PMID:15980968 NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100 		JBrowse link
G Masp1 MBL associated serine protease 1 affects response to substance ISO MASP1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr11:90,839,081...90,909,922
Ensembl chr11:90,839,061...90,917,470 		JBrowse link
G Mat1a methionine adenosyltransferase 1A decreases expression ISO Carmustine results in decreased expression of MAT1A mRNA CTD PMID:15980968 NCBI chr16:17,017,168...17,035,368
Ensembl chr16:17,016,030...17,035,367 		JBrowse link
G Mdk midkine decreases expression ISO Carmustine results in decreased expression of MDK mRNA CTD PMID:15980968 NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743 		JBrowse link
G Mdm4 MDM4 regulator of p53 multiple interactions
decreases response to substance 		ISO [Carmustine co-treated with MDM4 protein] results in increased expression of POLH protein; MDM4 protein promotes the reaction [Carmustine affects the localization of H2AX protein]; MDM4 protein promotes the reaction [Carmustine results in increased expression of CDKN1A protein]; MDM4 protein promotes the reaction [Carmustine results in increased expression of TP53 protein]; MDM4 protein promotes the reaction [Carmustine results in increased phosphorylation of H2AX protein]
MDM4 protein results in decreased susceptibility to Carmustine 		CTD PMID:20472715 NCBI chr13:46,922,236...47,068,241
Ensembl chr13:46,958,298...47,026,372 		JBrowse link
G Mecom MDS1 and EVI1 complex locus affects response to substance ISO MECOM mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:114,837,840...115,393,038 		JBrowse link
G Med1 mediator complex subunit 1 decreases expression ISO Carmustine results in decreased expression of MED1 mRNA CTD PMID:15980968 NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545 		JBrowse link
G Meg3 maternally expressed 3 affects response to substance ISO MEG3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:134,274,056...134,306,249 JBrowse link
G Mgat3 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase decreases expression ISO Carmustine results in decreased expression of MGAT3 mRNA CTD PMID:15980968 NCBI chr 7:113,614,011...113,640,201
Ensembl chr 7:113,598,059...113,643,481 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase increases alkylation
increases response to substance
multiple interactions
decreases expression
decreases response to substance
affects response to substance
decreases activity 		ISO
EXP 		Carmustine results in increased alkylation of MGMT protein
MGMT mutant form results in increased susceptibility to Carmustine
[MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Carmustine; [MGMT protein mutant form co-treated with FECH protein] results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine]; [O(6)-benzyl-2'-deoxyguanosine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine; [O(6)-benzyl-N-acetylguanosine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine; [O(6)-benzylguanine co-treated with Carmustine] results in decreased activity of MGMT protein; [O(6)-benzylguanine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine; [Tamoxifen results in increased degradation of MGMT protein] which results in increased susceptibility to Carmustine; MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine]; MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine]; MGMT protein results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine]; MGMT protein results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine]; O(6)-benzylguanine inhibits the reaction [MGMT protein mutant form results in decreased susceptibility to Carmustine]
Carmustine results in decreased expression of MGMT protein
MGMT protein results in decreased susceptibility to Carmustine
[O(6)-benzylguanine results in decreased activity of MGMT protein] which affects the susceptibility to Carmustine; MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine]; MGMT protein results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine]
MGMT protein affects the susceptibility to Carmustine
Carmustine results in decreased activity of MGMT protein
MGMT mRNA results in decreased susceptibility to Carmustine; MGMT protein mutant form results in decreased susceptibility to Carmustine; MGMT protein results in decreased susceptibility to Carmustine; MGMT protein results in decreased susceptibility to Carmustine analog; MGMT results in decreased susceptibility to Carmustine
MGMT gene modified form affects the susceptibility to Carmustine; MGMT promoter modified form affects the susceptibility to Carmustine; MGMT protein affects the susceptibility to Carmustine 		CTD PMID:8823159 PMID:9918549 PMID:11792417 PMID:11945064 PMID:12036916 More... NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mgst2 microsomal glutathione S-transferase 2 affects response to substance ISO MGST2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661 		JBrowse link
G Mlh1 mutL homolog 1 affects response to substance ISO MLH1 protein affects the susceptibility to Carmustine CTD PMID:18430789 NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011 		JBrowse link
G Mlph melanophilin affects response to substance ISO MLPH mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556 		JBrowse link
G Mpg N-methylpurine-DNA glycosylase decreases response to substance ISO MPG protein results in decreased susceptibility to Carmustine CTD PMID:16288039 NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052 		JBrowse link
G Mpst mercaptopyruvate sulfurtransferase affects response to substance ISO MPST mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650 		JBrowse link
G Msh2 mutS homolog 2 affects response to substance ISO MSH2 protein affects the susceptibility to Carmustine CTD PMID:18430789 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Msr1 macrophage scavenger receptor 1 decreases expression ISO Carmustine results in decreased expression of MSR1 mRNA CTD PMID:15980968 NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070 		JBrowse link
G Mt2 metallothionein 2 affects response to substance
multiple interactions 		ISO
EXP 		MT2A mRNA affects the susceptibility to Carmustine
MT2 protein inhibits the reaction [Carmustine results in decreased activity of GSR protein]; MT2 protein inhibits the reaction [Carmustine results in increased expression of TNF protein]
MT2 protein affects the susceptibility to Carmustine 		CTD PMID:16365179 PMID:18528683 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mturn maturin, neural progenitor differentiation regulator homolog affects response to substance ISO MTURN mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 4:85,137,825...85,158,790
Ensembl chr 4:85,137,846...85,158,789 		JBrowse link
G Muc2 mucin 2, oligomeric mucus/gel-forming decreases expression ISO Carmustine results in decreased expression of MUC2 mRNA CTD PMID:15980968 NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280 		JBrowse link
G Mug2 murinoglobulin 2 decreases expression ISO Carmustine results in decreased expression of PZP mRNA CTD PMID:15980968 NCBI chr 4:156,836,140...156,908,972 JBrowse link
G Mvd mevalonate diphosphate decarboxylase decreases expression ISO Carmustine results in decreased expression of MVD mRNA CTD PMID:15980968 NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366 		JBrowse link
G Mybl2 MYB proto-oncogene like 2 increases expression EXP Carmustine results in increased expression of MYBL2 mRNA CTD PMID:16005536 NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221 		JBrowse link
G Mybph myosin binding protein H decreases expression ISO Carmustine results in decreased expression of MYBPH mRNA CTD PMID:15980968 NCBI chr13:48,205,162...48,212,928
Ensembl chr13:48,205,269...48,212,928 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor decreases expression ISO Carmustine results in decreased expression of MYD88 mRNA CTD PMID:15980968 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230 		JBrowse link
G Myod1 myogenic differentiation 1 decreases expression ISO Carmustine results in decreased expression of MYOD1 mRNA CTD PMID:15980968 NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:106,021,161...106,023,871 		JBrowse link
G Myog myogenin decreases expression ISO Carmustine results in decreased expression of MYOG mRNA CTD PMID:15980968 NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065 		JBrowse link
G Nbl1 NBL1, DAN family BMP antagonist affects response to substance ISO NBL1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186 		JBrowse link
G Ndufc1 NADH:ubiquinone oxidoreductase subunit C1 decreases expression ISO Carmustine results in decreased expression of NDUFC1 mRNA CTD PMID:15980968 NCBI chr 2:137,597,944...137,601,819
Ensembl chr 2:137,600,156...137,601,735 		JBrowse link
G Nek6 NIMA-related kinase 6 increases expression EXP Carmustine results in increased expression of NEK6 mRNA CTD PMID:16005536 NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:42,693,971...42,767,773 		JBrowse link
G Nes nestin increases expression
multiple interactions 		EXP Carmustine results in increased expression of NES protein
Melatonin inhibits the reaction [Carmustine results in increased expression of NES protein] 		CTD PMID:17572393 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228 		JBrowse link
G Nfat5 nuclear factor of activated T-cells 5 affects response to substance ISO NFAT5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr19:52,108,982...52,196,418
Ensembl chr19:52,109,483...52,196,418 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 affects response to substance ISO [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Carmustine CTD PMID:19303893 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfib nuclear factor I/B affects response to substance ISO NFIB mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:101,805,168...102,020,618
Ensembl chr 5:101,805,168...102,019,945 		JBrowse link
G Nfix nuclear factor I X affects response to substance ISO NFIX mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO
EXP 		Carmustine results in increased activity of [NFKB1 protein binds to NFKB1 protein]; Carmustine results in increased activity of [NFKB1 protein binds to RELA protein]; NFKBIA gene mutant form inhibits the reaction [Carmustine results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; NFKBIA gene mutant form inhibits the reaction [Carmustine results in increased activity of [NFKB1 protein binds to RELA protein]]
Carmustine inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Carmustine inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]
[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to NFKB1 protein]; [Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to RELA protein]; diphenyleneiodonium inhibits the reaction [[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; diphenyleneiodonium inhibits the reaction [[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to RELA protein]] 		CTD PMID:11970852 PMID:12433058 PMID:12477282 PMID:12675310 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases response to substance 		ISO
EXP 		NFKBIA gene mutant form inhibits the reaction [Carmustine results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; NFKBIA gene mutant form inhibits the reaction [Carmustine results in increased activity of [NFKB1 protein binds to RELA protein]]
Carmustine inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Carmustine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]
NFKBIA gene mutant form results in increased susceptibility to Carmustine; NFKBIA mRNA results in increased susceptibility to Carmustine 		CTD PMID:11970852 PMID:12433058 PMID:12675310 PMID:16365179 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Ngef neuronal guanine nucleotide exchange factor decreases expression EXP Carmustine results in decreased expression of NGEF mRNA CTD PMID:16005536 NCBI chr 9:95,594,823...95,692,381
Ensembl chr 9:95,594,823...95,692,251 		JBrowse link
G Ngf nerve growth factor affects activity EXP Carmustine affects the activity of NGF protein CTD PMID:15935206 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834 		JBrowse link
G Nid2 nidogen 2 decreases expression EXP Carmustine results in decreased expression of NID2 mRNA CTD PMID:16005536 NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949 		JBrowse link
G Nin ninein affects response to substance ISO NIN mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:94,261,382...94,363,679
Ensembl chr 6:94,263,206...94,363,610 		JBrowse link
G Nkd2 NKD inhibitor of WNT signaling pathway 2 affects response to substance ISO NKD2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:31,268,856...31,299,390
Ensembl chr 1:31,272,519...31,299,387 		JBrowse link
G Nkx2-2 NK2 homeobox 2 decreases expression ISO Carmustine results in decreased expression of NKX2-2 mRNA CTD PMID:15980968 NCBI chr 3:155,072,621...155,083,699
Ensembl chr 3:155,073,250...155,083,249 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
decreases response to substance 		ISO
EXP 		[NOS2 protein results in increased chemical synthesis of S-Nitrosoglutathione] which results in decreased susceptibility to Carmustine
NOS2 protein results in decreased susceptibility to Carmustine
[Carmustine co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites]; [Carmustine co-treated with Buthionine Sulfoximine] inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Buthionine Sulfoximine promotes the reaction [Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]]; Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Carmustine] 		CTD PMID:7532384 PMID:15110396 PMID:15965067 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Npas1 neuronal PAS domain protein 1 decreases expression ISO Carmustine results in decreased expression of NPAS1 mRNA CTD PMID:15980968 NCBI chr 1:86,295,509...86,316,018
Ensembl chr 1:86,295,515...86,314,893 		JBrowse link
G Npas2 neuronal PAS domain protein 2 affects response to substance ISO NPAS2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 9:48,959,225...49,138,036
Ensembl chr 9:48,959,148...49,138,037 		JBrowse link
G Npl N-acetylneuraminate pyruvate lyase affects response to substance ISO NPL mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr13:68,205,602...68,247,940
Ensembl chr13:68,205,603...68,247,999 		JBrowse link
G Npr1 natriuretic peptide receptor 1 decreases expression EXP Carmustine results in decreased expression of NPR1 mRNA CTD PMID:16005536 NCBI chr 2:178,231,766...178,247,591
Ensembl chr 2:178,231,766...178,247,088 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 affects response to substance ISO NR2F1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 affects expression EXP Carmustine affects the expression of NR4A2 mRNA CTD PMID:19174181 NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769 		JBrowse link
G Nrtn neurturin decreases expression ISO Carmustine results in decreased expression of NRTN mRNA CTD PMID:15980968 NCBI chr 9:1,669,099...1,674,957
Ensembl chr 9:1,641,618...1,675,133 		JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase decreases response to substance ISO OGG1 protein results in decreased susceptibility to Carmustine CTD PMID:11181913 PMID:11741815 NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604 		JBrowse link
G Omp olfactory marker protein decreases expression ISO Carmustine results in decreased expression of OMP mRNA CTD PMID:15980968 NCBI chr 1:161,851,499...161,852,049 JBrowse link
G Orm1 orosomucoid 1 increases expression EXP Carmustine results in increased expression of ORM1 mRNA CTD PMID:16005536 NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667 		JBrowse link
G P3h3 prolyl 3-hydroxylase 3 affects response to substance ISO P3H3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 4:159,332,514...159,348,428
Ensembl chr 4:159,332,434...159,348,004 		JBrowse link
G Paep progestagen associated endometrial protein decreases expression ISO Carmustine results in decreased expression of PAEP mRNA CTD PMID:15980968 NCBI chr 3:28,929,252...28,932,592 JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases cleavage 		ISO Disulfiram promotes the reaction [Carmustine results in increased cleavage of PARP1 protein] CTD PMID:24193513 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pax8 paired box 8 decreases expression ISO Carmustine results in decreased expression of PAX8 mRNA CTD PMID:15980968 NCBI chr 3:27,584,000...27,641,094
Ensembl chr 3:27,584,002...27,640,631 		JBrowse link
G Pbx2 PBX homeobox 2 decreases expression ISO Carmustine results in decreased expression of PBX2 mRNA CTD PMID:15980968 NCBI chr20:4,156,107...4,161,503
Ensembl chr20:4,156,107...4,161,827 		JBrowse link
G Pcbd1 pterin-4 alpha-carbinolamine dehydratase 1 decreases expression ISO Carmustine results in decreased expression of PCBD1 mRNA CTD PMID:15980968 NCBI chr20:29,573,362...29,587,181
Ensembl chr20:29,573,423...29,587,180 		JBrowse link
G Pcdhb2 protocadherin beta 2 affects response to substance ISO PCDHB2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr18:29,280,004...29,282,790
Ensembl chr18:29,280,004...29,283,300 		JBrowse link
G Pcdhgc3 protocadherin gamma subfamily C, 3 decreases expression ISO Carmustine results in decreased expression of PCDHGC3 mRNA CTD PMID:15980968 NCBI chr18:29,884,245...29,919,095 JBrowse link
G Pcolce procollagen C-endopeptidase enhancer decreases expression ISO Carmustine results in decreased expression of PCOLCE mRNA CTD PMID:15980968 NCBI chr12:24,720,972...24,727,287
Ensembl chr12:24,720,936...24,727,287 		JBrowse link
G Pcyt1a phosphate cytidylyltransferase 1A, choline decreases expression ISO Carmustine results in decreased expression of PCYT1A mRNA CTD PMID:15980968 NCBI chr11:81,818,914...81,862,623
Ensembl chr11:81,819,285...81,862,395 		JBrowse link
G Pde5a phosphodiesterase 5A affects response to substance ISO PDE5A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298 		JBrowse link
G Pdgfb platelet derived growth factor subunit B increases expression ISO Carmustine results in increased expression of PDGFB protein CTD PMID:15286697 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 decreases expression ISO Carmustine results in decreased expression of PFKFB2 mRNA CTD PMID:15980968 NCBI chr13:44,683,499...44,727,135
Ensembl chr13:44,699,744...44,726,971 		JBrowse link
G Pfkm phosphofructokinase, muscle decreases expression ISO Carmustine results in decreased expression of PFKM mRNA CTD PMID:15980968 NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:131,100,753...131,138,248 		JBrowse link
G Pfn1 profilin 1 decreases expression ISO Carmustine results in decreased expression of PFN1 mRNA CTD PMID:15980968 NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611 		JBrowse link
G Pgm2 phosphoglucomutase 2 affects response to substance ISO PGM2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr14:44,519,906...44,553,420
Ensembl chr14:44,519,906...44,553,770 		JBrowse link
G Phc2 polyhomeotic homolog 2 affects response to substance ISO PHC2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:146,285,000...146,383,664
Ensembl chr 5:146,285,008...146,383,663 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 affects response to substance ISO PHLDA1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542 		JBrowse link
G Pik3c3 phosphatidylinositol 3-kinase, catalytic subunit type 3 affects response to substance ISO PIK3C3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr18:22,119,677...22,203,546
Ensembl chr18:22,119,792...22,203,539 		JBrowse link
G Pik3cd phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta affects response to substance ISO PIK3CD mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968 		JBrowse link
G Pik3r3 phosphoinositide-3-kinase regulatory subunit 3 increases expression ISO Carmustine results in increased expression of PIK3R3 mRNA CTD PMID:15980968 NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762 		JBrowse link
G Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 1 affects response to substance ISO PITPNC1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:92,663,260...92,928,616
Ensembl chr10:92,663,260...92,928,344 		JBrowse link
G Pknox2 PBX/knotted 1 homeobox 2 decreases expression EXP Carmustine results in decreased expression of PKNOX2 mRNA CTD PMID:16005536 NCBI chr 8:44,789,464...45,051,933
Ensembl chr 8:44,789,467...44,979,754 		JBrowse link
G Pkp2 plakophilin 2 increases expression EXP Carmustine results in increased expression of PKP2 mRNA CTD PMID:16005536 NCBI chr11:98,165,974...98,231,916
Ensembl chr11:98,165,974...98,231,916 		JBrowse link
G Pkp3 plakophilin 3 affects response to substance ISO PKP3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:205,617,511...205,628,441
Ensembl chr 1:205,617,511...205,628,440 		JBrowse link
G Plekhg5 pleckstrin homology and RhoGEF domain containing G5 affects response to substance ISO PLEKHG5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:167,860,730...167,904,229
Ensembl chr 5:167,860,794...167,904,229 		JBrowse link
G Pnpla2 patatin-like phospholipase domain containing 2 increases expression EXP Carmustine results in increased expression of PNPLA2 mRNA CTD PMID:16005536 NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359 		JBrowse link
G Polg2 DNA polymerase gamma 2, accessory subunit affects response to substance ISO POLG2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:92,212,303...92,222,849
Ensembl chr10:92,212,304...92,222,726 		JBrowse link
G Polh DNA polymerase eta multiple interactions ISO [Carmustine co-treated with MDM4 protein] results in increased expression of POLH protein CTD PMID:20472715 NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577 		JBrowse link
G Polr2e RNA polymerase II, I and III subunit E decreases expression ISO Carmustine results in decreased expression of POLR2E mRNA CTD PMID:15980968 NCBI chr 7:10,317,332...10,321,280
Ensembl chr 7:10,317,389...10,321,276 		JBrowse link
G Popdc3 popeye domain cAMP effector 3 affects response to substance ISO POPDC3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr20:50,354,775...50,383,050
Ensembl chr20:50,354,767...50,385,674 		JBrowse link
G Ppm1g protein phosphatase, Mg2+/Mn2+ dependent, 1G decreases expression ISO Carmustine results in decreased expression of PPM1G mRNA CTD PMID:15980968 NCBI chr 6:30,873,531...30,893,735
Ensembl chr 6:30,873,481...30,893,732 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO Carmustine results in decreased expression of PRC1 mRNA CTD PMID:17374387 NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012 		JBrowse link
G Prex1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 affects response to substance ISO PREX1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:175,724,939...175,875,764
Ensembl chr 3:175,726,012...175,875,764 		JBrowse link
G Prkaa2 protein kinase AMP-activated catalytic subunit alpha 2 affects response to substance ISO PRKAA2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324 		JBrowse link
G Prl prolactin decreases expression ISO Carmustine results in decreased expression of PRL mRNA CTD PMID:15980968 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Prm2 protamine 2 decreases expression ISO Carmustine results in decreased expression of PRM2 mRNA CTD PMID:15980968 NCBI chr10:5,383,208...5,383,949
Ensembl chr10:5,379,029...5,384,004 		JBrowse link
G Prph peripherin decreases expression EXP Carmustine results in decreased expression of PRPH mRNA CTD PMID:16005536 NCBI chr 7:132,096,888...132,101,070
Ensembl chr 7:132,097,285...132,101,068 		JBrowse link
G Prrx2 paired related homeobox 2 affects response to substance ISO PRRX2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:34,530,331...34,566,284
Ensembl chr 3:34,520,173...34,566,284 		JBrowse link
G Prss12 serine protease 12 affects response to substance ISO PRSS12 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:214,308,695...214,368,679
Ensembl chr 2:214,308,774...214,369,941 		JBrowse link
G Pth2r parathyroid hormone 2 receptor decreases expression EXP Carmustine results in decreased expression of PTH2R mRNA CTD PMID:16005536 NCBI chr 9:74,199,785...74,304,326
Ensembl chr 9:74,199,785...74,304,326 		JBrowse link
G Ptpn3 protein tyrosine phosphatase, non-receptor type 3 decreases expression ISO Carmustine results in decreased expression of PTPN3 mRNA CTD PMID:15980968 NCBI chr 5:76,703,687...76,822,584
Ensembl chr 5:76,703,687...76,860,470 		JBrowse link
G Qpct glutaminyl-peptide cyclotransferase affects response to substance ISO QPCT mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:21,716,824...21,748,895
Ensembl chr 6:21,716,824...21,748,895 		JBrowse link
G Rab27b RAB27B, member RAS oncogene family affects response to substance ISO RAB27B mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr18:65,870,230...66,069,597
Ensembl chr18:65,876,342...66,067,700 		JBrowse link
G Rad23a RAD23 homolog A, nucleotide excision repair protein decreases expression ISO Carmustine results in decreased expression of RAD23A mRNA CTD PMID:15980968 NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543 		JBrowse link
G Rad51 RAD51 recombinase decreases expression ISO Carmustine results in decreased expression of RAD51 mRNA CTD PMID:15980968 NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469 		JBrowse link
G Rad9a RAD9 checkpoint clamp component A decreases expression ISO Carmustine results in decreased expression of RAD9A mRNA CTD PMID:15980968 NCBI chr 1:210,917,970...210,983,038
Ensembl chr 1:210,917,970...210,925,161 		JBrowse link
G Rbm19 RNA binding motif protein 19 affects response to substance ISO RBM19 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr12:42,026,277...42,111,530
Ensembl chr12:42,026,278...42,111,530 		JBrowse link
G Rcn1 reticulocalbin 1 decreases expression ISO Carmustine results in decreased expression of RCN1 mRNA CTD PMID:15980968 NCBI chr 3:112,295,838...112,310,082
Ensembl chr 3:112,295,838...112,310,082 		JBrowse link
G Rel REL proto-oncogene, NF-kB subunit multiple interactions EXP Carmustine inhibits the reaction [Lipopolysaccharides affects the localization of REL protein] CTD PMID:11970852 PMID:12433058 NCBI chr14:101,891,238...101,922,324
Ensembl chr14:101,891,243...101,921,938 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO
EXP 		Carmustine results in increased activity of [NFKB1 protein binds to RELA protein]; NFKBIA gene mutant form inhibits the reaction [Carmustine results in increased activity of [NFKB1 protein binds to RELA protein]]
Carmustine inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Carmustine inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]
[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to RELA protein]; diphenyleneiodonium inhibits the reaction [[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to RELA protein]] 		CTD PMID:11970852 PMID:12433058 PMID:12477282 PMID:12675310 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Relb RELB proto-oncogene, NF-kB subunit multiple interactions EXP Carmustine inhibits the reaction [Lipopolysaccharides affects the localization of RELB protein] CTD PMID:11970852 PMID:12433058 NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:88,385,717...88,413,420 		JBrowse link
G Rfc3 replication factor C subunit 3 decreases expression EXP Carmustine results in decreased expression of RFC3 mRNA CTD PMID:16005536 NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340 		JBrowse link
G Rgcc regulator of cell cycle affects response to substance ISO RGCC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408 		JBrowse link
G Rgp1 RGP1 homolog, RAB6A GEF complex partner 1 affects response to substance ISO RGP1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:62,630,253...62,638,872
Ensembl chr 5:62,630,133...62,638,864 		JBrowse link
G Rgr retinal G protein coupled receptor decreases expression ISO Carmustine results in decreased expression of RGR mRNA CTD PMID:15980968 NCBI chr16:12,821,858...12,836,665
Ensembl chr16:12,821,858...12,836,486 		JBrowse link
G Rhobtb3 Rho-related BTB domain containing 3 affects response to substance ISO RHOBTB3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:7,095,253...7,150,906 		JBrowse link
G Rit2 Ras-like without CAAX 2 decreases expression ISO Carmustine results in decreased expression of RIT2 mRNA CTD PMID:15980968 NCBI chr18:22,839,914...23,196,137
Ensembl chr18:22,839,915...23,269,823 		JBrowse link
G Rnase4 ribonuclease A family member 4 increases expression ISO Carmustine results in increased expression of RNASE4 mRNA CTD PMID:15980968 NCBI chr15:26,786,287...26,803,634
Ensembl chr15:26,786,079...26,803,639 		JBrowse link
G Rorb RAR-related orphan receptor B affects expression EXP Carmustine affects the expression of RORB mRNA CTD PMID:19174181 NCBI chr 1:225,790,216...225,970,973
Ensembl chr 1:225,790,216...225,970,973 		JBrowse link
G S1pr3 sphingosine-1-phosphate receptor 3 affects response to substance ISO S1PR3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:13,932,773...13,946,213
Ensembl chr17:13,928,444...13,947,197 		JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 affects response to substance ISO SAT1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr  X:44,008,089...44,011,376
Ensembl chr  X:44,006,781...44,011,374 		JBrowse link
G Scamp5 secretory carrier membrane protein 5 affects response to substance ISO SCAMP5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 8:66,739,794...66,778,538
Ensembl chr 8:66,741,940...66,751,099 		JBrowse link
G Scn1b sodium voltage-gated channel beta subunit 1 increases expression EXP Carmustine results in increased expression of SCN1B mRNA CTD PMID:16005536 NCBI chr 1:95,481,298...95,491,211
Ensembl chr 1:95,481,298...95,491,197 		JBrowse link
G Scn8a sodium voltage-gated channel alpha subunit 8 affects response to substance ISO SCN8A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:133,860,901...134,034,809
Ensembl chr 7:133,861,227...134,030,026 		JBrowse link
G Sdc1 syndecan 1 affects response to substance ISO SDC1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:37,297,010...37,304,500 		JBrowse link
G Sema3a semaphorin 3A affects response to substance ISO SEMA3A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 4:22,239,418...22,709,907
Ensembl chr 4:22,245,322...22,535,774 		JBrowse link
G Septin4 septin 4 decreases expression EXP Carmustine results in decreased expression of SEPTIN4 mRNA CTD PMID:16005536 NCBI chr10:72,863,969...72,888,018
Ensembl chr10:72,864,014...72,888,019 		JBrowse link
G Septin5 septin 5 decreases expression ISO Carmustine results in decreased expression of SEPTIN5 mRNA CTD PMID:15980968 NCBI chr11:95,877,946...95,883,738
Ensembl chr11:95,873,864...95,883,737 		JBrowse link
G Serpinb1a serpin family B member 1A affects response to substance ISO SERPINB1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166 		JBrowse link
G Sf1 splicing factor 1 affects response to substance ISO SF1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:213,099,260...213,113,590 		JBrowse link
G Sfpq splicing factor proline and glutamine rich decreases expression ISO Carmustine results in decreased expression of SFPQ mRNA CTD PMID:15980968 NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:144,622,476...144,637,926 		JBrowse link
G Sgca sarcoglycan, alpha decreases expression ISO Carmustine results in decreased expression of SGCA mRNA CTD PMID:15980968 NCBI chr10:80,397,158...80,416,165
Ensembl chr10:80,405,566...80,419,616 		JBrowse link
G Shmt2 serine hydroxymethyltransferase 2 decreases expression ISO Carmustine results in decreased expression of SHMT2 mRNA CTD PMID:15980968 NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567 		JBrowse link
G Shox1 SHOX homeobox 1 decreases expression ISO Carmustine results in decreased expression of SHOX mRNA CTD PMID:15980968 NCBI chr  X:121,553,770...121,560,788 JBrowse link
G Slc10a1 solute carrier family 10 member 1 increases expression ISO Carmustine results in increased expression of SLC10A1 mRNA CTD PMID:15980968 NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944 		JBrowse link
G Slc12a1 solute carrier family 12 member 1 decreases expression EXP Carmustine results in decreased expression of SLC12A1 mRNA CTD PMID:17727784 NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340 		JBrowse link
G Slc12a2 solute carrier family 12 member 2 increases expression EXP Carmustine results in increased expression of SLC12A2 mRNA CTD PMID:17727784 NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470 		JBrowse link
G Slc14a1 solute carrier family 14 member 1 (Kidd blood group) affects response to substance ISO SLC14A1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr18:73,840,568...73,883,925
Ensembl chr18:73,840,569...73,870,489 		JBrowse link
G Slc15a2 solute carrier family 15 member 2 affects response to substance ISO SLC15A2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr11:77,519,565...77,548,609
Ensembl chr11:77,519,529...77,548,606 		JBrowse link
G Slc16a2 solute carrier family 16 member 2 increases expression ISO Carmustine results in increased expression of SLC16A2 mRNA CTD PMID:15980968 NCBI chr  X:72,791,096...72,914,299
Ensembl chr  X:72,781,876...72,914,498 		JBrowse link
G Slc19a2 solute carrier family 19 member 2 decreases expression EXP Carmustine results in decreased expression of SLC19A2 mRNA CTD PMID:16005536 NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315 		JBrowse link
G Slc22a5 solute carrier family 22 member 5 affects response to substance ISO SLC22A5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,509,072...38,536,077 		JBrowse link
G Slc30a3 solute carrier family 30 member 3 decreases expression ISO Carmustine results in decreased expression of SLC30A3 mRNA CTD PMID:15980968 NCBI chr 6:30,984,241...31,004,689
Ensembl chr 6:30,984,276...31,005,120 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression EXP Carmustine results in increased expression of SLC3A2 mRNA CTD PMID:16005536 NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064 		JBrowse link
G Slc6a2 solute carrier family 6 member 2 increases expression ISO Carmustine results in increased expression of SLC6A2 mRNA CTD PMID:15980968 NCBI chr19:30,183,289...30,228,292
Ensembl chr19:30,183,383...30,223,348 		JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 decreases expression ISO Carmustine results in decreased expression of SLCO1A2 mRNA CTD PMID:15980968 NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor affects response to substance ISO SLPI mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822 		JBrowse link
G Smarcd1 SWI/SNF related BAF chromatin remodeling complex subunit D1 increases expression ISO Carmustine results in increased expression of SMARCD1 mRNA CTD PMID:15980968 NCBI chr 7:132,708,627...132,719,167
Ensembl chr 7:132,708,432...132,719,167 		JBrowse link
G Smpd2 sphingomyelin phosphodiesterase 2 increases expression ISO Carmustine results in increased expression of SMPD2 mRNA CTD PMID:15980968 NCBI chr20:46,568,627...46,571,741
Ensembl chr20:46,568,629...46,571,741 		JBrowse link
G Snapc1 small nuclear RNA activating complex, polypeptide 1 increases expression ISO Carmustine results in increased expression of SNAPC1 mRNA CTD PMID:15980968 NCBI chr 6:98,420,588...98,442,065
Ensembl chr 6:98,420,340...98,442,489 		JBrowse link
G Snapc3 small nuclear RNA activating complex, polypeptide 3 increases expression ISO Carmustine results in increased expression of SNAPC3 mRNA CTD PMID:15980968 NCBI chr 5:102,863,867...102,890,573
Ensembl chr 5:102,863,854...102,893,499 		JBrowse link
G Sncg synuclein, gamma increases expression ISO Carmustine results in increased expression of SNCG mRNA CTD PMID:15980968 NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,706,753...9,712,076 		JBrowse link
G Snrpb2 small nuclear ribonucleoprotein polypeptide B2 increases expression ISO Carmustine results in increased expression of SNRPB2 mRNA CTD PMID:15980968 NCBI chr 3:150,852,814...150,862,364
Ensembl chr 3:150,852,790...150,863,428 		JBrowse link
G Socs1 suppressor of cytokine signaling 1 decreases expression ISO Carmustine results in decreased expression of SOCS1 mRNA CTD PMID:17374387 NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847 		JBrowse link
G Sod1 superoxide dismutase 1 decreases activity ISO Carmustine results in decreased activity of SOD1 protein CTD PMID:19856331 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 affects response to substance
increases response to substance
multiple interactions
decreases activity 		ISO SOD2 mRNA affects the susceptibility to Carmustine
SOD2 protein results in increased susceptibility to Carmustine
Pyruvates inhibits the reaction [SOD2 protein results in increased susceptibility to Carmustine]
Carmustine results in decreased activity of SOD2 protein 		CTD PMID:8877099 PMID:16365179 PMID:19856331 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sorbs2 sorbin and SH3 domain containing 2 decreases expression ISO Carmustine results in decreased expression of SORBS2 mRNA CTD PMID:15980968 NCBI chr16:53,167,795...53,481,300
Ensembl chr16:53,167,827...53,358,986 		JBrowse link
G Sox9 SRY-box transcription factor 9 affects response to substance ISO SOX9 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250 		JBrowse link
G Sparc secreted protein acidic and cysteine rich affects response to substance ISO SPARC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268 		JBrowse link
G Speg striated muscle enriched protein kinase decreases expression ISO Carmustine results in decreased expression of SPEG mRNA CTD PMID:15980968 NCBI chr 9:84,314,387...84,371,816
Ensembl chr 9:84,314,387...84,371,813 		JBrowse link
G Spen spen family transcriptional repressor affects response to substance ISO SPEN mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:159,058,258...159,131,789
Ensembl chr 5:159,058,258...159,165,934 		JBrowse link
G Sprr2b small proline rich protein 2B decreases expression ISO Carmustine results in decreased expression of SPRR2B mRNA CTD PMID:15980968 NCBI chr 2:180,548,428...180,548,700 JBrowse link
G Sqle squalene epoxidase affects response to substance ISO SQLE mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050 		JBrowse link
G Srp14 signal recognition particle 14 decreases expression ISO Carmustine results in decreased expression of SRP14 mRNA CTD PMID:15980968 NCBI chr 3:125,896,128...125,899,819
Ensembl chr 3:125,896,556...125,899,819 		JBrowse link
G Sry sex determining region Y decreases expression ISO Carmustine results in decreased expression of SRY mRNA CTD PMID:15980968 NCBI chr  Y:465,260...465,772
Ensembl chr  Y:465,260...465,772 		JBrowse link
G St3gal1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 affects response to substance ISO ST3GAL1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:100,734,300...100,802,443
Ensembl chr 7:100,734,300...100,745,242 		JBrowse link
G St6gal1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 increases expression ISO Carmustine results in increased expression of ST6GAL1 mRNA CTD PMID:15980968 NCBI chr11:91,031,481...91,158,111
Ensembl chr11:91,032,450...91,040,415 		JBrowse link
G St8sia1 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 increases expression ISO Carmustine results in increased expression of ST8SIA1 mRNA CTD PMID:15980968 NCBI chr 4:177,513,966...177,651,553
Ensembl chr 4:177,520,926...177,651,553 		JBrowse link
G Stam signal transducing adaptor molecule decreases expression ISO Carmustine results in decreased expression of STAM mRNA CTD PMID:15980968 NCBI chr17:82,028,779...82,074,717
Ensembl chr17:82,028,703...82,075,013 		JBrowse link
G Stc1 stanniocalcin 1 affects response to substance ISO STC1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082 		JBrowse link
G Stmn1 stathmin 1 affects response to substance ISO STMN1 mRNA affects the susceptibility to Carmustine CTD PMID:17440165 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Sts steroid sulfatase increases expression ISO Carmustine results in increased expression of STS mRNA CTD PMID:15980968 NCBI chr  X:46,102,524...46,110,868
Ensembl chr  X:46,102,548...46,111,104 		JBrowse link
G Stx1b syntaxin 1B decreases expression ISO Carmustine results in decreased expression of STX1B mRNA CTD PMID:15980968 NCBI chr 1:191,846,016...191,864,878
Ensembl chr 1:191,833,743...191,871,633 		JBrowse link
G Stxbp2 syntaxin binding protein 2 decreases expression ISO Carmustine results in decreased expression of STXBP2 mRNA CTD PMID:15980968 NCBI chr12:6,487,265...6,498,351
Ensembl chr12:6,487,297...6,504,212 		JBrowse link
G Stxbp6 syntaxin binding protein 6 affects response to substance ISO STXBP6 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 6:67,647,721...67,884,369
Ensembl chr 6:67,650,556...67,884,725 		JBrowse link
G Synpo2 synaptopodin 2 affects response to substance ISO SYNPO2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:213,901,685...214,055,844
Ensembl chr 2:213,900,868...214,055,844 		JBrowse link
G Syp synaptophysin multiple interactions
decreases expression 		EXP Melatonin inhibits the reaction [Carmustine results in decreased expression of SYP protein] CTD PMID:17572393 NCBI chr  X:17,521,348...17,536,449
Ensembl chr  X:17,521,348...17,536,984 		JBrowse link
G Tac1 tachykinin, precursor 1 decreases expression ISO Carmustine results in decreased expression of TAC1 mRNA CTD PMID:15980968 NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546 		JBrowse link
G Tagln transgelin affects response to substance ISO TAGLN mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563 		JBrowse link
G Tbx3 T-box transcription factor 3 affects response to substance ISO TBX3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr12:42,540,378...42,555,490
Ensembl chr12:42,540,378...42,554,171 		JBrowse link
G Tcf21 transcription factor 21 decreases expression ISO Carmustine results in decreased expression of TCF21 mRNA CTD PMID:15980968 NCBI chr 1:24,520,499...24,523,358
Ensembl chr 1:24,520,481...24,523,348 		JBrowse link
G Tcim transcriptional and immune response regulator increases response to substance ISO TCIM mRNA results in increased susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:74,298,344...74,299,637
Ensembl chr16:74,298,344...74,299,636 		JBrowse link
G Tdrp testis development related protein affects response to substance ISO TDRP mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:82,326,837...82,354,861
Ensembl chr16:82,314,220...82,354,861 		JBrowse link
G Tert telomerase reverse transcriptase decreases response to substance ISO TERT protein mutant form results in decreased susceptibility to Carmustine CTD PMID:12488552 NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111 		JBrowse link
G Tfap2c transcription factor AP-2 gamma affects response to substance ISO TFAP2C mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:181,733,524...181,742,412
Ensembl chr 3:181,733,419...181,741,404 		JBrowse link
G Tfdp1 transcription factor Dp-1 affects response to substance ISO TFDP1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:82,864,220...82,903,166
Ensembl chr16:82,864,226...82,902,996 		JBrowse link
G Tfpi2 tissue factor pathway inhibitor 2 affects response to substance ISO TFPI2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
decreases expression 		EXP Melatonin inhibits the reaction [Carmustine results in decreased expression of TGFB1 protein] CTD PMID:17572393 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Th tyrosine hydroxylase increases activity
increases expression 		EXP Carmustine results in increased activity of TH protein
Carmustine results in increased expression of TH mRNA; Carmustine results in increased expression of TH protein 		CTD PMID:14670008 NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227 		JBrowse link
G Thbd thrombomodulin affects response to substance ISO THBD mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582 		JBrowse link
G Tle3 TLE family member 3, transcriptional corepressor decreases expression ISO Carmustine results in decreased expression of TLE3 mRNA CTD PMID:15980968 NCBI chr 8:70,753,182...70,799,080
Ensembl chr 8:70,753,383...70,799,074 		JBrowse link
G Tmbim6 transmembrane BAX inhibitor motif containing 6 increases expression
decreases expression 		ISO Carmustine results in increased expression of TMBIM6 mRNA
Carmustine results in decreased expression of TMBIM6 mRNA 		CTD PMID:15980968 NCBI chr 7:132,405,217...132,422,492
Ensembl chr 7:132,386,134...132,422,492 		JBrowse link
G Tmem158 transmembrane protein 158 affects response to substance ISO TMEM158 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 8:131,791,137...131,792,135
Ensembl chr 8:131,787,277...131,796,882 		JBrowse link
G Tmem19 transmembrane protein 19 affects response to substance ISO TMEM19 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 7:52,844,985...52,871,708
Ensembl chr 7:52,844,985...52,872,012 		JBrowse link
G Tmprss15 transmembrane serine protease 15 affects response to substance ISO TMPRSS15 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr11:31,164,633...31,289,143
Ensembl chr11:31,164,633...31,288,953 		JBrowse link
G Tnc tenascin C affects response to substance ISO TNC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		EXP
ISO 		[Carmustine co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites]; [Carmustine co-treated with Buthionine Sulfoximine] inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Buthionine Sulfoximine promotes the reaction [Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]]; Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; Carmustine promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; MT2 protein inhibits the reaction [Carmustine results in increased expression of TNF protein]; Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Carmustine]; Zinc Sulfate inhibits the reaction [Carmustine results in increased expression of TNF protein]
Carmustine promotes the reaction [Oligodeoxyribonucleotides analog results in increased secretion of TNF protein] 		CTD PMID:7532384 PMID:11970852 PMID:12433058 PMID:12477282 PMID:18528683 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip3 TNF alpha induced protein 3 increases response to substance ISO TNFAIP3 mRNA results in increased susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979 		JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B decreases expression ISO Carmustine results in decreased expression of TNFRSF11B mRNA CTD PMID:15980968 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075 		JBrowse link
G Tnfrsf19 TNF receptor superfamily member 19 affects response to substance ISO TNFRSF19 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr15:39,268,305...39,334,566
Ensembl chr15:39,268,305...39,356,438 		JBrowse link
G Tnfsf10 TNF superfamily member 10 affects response to substance ISO TNFSF10 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 2:112,136,550...112,155,903 JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
increases response to substance
decreases response to substance
affects response to substance 		ISO [Carmustine co-treated with O(6)-benzylguanine] results in increased expression of TP53 protein; MDM4 protein promotes the reaction [Carmustine results in increased expression of TP53 protein]
TP53 results in increased susceptibility to Carmustine
TP53 protein results in decreased susceptibility to Carmustine
TP53 protein modified form affects the susceptibility to Carmustine 		CTD PMID:10455409 PMID:11861384 PMID:15735757 PMID:16193384 PMID:18632648 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tpd52l1 TPD52 like 1 affects response to substance ISO TPD52L1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:27,991,131...28,110,158 		JBrowse link
G Traf1 TNF receptor-associated factor 1 decreases expression ISO Carmustine results in decreased expression of TRAF1 mRNA CTD PMID:15980968 NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:38,619,506...38,636,264 		JBrowse link
G Trex1 three prime repair exonuclease 1 increases expression ISO Carmustine results in increased expression of TREX1 mRNA CTD PMID:23578789 NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083 		JBrowse link
G Trim50 tripartite motif-containing 50 affects response to substance ISO TRIM50 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr12:26,937,349...26,954,286
Ensembl chr12:26,937,349...26,954,270 		JBrowse link
G Tspan4 tetraspanin 4 decreases expression ISO Carmustine results in decreased expression of TSPAN4 mRNA CTD PMID:15980968 NCBI chr 1:206,001,731...206,021,414
Ensembl chr 1:206,001,731...206,021,413 		JBrowse link
G Tubb5 tubulin, beta 5 class I increases expression ISO Carmustine results in increased expression of TUBB mRNA CTD PMID:15980968 NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726 		JBrowse link
G Tubg1 tubulin, gamma 1 decreases expression ISO Carmustine results in decreased expression of TUBG1 mRNA CTD PMID:15980968 NCBI chr10:86,553,143...86,559,733
Ensembl chr10:86,552,499...86,559,730 		JBrowse link
G Tufm Tu translation elongation factor, mitochondrial affects response to substance ISO TUFM mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:190,504,373...190,507,980
Ensembl chr 1:190,504,373...190,508,952 		JBrowse link
G Tulp3 TUB like protein 3 affects response to substance ISO TULP3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 4:163,276,583...163,318,297
Ensembl chr 4:163,276,583...163,318,390 		JBrowse link
G Txnrd1 thioredoxin reductase 1 multiple interactions
decreases activity 		EXP [Carmustine co-treated with Buthionine Sulfoximine] results in decreased activity of TXNRD1 protein
Carmustine results in decreased activity of TXNRD1 protein 		CTD PMID:16085187 PMID:16288907 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
G Ugt8 UDP glycosyltransferase 8 increases expression ISO Carmustine results in increased expression of UGT8 mRNA CTD PMID:15980968 NCBI chr 2:216,938,884...217,007,167
Ensembl chr 2:216,938,990...217,007,167 		JBrowse link
G Upf1 UPF1, RNA helicase and ATPase decreases expression ISO Carmustine results in decreased expression of UPF1 mRNA CTD PMID:15980968 NCBI chr16:19,110,531...19,131,327
Ensembl chr16:19,110,538...19,131,327 		JBrowse link
G Vamp4 vesicle-associated membrane protein 4 affects response to substance ISO VAMP4 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr13:77,453,135...77,475,909
Ensembl chr13:77,453,121...77,476,024 		JBrowse link
G Vat1l vesicle amine transport 1-like affects response to substance ISO VAT1L mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr19:59,103,636...59,272,950
Ensembl chr19:59,103,636...59,272,950 		JBrowse link
G Vgf VGF nerve growth factor inducible decreases expression ISO Carmustine results in decreased expression of VGF mRNA CTD PMID:15980968 NCBI chr12:25,274,004...25,281,803
Ensembl chr12:25,273,333...25,282,703 		JBrowse link
G Vldlr very low density lipoprotein receptor affects response to substance ISO VLDLR mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154 		JBrowse link
G Wasf2 WASP family member 2 affects response to substance ISO WASF2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 5:150,620,733...150,685,943
Ensembl chr 5:150,620,733...150,685,943 		JBrowse link
G Wfdc1 WAP four-disulfide core domain 1 affects response to substance ISO WFDC1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr19:64,628,689...64,647,739
Ensembl chr19:64,607,794...64,648,028 		JBrowse link
G Wipf1 WAS/WASL interacting protein family, member 1 decreases expression ISO Carmustine results in decreased expression of WIPF1 mRNA CTD PMID:15980968 NCBI chr 3:78,721,486...78,824,199
Ensembl chr 3:78,714,299...78,780,277 		JBrowse link
G Wnt5a Wnt family member 5A affects response to substance ISO WNT5A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860 		JBrowse link
G Wt1 WT1 transcription factor decreases response to substance ISO WT1 results in decreased susceptibility to Carmustine CTD PMID:20820871 NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444 		JBrowse link
G Ywhah tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta decreases expression ISO Carmustine results in decreased expression of YWHAH mRNA CTD PMID:15980968 NCBI chr14:81,920,819...81,930,202
Ensembl chr14:81,920,590...81,947,930 		JBrowse link
G Zbtb17 zinc finger and BTB domain containing 17 decreases expression ISO Carmustine results in decreased expression of ZBTB17 mRNA CTD PMID:15980968 NCBI chr 5:159,036,482...159,057,580
Ensembl chr 5:159,036,515...159,057,581 		JBrowse link
G Zc3h13 zinc finger CCCH type containing 13 affects response to substance ISO ZC3H13 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr15:57,016,686...57,081,201
Ensembl chr15:57,016,781...57,081,201 		JBrowse link
G Zfp112 zinc finger protein 112 affects response to substance ISO ZNF112 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr 1:88,804,833...88,819,889
Ensembl chr 1:88,813,821...88,819,761 		JBrowse link
G Zfp189 zinc finger protein 189 increases expression EXP Carmustine results in increased expression of ZNF189 mRNA CTD PMID:16005536 NCBI chr 5:68,668,225...68,679,606
Ensembl chr 5:68,668,244...68,679,812 		JBrowse link
G Zfp655 zinc finger protein 655 affects response to substance ISO ZNF655 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 NCBI chr12:14,466,006...14,489,049
Ensembl chr12:14,471,415...14,488,678 		JBrowse link
G Zyx zyxin decreases expression ISO Carmustine results in decreased expression of ZYX mRNA CTD PMID:15980968 NCBI chr 4:72,203,991...72,213,181
Ensembl chr 4:72,204,007...72,213,181 		JBrowse link
fotemustine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO fotemustine results in increased expression of CDKN1A mRNA CTD PMID:25125662 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO fotemustine results in increased expression of FAS mRNA CTD PMID:25125662 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression 		ISO FOS mutant form inhibits the reaction [fotemustine results in increased expression of TREX1 mRNA]
fotemustine results in increased expression of FOS mRNA; fotemustine results in increased expression of FOS protein 		CTD PMID:23578789 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO fotemustine results in increased expression of GADD45A mRNA CTD PMID:25125662 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G H2ax H2A.X variant histone increases expression ISO fotemustine results in increased expression of H2AX protein modified form CTD PMID:25125662 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hsf1 heat shock transcription factor 1 increases activity ISO fotemustine results in increased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression 		ISO fotemustine promotes the reaction [JUN protein binds to TREX1 promoter]; JUN mutant form inhibits the reaction [fotemustine results in increased expression of TREX1 mRNA]
fotemustine results in increased expression of JUN mRNA; fotemustine results in increased expression of JUN protein 		CTD PMID:23578789 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase decreases response to substance ISO MGMT protein results in decreased susceptibility to fotemustine CTD PMID:12970393 PMID:16039682 PMID:20556481 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Polh DNA polymerase eta multiple interactions
decreases response to substance
increases expression 		ISO Dactinomycin inhibits the reaction [fotemustine results in increased expression of POLH mRNA]; fotemustine promotes the reaction [TP53 protein binds to POLH promoter]; pifithrin inhibits the reaction [fotemustine results in increased expression of POLH mRNA]; pifithrin inhibits the reaction [fotemustine results in increased expression of POLH protein]
POLH protein results in decreased susceptibility to fotemustine
fotemustine results in increased expression of POLH mRNA; fotemustine results in increased expression of POLH protein 		CTD PMID:25125662 NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression 		ISO fotemustine promotes the reaction [TP53 protein binds to POLH promoter]
fotemustine results in increased expression of TP53 protein; fotemustine results in increased expression of TP53 protein modified form 		CTD PMID:25125662 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Trex1 three prime repair exonuclease 1 multiple interactions
affects response to substance
increases expression 		ISO FOS mutant form inhibits the reaction [fotemustine results in increased expression of TREX1 mRNA]; fotemustine promotes the reaction [JUN protein binds to TREX1 promoter]; JUN mutant form inhibits the reaction [fotemustine results in increased expression of TREX1 mRNA]
TREX1 affects the susceptibility to fotemustine
fotemustine results in increased expression of TREX1 mRNA; fotemustine results in increased expression of TREX1 protein 		CTD PMID:23578789 NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083 		JBrowse link
lomustine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Lomustine results in increased expression of ABCB1 protein CTD PMID:15239124 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Ace2 angiotensin converting enzyme 2 decreases expression ISO Lomustine results in decreased expression of ACE2 mRNA CTD PMID:32808185 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO Lomustine results in increased expression of CDKN1A mRNA; Lomustine results in increased expression of CDKN1A protein CTD PMID:24211769 PMID:27358234 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO Lomustine results in increased expression of DDIT3 protein CTD PMID:27358234 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ina internexin neuronal intermediate filament protein, alpha multiple interactions ISO INA affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine] CTD PMID:21246521 NCBI chr 1:255,838,129...255,849,680
Ensembl chr 1:255,838,129...255,849,680 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions
decreases response to substance 		ISO MGMT protein affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine]
MGMT mRNA results in decreased susceptibility to Lomustine 		CTD PMID:15448748 PMID:16033832 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Polh DNA polymerase eta increases expression
multiple interactions
decreases response to substance 		ISO Lomustine results in increased expression of POLH mRNA; Lomustine results in increased expression of POLH protein
pifithrin inhibits the reaction [Lomustine results in increased expression of POLH protein]
POLH protein results in decreased susceptibility to Lomustine 		CTD PMID:25125662 NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577 		JBrowse link
G Socs1 suppressor of cytokine signaling 1 decreases expression ISO Lomustine results in decreased expression of SOCS1 mRNA CTD PMID:17374387 NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO Lomustine results in increased expression of SRXN1 protein CTD PMID:27358234 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Stmn1 stathmin 1 affects response to substance ISO STMN1 mRNA affects the susceptibility to Lomustine CTD PMID:17440165 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
N,N-bis(2-hydroxypropyl)nitrosamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression EXP diisopropanolnitrosamine results in increased expression of ALDH1A1 protein CTD PMID:33211169 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Cd44 CD44 molecule increases expression EXP diisopropanolnitrosamine results in increased expression of CD44 protein CTD PMID:33211169 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cp ceruloplasmin multiple interactions EXP [diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of CP protein CTD PMID:19497425 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions EXP [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein CTD PMID:34186418 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions EXP [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [bisphenol A co-treated with diisopropanolnitrosamine co-treated with Potassium Iodide] results in increased expression of ESR1 protein; [bisphenol A co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Potassium Iodide co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein CTD PMID:29050248 PMID:34186418 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G H2ax H2A.X variant histone increases phosphorylation EXP diisopropanolnitrosamine results in increased phosphorylation of H2AX protein CTD PMID:33211169 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hdac6 histone deacetylase 6 multiple interactions EXP [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein CTD PMID:34186418 NCBI chr  X:17,222,538...17,244,373
Ensembl chr  X:17,222,856...17,244,370 		JBrowse link
G Ifng interferon gamma multiple interactions EXP 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein]; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein CTD PMID:14736494 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Il2 interleukin 2 multiple interactions EXP [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IL2 protein CTD PMID:14736494 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Kras KRAS proto-oncogene, GTPase increases mutagenesis EXP diisopropanolnitrosamine results in increased mutagenesis of KRAS gene CTD PMID:18271921 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320 		JBrowse link
G Krt14 keratin 14 increases expression EXP diisopropanolnitrosamine results in increased expression of KRT14 protein CTD PMID:33211169 NCBI chr10:85,638,182...85,642,450 JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions EXP [diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein; [Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein; Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein] CTD PMID:19497425 PMID:22387750 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein CTD PMID:34186418 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP [Potassium Iodide co-treated with diisopropanolnitrosamine] results in increased expression of PCNA protein CTD PMID:29050248 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Tshb thyroid stimulating hormone subunit beta multiple interactions EXP [diisopropanolnitrosamine co-treated with Potassium Iodide] results in increased expression of TSHB protein CTD PMID:29050248 NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984 		JBrowse link
N,N-dimethyl-4-nitrosoaniline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Mgmt O-6-methylguanine-DNA methyltransferase decreases expression ISO
EXP 		4-nitrosodimethylaniline results in decreased expression of MGMT protein CTD PMID:15542103 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
N-butyl-N-(4-hydroxybutyl)nitrosamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression EXP Butylhydroxybutylnitrosamine results in increased expression of ALDH1A1 protein CTD PMID:33211169 PMID:35771629 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions EXP [Butylhydroxybutylnitrosamine co-treated with Propolis analog] results in increased expression of BIRC5 mRNA CTD PMID:26111810 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Cat catalase increases activity ISO Butylhydroxybutylnitrosamine results in increased activity of CAT protein CTD PMID:22095756 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions EXP [Butylhydroxybutylnitrosamine co-treated with Propolis analog] results in increased expression of CCND1 mRNA CTD PMID:26111810 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Cd44 CD44 molecule increases expression EXP Butylhydroxybutylnitrosamine results in increased expression of CD44 protein CTD PMID:33211169 PMID:35771629 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions EXP [Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of CHRNA7 protein CTD PMID:29501575 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 decreases expression ISO Butylhydroxybutylnitrosamine results in decreased expression of GSTM1 protein CTD PMID:24998975 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 increases expression ISO Butylhydroxybutylnitrosamine results in increased expression of GSTO1 protein CTD PMID:24998975 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G H2ax H2A.X variant histone increases expression EXP Butylhydroxybutylnitrosamine results in increased expression of H2AX protein CTD PMID:26338220 PMID:35771629 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hgf hepatocyte growth factor increases expression EXP Butylhydroxybutylnitrosamine results in increased expression of HGF protein CTD PMID:35771629 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Ifng interferon gamma multiple interactions EXP 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein]; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein CTD PMID:14736494 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Il2 interleukin 2 multiple interactions EXP [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IL2 protein CTD PMID:14736494 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Krt14 keratin 14 increases expression EXP Butylhydroxybutylnitrosamine results in increased expression of KRT14 protein CTD PMID:33211169 NCBI chr10:85,638,182...85,642,450 JBrowse link
G Krt15 keratin 15 increases expression ISO Butylhydroxybutylnitrosamine results in increased expression of KRT15 protein CTD PMID:24998975 NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142 		JBrowse link
G Krt18 keratin 18 decreases expression ISO Butylhydroxybutylnitrosamine results in decreased expression of KRT18 protein CTD PMID:24998975 NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848 		JBrowse link
G Krt8 keratin 8 decreases expression ISO Butylhydroxybutylnitrosamine results in decreased expression of KRT8 protein CTD PMID:24998975 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Ldhb lactate dehydrogenase B decreases expression ISO Butylhydroxybutylnitrosamine results in decreased expression of LDHB protein CTD PMID:24998975 NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408 		JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions EXP [Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein] CTD PMID:29501575 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I decreases expression ISO Butylhydroxybutylnitrosamine results in decreased expression of COX1 protein CTD PMID:22095756 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression 		ISO
EXP 		Butylhydroxybutylnitrosamine results in increased expression of and results in increased localization of MYC protein; Niacinamide inhibits the reaction [Butylhydroxybutylnitrosamine results in increased expression of and results in increased localization of MYC protein]
Butylhydroxybutylnitrosamine results in increased expression of MYC mRNA 		CTD PMID:22028816 PMID:35771629 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 decreases expression ISO Butylhydroxybutylnitrosamine results in decreased expression of NQO1 protein CTD PMID:24998975 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Numa1 nuclear mitotic apparatus protein 1 multiple interactions EXP 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein] CTD PMID:26251508 NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:165,709,905...165,784,848 		JBrowse link
G Pmp22 peripheral myelin protein 22 multiple interactions ISO Butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein; Niacinamide inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein] CTD PMID:22028816 NCBI chr10:48,294,932...48,324,941
Ensembl chr10:48,297,437...48,324,940 		JBrowse link
G Pten phosphatase and tensin homolog multiple interactions EXP 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein] CTD PMID:26251508 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein] CTD PMID:26251508 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein] CTD PMID:26251508 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Sp1 Sp1 transcription factor increases expression ISO Butylhydroxybutylnitrosamine results in increased expression of SP1 protein CTD PMID:24998975 NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
increases expression 		EXP [Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form]
Butylhydroxybutylnitrosamine results in increased expression of STAT3 mRNA 		CTD PMID:29501575 PMID:35771629 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein] CTD PMID:26251508 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Top2a DNA topoisomerase II alpha multiple interactions EXP [Butylhydroxybutylnitrosamine co-treated with Propolis analog] results in increased expression of TOP2A mRNA CTD PMID:26111810 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366 		JBrowse link
G Tp53 tumor protein p53 affects activity ISO TRP53 affects the activity of Butylhydroxybutylnitrosamine CTD PMID:10395176 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions
decreases expression 		ISO oltipraz inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of UGT1A7 mRNA] CTD PMID:15374950 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a6a UDP glucuronosyltransferase family 1 member A6a decreases expression
multiple interactions 		ISO Butylhydroxybutylnitrosamine results in decreased expression of UGT1A mRNA
oltipraz inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of UGT1A mRNA] 		CTD PMID:15374950 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression EXP Butylhydroxybutylnitrosamine results in increased expression of VEGFA protein CTD PMID:24888239 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
N-ethyl-N-(2-hydroxyethyl)nitrosamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gjb1 gap junction protein, beta 1 decreases expression EXP N-ethyl-N-hydroxyethylnitrosamine results in decreased expression of GJB1 mRNA CTD PMID:2559087 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
N-ethyl-N-nitrosourea term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aars1 alanyl-tRNA synthetase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AARS1 mRNA CTD PMID:27776689 NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497 		JBrowse link
G Abcd1 ATP binding cassette subfamily D member 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ABCD1 mRNA CTD PMID:27776689 NCBI chr  X:156,579,669...156,601,448
Ensembl chr  X:156,579,785...156,601,446 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of ABCG5 gene CTD PMID:16495775 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ACACA intron CTD PMID:27776689 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain increases expression EXP Ethylnitrosourea results in increased expression of ACADL mRNA CTD PMID:15954086 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Actn4 actinin alpha 4 increases expression EXP Ethylnitrosourea results in increased expression of ACTN4 mRNA CTD PMID:15954086 NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320 		JBrowse link
G Adam1a ADAM metallopeptidase domain 1a increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ADAM1A mRNA CTD PMID:27776689 NCBI chr12:40,674,460...40,680,988
Ensembl chr12:40,676,918...40,684,619 		JBrowse link
G Adgrf4 adhesion G protein-coupled receptor F4 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of ADGRF4 gene CTD PMID:16495775 NCBI chr 9:25,769,265...25,800,438
Ensembl chr 9:25,769,265...25,800,438 		JBrowse link
G Adgrv1 adhesion G protein-coupled receptor V1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ADGRV1 gene CTD PMID:17329413 NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:13,067,150...13,647,372 		JBrowse link
G Adra2b adrenoceptor alpha 2B increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of ADRA2B gene CTD PMID:16495775 NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525 		JBrowse link
G Aen apoptosis enhancing nuclease increases expression ISO Ethylnitrosourea results in increased expression of AEN mRNA CTD PMID:19100860 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Aff1 ALF transcription elongation factor 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AFF1 gene CTD PMID:16724327 NCBI chr14:6,165,864...6,328,848
Ensembl chr14:6,169,562...6,328,879 		JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AGAP1 mRNA CTD PMID:27776689 NCBI chr 9:97,487,382...97,922,870
Ensembl chr 9:97,487,406...97,922,870 		JBrowse link
G Aip aryl-hydrocarbon receptor-interacting protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AIP gene CTD PMID:27776689 NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation ISO Ethylnitrosourea results in increased phosphorylation of AKT1 protein CTD PMID:32902906 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ALDH1L2 mRNA CTD PMID:27776689 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Alg5 ALG5, dolichyl-phosphate beta-glucosyltransferase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ALG5 gene CTD PMID:15755804 NCBI chr 2:141,087,126...141,101,397
Ensembl chr 2:141,087,147...141,102,951 		JBrowse link
G Alk ALK receptor tyrosine kinase multiple interactions
increases mutagenesis 		ISO [Ethylnitrosourea results in increased mutagenesis of ALK protein] inhibits the reaction [crizotinib results in decreased phosphorylation of ALK protein]; [Ethylnitrosourea results in increased mutagenesis of ALK protein] which results in decreased susceptibility to crizotinib; [Ethylnitrosourea results in increased mutagenesis of ALK protein] which results in decreased susceptibility to NVP-TAE684 CTD PMID:21948233 PMID:22034911 NCBI chr 6:28,631,431...29,351,321
Ensembl chr 6:28,632,197...29,349,721 		JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ALMS1 mRNA CTD PMID:27776689 NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471 		JBrowse link
G Ankrd11 ankyrin repeat domain containing 11 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ANKRD11 gene CTD PMID:17986521 NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491 		JBrowse link
G Ankrd35 ankyrin repeat domain 35 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ANKRD35 intron CTD PMID:27776689 NCBI chr 2:186,895,896...186,915,903
Ensembl chr 2:186,895,945...186,915,902 		JBrowse link
G Ankrd6 ankyrin repeat domain 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ANKRD6 mRNA CTD PMID:27776689 NCBI chr 5:51,999,225...52,139,623
Ensembl chr 5:51,999,221...52,139,594 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ANTXR1 intron CTD PMID:16300676 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Aoc3 amine oxidase, copper containing 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AOC3 intron CTD PMID:27776689 NCBI chr10:86,773,018...86,780,961 JBrowse link
G Ap2a1 adaptor related protein complex 2 subunit alpha 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AP2A1 exon CTD PMID:16300676 NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655 		JBrowse link
G Ap2m1 adaptor related protein complex 2 subunit mu 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AP2M1 gene CTD PMID:27776689 NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480 		JBrowse link
G Apc APC regulator of WNT signaling pathway increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of APC gene CTD PMID:16724327 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Aplnr apelin receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of APLNR 3' UTR CTD PMID:27776689 NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908 		JBrowse link
G Aqp2 aquaporin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of AQP2 exon CTD PMID:16121255 NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:132,590,225...132,595,319 		JBrowse link
G Arcn1 archain 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ARCN1 gene CTD PMID:20502676 NCBI chr 8:53,954,401...53,979,005
Ensembl chr 8:53,954,404...53,979,005 		JBrowse link
G Arl13b ARF like GTPase 13B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ARL13B gene CTD PMID:15755804 NCBI chr11:13,597,538...13,663,681
Ensembl chr11:13,597,538...13,663,546 		JBrowse link
G Asip agouti signaling protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of A gene CTD PMID:9475716 PMID:10517996 NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378 		JBrowse link
G Atf7ip activating transcription factor 7 interacting protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ATF7IP mRNA CTD PMID:27776689 NCBI chr 4:171,117,122...171,202,871
Ensembl chr 4:171,117,122...171,202,867 		JBrowse link
G Atg12 autophagy related 12 multiple interactions
decreases expression 		ISO Quercetin inhibits the reaction [Ethylnitrosourea results in decreased expression of ATG12 protein] CTD PMID:32902906 NCBI chr18:41,638,841...41,649,311
Ensembl chr18:41,635,835...41,649,261 		JBrowse link
G Atrx ATRX, chromatin remodeler increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of ATRX gene CTD PMID:16495775 NCBI chr  X:74,916,548...75,062,880
Ensembl chr  X:74,916,548...75,062,880 		JBrowse link
G Avpr1a arginine vasopressin receptor 1A increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of AVPR1A gene CTD PMID:16495775 NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837 		JBrowse link
G Bad BCL2-associated agonist of cell death increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BAD gene CTD PMID:27776689 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bahd1 bromo adjacent homology domain containing 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BAHD1 gene CTD PMID:27776689 NCBI chr 3:126,341,853...126,368,281
Ensembl chr 3:126,345,371...126,368,278 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
affects expression 		ISO
EXP 		Ethylnitrosourea results in increased expression of BAX mRNA
Ethylnitrosourea affects the expression of BAX mRNA 		CTD PMID:11356909 PMID:15954086 PMID:19100860 PMID:30944280 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcap31 B-cell receptor-associated protein 31 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BCAP31 gene CTD PMID:27776689 NCBI chr  X:156,548,911...156,581,002
Ensembl chr  X:156,548,911...156,579,371 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BCAT2 gene CTD PMID:14755340 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression ISO Ethylnitrosourea results in increased expression of BCL2 mRNA CTD PMID:30944280 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 increases expression ISO Ethylnitrosourea results in increased expression of BCL2L1 mRNA CTD PMID:30944280 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bdnf brain-derived neurotrophic factor increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of BDNF gene CTD PMID:16495775 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Becn1 beclin 1 decreases phosphorylation
multiple interactions 		ISO Ethylnitrosourea results in decreased phosphorylation of BECN1 protein
Quercetin inhibits the reaction [Ethylnitrosourea results in decreased phosphorylation of BECN1 protein] 		CTD PMID:32902906 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bmp5 bone morphogenetic protein 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BMP5 gene CTD PMID:9475716 PMID:9825669 PMID:10517996 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BOP1 gene CTD PMID:27776689 NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529 		JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of BRWD1 gene CTD PMID:18353305 NCBI chr11:48,756,174...48,853,692
Ensembl chr11:48,756,811...48,848,256 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO Ethylnitrosourea results in increased expression of BTG2 mRNA CTD PMID:19100860 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G C3 complement C3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of C3 mRNA CTD PMID:27776689 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G Cabcoco1 ciliary associated calcium binding coiled-coil 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CABCOCO1 mRNA CTD PMID:27776689 NCBI chr20:20,057,462...20,166,732
Ensembl chr20:20,057,517...20,167,174 		JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CACNA1A exon; Ethylnitrosourea results in increased mutagenesis of CACNA1A gene CTD PMID:16724327 PMID:17376154 NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599 		JBrowse link
G Cacna2d2 calcium voltage-gated channel auxiliary subunit alpha2delta 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CACNA2D2 gene CTD PMID:16724327 NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:116,950,907...117,081,759 		JBrowse link
G Capsl calcyphosine-like increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CAPSL exon; Ethylnitrosourea results in increased mutagenesis of CAPSL intron CTD PMID:16300676 NCBI chr 2:60,122,162...60,152,692
Ensembl chr 2:60,138,589...60,152,838 		JBrowse link
G Card11 caspase recruitment domain family, member 11 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CARD11 gene CTD PMID:16724327 NCBI chr12:18,735,088...18,872,045
Ensembl chr12:18,735,088...18,872,045 		JBrowse link
G Casp3 caspase 3 increases cleavage ISO Ethylnitrosourea results in increased cleavage of CASP3 protein CTD PMID:28549617 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Cckbr cholecystokinin B receptor increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of CCKBR gene CTD PMID:16495775 NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745 		JBrowse link
G Ccnd1 cyclin D1 increases expression EXP Ethylnitrosourea results in increased expression of CCND1 mRNA CTD PMID:15954086 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccne2 cyclin E2 multiple interactions
decreases expression 		ISO DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of CCNE2 mRNA]; Ethylnitrosourea affects the reaction [DICER1 protein affects the expression of CCNE2 mRNA] CTD PMID:24478143 NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882 		JBrowse link
G Ccng1 cyclin G1 increases expression ISO
EXP 		Ethylnitrosourea results in increased expression of CCNG1 mRNA CTD PMID:15954086 PMID:19100860 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Cct8 chaperonin containing TCP1 subunit 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CCT8 mRNA CTD PMID:27776689 NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328 		JBrowse link
G Cd302 CD302 molecule increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CD302 intron CTD PMID:27776689 NCBI chr 3:65,131,017...65,164,737
Ensembl chr 3:65,113,102...65,164,737 		JBrowse link
G Cd36 CD36 molecule increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CD36 gene CTD PMID:15690042 PMID:16724327 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd4 Cd4 molecule increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CD4 intron CTD PMID:27776689 NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461 		JBrowse link
G Cd59b CD59b molecule increases mutagenesis
decreases lipidation
multiple interactions 		ISO
EXP 		Ethylnitrosourea results in increased mutagenesis of CD59 protein
Ethylnitrosourea results in decreased lipidation of CD59 protein
[Ethylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Ethylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein 		CTD PMID:17045307 PMID:19965957 PMID:20202993 PMID:27931811 NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310 		JBrowse link
G Cd83 CD83 molecule increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CD83 gene CTD PMID:16724327 NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047 		JBrowse link
G Cdan1 codanin 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CDAN1 mRNA CTD PMID:27776689 NCBI chr 3:128,129,664...128,143,520
Ensembl chr 3:128,129,301...128,143,549 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions 		EXP
ISO 		Ethylnitrosourea results in increased expression of CDKN1A mRNA
Ethylnitrosourea results in decreased expression of CDKN1A mRNA
DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of CDKN1A mRNA] 		CTD PMID:15954086 PMID:19100860 PMID:24211769 PMID:24478143 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases response to substance
multiple interactions
decreases expression 		ISO CDKN2A gene mutant form results in increased susceptibility to Ethylnitrosourea
Phytic Acid inhibits the reaction [Ethylnitrosourea results in decreased expression of CDKN2A] 		CTD PMID:17943659 PMID:21154115 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C decreases expression ISO Ethylnitrosourea results in decreased expression of CDKN2C protein CTD PMID:28549617 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CELSR1 gene CTD PMID:16724327 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Cep104 centrosomal protein 104 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CEP104 gene CTD PMID:27776689 NCBI chr 5:169,817,383...169,849,681
Ensembl chr 5:169,817,182...169,852,695 		JBrowse link
G Cep95 centrosomal protein 95 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CEP95 mRNA CTD PMID:27776689 NCBI chr10:92,231,829...92,259,813
Ensembl chr10:92,231,512...92,259,810 		JBrowse link
G Chd9 chromodomain helicase DNA binding protein 9 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CHD9 mRNA CTD PMID:27776689 NCBI chr19:32,114,379...32,337,488
Ensembl chr19:32,115,920...32,319,042 		JBrowse link
G Chek2 checkpoint kinase 2 decreases expression ISO Ethylnitrosourea results in decreased expression of CHEK2 protein CTD PMID:28549617 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Chgb chromogranin B increases expression EXP Ethylnitrosourea results in increased expression of CHGB mRNA CTD PMID:15954086 NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054 		JBrowse link
G Chrm5 cholinergic receptor, muscarinic 5 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of CHRM5 gene CTD PMID:16495775 NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:119,735,975...119,792,166 		JBrowse link
G Chrna6 cholinergic receptor nicotinic alpha 6 subunit increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of CHRNA6 gene CTD PMID:16495775 NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315 		JBrowse link
G Chrnd cholinergic receptor nicotinic delta subunit increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of CHRND gene CTD PMID:16495775 NCBI chr 9:95,310,316...95,318,734
Ensembl chr 9:95,310,298...95,318,745 		JBrowse link
G Chst14 carbohydrate sulfotransferase 14 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CHST14 intron; Ethylnitrosourea results in increased mutagenesis of CHST14 mRNA CTD PMID:27776689 NCBI chr 3:126,370,348...126,372,405
Ensembl chr 3:126,370,348...126,372,777 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of COL1A2 intron CTD PMID:27776689 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of COL4A1 gene CTD PMID:16724327 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of COL6A3 mRNA CTD PMID:27776689 NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Commd4 COMM domain containing 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of COMMD4 gene CTD PMID:27776689 NCBI chr 8:66,462,188...66,465,700
Ensembl chr 8:66,462,188...66,465,756 		JBrowse link
G Cox11 cytochrome c oxidase copper chaperone COX11 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of COX11 mRNA CTD PMID:27776689 NCBI chr10:75,955,825...75,962,398
Ensembl chr10:75,955,783...75,963,489 		JBrowse link
G Cpn1 carboxypeptidase N subunit 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CPN1 mRNA CTD PMID:27776689 NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:252,793,423...252,822,664 		JBrowse link
G Cryaa crystallin, alpha A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CRYAA gene CTD PMID:16724327 NCBI chr20:9,784,872...9,788,656
Ensembl chr20:9,784,857...9,788,654 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CRYBG2 intron CTD PMID:27776689 NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163 		JBrowse link
G Crygb crystallin, gamma B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CRYGB exon CTD PMID:15878859 NCBI chr 9:73,955,204...73,957,264
Ensembl chr 9:73,955,204...73,957,264 		JBrowse link
G Ctnna1 catenin alpha 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CTNNA1 intron CTD PMID:27776689 NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007 		JBrowse link
G Ctrl chymotrypsin-like increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CTRB1 intron CTD PMID:27776689 NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979 		JBrowse link
G Cux2 cut-like homeobox 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CUX2 intron CTD PMID:27776689 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CYP17A1 mRNA CTD PMID:27776689 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp46a1 cytochrome P450, family 46, subfamily a, polypeptide 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of CYP46A1 mRNA CTD PMID:27776689 NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971 		JBrowse link
G Cysltr2 cysteinyl leukotriene receptor 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of CYSLTR2 gene CTD PMID:16495775 NCBI chr15:54,599,043...54,638,314
Ensembl chr15:54,598,818...54,713,597 		JBrowse link
G Dalrd3 DALR anticodon binding domain containing 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DALRD3 mRNA CTD PMID:27776689 NCBI chr 8:118,142,009...118,147,082
Ensembl chr 8:118,144,197...118,147,822 		JBrowse link
G Dbh dopamine beta-hydroxylase increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of DBH gene CTD PMID:16495775 NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316 		JBrowse link
G Dcbld2 discoidin, CUB and LCCL domain containing 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of DCBLD2 gene CTD PMID:16495775 NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085 		JBrowse link
G Dchs1 dachsous cadherin-related 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DCHS1 mRNA CTD PMID:27776689 NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:169,516,762...169,536,639 		JBrowse link
G Dclre1b DNA cross-link repair 1B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DCLRE1B mRNA CTD PMID:27776689 NCBI chr 2:193,998,350...194,006,873
Ensembl chr 2:193,998,354...194,006,864 		JBrowse link
G Dcp1b decapping mRNA 1B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DCP1B mRNA CTD PMID:27776689 NCBI chr 4:154,030,181...154,068,038
Ensembl chr 4:154,030,690...154,068,035 		JBrowse link
G Ddx5 DEAD-box helicase 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DDX5 gene CTD PMID:27776689 NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300 		JBrowse link
G Depdc1b DEP domain containing 1B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DEPDC1B intron CTD PMID:27776689 NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:41,624,922...41,697,202 		JBrowse link
G Derl3 derlin 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DERL3 mRNA CTD PMID:27776689 NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477 		JBrowse link
G Dffb DNA fragmentation factor subunit beta increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DFFB intron CTD PMID:27776689 NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225 		JBrowse link
G Dhx37 DEAH-box helicase 37 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DHX37 mRNA CTD PMID:27776689 NCBI chr12:36,856,119...36,876,245
Ensembl chr12:36,849,701...36,876,240 		JBrowse link
G Dhx38 DEAH-box helicase 38 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DHX38 mRNA CTD PMID:27776689 NCBI chr19:54,422,418...54,439,434
Ensembl chr19:54,422,418...54,439,423 		JBrowse link
G Dicer1 dicer 1 ribonuclease III multiple interactions ISO DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of CCNE2 mRNA]; DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of CDKN1A mRNA]; DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of GADD45B mRNA]; DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of JUN mRNA]; Ethylnitrosourea affects the reaction [DICER1 protein affects the expression of CCNE2 mRNA] CTD PMID:24478143 NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252 		JBrowse link
G Dip2a disco-interacting protein 2 homolog A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DIP2A intron CTD PMID:27776689 NCBI chr20:12,284,037...12,373,519
Ensembl chr20:12,284,038...12,370,532 		JBrowse link
G Disp1 dispatched RND transporter family member 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DISP1 gene CTD PMID:15755804 PMID:16724327 NCBI chr13:97,252,574...97,398,329
Ensembl chr13:97,252,574...97,398,460 		JBrowse link
G Dmd dystrophin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DMD gene CTD PMID:16724327 NCBI chr  X:51,070,098...53,437,845
Ensembl chr  X:51,070,273...53,437,835 		JBrowse link
G Dnah5 dynein, axonemal, heavy chain 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DNAH5 mRNA CTD PMID:27776689 NCBI chr 2:80,668,182...80,985,918
Ensembl chr 2:80,668,208...80,985,914 		JBrowse link
G Dnajc2 DnaJ heat shock protein family (Hsp40) member C2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DNAJC2 gene CTD PMID:27776689 NCBI chr 4:14,162,490...14,189,662
Ensembl chr 4:14,163,838...14,192,846 		JBrowse link
G Dnm3 dynamin 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DNM3 gene CTD PMID:27776689 NCBI chr13:76,892,381...77,371,346
Ensembl chr13:76,892,171...77,371,350 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Ethylnitrosourea results in increased expression of DNMT1 CTD PMID:21154115 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Drd1 dopamine receptor D1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of DRD1 gene CTD PMID:16495775 NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166 		JBrowse link
G Dscam DS cell adhesion molecule increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DSCAM mRNA CTD PMID:27776689 NCBI chr11:49,391,385...49,976,861
Ensembl chr11:49,347,531...49,976,238 		JBrowse link
G Dst dystonin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DST gene CTD PMID:16724327 NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533 		JBrowse link
G Dtx3l deltex E3 ubiquitin ligase 3L increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DTX3L mRNA CTD PMID:27776689 NCBI chr11:78,320,225...78,329,837
Ensembl chr11:78,317,650...78,329,837 		JBrowse link
G Dvl3 dishevelled segment polarity protein 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DVL3 mRNA CTD PMID:27776689 NCBI chr11:93,869,834...93,887,013
Ensembl chr11:93,869,834...93,886,903 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DYNC1H1 gene CTD PMID:16724327 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116 		JBrowse link
G Dync2h1 dynein cytoplasmic 2 heavy chain 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of DYNC2H1 gene CTD PMID:15755804 NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:12,473,955...12,697,058 		JBrowse link
G Edn3 endothelin 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EDN3 exon CTD PMID:17516928 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329 		JBrowse link
G Ednrb endothelin receptor type B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EDNRB gene CTD PMID:9475716 PMID:17174358 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Egfr epidermal growth factor receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EGFR gene CTD PMID:15366372 PMID:16724327 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EIF3J gene CTD PMID:27776689 NCBI chr 3:129,438,715...129,460,953
Ensembl chr 3:129,438,722...129,462,246 		JBrowse link
G Emx2 empty spiracles homeobox 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EMX2 gene CTD PMID:16724327 NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671 		JBrowse link
G Enam enamelin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ENAM exon; Ethylnitrosourea results in increased mutagenesis of ENAM intron CTD PMID:15649948 PMID:17652207 NCBI chr14:19,840,773...19,865,476
Ensembl chr14:19,840,773...19,865,468 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EPB41L5 gene CTD PMID:15755804 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression EXP Ethylnitrosourea results in increased expression of EPHX1 mRNA CTD PMID:15954086 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of ERBB2 gene CTD PMID:16651423 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Exosc5 exosome component 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of EXOSC5 gene CTD PMID:27776689 NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046 		JBrowse link
G Fah fumarylacetoacetate hydrolase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FAH gene CTD PMID:16180137 PMID:16724327 NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046 		JBrowse link
G Fam216a family with sequence similarity 216, member A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FAM216A gene CTD PMID:27776689 NCBI chr12:39,859,307...39,868,450
Ensembl chr12:39,859,172...39,868,442 		JBrowse link
G Fam98a family with sequence similarity 98, member A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FAM98A mRNA CTD PMID:27776689 NCBI chr 6:25,626,108...25,640,767
Ensembl chr 6:25,625,984...25,640,767 		JBrowse link
G Fancc FA complementation group C increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FANCC mRNA CTD PMID:27776689 NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096 		JBrowse link
G Fat2 FAT atypical cadherin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FAT2 mRNA CTD PMID:27776689 NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression EXP Ethylnitrosourea results in decreased expression of FDFT1 mRNA CTD PMID:15954086 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fech ferrochelatase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FECH gene CTD PMID:16724327 NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546 		JBrowse link
G Fmn2 formin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FMN2 mRNA CTD PMID:27776689 NCBI chr13:88,986,863...89,303,789
Ensembl chr13:88,986,842...89,303,789 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Ethylnitrosourea results in increased expression of FOS mRNA CTD PMID:19100860 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Foxf2 forkhead box F2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FOXF2 gene CTD PMID:16724327 NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259 		JBrowse link
G Foxn1 forkhead box N1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FOXN1 gene CTD PMID:16972005 NCBI chr10:63,749,461...63,778,468
Ensembl chr10:63,749,461...63,771,771 		JBrowse link
G Foxo1 forkhead box O1 increases expression ISO Ethylnitrosourea results in increased expression of FOXO1 protein CTD PMID:32902906 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Frem1 Fras1 related extracellular matrix 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FREM1 gene CTD PMID:23221805 NCBI chr 5:102,367,201...102,515,464
Ensembl chr 5:102,367,201...102,515,404 		JBrowse link
G Fryl FRY like transcription coactivator increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of FRYL mRNA CTD PMID:27776689 NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147 		JBrowse link
G Fshr follicle stimulating hormone receptor increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of FSHR gene CTD PMID:16495775 NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression
decreases expression
multiple interactions 		ISO Ethylnitrosourea results in increased expression of GADD45B mRNA
Ethylnitrosourea results in decreased expression of GADD45B mRNA
DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of GADD45B mRNA] 		CTD PMID:19100860 PMID:24478143 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718 		JBrowse link
G Gal3st3 galactose-3-O-sulfotransferase 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GAL3ST3 gene CTD PMID:27776689 NCBI chr 1:212,022,989...212,032,802
Ensembl chr 1:212,023,000...212,032,801 		JBrowse link
G Gata1 GATA binding protein 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GATA1 gene CTD PMID:16966598 NCBI chr  X:17,193,291...17,209,462
Ensembl chr  X:17,201,633...17,209,459 		JBrowse link
G Gata6 GATA binding protein 6 multiple interactions
increases activity 		ISO Ethylnitrosourea promotes the reaction [GATA6 protein binds to KRAS exon]
Ethylnitrosourea results in increased activity of GATA6 protein 		CTD PMID:16271038 NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322 		JBrowse link
G Gck glucokinase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GCK exon; Ethylnitrosourea results in increased mutagenesis of GCK gene CTD PMID:15102714 PMID:15161764 PMID:16724327 PMID:18056790 NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949 		JBrowse link
G Gcm2 glial cells missing transcription factor 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GCM2 mRNA CTD PMID:27776689 NCBI chr17:23,858,379...23,867,495
Ensembl chr17:23,858,379...23,867,495 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO Ethylnitrosourea results in increased expression of GDF15 mRNA CTD PMID:19100860 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gfi1 growth factor independent 1 transcriptional repressor decreases expression ISO Ethylnitrosourea results in decreased expression of GFI1 protein CTD PMID:28549617 NCBI chr14:2,185,489...2,204,191
Ensembl chr14:2,187,286...2,196,730 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GGT1 gene CTD PMID:16724327 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050 		JBrowse link
G Gja1 gap junction protein, alpha 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GJA1 exon; Ethylnitrosourea results in increased mutagenesis of GJA1 gene CTD PMID:15548583 PMID:16155213 PMID:16724327 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gja8 gap junction protein, alpha 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GJA8 gene CTD PMID:16724327 NCBI chr 2:187,179,668...187,181,284
Ensembl chr 2:187,175,507...187,186,167 		JBrowse link
G Gjb1 gap junction protein, beta 1 multiple interactions EXP [Ethylnitrosourea co-treated with chlorendic acid] results in decreased expression of GJB1 protein; [Ethylnitrosourea co-treated with ciprofibrate] results in decreased expression of GJB1 protein; [Ethylnitrosourea co-treated with Dioxins] results in decreased expression of GJB1 protein; [Ethylnitrosourea co-treated with Phenobarbital] results in decreased expression of GJB1 protein; [Ethylnitrosourea co-treated with pirinixic acid] results in decreased expression of GJB1 protein; [Ethylnitrosourea co-treated with Tamoxifen] results in decreased expression of GJB1 protein CTD PMID:1973356 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
G Gjb2 gap junction protein, beta 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GJB2 gene CTD PMID:16724327 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Gli1 GLI family zinc finger 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GLI1 mRNA CTD PMID:27776689 NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gli3 GLI family zinc finger 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GLI3 gene CTD PMID:18397875 NCBI chr17:54,134,064...54,405,198
Ensembl chr17:54,134,064...54,405,198 		JBrowse link
G Glra1 glycine receptor, alpha 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GLRA1 exon CTD PMID:16964444 NCBI chr10:40,128,284...40,228,612
Ensembl chr10:40,130,121...40,227,815 		JBrowse link
G Gna11 G protein subunit alpha 11 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GNA11 gene CTD PMID:16724327 NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558 		JBrowse link
G Gnaq G protein subunit alpha q increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GNAQ gene CTD PMID:16724327 NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742 		JBrowse link
G Gnas GNAS complex locus increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GNAS gene CTD PMID:16724327 NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536 		JBrowse link
G Gnptg N-acetylglucosamine-1-phosphate transferase subunit gamma increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GNPTG intron CTD PMID:27776689 NCBI chr10:14,756,685...14,761,636 JBrowse link
G Gnrhr gonadotropin releasing hormone receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GNRHR gene CTD PMID:15625238 NCBI chr14:22,211,666...22,229,654 JBrowse link
G Gpatch2 G patch domain containing 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GPATCH2 mRNA CTD PMID:27776689 NCBI chr13:101,316,413...101,457,109
Ensembl chr13:101,316,413...101,457,109 		JBrowse link
G Gpkow G patch domain and KOW motifs increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GPKOW mRNA CTD PMID:27776689 NCBI chr  X:17,463,521...17,478,298
Ensembl chr  X:17,463,525...17,478,298 		JBrowse link
G Gpr137 G protein-coupled receptor 137 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GPR137 intron CTD PMID:27776689 NCBI chr 1:213,558,846...213,562,422
Ensembl chr 1:213,558,846...213,563,966 		JBrowse link
G Gpr153 G protein-coupled receptor 153 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GPR153 gene CTD PMID:27776689 NCBI chr 5:168,064,134...168,075,697
Ensembl chr 5:168,064,311...168,074,532 		JBrowse link
G Gpr33-ps1 G protein-coupled receptor 33, pseudogene 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GPR33 gene CTD PMID:16720677 NCBI chr 6:75,209,776...75,210,781
Ensembl chr 6:75,209,776...75,210,781 		JBrowse link
G Grid2 glutamate ionotropic receptor delta type subunit 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GRID2 gene CTD PMID:16724327 NCBI chr 4:93,745,165...95,222,354
Ensembl chr 4:93,745,277...95,219,868 		JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of GRIK1 gene CTD PMID:16495775 NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517 		JBrowse link
G Grm6 glutamate metabotropic receptor 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GRM6 exon CTD PMID:17430614 NCBI chr10:35,669,003...35,683,729
Ensembl chr10:35,669,003...35,683,729 		JBrowse link
G Grm8 glutamate metabotropic receptor 8 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of GRM8 gene CTD PMID:16495775 NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:56,770,771...57,687,639 		JBrowse link
G Grpr gastrin releasing peptide receptor increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of GRPR gene CTD PMID:16495775 NCBI chr  X:34,630,238...34,670,245
Ensembl chr  X:34,630,229...34,670,245 		JBrowse link
G Gsdme gasdermin E increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of GSDME mRNA CTD PMID:27776689 NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta decreases expression ISO Ethylnitrosourea results in decreased expression of GSK3B protein CTD PMID:28549617 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 affects response to substance ISO GSTT1 gene polymorphism affects the susceptibility to Ethylnitrosourea CTD PMID:17158087 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G H2ax H2A.X variant histone increases phosphorylation ISO Ethylnitrosourea results in increased phosphorylation of H2AX protein CTD PMID:34510228 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HADHB exon CTD PMID:17116638 NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835 		JBrowse link
G Hdac1 histone deacetylase 1 increases expression ISO Ethylnitrosourea results in increased expression of HDAC1 CTD PMID:21154115 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HECTD1 gene CTD PMID:15755804 NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408 		JBrowse link
G Hes3 hes family bHLH transcription factor 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HES3 mRNA CTD PMID:27776689 NCBI chr 5:168,076,337...168,082,270
Ensembl chr 5:168,077,093...168,078,987 		JBrowse link
G Hfe homeostatic iron regulator increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HFE mRNA CTD PMID:27776689 NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208 		JBrowse link
G Hikeshi heat shock protein nuclear import factor hikeshi increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HIKESHI gene CTD PMID:16157679 NCBI chr 1:153,237,948...153,261,856
Ensembl chr 1:153,237,948...153,261,911 		JBrowse link
G Hmcn2 hemicentin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HMCN2 3' UTR; Ethylnitrosourea results in increased mutagenesis of HMCN2 intron; Ethylnitrosourea results in increased mutagenesis of HMCN2 mRNA CTD PMID:27776689 NCBI chr 3:34,986,246...35,136,047
Ensembl chr 3:34,986,263...35,136,106 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression EXP Ethylnitrosourea results in decreased expression of HMGCS1 mRNA CTD PMID:15954086 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO Ethylnitrosourea results in increased expression of HMOX1 mRNA CTD PMID:19100860 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hoxd12 homeo box D12 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HOXD12 gene CTD PMID:19108020 NCBI chr 3:79,985,106...79,986,227
Ensembl chr 3:79,985,106...79,986,227 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases mutagenesis EXP
ISO 		Ethylnitrosourea results in increased mutagenesis of HPRT1 gene CTD PMID:22167886 PMID:32529823 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hr HR, lysine demethylase and nuclear receptor corepressor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HR exon; Ethylnitrosourea results in increased mutagenesis of HR gene CTD PMID:16455232 PMID:16461637 PMID:16724327 NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015 		JBrowse link
G Hras HRas proto-oncogene, GTPase increases response to substance ISO HRAS protein results in increased susceptibility to Ethylnitrosourea CTD PMID:11182032 PMID:26558449 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrc histidine rich calcium binding protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HRC mRNA CTD PMID:27776689 NCBI chr 1:104,949,750...104,953,475
Ensembl chr 1:104,949,741...104,954,193 		JBrowse link
G Hsf1 heat shock transcription factor 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of HSF1 3' UTR CTD PMID:27776689 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of HSP90AB1 gene CTD PMID:16495775 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926 		JBrowse link
G Htt huntingtin increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of HTT gene CTD PMID:16495775 NCBI chr14:80,070,456...80,219,668
Ensembl chr14:80,070,456...80,219,668 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression EXP Ethylnitrosourea results in increased expression of ID1 mRNA CTD PMID:15954086 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression EXP Ethylnitrosourea results in increased expression of ID3 mRNA CTD PMID:15954086 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Ifi35 interferon-induced protein 35 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IFI35 gene CTD PMID:27776689 NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750 		JBrowse link
G Ift172 intraflagellar transport 172 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IFT172 gene CTD PMID:15755804 NCBI chr 6:30,801,841...30,841,239
Ensembl chr 6:30,801,918...30,840,830 		JBrowse link
G Ift88 intraflagellar transport 88 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IFT88 gene CTD PMID:15755804 PMID:16724327 NCBI chr15:35,685,678...35,786,875
Ensembl chr15:35,688,927...35,781,634 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor increases mutagenesis
increases phosphorylation 		ISO Ethylnitrosourea results in increased mutagenesis of IGF1R gene
Ethylnitrosourea results in increased phosphorylation of IGF1R protein 		CTD PMID:16461637 PMID:32902906 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Ikzf1 IKAROS family zinc finger 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IKZF1 gene CTD PMID:15790496 NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574 		JBrowse link
G Il7 interleukin 7 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IL7 exon CTD PMID:17151827 PMID:17179092 NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:96,142,092...96,187,389 		JBrowse link
G Ina internexin neuronal intermediate filament protein, alpha increases expression EXP Ethylnitrosourea results in increased expression of INA mRNA CTD PMID:15954086 NCBI chr 1:255,838,129...255,849,680
Ensembl chr 1:255,838,129...255,849,680 		JBrowse link
G Inpp5d inositol polyphosphate-5-phosphatase D decreases expression ISO Ethylnitrosourea results in decreased expression of INPP5D protein CTD PMID:32902906 NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589 		JBrowse link
G Ins2 insulin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of INS2 gene CTD PMID:18056790 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Insig1 insulin induced gene 1 decreases expression EXP Ethylnitrosourea results in decreased expression of INSIG1 mRNA CTD PMID:15954086 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Insr insulin receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of INSR gene CTD PMID:18056790 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803 		JBrowse link
G Iqck IQ motif containing K increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IQCK mRNA CTD PMID:27776689 NCBI chr 1:182,630,678...182,748,325
Ensembl chr 1:182,630,673...182,748,325 		JBrowse link
G Irx6 iroquois homeobox 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of IRX6 mRNA CTD PMID:27776689 NCBI chr19:30,503,416...30,509,396
Ensembl chr19:30,503,419...30,509,382 		JBrowse link
G Itpkb inositol-trisphosphate 3-kinase B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ITPKB gene CTD PMID:16724327 NCBI chr13:94,601,072...94,696,180
Ensembl chr13:94,601,167...94,696,179 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of JAG1 gene CTD PMID:16724327 NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872 		JBrowse link
G Jak1 Janus kinase 1 increases phosphorylation ISO Ethylnitrosourea results in increased phosphorylation of JAK1 protein CTD PMID:27725143 NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758 		JBrowse link
G Jak3 Janus kinase 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of JAK3 gene CTD PMID:16724327 NCBI chr16:18,418,807...18,432,515
Ensembl chr16:18,420,415...18,433,222 		JBrowse link
G Jchain joining chain of multimeric IgA and IgM increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of JCHAIN gene CTD PMID:15175647 NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,822,976...19,838,307 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
decreases expression
multiple interactions 		ISO Ethylnitrosourea results in increased expression of JUN mRNA
Ethylnitrosourea results in decreased expression of JUN mRNA
DICER1 protein affects the reaction [Ethylnitrosourea results in decreased expression of JUN mRNA] 		CTD PMID:19100860 PMID:24478143 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kcna2 potassium voltage-gated channel subfamily A member 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNA2 mRNA CTD PMID:27776689 NCBI chr 2:197,392,746...197,406,606
Ensembl chr 2:197,392,698...197,407,519 		JBrowse link
G Kcne1 potassium voltage-gated channel subfamily E regulatory subunit 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNE1 gene CTD PMID:16724327 NCBI chr11:45,066,875...45,080,024
Ensembl chr11:45,064,162...45,081,247 		JBrowse link
G Kcnh3 potassium voltage-gated channel subfamily H member 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNH3 gene CTD PMID:27776689 NCBI chr 7:132,244,492...132,262,725
Ensembl chr 7:132,244,880...132,262,721 		JBrowse link
G Kcnj11 potassium inwardly-rectifying channel, subfamily J, member 11 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNJ11 gene CTD PMID:16724327 NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169 		JBrowse link
G Kcnj8 potassium inwardly-rectifying channel, subfamily J, member 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNJ8 gene CTD PMID:18026101 NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531 		JBrowse link
G Kcnk4 potassium two pore domain channel subfamily K member 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNK4 gene CTD PMID:27776689 NCBI chr 1:213,547,577...213,558,706
Ensembl chr 1:213,547,577...213,555,861 		JBrowse link
G Kcnq1 potassium voltage-gated channel subfamily Q member 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNQ1 gene CTD PMID:16724327 NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:207,721,131...208,054,072 		JBrowse link
G Kcnq2 potassium voltage-gated channel subfamily Q member 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KCNQ2 exon CTD PMID:16464983 NCBI chr 3:188,572,345...188,631,391
Ensembl chr 3:188,572,926...188,631,302 		JBrowse link
G Kdr kinase insert domain receptor increases expression ISO Ethylnitrosourea results in increased expression of KDR protein CTD PMID:28549617 NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192 		JBrowse link
G Kif3a kinesin family member 3a increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KIF3A gene CTD PMID:15755804 PMID:16724327 NCBI chr10:38,226,388...38,263,062
Ensembl chr10:38,226,741...38,260,516 		JBrowse link
G Kiss1r KISS1 receptor increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of KISS1R gene CTD PMID:16495775 NCBI chr 7:10,435,766...10,439,424
Ensembl chr 7:10,435,766...10,439,424 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KIT exon; Ethylnitrosourea results in increased mutagenesis of KIT gene CTD PMID:15731517 PMID:15820307 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812 		JBrowse link
G Klk8 kallikrein related-peptidase 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KLK8 mRNA CTD PMID:27776689 NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195 		JBrowse link
G Kmt2b lysine methyltransferase 2B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KMT2B gene CTD PMID:27776689 NCBI chr 1:94,949,144...94,969,239
Ensembl chr 1:94,949,144...94,968,441 		JBrowse link
G Kras KRAS proto-oncogene, GTPase multiple interactions
increases mutagenesis 		ISO Ethylnitrosourea promotes the reaction [GATA6 protein binds to KRAS exon]; Ethylnitrosourea promotes the reaction [NFYA protein binds to KRAS exon]
Ethylnitrosourea results in increased mutagenesis of KRAS gene 		CTD PMID:15790496 PMID:16271038 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320 		JBrowse link
G Krt35 keratin 35 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KRT35 mRNA CTD PMID:27776689 NCBI chr10:85,526,571...85,529,968
Ensembl chr10:85,526,571...85,529,968 		JBrowse link
G Krt71 keratin 71 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of KRT71 gene CTD PMID:17143583 NCBI chr 7:134,752,240...134,778,765
Ensembl chr 7:134,752,248...134,761,033 		JBrowse link
G Lama2 laminin subunit alpha 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LAMA2 gene CTD PMID:16724327 NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056 		JBrowse link
G Lamb3 laminin subunit beta 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LAMB3 mRNA CTD PMID:27776689 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lamc2 laminin subunit gamma 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LAMC2 intron CTD PMID:27776689 NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102 		JBrowse link
G Large1 LARGE xylosyl- and glucuronyltransferase 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of LARGE1 gene CTD PMID:16495775 NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,609,004...12,054,707 		JBrowse link
G Ldha lactate dehydrogenase A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LDHA exon; Ethylnitrosourea results in increased mutagenesis of LDHA gene CTD PMID:7534515 PMID:16180137 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521 		JBrowse link
G Lepr leptin receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LEPR gene CTD PMID:16724327 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215 		JBrowse link
G Lgals3 galectin 3 increases expression EXP Ethylnitrosourea results in increased expression of LGALS3 mRNA CTD PMID:15954086 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of LHCGR gene CTD PMID:16495775 NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061 		JBrowse link
G Lhx2 LIM homeobox 2 decreases expression EXP Ethylnitrosourea results in decreased expression of LHX2 mRNA CTD PMID:15954086 NCBI chr 3:42,523,345...42,553,646
Ensembl chr 3:42,535,744...42,553,645 		JBrowse link
G Lhx4 LIM homeobox 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LHX4 mRNA CTD PMID:27776689 NCBI chr13:70,423,768...70,477,337
Ensembl chr13:70,427,399...70,467,505 		JBrowse link
G Lif LIF, interleukin 6 family cytokine increases expression ISO Ethylnitrosourea results in increased expression of LIF mRNA CTD PMID:26198647 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053 		JBrowse link
G Lmbr1 limb development membrane protein 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LMBR1 intron CTD PMID:27776689 NCBI chr 4:6,649,824...6,820,525
Ensembl chr 4:6,649,821...6,822,238 		JBrowse link
G Lnx2 ligand of numb-protein X 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LNX2 mRNA CTD PMID:27776689 NCBI chr12:13,119,139...13,184,401
Ensembl chr12:13,119,139...13,184,401 		JBrowse link
G Lpar3 lysophosphatidic acid receptor 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LPAR3 mRNA CTD PMID:27776689 NCBI chr 2:237,785,371...237,854,199
Ensembl chr 2:237,787,766...237,854,197 		JBrowse link
G Lrp2 LDL receptor related protein 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LRP2 mRNA CTD PMID:27776689 NCBI chr 3:74,597,148...74,754,535
Ensembl chr 3:74,597,148...74,754,535 		JBrowse link
G Lrp5 LDL receptor related protein 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LRP5 gene CTD PMID:18263894 NCBI chr 1:210,243,499...210,346,886
Ensembl chr 1:210,243,502...210,346,822 		JBrowse link
G Lrp8 LDL receptor related protein 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LRP8 mRNA CTD PMID:27776689 NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207 		JBrowse link
G Lrrc14 leucine rich repeat containing 14 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LRRC14 mRNA CTD PMID:27776689 NCBI chr 7:110,311,384...110,317,757
Ensembl chr 7:110,311,369...110,317,760 		JBrowse link
G Lsm3 LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LSM3 3' UTR; Ethylnitrosourea results in increased mutagenesis of LSM3 gene CTD PMID:27776689 NCBI chr 4:125,578,185...125,584,429
Ensembl chr 4:125,578,185...125,584,429 		JBrowse link
G Lta lymphotoxin alpha increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LTA gene CTD PMID:18384745 NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533 		JBrowse link
G Lum lumican increases expression EXP Ethylnitrosourea results in increased expression of LUM mRNA CTD PMID:15954086 NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508 		JBrowse link
G Lxn latexin increases expression EXP Ethylnitrosourea results in increased expression of LXN mRNA CTD PMID:15954086 NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488 		JBrowse link
G Ly9 lymphocyte antigen 9 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LY9 mRNA CTD PMID:27776689 NCBI chr13:86,610,762...86,633,314
Ensembl chr13:86,611,784...86,657,293 		JBrowse link
G Lypd2 Ly6/Plaur domain containing 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of LYPD2 mRNA CTD PMID:27776689 NCBI chr 7:108,506,545...108,508,582
Ensembl chr 7:108,506,545...108,508,582 		JBrowse link
G Madd MAP-kinase activating death domain increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MADD mRNA CTD PMID:27776689 NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:97,570,787...97,613,509 		JBrowse link
G Man2c1 mannosidase, alpha, class 2C, member 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MAN2C1 gene CTD PMID:27776689 NCBI chr 8:66,434,480...66,445,649
Ensembl chr 8:66,434,421...66,445,648 		JBrowse link
G Mapk6 mitogen-activated protein kinase 6 increases expression EXP Ethylnitrosourea results in increased expression of MAPK6 mRNA CTD PMID:15954086 NCBI chr 8:85,027,141...85,050,236
Ensembl chr 8:85,027,144...85,050,236 		JBrowse link
G Mbd1 methyl-CpG binding domain protein 1 increases expression ISO Ethylnitrosourea results in increased expression of MBD1; Ethylnitrosourea results in increased expression of MBD1 mRNA CTD PMID:19100860 PMID:21154115 NCBI chr18:70,145,093...70,159,744
Ensembl chr18:70,145,114...70,159,703 		JBrowse link
G Mc1r melanocortin 1 receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MC1R exon; Ethylnitrosourea results in increased mutagenesis of MC1R promoter CTD PMID:16300676 NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877 		JBrowse link
G Mc3r melanocortin 3 receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MC3R gene CTD PMID:16720677 NCBI chr 3:181,434,776...181,435,873
Ensembl chr 3:181,434,776...181,435,873 		JBrowse link
G Mc4r melanocortin 4 receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MC4R gene CTD PMID:16720677 PMID:17143585 NCBI chr18:62,689,798...62,691,685 JBrowse link
G Mcm3ap minichromosome maintenance complex component 3 associated protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MCM3AP gene CTD PMID:27776689 NCBI chr20:12,127,060...12,164,651
Ensembl chr20:12,127,060...12,164,651 		JBrowse link
G Mcrs1 microspherule protein 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MCRS1 intron CTD PMID:27776689 NCBI chr 7:132,262,719...132,271,533
Ensembl chr 7:132,262,722...132,271,533 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression EXP
ISO 		Ethylnitrosourea results in increased expression of MDM2 mRNA CTD PMID:15954086 PMID:19100860 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Mecp2 methyl CpG binding protein 2 increases expression ISO Ethylnitrosourea results in increased expression of MECP2 CTD PMID:21154115 NCBI chr  X:156,932,481...156,995,981
Ensembl chr  X:156,941,234...156,943,560 		JBrowse link
G Med12l mediator complex subunit 12L increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MED12L mRNA CTD PMID:27776689 NCBI chr 2:145,403,318...145,726,317
Ensembl chr 2:145,404,375...145,723,516 		JBrowse link
G Mettl24 methyltransferase like 24 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of METTL24 mRNA CTD PMID:27776689 NCBI chr20:45,724,506...45,847,300
Ensembl chr20:45,724,982...45,843,959 		JBrowse link
G Mfsd3 major facilitator superfamily domain containing 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MFSD3 gene CTD PMID:27776689 NCBI chr 7:110,300,254...110,304,108
Ensembl chr 7:110,302,018...110,304,112 		JBrowse link
G Mfsd4b1 major facilitator superfamily domain containing 4B1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MFSD4B1 mRNA CTD PMID:27776689 NCBI chr20:44,991,384...45,004,590
Ensembl chr20:44,991,384...45,006,161 		JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase increases expression EXP Ethylnitrosourea results in increased expression of MGAT2 mRNA CTD PMID:15954086 NCBI chr 6:93,392,416...93,394,905
Ensembl chr 6:93,390,555...93,395,176 		JBrowse link
G Mgat5b alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MGAT5B intron CTD PMID:27776689 NCBI chr10:102,619,559...102,689,023
Ensembl chr10:102,619,559...102,689,017 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase increases alkylation
increases expression 		ISO
EXP 		Ethylnitrosourea results in increased alkylation of MGMT protein
Ethylnitrosourea results in increased expression of MGMT mRNA 		CTD PMID:8823159 PMID:11599795 PMID:15954086 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mir22 microRNA 22 increases expression ISO Ethylnitrosourea results in increased expression of MIR22 mRNA CTD PMID:29777724 NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425 		JBrowse link
G Mir34a microRNA 34a increases expression ISO Ethylnitrosourea results in increased expression of MIR34A mRNA CTD PMID:22297810 NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053 		JBrowse link
G Mir409 microRNA 409 increases expression ISO Ethylnitrosourea results in increased expression of MIR409 mRNA CTD PMID:29777724 NCBI chr 6:134,579,185...134,579,261 JBrowse link
G Mir425 microRNA 425 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MIR425 gene CTD PMID:27776689 NCBI chr 8:118,143,084...118,143,166
Ensembl chr 8:118,143,084...118,143,166 		JBrowse link
G Mir96 microRNA 96 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MIR96 gene CTD PMID:19363478 NCBI chr 4:59,755,841...59,755,946 JBrowse link
G Mlh1 mutL homolog 1 increases expression
multiple interactions 		ISO Ethylnitrosourea results in increased expression of MLH1
Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of MLH1] 		CTD PMID:21154115 NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011 		JBrowse link
G Mpo myeloperoxidase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MPO mRNA CTD PMID:27776689 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Msh2 mutS homolog 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of MSH2 gene CTD PMID:16495775 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Msh6 mutS homolog 6 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of MSH6 gene CTD PMID:16495775 PMID:18417481 NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:12,316,198...12,333,844 		JBrowse link
G Mt-nd1 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 decreases expression ISO Ethylnitrosourea results in decreased expression of ND1 mRNA CTD PMID:20438828 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685 		JBrowse link
G Mtor mechanistic target of rapamycin kinase increases mutagenesis
decreases expression 		ISO Ethylnitrosourea results in increased mutagenesis of MTOR gene
Ethylnitrosourea results in decreased expression of MTOR protein 		CTD PMID:15485918 PMID:16724327 PMID:32902906 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Muc4 mucin 4, cell surface associated increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MUC4 mRNA CTD PMID:27776689 NCBI chr11:81,513,321...81,575,200 JBrowse link
G Muc6 mucin 6, oligomeric mucus/gel-forming increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MUC6 mRNA CTD PMID:27776689 NCBI chr 1:206,155,826...206,194,384
Ensembl chr 1:206,155,593...206,191,864 		JBrowse link
G Myb MYB proto-oncogene, transcription factor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYB gene CTD PMID:16724327 NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression ISO Ethylnitrosourea results in increased expression of MYC mRNA CTD PMID:19100860 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYD88 exon CTD PMID:16300676 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230 		JBrowse link
G Myh2 myosin heavy chain 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYH2 mRNA CTD PMID:27776689 NCBI chr10:52,355,739...52,382,235
Ensembl chr10:52,355,739...52,382,235 		JBrowse link
G Myo1f myosin IF increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYO1F intron CTD PMID:27776689 NCBI chr 7:15,065,530...15,116,087
Ensembl chr 7:15,065,530...15,116,087 		JBrowse link
G Myo5a myosin VA increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYO5A gene CTD PMID:9475716 PMID:9825669 PMID:10517996 PMID:17174358 NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265 		JBrowse link
G Myo6 myosin VI increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYO6 gene CTD PMID:17329413 NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:89,967,377...90,122,215 		JBrowse link
G Myo7a myosin VIIA increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of MYO7A gene CTD PMID:15965244 NCBI chr 1:161,755,110...161,825,397
Ensembl chr 1:161,755,110...161,825,365 		JBrowse link
G Myoc myocilin increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of MYOC gene CTD PMID:16495775 NCBI chr13:77,509,963...77,520,361
Ensembl chr13:77,509,963...77,520,361 		JBrowse link
G Myrfl myelin regulatory factor-like increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MYRFL intron CTD PMID:27776689 NCBI chr 7:54,289,430...54,406,097
Ensembl chr 7:54,289,332...54,405,868 		JBrowse link
G Myt1 myelin transcription factor 1 decreases expression ISO Ethylnitrosourea results in decreased expression of MYT1 protein CTD PMID:28549617 NCBI chr 3:189,263,569...189,327,844
Ensembl chr 3:189,263,467...189,327,844 		JBrowse link
G Ncaph2 non-SMC condensin II complex, subunit H2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NCAPH2 gene CTD PMID:17640884 NCBI chr 7:122,302,550...122,319,570
Ensembl chr 7:122,300,252...122,319,569 		JBrowse link
G Nckap1 NCK-associated protein 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NCKAP1 gene CTD PMID:15755804 NCBI chr 3:85,824,333...85,898,748
Ensembl chr 3:85,824,336...85,898,797 		JBrowse link
G Ndn necdin, MAGE family member decreases expression ISO Ethylnitrosourea results in decreased expression of NDN protein CTD PMID:28549617 NCBI chr 1:125,261,059...125,262,658
Ensembl chr 1:125,260,997...125,262,785 		JBrowse link
G Neil1 nei-like DNA glycosylase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NEIL1 intron CTD PMID:27776689 NCBI chr 8:66,446,106...66,452,844
Ensembl chr 8:66,445,953...66,452,378 		JBrowse link
G Net1 neuroepithelial cell transforming 1 increases expression ISO Ethylnitrosourea results in increased expression of NET1 mRNA CTD PMID:19100860 NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270 		JBrowse link
G Neurl2 neuralized E3 ubiquitin protein ligase 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NEURL2 mRNA CTD PMID:27776689 NCBI chr 3:173,985,996...173,988,717
Ensembl chr 3:173,986,857...173,989,043 		JBrowse link
G Nfix nuclear factor I X decreases expression EXP Ethylnitrosourea results in decreased expression of NFIX mRNA CTD PMID:15954086 NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092 		JBrowse link
G Nfya nuclear transcription factor Y subunit alpha multiple interactions
increases activity 		ISO Ethylnitrosourea promotes the reaction [NFYA protein binds to KRAS exon]
Ethylnitrosourea results in increased activity of NFYA protein 		CTD PMID:16271038 NCBI chr 9:20,085,067...20,111,521
Ensembl chr 9:20,085,073...20,111,504 		JBrowse link
G Nifk nucleolar protein interacting with the FHA domain of MKI67 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of MKI67IP mRNA CTD PMID:27776689 NCBI chr13:31,946,119...31,955,950
Ensembl chr13:31,946,108...31,959,561 		JBrowse link
G Nlgn3 neuroligin 3 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NLGN3 gene CTD PMID:16495775 NCBI chr  X:70,469,251...70,497,380
Ensembl chr  X:70,469,457...70,497,379 		JBrowse link
G Nmur2 neuromedin U receptor 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NMUR2 gene CTD PMID:16495775 NCBI chr10:40,666,824...40,682,679
Ensembl chr10:40,645,101...40,682,679 		JBrowse link
G Nol9 nucleolar protein 9 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NOL9 intron CTD PMID:27776689 NCBI chr 5:167,829,249...167,849,364
Ensembl chr 5:167,829,264...167,849,366 		JBrowse link
G Nos1 nitric oxide synthase 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NOS1 gene CTD PMID:16495775 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837 		JBrowse link
G Npr3 natriuretic peptide receptor 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NPR3 gene CTD PMID:16724327 NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066 		JBrowse link
G Npy2r neuropeptide Y receptor Y2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NPY2R gene CTD PMID:16495775 NCBI chr 2:170,200,027...170,210,286
Ensembl chr 2:170,200,027...170,210,448 		JBrowse link
G Npy4r neuropeptide Y receptor Y4 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NPY4R gene CTD PMID:16495775 NCBI chr16:9,474,051...9,475,307
Ensembl chr16:9,472,011...9,482,405 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NR0B2 gene CTD PMID:16495775 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NR1D1 gene CTD PMID:16495775 NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812 		JBrowse link
G Nsun7 NOP2/Sun RNA methyltransferase family member 7 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NSUN7 gene CTD PMID:17442852 NCBI chr14:42,233,062...42,289,013
Ensembl chr14:42,233,062...42,288,958 		JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NTRK2 gene CTD PMID:16495775 NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628 		JBrowse link
G Nts neurotensin increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of NTS gene CTD PMID:16495775 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961 		JBrowse link
G Nup133 nucleoporin 133 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of NUP133 gene CTD PMID:15755804 NCBI chr19:68,789,065...68,838,692
Ensembl chr19:68,789,065...68,838,692 		JBrowse link
G Obscn obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OBSCN mRNA CTD PMID:27776689 NCBI chr10:44,273,686...44,419,275
Ensembl chr10:44,288,866...44,419,297 		JBrowse link
G Oca2 OCA2 melanosomal transmembrane protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OCA2 gene CTD PMID:17174358 NCBI chr 1:116,252,026...116,581,838
Ensembl chr 1:116,251,796...116,581,838 		JBrowse link
G Oprl1 opioid related nociceptin receptor 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of OPRL1 gene CTD PMID:16495775 NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:189,212,175...189,217,426 		JBrowse link
G Oprm1 opioid receptor, mu 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of OPRM1 gene CTD PMID:16495775 NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:45,565,371...45,638,756 		JBrowse link
G Or10d3 olfactory receptor family 10 subfamily D member 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OR10D3 mRNA CTD PMID:27776689 NCBI chr 8:48,734,800...48,735,738
Ensembl chr 8:48,734,800...48,735,738 		JBrowse link
G Or5e1 olfactory receptor family 5 subfamily E member 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OR5E1 mRNA CTD PMID:27776689 NCBI chr 1:172,159,177...172,160,112
Ensembl chr 1:172,159,177...172,160,112 		JBrowse link
G Osbp2 oxysterol binding protein 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OSBP2 mRNA CTD PMID:27776689 NCBI chr14:82,808,693...82,970,386
Ensembl chr14:82,808,693...82,970,532 		JBrowse link
G Osbpl6 oxysterol binding protein-like 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OSBPL6 mRNA CTD PMID:27776689 NCBI chr 3:81,751,020...81,948,186
Ensembl chr 3:81,750,982...81,946,615 		JBrowse link
G Otof otoferlin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OTOF exon; Ethylnitrosourea results in increased mutagenesis of OTOF gene CTD PMID:17329413 PMID:17967520 NCBI chr 6:31,647,869...31,744,476
Ensembl chr 6:31,647,914...31,744,476 		JBrowse link
G Otop1 otopetrin 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of OTOP1 gene CTD PMID:16972005 NCBI chr14:76,717,330...76,744,785
Ensembl chr14:76,716,329...76,744,785 		JBrowse link
G Pak4 p21 (RAC1) activated kinase 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PAK4 exon CTD PMID:16300676 NCBI chr 1:92,977,437...93,016,721
Ensembl chr 1:92,977,437...93,016,721 		JBrowse link
G Parp9 poly (ADP-ribose) polymerase family, member 9 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PARP9 gene CTD PMID:27776689 NCBI chr11:78,286,282...78,320,409
Ensembl chr11:78,286,287...78,320,608 		JBrowse link
G Pax3 paired box 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PAX3 gene CTD PMID:16724327 NCBI chr 9:87,015,960...87,112,531
Ensembl chr 9:87,016,999...87,124,141 		JBrowse link
G Pax6 paired box 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PAX6 exon; Ethylnitrosourea results in increased mutagenesis of PAX6 gene; Ethylnitrosourea results in increased mutagenesis of PAX6 intron CTD PMID:16303964 PMID:16724327 NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763 		JBrowse link
G Pcdh15 protocadherin related 15 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PCDH15 gene CTD PMID:15811708 NCBI chr20:13,996,383...15,495,206
Ensembl chr20:13,999,116...15,493,958 		JBrowse link
G Pcdha4 protocadherin alpha 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PCDHA4 intron CTD PMID:27776689 NCBI chr18:28,688,274...29,120,227
Ensembl chr18:28,855,256...29,120,227 		JBrowse link
G Pcdhb19 protocadherin beta 19 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PCDHB19 mRNA CTD PMID:27776689 NCBI chr18:29,478,848...29,481,656 JBrowse link
G Pcna proliferating cell nuclear antigen increases expression EXP
ISO 		Ethylnitrosourea results in increased expression of PCNA mRNA
Ethylnitrosourea results in increased expression of PCNA protein 		CTD PMID:15954086 PMID:28549617 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcsk5 proprotein convertase subtilisin/kexin type 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PCSK5 gene CTD PMID:18519639 NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347 		JBrowse link
G Pde4c phosphodiesterase 4C increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PDE4C mRNA CTD PMID:27776689 NCBI chr16:18,724,703...18,745,528
Ensembl chr16:18,725,674...18,744,037 		JBrowse link
G Pde6b phosphodiesterase 6B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PDE6B gene CTD PMID:16123450 NCBI chr14:1,468,302...1,511,435
Ensembl chr14:1,468,302...1,511,435 		JBrowse link
G Pdp1 pyruvate dehydrogenase phosphatase catalytic subunit 1 increases expression EXP Ethylnitrosourea results in increased expression of PDP1 mRNA CTD PMID:15954086 NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960 		JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 increases expression ISO Ethylnitrosourea results in increased expression of PDPK1 protein CTD PMID:32902906 NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181 		JBrowse link
G Phf2 PHD finger protein 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PHF2 intron CTD PMID:27776689 NCBI chr17:15,989,594...16,057,583
Ensembl chr17:15,981,604...16,057,583 		JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A multiple interactions
increases mutagenesis 		EXP
ISO 		[Ethylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Ethylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein; Ethylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein
Ethylnitrosourea results in increased mutagenesis of PIGA; Ethylnitrosourea results in increased mutagenesis of PIGA gene 		CTD PMID:19965957 PMID:20202993 PMID:20857433 PMID:21729764 PMID:22167886 More... NCBI chr  X:33,672,832...33,687,747
Ensembl chr  X:33,674,923...33,687,636 		JBrowse link
G Pink1 PTEN induced kinase 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of PINK1 gene CTD PMID:16495775 NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950 		JBrowse link
G Pitpnm1 phosphatidylinositol transfer protein, membrane-associated 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PITPNM1 gene; Ethylnitrosourea results in increased mutagenesis of PITPNM1 intron CTD PMID:27776689 NCBI chr 1:210,823,568...210,836,989
Ensembl chr 1:210,823,565...210,836,990 		JBrowse link
G Pjvk pejvakin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PJVK gene CTD PMID:17329413 NCBI chr 3:82,002,106...82,012,273
Ensembl chr 3:82,002,368...82,012,451 		JBrowse link
G Pkd1 polycystin 1, transient receptor potential channel interacting increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PKD1 gene; Ethylnitrosourea results in increased mutagenesis of PKD1 mRNA CTD PMID:16724327 PMID:27776689 NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681 		JBrowse link
G Pkdrej polycystin family receptor for egg jelly increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PKDREJ mRNA CTD PMID:27776689 NCBI chr 7:118,788,939...118,795,313
Ensembl chr 7:118,784,555...118,797,948 		JBrowse link
G Plaa phospholipase A2, activating protein increases expression EXP Ethylnitrosourea results in increased expression of PLAA mRNA CTD PMID:15954086 NCBI chr 5:114,544,327...114,576,023
Ensembl chr 5:114,544,325...114,576,109 		JBrowse link
G Plcb3 phospholipase C beta 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PLCB3 mRNA CTD PMID:27776689 NCBI chr 1:213,572,499...213,589,585
Ensembl chr 1:213,574,166...213,589,583 		JBrowse link
G Plcg2 phospholipase C, gamma 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PLCG2 gene CTD PMID:16724327 NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684 		JBrowse link
G Plekhm3 pleckstrin homology domain containing M3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PLEKHM3 mRNA CTD PMID:27776689 NCBI chr 9:73,659,998...73,819,079
Ensembl chr 9:73,664,817...73,799,503 		JBrowse link
G Plin1 perilipin 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PLIN1 mRNA CTD PMID:27776689 NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206 		JBrowse link
G Plin3 perilipin 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PLIN3 mRNA CTD PMID:27776689 NCBI chr 9:1,198,336...1,210,212
Ensembl chr 9:1,198,336...1,210,231 		JBrowse link
G Plk2 polo-like kinase 2 increases expression ISO Ethylnitrosourea results in increased expression of PLK2 mRNA CTD PMID:19100860 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plxnb2 plexin B2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PLXNB2 intron; Ethylnitrosourea results in increased mutagenesis of PLXNB2 mRNA CTD PMID:27776689 NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746 		JBrowse link
G Pmch pro-melanin-concentrating hormone increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of PMCH gene CTD PMID:16495775 NCBI chr 7:24,399,404...24,400,720
Ensembl chr 7:24,399,404...24,400,720 		JBrowse link
G Pmp22 peripheral myelin protein 22 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PMP22 gene CTD PMID:16724327 NCBI chr10:48,294,932...48,324,941
Ensembl chr10:48,297,437...48,324,940 		JBrowse link
G Poglut1 protein O-glucosyltransferase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of POGLUT1 gene CTD PMID:15755804 NCBI chr11:75,704,119...75,731,964
Ensembl chr11:75,703,833...75,733,519 		JBrowse link
G Pold1 DNA polymerase delta 1, catalytic subunit increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of POLD1 3' UTR; Ethylnitrosourea results in increased mutagenesis of POLD1 gene CTD PMID:27776689 NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982 		JBrowse link
G Polq DNA polymerase theta increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of POLQ gene CTD PMID:16724327 NCBI chr11:77,179,190...77,281,270
Ensembl chr11:77,179,209...77,281,268 		JBrowse link
G Polr1e RNA polymerase I subunit E increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of POLR1E mRNA CTD PMID:27776689 NCBI chr 5:64,075,123...64,090,900
Ensembl chr 5:64,075,122...64,091,039 		JBrowse link
G Pomt1 protein-O-mannosyltransferase 1 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of POMT1 gene CTD PMID:16495775 NCBI chr 3:35,918,370...35,936,330
Ensembl chr 3:35,918,188...35,936,364 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases expression
decreases activity 		ISO Ethylnitrosourea results in decreased expression of PPARA mRNA
Ethylnitrosourea results in decreased activity of PPARA protein 		CTD PMID:25689681 PMID:30203046 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppfia3 PTPRF interacting protein alpha 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PPFIA3 gene CTD PMID:27776689 NCBI chr 1:104,953,598...104,982,373
Ensembl chr 1:104,953,598...104,982,278 		JBrowse link
G Ppia peptidylprolyl isomerase A increases expression EXP Ethylnitrosourea results in increased expression of PPIA mRNA CTD PMID:15954086 NCBI chr14:85,491,223...85,496,884
Ensembl chr14:85,492,484...85,497,115 		JBrowse link
G Ppp1r21 protein phosphatase 1, regulatory subunit 21 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PPP1R21 intron CTD PMID:27776689 NCBI chr 6:11,655,059...11,724,219
Ensembl chr 6:11,655,059...11,724,219 		JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C increases expression ISO Ethylnitrosourea results in increased expression of PPP1R3C mRNA CTD PMID:19100860 NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835 		JBrowse link
G Prim1 DNA primase subunit 1 increases expression EXP Ethylnitrosourea results in increased expression of PRIM1 mRNA CTD PMID:15954086 NCBI chr 7:1,031,436...1,047,134 JBrowse link
G Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PRKAR1B mRNA CTD PMID:27776689 NCBI chr12:20,606,066...20,738,766
Ensembl chr12:20,618,757...20,738,766 		JBrowse link
G Prkar2b protein kinase cAMP-dependent type II regulatory subunit beta increases expression EXP Ethylnitrosourea results in increased expression of PRKAR2B mRNA CTD PMID:15954086 NCBI chr 6:54,291,143...54,381,639
Ensembl chr 6:54,291,151...54,381,411 		JBrowse link
G Prss1 serine protease 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TRY10 intron CTD PMID:27776689 NCBI chr 4:71,331,249...71,334,452
Ensembl chr 4:71,331,246...71,334,452 		JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PSMC2 intron CTD PMID:27776689 NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390 		JBrowse link
G Psmd13 proteasome 26S subunit, non-ATPase 13 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PSMD13 intron CTD PMID:27776689 NCBI chr 1:205,394,248...205,406,525
Ensembl chr 1:205,393,746...205,411,651 		JBrowse link
G Pten phosphatase and tensin homolog increases mutagenesis
decreases expression 		ISO Ethylnitrosourea results in increased mutagenesis of PTEN gene
Ethylnitrosourea results in decreased expression of PTEN protein 		CTD PMID:15755804 PMID:16724327 PMID:32902906 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression
multiple interactions 		ISO Ethylnitrosourea results in increased expression of PTGS2
Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of PTGS2] 		CTD PMID:21154115 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptpn18 protein tyrosine phosphatase, non-receptor type 18 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of PTPN18 mRNA CTD PMID:27776689 NCBI chr 9:44,166,571...44,185,885
Ensembl chr 9:44,168,269...44,186,917 		JBrowse link
G Ptprc protein tyrosine phosphatase, receptor type, C increases mutagenesis
decreases expression 		ISO Ethylnitrosourea results in increased mutagenesis of PTPRC gene
Ethylnitrosourea results in decreased expression of PTPRC protein 		CTD PMID:16724327 PMID:27725143 NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746 		JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin decreases expression EXP Ethylnitrosourea results in decreased expression of PTTG1 mRNA CTD PMID:15954086 NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309 		JBrowse link
G Qki QKI, KH domain containing RNA binding increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of QKI gene CTD PMID:16245024 NCBI chr 1:52,935,357...53,047,338
Ensembl chr 1:52,935,382...53,047,337 		JBrowse link
G Rab14 RAB14, member RAS oncogene family decreases expression EXP Ethylnitrosourea results in decreased expression of RAB14 mRNA CTD PMID:15954086 NCBI chr 3:38,899,430...38,920,572
Ensembl chr 3:38,901,400...38,912,273 		JBrowse link
G Rab23 RAB23, member RAS oncogene family increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RAB23 gene CTD PMID:15755804 NCBI chr 9:43,440,047...43,463,327
Ensembl chr 9:43,440,273...43,463,325 		JBrowse link
G Rab3a RAB3A, member RAS oncogene family increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RAB3A gene CTD PMID:16724327 NCBI chr16:18,718,164...18,722,273
Ensembl chr16:18,718,167...18,721,842 		JBrowse link
G Rapgef6 Rap guanine nucleotide exchange factor 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RAPGEF6 intron CTD PMID:27776689 NCBI chr10:39,156,573...39,324,947
Ensembl chr10:39,156,620...39,324,946 		JBrowse link
G Rasa3 RAS p21 protein activator 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RASA3 intron CTD PMID:27776689 NCBI chr16:82,557,556...82,671,527
Ensembl chr16:82,557,428...82,672,984 		JBrowse link
G Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RASGRF1 gene CTD PMID:16724327 NCBI chr 8:99,324,986...99,454,099
Ensembl chr 8:99,324,749...99,454,089 		JBrowse link
G Rb1 RB transcriptional corepressor 1 increases expression EXP Ethylnitrosourea results in increased expression of RB1 mRNA CTD PMID:15954086 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbm22 RNA binding motif protein 22 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RBM22 mRNA CTD PMID:27776689 NCBI chr18:56,283,807...56,294,615
Ensembl chr18:56,283,770...56,295,073 		JBrowse link
G Rcan1 regulator of calcineurin 1 increases expression ISO Ethylnitrosourea results in increased expression of RCAN1 mRNA CTD PMID:19100860 NCBI chr11:45,108,123...45,188,065
Ensembl chr11:45,108,124...45,118,236 		JBrowse link
G Rdh10 retinol dehydrogenase 10 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RDH10 mRNA CTD PMID:27776689 NCBI chr 5:7,969,931...7,998,834
Ensembl chr 5:7,971,705...7,999,019 		JBrowse link
G Recql4 RecQ like helicase 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RECQL4 mRNA CTD PMID:27776689 NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:110,304,094...110,311,258 		JBrowse link
G Reln reelin increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of RELN gene CTD PMID:16495775 NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162 		JBrowse link
G Repin1 replication initiator 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of REPIN1 3' UTR CTD PMID:27776689 NCBI chr 4:78,879,910...78,885,143
Ensembl chr 4:78,880,976...78,886,413 		JBrowse link
G Rfx4 regulatory factor X4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RFX4 mRNA CTD PMID:27776689 NCBI chr 7:20,740,760...20,903,355
Ensembl chr 7:20,741,079...20,902,851 		JBrowse link
G Rgs2 regulator of G-protein signaling 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RGS2 gene CTD PMID:16724327 NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697 		JBrowse link
G Rho rhodopsin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RHO gene CTD PMID:16332273 NCBI chr 4:150,653,205...150,658,367
Ensembl chr 4:150,653,205...150,658,367 		JBrowse link
G Rnf38 ring finger protein 38 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RNF38 intron CTD PMID:27776689 NCBI chr 5:63,154,507...63,263,138
Ensembl chr 5:63,154,507...63,263,137 		JBrowse link
G Rpl27a ribosomal protein L27A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RPL27A gene CTD PMID:21674502 NCBI chr 1:172,971,957...172,977,591 JBrowse link
G Rpl7 ribosomal protein L7 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RPL7 mRNA CTD PMID:27776689 NCBI chr 5:8,000,446...8,003,454
Ensembl chr 5:7,850,630...8,003,451 		JBrowse link
G Rprd1a regulation of nuclear pre-mRNA domain containing 1A increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of RPRD1A gene CTD PMID:16495775 NCBI chr18:16,066,169...16,114,102
Ensembl chr18:16,066,169...16,114,282 		JBrowse link
G Rptor regulatory associated protein of MTOR, complex 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RPTOR intron CTD PMID:27776689 NCBI chr10:105,376,943...105,675,416
Ensembl chr10:105,376,943...105,675,413 		JBrowse link
G Rrm2b ribonucleotide reductase regulatory TP53 inducible subunit M2B increases expression ISO Ethylnitrosourea results in increased expression of RRM2B mRNA CTD PMID:21704725 NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:70,965,590...70,993,670 		JBrowse link
G Rs1 retinoschisin 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RS1 intron CTD PMID:16088326 NCBI chr  X:37,771,135...37,800,894
Ensembl chr  X:37,771,135...37,800,894 		JBrowse link
G Rtel1 regulator of telomere elongation helicase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RTEL1 mRNA CTD PMID:27776689 NCBI chr 3:188,778,329...188,842,877
Ensembl chr 3:188,807,951...188,843,709 		JBrowse link
G Rtf1 Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of RTF1 mRNA CTD PMID:27776689 NCBI chr 3:127,113,171...127,172,761
Ensembl chr 3:127,113,163...127,172,761 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression EXP Ethylnitrosourea results in decreased expression of SCD1 mRNA CTD PMID:15954086 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scn8a sodium voltage-gated channel alpha subunit 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SCN8A exon; Ethylnitrosourea results in increased mutagenesis of SCN8A gene CTD PMID:15170223 PMID:19261867 NCBI chr 7:133,860,901...134,034,809
Ensembl chr 7:133,861,227...134,030,026 		JBrowse link
G Scnn1g sodium channel epithelial 1 subunit gamma increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SCNN1G intron CTD PMID:27776689 NCBI chr 1:185,736,225...185,770,099
Ensembl chr 1:185,736,191...185,770,097 		JBrowse link
G Scube2 signal peptide, CUB domain and EGF like domain containing 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SCUBE2 intron CTD PMID:27776689 NCBI chr 1:173,264,862...173,341,323
Ensembl chr 1:173,264,865...173,334,372 		JBrowse link
G Sema3c semaphorin 3C increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SEMA3C gene CTD PMID:15548583 NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740 		JBrowse link
G Sf3b2 splicing factor 3b, subunit 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SF3B2 intron CTD PMID:27776689 NCBI chr 1:211,999,777...212,040,686
Ensembl chr 1:211,999,778...212,020,113 		JBrowse link
G Sfi1 SFI1 centrin binding protein increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SFI1 gene; Ethylnitrosourea results in increased mutagenesis of SFI1 intron CTD PMID:27776689 NCBI chr14:82,215,423...82,272,811
Ensembl chr14:82,214,608...82,272,711 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression EXP Ethylnitrosourea results in increased expression of SGK1 mRNA CTD PMID:15954086 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Sh2d4a SH2 domain containing 4A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SH2D4A intron CTD PMID:27776689 NCBI chr16:26,106,721...26,176,069
Ensembl chr16:26,106,730...26,175,974 		JBrowse link
G Shh sonic hedgehog signaling molecule increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SHH enhancer CTD PMID:17049204 NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:7,687,846...7,697,901 		JBrowse link
G Sim1 SIM bHLH transcription factor 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SIM1 gene CTD PMID:18056790 NCBI chr20:55,409,814...55,489,450
Ensembl chr20:55,410,577...55,489,449 		JBrowse link
G Slc4a1 solute carrier family 4 member 1 (Diego blood group) increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SLC4A1 gene CTD PMID:16724327 NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,807,013...87,823,258 		JBrowse link
G Slc6a3 solute carrier family 6 member 3 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of SLC6A3 gene CTD PMID:16495775 NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962 		JBrowse link
G Slc6a4 solute carrier family 6 member 4 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of SLC6A4 gene CTD PMID:16495775 NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of SLC6A8 gene CTD PMID:16495775 NCBI chr  X:156,536,017...156,545,321
Ensembl chr  X:156,536,017...156,545,321 		JBrowse link
G Slc8b1 solute carrier family 8 member B1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SLC8B1 mRNA CTD PMID:27776689 NCBI chr12:41,690,333...41,713,657
Ensembl chr12:41,690,334...41,713,601 		JBrowse link
G Slco2a1 solute carrier organic anion transporter family, member 2a1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SLCO2A1 mRNA CTD PMID:27776689 NCBI chr 8:112,467,739...112,551,923
Ensembl chr 8:112,467,160...112,551,921 		JBrowse link
G Slfn5 schlafen family member 5 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SLFN5 mRNA CTD PMID:27776689 NCBI chr10:68,378,440...68,392,515
Ensembl chr10:68,378,449...68,392,544 		JBrowse link
G Smad2 SMAD family member 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SMAD2 gene CTD PMID:16724327 NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388 		JBrowse link
G Smad4 SMAD family member 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SMAD4 gene CTD PMID:16724327 NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684 		JBrowse link
G Smarcb1 SWI/SNF related BAF chromatin remodeling complex subunit B1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SMARCB1 gene CTD PMID:27776689 NCBI chr20:12,740,105...12,763,054
Ensembl chr20:12,740,943...12,763,055 		JBrowse link
G Smo smoothened, frizzled class receptor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SMO gene CTD PMID:15755804 PMID:16724327 NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281 		JBrowse link
G Snn stannin increases expression EXP Ethylnitrosourea results in increased expression of SNN mRNA CTD PMID:15954086 NCBI chr10:5,079,885...5,088,565
Ensembl chr 1:82,440,586...82,441,390
Ensembl chr10:82,440,586...82,441,390 		JBrowse link
G Snora75 small nucleolar RNA, H/ACA box 75 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SNORA75 gene CTD PMID:27776689 NCBI chr 9:94,448,219...94,448,355
Ensembl chr 9:94,448,219...94,448,355 		JBrowse link
G Sod1 superoxide dismutase 1 decreases expression ISO Ethylnitrosourea results in decreased expression of SOD1 mRNA CTD PMID:20438828 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sowahb sosondowah ankyrin repeat domain family member B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SOWAHB mRNA CTD PMID:27776689 NCBI chr14:15,313,561...15,317,396
Ensembl chr14:15,309,246...15,321,591 		JBrowse link
G Sparc secreted protein acidic and cysteine rich increases expression EXP Ethylnitrosourea results in increased expression of SPARC mRNA CTD PMID:15954086 NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268 		JBrowse link
G Spata25 spermatogenesis associated 25 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SPATA25 gene CTD PMID:27776689 NCBI chr 3:173,981,863...173,983,818
Ensembl chr 3:173,981,866...173,983,818 		JBrowse link
G Speg striated muscle enriched protein kinase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SPEG mRNA CTD PMID:27776689 NCBI chr 9:84,314,387...84,371,816
Ensembl chr 9:84,314,387...84,371,813 		JBrowse link
G Spg11 SPG11 vesicle trafficking associated, spatacsin increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SPG11 mRNA CTD PMID:27776689 NCBI chr 3:129,453,118...129,526,469
Ensembl chr 3:129,461,477...129,526,742 		JBrowse link
G Spib Spi-B transcription factor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SPIB gene CTD PMID:27776689 NCBI chr 1:104,155,456...104,161,311
Ensembl chr 1:104,155,464...104,161,517 		JBrowse link
G Spint1 serine peptidase inhibitor, Kunitz type 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SPINT1 intron CTD PMID:27776689 NCBI chr 3:126,685,017...126,697,957
Ensembl chr 3:126,685,422...126,697,956 		JBrowse link
G Spon2 spondin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SPON2 intron CTD PMID:27776689 NCBI chr14:81,713,070...81,742,510
Ensembl chr14:81,731,188...81,742,609 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression EXP Ethylnitrosourea results in increased expression of SPP1 mRNA CTD PMID:15954086 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of STAT1 gene CTD PMID:16688530 PMID:16724327 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 decreases phosphorylation
increases mutagenesis 		ISO Ethylnitrosourea results in decreased phosphorylation of STAT3 protein
Ethylnitrosourea results in increased mutagenesis of STAT3 mRNA 		CTD PMID:27725143 PMID:27776689 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Stat5a signal transducer and activator of transcription 5A increases phosphorylation ISO Ethylnitrosourea results in increased phosphorylation of STAT5 protein CTD PMID:27725143 NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184 		JBrowse link
G Stat5b signal transducer and activator of transcription 5B increases activity ISO Ethylnitrosourea results in increased activity of STAT5B protein CTD PMID:30114225 NCBI chr10:86,205,148...86,276,178
Ensembl chr10:86,207,293...86,275,990 		JBrowse link
G Strip1 striatin interacting protein 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of STRIP1 intron CTD PMID:27776689 NCBI chr 2:197,936,569...197,956,515
Ensembl chr 2:197,936,569...197,956,865 		JBrowse link
G Stx2 syntaxin 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of STX2 gene CTD PMID:18277055 NCBI chr12:33,315,447...33,350,788
Ensembl chr12:33,315,750...33,350,788 		JBrowse link
G Stxbp4 syntaxin binding protein 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of STXBP4 gene CTD PMID:27776689 NCBI chr10:75,798,938...75,955,817
Ensembl chr10:75,798,938...75,955,737 		JBrowse link
G Syne2 spectrin repeat containing nuclear envelope protein 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of SYNE2 intron CTD PMID:27776689 NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723 		JBrowse link
G Syp synaptophysin increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of SYP gene CTD PMID:16495775 NCBI chr  X:17,521,348...17,536,449
Ensembl chr  X:17,521,348...17,536,984 		JBrowse link
G Tbcd tubulin folding cofactor D increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TBCD intron CTD PMID:27776689 NCBI chr10:107,215,626...107,372,398
Ensembl chr10:107,215,633...107,372,402 		JBrowse link
G Tbx6 T-box transcription factor 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TBX6 gene CTD PMID:15755804 PMID:16724327 NCBI chr 1:190,818,397...190,823,824
Ensembl chr 1:190,819,229...190,823,138 		JBrowse link
G Tek TEK receptor tyrosine kinase increases expression ISO Ethylnitrosourea results in increased expression of TEK protein CTD PMID:28549617 NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991 		JBrowse link
G Tex46 testis expressed 46 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TEX46 mRNA CTD PMID:27776689 NCBI chr 5:154,132,763...154,137,196
Ensembl chr 5:154,132,763...154,137,196 		JBrowse link
G Tfcp2l1 transcription factor CP2-like 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TFCP2L1 intron CTD PMID:27776689 NCBI chr13:32,286,643...32,346,671
Ensembl chr13:32,286,643...32,346,671 		JBrowse link
G Tfrc transferrin receptor increases expression ISO Ethylnitrosourea results in increased expression of TFRC protein CTD PMID:27725143 NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318 		JBrowse link
G Th tyrosine hydroxylase increases mutagenesis EXP Ethylnitrosourea results in increased mutagenesis of TH gene CTD PMID:16495775 NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227 		JBrowse link
G Ticam1 TIR domain containing adaptor molecule 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TICAM1 gene CTD PMID:16724327 PMID:27776689 NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,172,963...1,196,892 		JBrowse link
G Tlr8 toll-like receptor 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TLR8 mRNA CTD PMID:27776689 NCBI chr  X:30,708,714...30,733,104
Ensembl chr  X:30,708,033...30,737,079 		JBrowse link
G Tlr9 toll-like receptor 9 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TLR9 gene CTD PMID:16724327 NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148 		JBrowse link
G Tmed4 transmembrane p24 trafficking protein 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TMED4 gene; Ethylnitrosourea results in increased mutagenesis of TMED4 intron CTD PMID:27776689 NCBI chr14:85,338,980...85,343,577
Ensembl chr14:85,338,980...85,343,577 		JBrowse link
G Tmem8b transmembrane protein 8B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TMEM8B intron CTD PMID:27776689 NCBI chr 5:62,715,238...62,744,187
Ensembl chr 5:62,715,203...62,744,174 		JBrowse link
G Tmem91 transmembrane protein 91 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TMEM91 3' UTR; Ethylnitrosourea results in increased mutagenesis of TMEM91 mRNA CTD PMID:27776689 NCBI chr 1:90,307,264...90,314,796
Ensembl chr 1:90,306,289...90,313,320 		JBrowse link
G Tmprss7 transmembrane serine protease 7 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TMPRSS7 mRNA CTD PMID:27776689 NCBI chr11:68,583,710...68,629,200
Ensembl chr11:68,586,092...68,629,145 		JBrowse link
G Tnf tumor necrosis factor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TNF exon CTD PMID:16751399 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 increases mutagenesis
decreases expression
multiple interactions
increases expression
increases response to substance
affects response to substance 		EXP
ISO 		Ethylnitrosourea results in increased mutagenesis of TP53 gene
Ethylnitrosourea results in decreased expression of TRP53 protein
[Ethylnitrosourea results in increased mutagenesis of TP53 gene] which results in decreased activity of TP53 protein
Ethylnitrosourea results in increased expression of TRP53 protein
TRP53 gene mutant form results in increased susceptibility to Ethylnitrosourea
TRP53 affects the susceptibility to Ethylnitrosourea
Ethylnitrosourea results in increased mutagenesis of TRP53 exon; Ethylnitrosourea results in increased mutagenesis of TRP53 gene 		CTD PMID:9667752 PMID:11053539 PMID:14715658 PMID:15790496 PMID:16357521 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Trim11 tripartite motif-containing 11 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TRIM11 gene CTD PMID:27776689 NCBI chr10:44,255,019...44,270,711
Ensembl chr10:44,257,874...44,270,711 		JBrowse link
G Trim60 tripartite motif containing 60 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TRIM60 intron CTD PMID:27776689 NCBI chr16:29,489,264...29,490,876 JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TRPM4 gene CTD PMID:27776689 NCBI chr 1:104,918,462...104,949,453
Ensembl chr 1:104,918,462...104,948,653 		JBrowse link
G Tsr3 TSR3 ribosome maturation factor increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TSR3 gene CTD PMID:27776689 NCBI chr10:14,761,656...14,764,061
Ensembl chr10:14,761,663...14,764,061 		JBrowse link
G Ttc13 tetratricopeptide repeat domain 13 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TTC13 mRNA CTD PMID:27776689 NCBI chr19:69,534,989...69,589,590
Ensembl chr19:69,534,989...69,589,563 		JBrowse link
G Ttc21b tetratricopeptide repeat domain 21B increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TTC21B gene CTD PMID:18327258 NCBI chr 3:71,269,425...71,343,936
Ensembl chr 3:71,269,425...71,343,936 		JBrowse link
G Ttc8 tetratricopeptide repeat domain 8 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TTC8 mRNA CTD PMID:27776689 NCBI chr 6:123,927,657...124,025,354
Ensembl chr 6:123,927,907...123,982,117 		JBrowse link
G Ttll10 tubulin tyrosine ligase like 10 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TTLL10 intron CTD PMID:27776689 NCBI chr 5:171,912,371...171,937,733
Ensembl chr 5:171,912,376...171,926,337 		JBrowse link
G Tubb4b tubulin, beta 4B class IVb increases expression ISO Ethylnitrosourea results in increased expression of TUBB4B mRNA CTD PMID:19100860 NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TWIST1 gene CTD PMID:16724327 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Txnrd3 thioredoxin reductase 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TXNRD3 intron CTD PMID:27776689 NCBI chr 4:123,629,768...123,669,713
Ensembl chr 4:123,648,750...123,668,552 		JBrowse link
G Tyr tyrosinase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TYR gene CTD PMID:9475716 PMID:16180137 PMID:17174358 NCBI chr 1:150,527,687...150,622,857
Ensembl chr 1:150,527,687...150,622,857 		JBrowse link
G Tyrp1 tyrosinase-related protein 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of TYRP1 gene CTD PMID:9475716 PMID:10517996 PMID:17174358 NCBI chr 5:100,327,111...100,345,657
Ensembl chr 5:100,327,125...100,345,657 		JBrowse link
G U2af1l4 U2 small nuclear RNA auxiliary factor 1-like 4 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of U2AF1L4 mRNA CTD PMID:27776689 NCBI chr 1:94,943,684...94,945,906
Ensembl chr 1:94,942,544...94,946,391 		JBrowse link
G Ubash3a ubiquitin associated and SH3 domain containing, A increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UBASH3A intron CTD PMID:27776689 NCBI chr20:9,292,819...9,336,036
Ensembl chr20:9,287,590...9,344,772 		JBrowse link
G Ugcg UDP-glucose ceramide glucosyltransferase increases expression EXP Ethylnitrosourea results in increased expression of UGCG mRNA CTD PMID:15954086 NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:78,828,006...78,860,417 		JBrowse link
G Ugdh UDP-glucose 6-dehydrogenase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UGDH gene CTD PMID:15755804 NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629 		JBrowse link
G Ugt3a1 UDP glycosyltransferase family 3 member A1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UGT3A1 mRNA CTD PMID:27776689 NCBI chr 2:60,062,257...60,077,354
Ensembl chr 2:60,061,775...60,077,354 		JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 decreases phosphorylation
multiple interactions 		ISO Ethylnitrosourea results in decreased phosphorylation of ULK1 protein
Quercetin inhibits the reaction [Ethylnitrosourea results in decreased phosphorylation of ULK1 protein] 		CTD PMID:32902906 NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746 		JBrowse link
G Unc13d unc-13 homolog D increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UNC13D mRNA CTD PMID:27776689 NCBI chr10:101,795,652...101,810,409
Ensembl chr10:101,795,652...101,810,409 		JBrowse link
G Unkl unk like zinc finger increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UNKL gene CTD PMID:27776689 NCBI chr10:14,710,627...14,756,725
Ensembl chr10:14,710,563...14,756,724 		JBrowse link
G Upf1 UPF1, RNA helicase and ATPase increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UPF1 intron CTD PMID:27776689 NCBI chr16:19,110,531...19,131,327
Ensembl chr16:19,110,538...19,131,327 		JBrowse link
G Usp16 ubiquitin specific peptidase 16 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of USP16 gene CTD PMID:27776689 NCBI chr11:40,166,651...40,196,792
Ensembl chr11:40,167,692...40,196,823 		JBrowse link
G Usp29 ubiquitin specific peptidase 29 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of USP29 exon CTD PMID:16300676 NCBI chr 1:75,907,331...75,959,896
Ensembl chr 1:75,906,632...76,131,141 		JBrowse link
G Utp20 UTP20 small subunit processome component increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of UTP20 intron CTD PMID:27776689 NCBI chr 7:25,022,029...25,103,024
Ensembl chr 7:25,022,036...25,103,041 		JBrowse link
G Vat1 vesicle amine transport 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of VAT1 mRNA CTD PMID:27776689 NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411 		JBrowse link
G Vkorc1l1 vitamin K epoxide reductase complex, subunit 1-like 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of VKORC1L1 mRNA CTD PMID:27776689 NCBI chr12:32,354,078...32,404,327 JBrowse link
G Wdfy3 WD repeat and FYVE domain containing 3 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of WDFY3 intron CTD PMID:27776689 NCBI chr14:7,873,946...8,115,002
Ensembl chr14:7,911,151...8,114,993 		JBrowse link
G Wdr6 WD repeat domain 6 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of WDR6 gene CTD PMID:27776689 NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092 		JBrowse link
G Xrcc1 X-ray repair cross complementing 1 decreases expression ISO Ethylnitrosourea results in decreased expression of XRCC1 mRNA CTD PMID:21071726 NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613 		JBrowse link
G Xrcc3 X-ray repair cross complementing 3 affects response to substance ISO XRCC3 gene polymorphism affects the susceptibility to Ethylnitrosourea CTD PMID:17158087 NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822 		JBrowse link
G Xxylt1 xyloside xylosyltransferase 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of XXYLT1 mRNA CTD PMID:27776689 NCBI chr11:83,163,432...83,295,879
Ensembl chr11:83,163,189...83,295,988 		JBrowse link
G Ybey ybeY metalloendoribonuclease increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of YBEY intron CTD PMID:27776689 NCBI chr20:12,164,678...12,175,150
Ensembl chr20:12,164,723...12,174,199 		JBrowse link
G Zap70 zeta chain of T cell receptor associated protein kinase 70 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZAP70 gene CTD PMID:17767948 NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062 		JBrowse link
G Zdhhc14 zinc finger DHHC-type palmitoyltransferase 14 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZDHHC14 intron CTD PMID:27776689 NCBI chr 1:48,473,860...48,746,201
Ensembl chr 1:48,474,274...48,744,413 		JBrowse link
G Zfp110 zinc finger protein 110 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZFP110 mRNA CTD PMID:27776689 NCBI chr 1:82,509,563...82,533,294
Ensembl chr 1:82,517,769...82,533,292 		JBrowse link
G Zfp319 zinc finger protein 319 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZFP319 mRNA CTD PMID:27776689 NCBI chr19:9,708,881...9,712,860
Ensembl chr19:9,707,983...9,728,711 		JBrowse link
G Zfp568 zinc finger protein 568 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZFP568 gene CTD PMID:15755804 NCBI chr 1:94,334,011...94,385,166
Ensembl chr 1:94,334,983...94,393,003 		JBrowse link
G Zfpm2 zinc finger protein, multitype 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZFPM2 gene CTD PMID:16724327 NCBI chr 7:73,563,732...74,001,041
Ensembl chr 7:73,563,732...74,001,041 		JBrowse link
G Zic2 Zic family member 2 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZIC2 gene CTD PMID:16724327 NCBI chr15:105,982,711...105,988,167
Ensembl chr15:105,983,342...105,988,167 		JBrowse link
G Zmiz1 zinc finger, MIZ-type containing 1 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZMIZ1 intron CTD PMID:27776689 NCBI chr16:1,033,983...1,239,425
Ensembl chr16:1,034,020...1,239,406 		JBrowse link
G Znf750 zinc finger protein 750 increases mutagenesis ISO Ethylnitrosourea results in increased mutagenesis of ZFP750 mRNA CTD PMID:27776689 NCBI chr10:107,270,926...107,279,904
Ensembl chr10:107,270,763...107,279,300 		JBrowse link
N-methyl-N'-nitro-N-nitrosoguanidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ABL1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ABL1 mRNA CTD PMID:19840844 NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846 		JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of ACOX2 mRNA CTD PMID:15120970 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 increases expression ISO Methylnitronitrosoguanidine results in increased expression of ADAM10 mRNA CTD PMID:12634122 NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600 		JBrowse link
G Agt angiotensinogen multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of AGT mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of AGT mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of AGT mRNA CTD PMID:19840844 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 multiple interactions
increases localization 		ISO benzamide inhibits the reaction [Methylnitronitrosoguanidine results in increased localization of AIFM1 protein]; phenanthridone inhibits the reaction [Methylnitronitrosoguanidine results in increased localization of AIFM1 protein] CTD PMID:15589979 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of AKT1 mRNA
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of AKT1 mRNA] 		CTD PMID:35103375 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Alb albumin decreases secretion EXP Methylnitronitrosoguanidine results in decreased secretion of ALB protein CTD PMID:15772367 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of ALDH1A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of ALDH1A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of ALDH1A1 mRNA CTD PMID:19840844 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated increases expression ISO Methylnitronitrosoguanidine results in increased expression of ALPL mRNA CTD PMID:12634122 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Ambp alpha-1-microglobulin/bikunin precursor decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of AMBP mRNA CTD PMID:12773770 NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:81,583,622...81,593,850 		JBrowse link
G Anxa5 annexin A5 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ANXA5 mRNA CTD PMID:19840844 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 affects response to substance
decreases expression
multiple interactions 		ISO APAF1 protein affects the susceptibility to Methylnitronitrosoguanidine
Methylnitronitrosoguanidine results in decreased expression of APAF1 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein] 		CTD PMID:16019050 PMID:20434464 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apc APC regulator of WNT signaling pathway increases expression ISO Methylnitronitrosoguanidine results in increased expression of APC mRNA CTD PMID:12634122 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of APP mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of APP mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of APP mRNA CTD PMID:19840844 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Araf A-Raf proto-oncogene, serine/threonine kinase increases expression ISO Methylnitronitrosoguanidine results in increased expression of ARAF mRNA CTD PMID:12634122 NCBI chr  X:3,780,932...3,845,919
Ensembl chr  X:3,780,932...3,792,611 		JBrowse link
G Atm ATM serine/threonine kinase increases response to substance ISO ATM gene mutant form results in increased susceptibility to Methylnitronitrosoguanidine CTD PMID:15010311 NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629 		JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of ATP1B3 mRNA CTD PMID:12634122 NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304 		JBrowse link
G Atr ATR serine/threonine kinase multiple interactions ISO ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein] CTD PMID:26921499 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Axl Axl receptor tyrosine kinase increases expression ISO Methylnitronitrosoguanidine results in increased expression of AXL mRNA CTD PMID:12634122 NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009 		JBrowse link
G Bad BCL2-associated agonist of cell death decreases expression
decreases phosphorylation
multiple interactions 		ISO Methylnitronitrosoguanidine results in decreased expression of BAD mRNA
Methylnitronitrosoguanidine results in decreased phosphorylation of BAD protein
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of BAD protein]
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA] 		CTD PMID:17828454 PMID:20434464 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag1 BAG cochaperone 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of BAG1 mRNA CTD PMID:12634122 NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions ISO BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
decreases expression 		EXP
ISO 		[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BAX protein; corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein]
Methylnitronitrosoguanidine results in decreased expression of BAX mRNA; Methylnitronitrosoguanidine results in decreased expression of BAX protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein]
BAX protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] 		CTD PMID:16030430 PMID:18376143 PMID:20434464 PMID:35103375 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BCAT2 mRNA CTD PMID:19840844 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
increases expression
multiple interactions 		ISO
EXP 		Methylnitronitrosoguanidine results in decreased expression of BCL2 protein
Methylnitronitrosoguanidine results in increased expression of BCL2 protein
weifuchun affects the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]
Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA; Methylnitronitrosoguanidine results in increased expression of BCL2 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]; Lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] 		CTD PMID:16019050 PMID:16030430 PMID:20434464 PMID:35103375 PMID:36403744 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
increases expression 		ISO BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib]
Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] 		CTD PMID:18376143 PMID:20434464 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions EXP [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bdnf brain-derived neurotrophic factor increases expression EXP Methylnitronitrosoguanidine results in increased expression of BDNF mRNA CTD PMID:15120970 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Bgn biglycan multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of BGN mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of BGN mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BGN mRNA CTD PMID:19840844 NCBI chr  X:156,348,633...156,360,797
Ensembl chr  X:156,348,615...156,360,799 		JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions
decreases expression 		ISO Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA] CTD PMID:20434464 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of BIRC2 mRNA CTD PMID:12634122 NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911 		JBrowse link
G Blvrb biliverdin reductase B multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA CTD PMID:19840844 NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225 		JBrowse link
G Bmp4 bone morphogenetic protein 4 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of BMP4 mRNA CTD PMID:12773770 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Brca1 BRCA1, DNA repair associated increases expression ISO Methylnitronitrosoguanidine results in increased expression of BRCA1 mRNA CTD PMID:12634122 NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763 		JBrowse link
G Brca2 BRCA2, DNA repair associated increases expression ISO Methylnitronitrosoguanidine results in increased expression of BRCA2 mRNA CTD PMID:12634122 NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194 		JBrowse link
G Bsg basigin multiple interactions
increases expression 		EXP corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BSG mRNA] CTD PMID:35103375 NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of BTG2 protein CTD PMID:24821435 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G C1qb complement C1q B chain increases expression EXP Methylnitronitrosoguanidine results in increased expression of C1QB mRNA CTD PMID:15120970 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1s complement C1s increases expression EXP Methylnitronitrosoguanidine results in increased expression of C1S mRNA CTD PMID:15120970 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G Calm1 calmodulin 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CALM1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CALM1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CALM1 mRNA CTD PMID:19840844 NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381 		JBrowse link
G Casp3 caspase 3 increases activity
decreases expression
multiple interactions 		ISO
EXP 		Methylnitronitrosoguanidine results in increased activity of CASP3 protein
Methylnitronitrosoguanidine results in decreased expression of CASP3 protein
Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA; Methylnitronitrosoguanidine results in decreased expression of CASP3 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Methylnitronitrosoguanidine results in increased activity of CASP3 protein]
[Methylnitronitrosoguanidine co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased activity of CASP3 protein; [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein]; corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein] 		CTD PMID:15589979 PMID:16019050 PMID:16030430 PMID:17428624 PMID:20434464 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 increases expression ISO Methylnitronitrosoguanidine results in increased expression of CASP4 mRNA CTD PMID:12634122 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp8 caspase 8 multiple interactions EXP [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein; [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] CTD PMID:16030430 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 increases activity
decreases expression
multiple interactions 		ISO
EXP 		Methylnitronitrosoguanidine results in increased activity of CASP9 protein
Methylnitronitrosoguanidine results in decreased expression of CASP9 protein
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein]
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] 		CTD PMID:15589979 PMID:16019050 PMID:20434464 PMID:35103375 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase multiple interactions
decreases activity 		EXP corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased activity of CAT protein] CTD PMID:35103375 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cbx5 chromobox 5 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of CBX5 mRNA CTD PMID:12634122 NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118 		JBrowse link
G Ccna1 cyclin A1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of CCNA1 mRNA CTD PMID:12634122 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions
decreases expression
increases expression 		EXP
ISO 		Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA]
Methylnitronitrosoguanidine results in decreased expression of CCNB1 mRNA
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCNB1 mRNA 		CTD PMID:11516527 PMID:12135628 PMID:19851710 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression 		EXP
ISO 		Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA]
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCND1 protein
Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA; Methylnitronitrosoguanidine results in increased expression of CCND1 protein 		CTD PMID:12135628 PMID:19851710 PMID:21628965 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccng1 cyclin G1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of CCNG1 mRNA CTD PMID:11516527 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccnh cyclin H increases expression ISO Methylnitronitrosoguanidine results in increased expression of CCNH mRNA CTD PMID:12634122 NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCT2 mRNA CTD PMID:19840844 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cd14 CD14 molecule increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of CD14 protein
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CD14 protein] 		CTD PMID:36403744 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd59b CD59b molecule increases mutagenesis ISO Methylnitronitrosoguanidine results in increased mutagenesis of CD59 protein CTD PMID:17045307 NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310 		JBrowse link
G Cd9 CD9 molecule multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CD9 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CD9 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD9 mRNA CTD PMID:19840844 NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression 		EXP
ISO 		geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein]
Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]
KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein]
Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA; Methylnitronitrosoguanidine results in decreased expression of CDH1 protein 		CTD PMID:28428697 PMID:38184286 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh2 cadherin 2 increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA
KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 protein]
Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA; Methylnitronitrosoguanidine results in increased expression of CDH2 protein
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA] 		CTD PMID:38184286 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh8 cadherin 8 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of CDH8 mRNA CTD PMID:12634122 NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression
multiple interactions 		EXP
ISO 		Methylnitronitrosoguanidine results in increased expression of CDK4 protein
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDK4 protein]
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein 		CTD PMID:12135628 PMID:21628965 PMID:36403744 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk5 cyclin-dependent kinase 5 increases expression ISO Methylnitronitrosoguanidine results in increased expression of CDK5 mRNA CTD PMID:12634122 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A decreases expression
multiple interactions 		ISO
EXP 		Methylnitronitrosoguanidine results in decreased expression of CDKN1A mRNA
Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein] 		CTD PMID:12634122 PMID:19851710 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression
multiple interactions
increases expression 		ISO Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA
Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein]; Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] 		CTD PMID:11516527 PMID:12135628 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cep43 centrosomal protein 43 increases expression ISO Methylnitronitrosoguanidine results in increased expression of CEP43 mRNA CTD PMID:12634122 NCBI chr 1:55,080,983...55,111,509
Ensembl chr 1:55,082,712...55,111,509 		JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein] CTD PMID:26921499 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein] CTD PMID:26921499 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Ckb creatine kinase B decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of CKB mRNA CTD PMID:12634122 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Clta clathrin, light chain A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CLTA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CLTA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CLTA mRNA CTD PMID:19840844 NCBI chr 5:63,022,046...63,059,223
Ensembl chr 5:63,041,184...63,059,215 		JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL1A2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL1A2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL1A2 mRNA CTD PMID:19840844 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL6A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL6A1 mRNA CTD PMID:19840844 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL8A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL8A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL8A1 mRNA CTD PMID:19840844 NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229 		JBrowse link
G Cox6a1 cytochrome c oxidase subunit 6A1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of COX6A1 mRNA CTD PMID:19840844 NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768 		JBrowse link
G Cox8a cytochrome c oxidase subunit 8A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of COX8A mRNA CTD PMID:19840844 NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions
increases expression 		EXP geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA] CTD PMID:28428697 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctsb cathepsin B multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of CTSB mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of CTSB mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CTSB mRNA CTD PMID:19840844 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsl cathepsin L multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CTSL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CTSL mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CTSL mRNA CTD PMID:19840844 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CXCL12 mRNA CTD PMID:19840844 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of CXCR4 mRNA CTD PMID:12634122 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyb561d2 cytochrome b561 family, member D2 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of CYB561D2 mRNA CTD PMID:12634122 NCBI chr 8:117,091,844...117,094,434
Ensembl chr 8:117,091,845...117,094,366 		JBrowse link
G Cycs cytochrome c, somatic multiple interactions
decreases expression 		ISO Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein]
Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA; Methylnitronitrosoguanidine results in decreased expression of CYCS protein 		CTD PMID:20434464 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Dab2 DAB adaptor protein 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of DAB2 mRNA CTD PMID:12634122 PMID:12773770 NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888 		JBrowse link
G Dcn decorin decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of DCN mRNA CTD PMID:15120970 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Deaf1 DEAF1 transcription factor decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of DEAF1 mRNA CTD PMID:12634122 NCBI chr 1:205,831,428...205,865,106
Ensembl chr 1:205,831,336...205,865,106 		JBrowse link
G Dek DEK proto-oncogene increases expression ISO Methylnitronitrosoguanidine results in increased expression of DEK mRNA CTD PMID:12634122 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of DLG1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of DLG1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of DLG1 mRNA CTD PMID:19840844 NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797 		JBrowse link
G Dstn destrin, actin depolymerizing factor increases expression ISO Methylnitronitrosoguanidine results in increased expression of DSTN mRNA CTD PMID:12634122 NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769 		JBrowse link
G Dut deoxyuridine triphosphatase affects localization
increases secretion 		ISO Methylnitronitrosoguanidine affects the localization of DUT protein
Methylnitronitrosoguanidine results in increased secretion of DUT protein 		CTD PMID:21658424 NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956 		JBrowse link
G E2f1 E2F transcription factor 1 increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of E2F1 protein
ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein results in increased expression of RRM2 mRNA] 		CTD PMID:26921499 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563 		JBrowse link
G E2f3 E2F transcription factor 3 multiple interactions ISO [[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; [Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHIR-124 inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; E2F3 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]] CTD PMID:26921499 NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725 		JBrowse link
G Egf epidermal growth factor affects activity
multiple interactions 		ISO Methylnitronitrosoguanidine affects the activity of EGF protein
Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein]; Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] 		CTD PMID:15708576 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfr epidermal growth factor receptor affects localization
multiple interactions 		ISO Methylnitronitrosoguanidine affects the localization of EGFR protein
Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] 		CTD PMID:15708576 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr1 early growth response 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA CTD PMID:19840844 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Eif1 eukaryotic translation initiation factor 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EIF1 mRNA CTD PMID:19840844 NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654 		JBrowse link
G Eif3e eukaryotic translation initiation factor 3 subunit E increases expression ISO Methylnitronitrosoguanidine results in increased expression of EIF3E mRNA CTD PMID:12634122 NCBI chr 7:76,224,567...76,257,346
Ensembl chr 7:76,224,568...76,257,785 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of EIF5 mRNA CTD PMID:12634122 NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821 		JBrowse link
G Eif5a eukaryotic translation initiation factor 5A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EIF5A mRNA CTD PMID:19840844 NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330 		JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression ISO Methylnitronitrosoguanidine results in increased expression of ELK3 mRNA CTD PMID:12634122 NCBI chr 7:29,655,676...29,718,163
Ensembl chr 7:29,655,693...29,691,661 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of EMP1 mRNA CTD PMID:12634122 NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of ENPP2 mRNA CTD PMID:15120970 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Epcam epithelial cell adhesion molecule increases expression ISO Methylnitronitrosoguanidine results in increased expression of EPCAM mRNA CTD PMID:12634122 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epha1 Eph receptor A1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA CTD PMID:12634122 NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474 		JBrowse link
G Ephb3 Eph receptor B3 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of EPHB3 mRNA CTD PMID:12634122 NCBI chr11:93,345,098...93,363,775
Ensembl chr11:93,345,098...93,363,775 		JBrowse link
G Eps8 EGFR pathway substrate 8, signaling adaptor multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EPS8 mRNA CTD PMID:19840844 NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of ERBB2 mRNA CTD PMID:12634122 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 increases expression ISO Methylnitronitrosoguanidine results in increased expression of ERBB4 mRNA CTD PMID:12634122 NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772 		JBrowse link
G Esr2 estrogen receptor 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of ESR2 mRNA; Methylnitronitrosoguanidine results in increased expression of ESR2 protein CTD PMID:21628965 PMID:22330348 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor increases expression ISO Methylnitronitrosoguanidine results in increased expression of ETS1 mRNA CTD PMID:12634122 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021 		JBrowse link
G Faslg Fas ligand decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of FASLG protein CTD PMID:24821435 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fasn fatty acid synthase increases expression ISO Methylnitronitrosoguanidine results in increased expression of FASN mRNA CTD PMID:12634122 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fau FAU ubiquitin like and ribosomal protein S30 fusion multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of FAU mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of FAU mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FAU mRNA CTD PMID:19840844 NCBI chr 1:212,779,429...212,781,028
Ensembl chr 1:212,779,473...212,781,026
Ensembl chr 1:212,779,473...212,781,026 		JBrowse link
G Fcer1a Fc epsilon receptor Ia increases expression EXP Methylnitronitrosoguanidine results in increased expression of FCER1A mRNA CTD PMID:15120970 NCBI chr13:88,218,427...88,224,723
Ensembl chr13:88,218,420...88,224,681 		JBrowse link
G Fcgr2a Fc gamma receptor 2A increases expression EXP Methylnitronitrosoguanidine results in increased expression of FCGR3 mRNA CTD PMID:15120970 NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394 		JBrowse link
G Fcgrt Fc gamma receptor and transporter decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of FCGRT mRNA CTD PMID:12634122 NCBI chr 1:104,710,902...104,720,685
Ensembl chr 1:104,710,909...104,720,532 		JBrowse link
G Fes FES proto-oncogene, tyrosine kinase increases expression ISO Methylnitronitrosoguanidine results in increased expression of FES mRNA CTD PMID:12634122 NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:143,746,945...143,756,181 		JBrowse link
G Fgf10 fibroblast growth factor 10 increases expression EXP Methylnitronitrosoguanidine results in increased expression of FGF10 mRNA CTD PMID:15120970 NCBI chr 2:52,533,939...52,610,980
Ensembl chr 2:52,533,939...52,610,980 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions
increases expression 		EXP Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of FLT1 mRNA] CTD PMID:20434464 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Folr1 folate receptor alpha increases methylation ISO Methylnitronitrosoguanidine results in increased methylation of FOLR1 promoter CTD PMID:29644877 NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit decreases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in decreased expression of FOSL1 mRNA
Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein results in increased expression of RRM2 mRNA] 		CTD PMID:12634122 PMID:26921499 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Fst follistatin increases expression EXP Methylnitronitrosoguanidine results in increased expression of FST mRNA CTD PMID:15120970 NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491 		JBrowse link
G Fstl1 follistatin-like 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of FSTL1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of FSTL1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FSTL1 mRNA CTD PMID:19840844 NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase increases expression ISO Methylnitronitrosoguanidine results in increased expression of FYN mRNA CTD PMID:12634122 NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha decreases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA] 		CTD PMID:19851710 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gcgr glucagon receptor decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of GCGR mRNA CTD PMID:15120970 NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO Methylnitronitrosoguanidine results in increased expression of GDF15 mRNA CTD PMID:12634122 PMID:12773770 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GJA1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GJA1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GJA1 mRNA CTD PMID:19840844 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gjb2 gap junction protein, beta 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of GJB2 mRNA CTD PMID:15120970 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Gli1 GLI family zinc finger 1 increases expression EXP MNNG increases expression of Gli1 mRNA in rat stomach RGD PMID:30537251 RGD:150520178 NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gpc4 glypican 4 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GPC4 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GPC4 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GPC4 mRNA CTD PMID:19840844 NCBI chr  X:136,565,536...136,676,142
Ensembl chr  X:136,565,591...136,676,057 		JBrowse link
G Gss glutathione synthetase decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of GSS mRNA CTD PMID:12634122 NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GSTM2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GSTM2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GSTM2 mRNA CTD PMID:19840844 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G Gsto1 glutathione S-transferase omega 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of GSTO1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTO1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GSTO1 mRNA CTD PMID:19840844 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of GSTP1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTP1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GSTP1 mRNA CTD PMID:19840844 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gtf2i general transcription factor II I multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [GTF2I protein binds to RRM2 promoter] CTD PMID:26921499 NCBI chr12:28,037,344...28,112,677
Ensembl chr12:28,037,853...28,112,677 		JBrowse link
G Gzmf granzyme F increases expression EXP Methylnitronitrosoguanidine results in increased expression of GZMG mRNA CTD PMID:15120970 NCBI chr15:33,975,543...33,997,505
Ensembl chr15:33,977,505...33,997,572 		JBrowse link
G H2ax H2A.X variant histone increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form
[[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; E2F3 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; RRM2 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form] 		CTD PMID:26921499 PMID:27233451 PMID:38563870 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H4c14 H4 clustered histone 14 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of H4C2 mRNA CTD PMID:12634122 NCBI chr 2:186,520,468...186,520,863
Ensembl chr 4:171,403,627...171,403,938
Ensembl chr17:171,403,627...171,403,938
Ensembl chr17:171,403,627...171,403,938
Ensembl chr17:171,403,627...171,403,938 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of HBA1 mRNA CTD PMID:15120970 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of HES1 protein
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HES1 protein] 		CTD PMID:36403744 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hes6 hes family bHLH transcription factor 6 multiple interactions
increases expression 		EXP weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HES6 protein] CTD PMID:36403744 NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of HIF1A mRNA; Methylnitronitrosoguanidine results in increased expression of HIF1A protein
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HIF1A mRNA]; weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HIF1A protein] 		CTD PMID:35103375 PMID:36403744 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hmgb1 high mobility group box 1 increases expression
multiple interactions 		ISO
EXP 		Methylnitronitrosoguanidine results in increased expression of HMGB1 mRNA
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HMGB1 mRNA] 		CTD PMID:12634122 PMID:35103375 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgb2 high mobility group box 2 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of HMGB2 mRNA CTD PMID:12634122 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of HPGD mRNA CTD PMID:15120970 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HPRT1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of HPRT1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HPRT1 mRNA CTD PMID:19840844 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions ISO Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein] CTD PMID:15708576 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSP90AA1 mRNA CTD PMID:19840844 NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSP90AB1 mRNA CTD PMID:19840844 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of HSP90B1 mRNA CTD PMID:12634122 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of HSPA1A mRNA CTD PMID:15120970 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSPD1 mRNA CTD PMID:19840844 NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases response to substance
multiple interactions
increases expression 		ISO ICAM1 protein results in decreased susceptibility to Methylnitronitrosoguanidine
prolinedithiocarbamate inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of ICAM1 protein]
Methylnitronitrosoguanidine results in increased expression of ICAM1 mRNA; Methylnitronitrosoguanidine results in increased expression of ICAM1 protein 		CTD PMID:22001597 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Id1 inhibitor of DNA binding 1 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of ID1 mRNA CTD PMID:12634122 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Ier3 immediate early response 3 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IER3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IER3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IER3 mRNA CTD PMID:19840844 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ifitm1 interferon induced transmembrane protein 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of IFITM1 mRNA CTD PMID:12634122 PMID:12773770 NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of IFRD1 mRNA CTD PMID:12634122 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Igkc immunoglobulin kappa constant increases expression EXP Methylnitronitrosoguanidine results in increased expression of IGKC mRNA CTD PMID:15120970
G Igsf6 immunoglobulin superfamily, member 6 increases expression EXP Methylnitronitrosoguanidine results in increased expression of IGSF6 mRNA CTD PMID:15120970 NCBI chr 1:185,041,462...185,051,956
Ensembl chr 1:185,041,462...185,052,245 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions
increases expression 		EXP Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IKBKB protein] CTD PMID:19851710 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Il1b interleukin 1 beta increases secretion
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased secretion of IL1B protein
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased secretion of IL1B protein] 		CTD PMID:38184286 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion
increases expression 		ISO
EXP 		weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased secretion of IL6 protein]
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased secretion of IL6 protein]
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IL6 protein] 		CTD PMID:36403744 PMID:38184286 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IRAK1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IRAK1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IRAK1 mRNA CTD PMID:19840844 NCBI chr  X:156,919,927...156,929,825
Ensembl chr  X:156,920,081...156,929,825 		JBrowse link
G Itgb4 integrin subunit beta 4 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of ITGB4 mRNA CTD PMID:12634122 PMID:12773770 NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932 		JBrowse link
G Jmjd6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JMJD6 mRNA CTD PMID:19840844 NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986 		JBrowse link
G Jpt1 Jupiter microtubule associated homolog 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JPT1 mRNA CTD PMID:19840844 NCBI chr10:101,243,428...101,261,464
Ensembl chr10:101,243,424...101,261,469 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218 		JBrowse link
G Kctd12 potassium channel tetramerization domain containing 12 increases expression EXP Methylnitronitrosoguanidine results in increased expression of KCTD12 mRNA CTD PMID:15120970 NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539 		JBrowse link
G Kdm8 lysine demethylase 8 multiple interactions ISO Methylnitronitrosoguanidine inhibits the reaction [TP53 protein binds to KDM8 protein] CTD PMID:26025680 NCBI chr 1:189,444,527...189,459,507
Ensembl chr 1:189,444,555...189,459,491 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase increases expression ISO Methylnitronitrosoguanidine results in increased expression of KIT mRNA CTD PMID:12634122 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812 		JBrowse link
G Kitlg KIT ligand decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of KITLG mRNA CTD PMID:15120970 NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793 		JBrowse link
G Klf10 KLF transcription factor 10 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of KLF10 mRNA CTD PMID:15120970 NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948 		JBrowse link
G Klf7 KLF transcription factor 7 multiple interactions
increases expression 		ISO KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KLF7 mRNA]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KLF7 protein]
Methylnitronitrosoguanidine results in increased expression of KLF7 mRNA; Methylnitronitrosoguanidine results in increased expression of KLF7 protein
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased phosphorylation of RELA protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased secretion of IL1B protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased secretion of IL6 protein] 		CTD PMID:38184286 NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:72,933,136...73,020,056 		JBrowse link
G Kras KRAS proto-oncogene, GTPase multiple interactions
increases expression 		EXP geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KRAS mRNA] CTD PMID:28428697 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320 		JBrowse link
G Krt17 keratin 17 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of KRT17 mRNA CTD PMID:12634122 NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787 		JBrowse link
G Ldha lactate dehydrogenase A multiple interactions
increases expression 		EXP corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of LDHA mRNA] CTD PMID:35103375 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521 		JBrowse link
G Lgals3 galectin 3 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lgals8 galectin 8 increases expression ISO Methylnitronitrosoguanidine results in increased expression of LGALS8 mRNA CTD PMID:12634122 NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482 		JBrowse link
G Lig1 DNA ligase 1 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of LIG1 mRNA CTD PMID:12634122 NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708 		JBrowse link
G Lipa lipase A, lysosomal acid type increases expression EXP Methylnitronitrosoguanidine results in increased expression of LIP1 mRNA CTD PMID:15120970 NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740 		JBrowse link
G Lox lysyl oxidase multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LOX mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LOX mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LOX mRNA CTD PMID:19840844 NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810 		JBrowse link
G Lpl lipoprotein lipase multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LPL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LPL mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LPL mRNA CTD PMID:19840844 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA] 		CTD PMID:28428697 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184 		JBrowse link
G Map3k12 mitogen activated protein kinase kinase kinase 12 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MAP3K12 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MAP3K12 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MAP3K12 mRNA CTD PMID:19840844 NCBI chr 7:135,507,082...135,527,396
Ensembl chr 7:135,508,790...135,515,137 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
decreases phosphorylation 		ISO N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK1 protein]] CTD PMID:17828454 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 increases phosphorylation ISO Methylnitronitrosoguanidine results in increased phosphorylation of MAPK14 protein CTD PMID:22001597 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
decreases phosphorylation 		ISO N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK3 protein]] CTD PMID:17828454 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk4 mitogen-activated protein kinase 4 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MAPK4 mRNA CTD PMID:12634122 NCBI chr18:69,788,058...69,937,524
Ensembl chr18:69,788,060...69,837,037 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation ISO Methylnitronitrosoguanidine results in increased phosphorylation of MAPK8 protein CTD PMID:22001597 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MAPK9 mRNA CTD PMID:12634122 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of MARCKS mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MARCKS mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARCKS mRNA CTD PMID:19840844 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Max MYC associated factor X increases expression ISO Methylnitronitrosoguanidine results in increased expression of MAX mRNA CTD PMID:12634122 NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:101,369,988...101,395,549 		JBrowse link
G Mcam melanoma cell adhesion molecule increases expression ISO Methylnitronitrosoguanidine results in increased expression of MCAM mRNA CTD PMID:12634122 PMID:12773770 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 decreases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in decreased expression of MCM2 mRNA
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM2 mRNA 		CTD PMID:12634122 PMID:19840844 NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of MCM4 mRNA CTD PMID:12634122 NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM6 mRNA CTD PMID:19840844 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mcpt1 mast cell protease 1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of MCPT1 mRNA CTD PMID:15120970 NCBI chr15:33,841,606...33,844,174
Ensembl chr15:33,841,606...33,844,174 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of MDM2 mRNA
Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MDM2 protein] 		CTD PMID:12135628 PMID:12634122 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Mecom MDS1 and EVI1 complex locus increases expression ISO Methylnitronitrosoguanidine results in increased expression of MECOM mRNA CTD PMID:12634122 NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:114,837,840...115,393,038 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase increases expression ISO Methylnitronitrosoguanidine results in increased expression of MET mRNA CTD PMID:12634122 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase decreases response to substance ISO MGMT protein results in decreased susceptibility to Methylnitronitrosoguanidine CTD PMID:1727384 PMID:15010311 PMID:16043385 NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mgst2 microsomal glutathione S-transferase 2 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of MGST2 mRNA CTD PMID:12634122 NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661 		JBrowse link
G Mgst3 microsomal glutathione S-transferase 3 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MGST3 mRNA CTD PMID:19840844 NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575 		JBrowse link
G Mir21 microRNA 21 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MIR21 mRNA CTD PMID:24821435 NCBI chr10:71,902,600...71,902,691 JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MKI67 protein CTD PMID:38563870 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mlh1 mutL homolog 1 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of MLH1 protein CTD PMID:17671175 NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
increases expression 		EXP
ISO 		Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP2 mRNA]; Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MMP2 mRNA 		CTD PMID:19840844 PMID:20434464 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
increases expression 		EXP Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA]; Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein CTD PMID:20434464 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mpg N-methylpurine-DNA glycosylase increases response to substance ISO MPG protein results in increased susceptibility to Methylnitronitrosoguanidine CTD PMID:15299078 NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052 		JBrowse link
G Mpp1 MAGUK p55 scaffold protein 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of MPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MPP1 mRNA CTD PMID:19840844
G Msh2 mutS homolog 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MSH2 mRNA CTD PMID:12634122 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Mst1 macrophage stimulating 1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of MST1 mRNA CTD PMID:15120970 NCBI chr 8:117,646,485...117,652,016
Ensembl chr 8:117,647,438...117,652,015 		JBrowse link
G Mt1a metallothionein 1A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MT1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MT1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MT1 mRNA CTD PMID:19840844 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mthfr methylenetetrahydrofolate reductase increases methylation ISO Methylnitronitrosoguanidine results in increased methylation of MTHFR promoter CTD PMID:29644877 NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105 		JBrowse link
G Mutyh mutY DNA glycosylase multiple interactions ISO MUTYH protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of PARP1 protein] CTD PMID:26954031 NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:135,517,695...135,522,776 		JBrowse link
G Mx2 MX dynamin like GTPase 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of MX2 mRNA CTD PMID:12082013 NCBI chr11:50,375,101...50,399,373
Ensembl chr11:50,375,191...50,402,478 		JBrowse link
G Mybl1 MYB proto-oncogene like 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MYBL1 mRNA CTD PMID:12634122 NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of MYC protein
Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MYC protein] 		CTD PMID:12135628 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myl2 myosin light chain 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MYL2 mRNA CTD PMID:12634122 NCBI chr12:40,114,964...40,126,236
Ensembl chr12:40,114,958...40,129,149 		JBrowse link
G Myl9 myosin light chain 9 increases expression ISO Methylnitronitrosoguanidine results in increased expression of MYL9 mRNA CTD PMID:12634122 NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:165,742,046...165,748,410 		JBrowse link
G Mylk myosin light chain kinase decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of MYLK mRNA CTD PMID:12634122 NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Nbl1 NBL1, DAN family BMP antagonist decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of NBL1 mRNA CTD PMID:12634122 NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions
increases expression 		EXP
ISO 		Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]
KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]
Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA; Methylnitronitrosoguanidine results in increased expression of NFKB1 protein 		CTD PMID:19851710 PMID:38184286 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression
decreases expression 		EXP
ISO 		Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKBIA protein modified form]
Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased degradation of NFKBIA protein
Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA; Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein 		CTD PMID:19851710 PMID:22001597 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nfya nuclear transcription factor Y subunit alpha multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [NFYA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYA protein results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr 9:20,085,067...20,111,521
Ensembl chr 9:20,085,073...20,111,504 		JBrowse link
G Nfyb nuclear transcription factor Y subunit beta multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [NFYB protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYB protein results in increased expression of RRM2 mRNA]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein] CTD PMID:26921499 NCBI chr 7:22,852,543...22,868,116
Ensembl chr 7:22,852,546...22,882,294 		JBrowse link
G Nfyc nuclear transcription factor Y subunit gamma multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [NFYC protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYC protein results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr 5:139,622,020...139,690,545
Ensembl chr 5:139,622,020...139,679,884 		JBrowse link
G Nnmt nicotinamide N-methyltransferase increases activity EXP Methylnitronitrosoguanidine results in increased activity of NNMT protein CTD PMID:6652621 NCBI chr 8:57,820,156...57,851,301
Ensembl chr 8:57,825,464...57,843,174 		JBrowse link
G Nrp1 neuropilin 1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of NRP1 mRNA CTD PMID:15120970 NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702 		JBrowse link
G Odc1 ornithine decarboxylase 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ODC1 mRNA CTD PMID:19840844 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146 		JBrowse link
G Pa2g4 proliferation-associated 2G4 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PA2G4 mRNA CTD PMID:19840844 NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802 		JBrowse link
G Parg poly (ADP-ribose) glycohydrolase multiple interactions
affects response to substance 		ISO [Hydrolyzable Tannins results in decreased activity of PARG protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; [nobotanin B results in decreased activity of PARG protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; benzamide inhibits the reaction [PARG affects the susceptibility to Methylnitronitrosoguanidine] CTD PMID:11593040 PMID:15591342 NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases expression
increases response to substance
affects cleavage
increases activity 		ISO [benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; [Methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD; benzamide inhibits the reaction [[Methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein]; Hydrolyzable Tannins inhibits the reaction [[Methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; MUTYH protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of PARP1 protein]
PARP1 protein results in increased susceptibility to Methylnitronitrosoguanidine 		CTD PMID:11593040 PMID:20434464 PMID:22001597 PMID:26954031 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pcbp2 poly(rC) binding protein 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PCBP2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCBP2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCBP2 mRNA CTD PMID:19840844 NCBI chr 7:135,483,702...135,508,254
Ensembl chr 7:135,483,856...135,509,412 		JBrowse link
G Pcdh7 protocadherin 7 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of PCDH7 mRNA CTD PMID:12634122 NCBI chr14:56,684,817...57,114,976
Ensembl chr14:56,687,725...57,112,665 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression
increases expression
multiple interactions 		ISO
EXP 		Methylnitronitrosoguanidine results in decreased expression of PCNA mRNA
Methylnitronitrosoguanidine results in increased expression of PCNA mRNA; Methylnitronitrosoguanidine results in increased expression of PCNA protein
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PCNA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCNA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA; Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PCNA mRNA]; Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein]
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein]; geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein] 		CTD PMID:11516527 PMID:12135628 PMID:12634122 PMID:19840844 PMID:19851710 More... NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pdgfb platelet derived growth factor subunit B increases expression ISO Methylnitronitrosoguanidine results in increased expression of PDGFB mRNA CTD PMID:12634122 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pdgfra platelet derived growth factor receptor alpha multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PDGFRA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PDGFRA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PDGFRA mRNA CTD PMID:19840844 NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PDIA3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PDIA3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PDIA3 mRNA CTD PMID:19840844 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327 		JBrowse link
G Pea15 proliferation and apoptosis adaptor protein 15 increases expression ISO Methylnitronitrosoguanidine results in increased expression of PEA15 mRNA CTD PMID:12634122 NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859 		JBrowse link
G Pgk1 phosphoglycerate kinase 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of PGK1 mRNA CTD PMID:12634122 NCBI chr  X:75,336,988...75,352,962
Ensembl chr  X:75,336,687...75,352,959 		JBrowse link
G Pgr progesterone receptor decreases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in decreased expression of PGR protein
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PGR protein] 		CTD PMID:28428697 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pik3cg phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA] 		CTD PMID:35103375 NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:54,478,603...54,529,509 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of PIK3R1 mRNA
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3R1 mRNA] 		CTD PMID:28428697 NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347 		JBrowse link
G Plxna3 plexin A3 increases expression ISO Methylnitronitrosoguanidine results in increased expression of PLXNA3 mRNA CTD PMID:12634122 NCBI chr  X:157,266,986...157,282,896
Ensembl chr  X:157,267,107...157,282,891 		JBrowse link
G Podxl podocalyxin-like multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PODXL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PODXL mRNA CTD PMID:19840844 NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789 		JBrowse link
G Postn periostin decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of POSTN mRNA CTD PMID:15120970 NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300 		JBrowse link
G Ppp2r2a protein phosphatase 2, regulatory subunit B, alpha decreases response to substance ISO PPP2R2A protein results in decreased susceptibility to Methylnitronitrosoguanidine CTD PMID:25772433 NCBI chr15:45,380,142...45,439,428
Ensembl chr15:45,379,683...45,439,405 		JBrowse link
G Ppp2r5c protein phosphatase 2, regulatory subunit B', gamma increases response to substance ISO PPP2R5C protein results in increased susceptibility to Methylnitronitrosoguanidine CTD PMID:25772433 NCBI chr 6:135,282,947...135,419,591
Ensembl chr 6:135,324,067...135,419,597 		JBrowse link
G Ppp2r5e protein phosphatase 2 regulatory subunit B', epsilon decreases response to substance ISO PPP2R5E protein results in decreased susceptibility to Methylnitronitrosoguanidine CTD PMID:25772433 NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:99,904,569...100,053,573 		JBrowse link
G Prkd1 protein kinase D1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of PRKD1 mRNA CTD PMID:12634122 NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509 		JBrowse link
G Pten phosphatase and tensin homolog decreases response to substance
multiple interactions
decreases expression 		ISO
EXP 		PTEN protein results in decreased susceptibility to Methylnitronitrosoguanidine
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PTEN protein] 		CTD PMID:20530668 PMID:28428697 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptn pleiotrophin multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PTN mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PTN mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTN mRNA CTD PMID:19840844 NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of PTP4A1 mRNA CTD PMID:12634122 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptpra protein tyrosine phosphatase, receptor type, A decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of PTPRA mRNA CTD PMID:12634122 NCBI chr 3:138,103,261...138,212,835
Ensembl chr 3:138,098,110...138,213,126 		JBrowse link
G Ptprg protein tyrosine phosphatase, receptor type, G decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of PTPRG mRNA CTD PMID:12634122 NCBI chr15:15,298,669...15,982,581
Ensembl chr15:15,302,133...15,982,668 		JBrowse link
G Ptprs protein tyrosine phosphatase, receptor type, S decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of PTPRS mRNA CTD PMID:12634122 NCBI chr 9:1,332,558...1,394,161
Ensembl chr 9:1,332,559...1,394,093 		JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PTTG1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PTTG1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTTG1 mRNA CTD PMID:19840844 NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309 		JBrowse link
G Pura purine rich element binding protein A multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [PURA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [PURA protein results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr18:28,159,103...28,179,539
Ensembl chr18:28,125,126...28,211,111 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA CTD PMID:19840844 NCBI chr 7:132,629,789...132,659,738
Ensembl chr 7:132,620,595...132,659,738 		JBrowse link
G Rad21 RAD21 cohesin complex component multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RAD21 mRNA CTD PMID:19840844 NCBI chr 7:85,177,715...85,204,657
Ensembl chr 7:85,177,716...85,204,657 		JBrowse link
G Rad23a RAD23 homolog A, nucleotide excision repair protein decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of RAD23A mRNA CTD PMID:12634122 PMID:12773770 NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543 		JBrowse link
G Rbbp5 RB binding protein 5, histone lysine methyltransferase complex subunit increases expression ISO Methylnitronitrosoguanidine results in increased expression of RBBP5 mRNA CTD PMID:12634122 NCBI chr13:46,464,389...46,494,244
Ensembl chr13:46,464,389...46,491,238 		JBrowse link
G Rbm6 RNA binding motif protein 6 increases expression ISO Methylnitronitrosoguanidine results in increased expression of RBM6 mRNA CTD PMID:12634122 NCBI chr 8:117,327,607...117,431,397
Ensembl chr 8:117,331,325...117,431,397 		JBrowse link
G Reck reversion-inducing-cysteine-rich protein with kazal motifs multiple interactions
decreases expression 		EXP Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein]
Methylnitronitrosoguanidine results in decreased expression of RECK mRNA; Methylnitronitrosoguanidine results in decreased expression of RECK protein 		CTD PMID:20434464 NCBI chr 5:62,898,717...62,965,274
Ensembl chr 5:62,898,668...62,965,270 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression
increases phosphorylation 		EXP
ISO 		Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]
KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]
Methylnitronitrosoguanidine results in increased phosphorylation of RELA protein
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased phosphorylation of RELA protein]
Methylnitronitrosoguanidine results in increased expression of RELA mRNA; Methylnitronitrosoguanidine results in increased expression of RELA protein 		CTD PMID:19851710 PMID:38184286 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Reln reelin increases expression EXP Methylnitronitrosoguanidine results in increased expression of RELN mRNA CTD PMID:15120970 NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162 		JBrowse link
G Rgs18 regulator of G-protein signaling 18 increases expression EXP Methylnitronitrosoguanidine results in increased expression of RGS18 mRNA CTD PMID:15120970 NCBI chr13:59,043,431...59,066,342
Ensembl chr13:59,043,431...59,066,342 		JBrowse link
G Ros1 ROS proto-oncogene 1 , receptor tyrosine kinase increases expression EXP Methylnitronitrosoguanidine results in increased expression of ROS1 mRNA CTD PMID:15120970 NCBI chr20:31,975,328...32,126,675
Ensembl chr20:31,975,329...32,126,547 		JBrowse link
G Rpl7 ribosomal protein L7 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of RPL7 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RPL7 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of RPL7 mRNA CTD PMID:19840844 NCBI chr 5:8,000,446...8,003,454
Ensembl chr 5:7,850,630...8,003,451 		JBrowse link
G Rps11 ribosomal protein S11 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of RPS11 mRNA CTD PMID:19840844 NCBI chr 1:104,742,153...104,744,261
Ensembl chr 1:104,742,155...104,744,337 		JBrowse link
G Rps20 ribosomal protein S20 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of RPS20 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RPS20 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of RPS20 mRNA CTD PMID:19840844 NCBI chr 5:21,616,687...21,618,068
Ensembl chr 3:42,839,965...43,095,621
Ensembl chr 9:42,839,965...43,095,621
Ensembl chr 5:42,839,965...43,095,621 		JBrowse link
G Rpsa ribosomal protein SA increases expression ISO Methylnitronitrosoguanidine results in increased expression of RPSA mRNA CTD PMID:12773770 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA
[[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; [Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; CHIR-124 inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [DP1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [DP1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [GTF2I protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [IFI16 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [IFI16 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [NFYA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYA protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [NFYB protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYB protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [NFYC protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYC protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [PURA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [PURA protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [YY1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [YY1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine results in increased expression of and affects the localization of RRM2 protein; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; RRM2 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form] 		CTD PMID:26921499 NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370 		JBrowse link
G Rrm2b ribonucleotide reductase regulatory TP53 inducible subunit M2B increases expression
multiple interactions
affects expression 		ISO Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA
ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine results in increased expression of and affects the localization of RRM2B protein; TP53 protein mutant form inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]
Methylnitronitrosoguanidine affects the expression of RRM2B mRNA 		CTD PMID:21704725 PMID:26921499 NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:70,965,590...70,993,670 		JBrowse link
G RT1-Db1 RT1 class II, locus Db1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of HLA-DRB1 mRNA CTD PMID:12634122 NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,550,596...4,560,165 		JBrowse link
G Ruvbl1 RuvB-like AAA ATPase 1 multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr 4:122,489,754...122,524,666
Ensembl chr 4:122,489,680...122,524,665 		JBrowse link
G Sec61g Sec61 translocon subunit gamma multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SEC61G mRNA CTD PMID:19840844 NCBI chr14:95,113,083...95,119,458
Ensembl chr 9:48,798,504...48,798,710
Ensembl chr14:48,798,504...48,798,710 		JBrowse link
G Selenop selenoprotein P multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of SELENOP mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of SELENOP mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SELENOP mRNA CTD PMID:19840844 NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019 		JBrowse link
G Serpine1 serpin family E member 1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of SERPINE1 mRNA CTD PMID:15120970 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Serping1 serpin family G member 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of SERPING1 mRNA CTD PMID:12634122 NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717 		JBrowse link
G Slc16a3 solute carrier family 16 member 3 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of SLC16A3 mRNA
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of SLC16A3 mRNA] 		CTD PMID:35103375 NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,714,466...106,720,903 		JBrowse link
G Smad2 SMAD family member 2 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of SMAD2 mRNA CTD PMID:12634122 NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388 		JBrowse link
G Smo smoothened, frizzled class receptor increases expression EXP MNNG increases expression of Smo mRNA in rat stomach RGD PMID:30537251 RGD:150520178 NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281 		JBrowse link
G Snai1 snail family transcriptional repressor 1 increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of SNAI1 protein
KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein]
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein] 		CTD PMID:38184286 NCBI chr 3:176,667,476...176,671,965 JBrowse link
G Snora62 small nucleolar RNA, H/ACA box 62 increases expression ISO Methylnitronitrosoguanidine results in increased expression of SNORA62 mRNA CTD PMID:12773770 NCBI chr 8:128,731,591...128,731,739
Ensembl chr 8:128,731,591...128,731,739 		JBrowse link
G Snrpn small nuclear ribonucleoprotein polypeptide N increases expression ISO Methylnitronitrosoguanidine results in increased expression of SNRPN mRNA CTD PMID:12634122 NCBI chr 1:120,316,846...120,338,919
Ensembl chr 1:120,315,556...120,323,924 		JBrowse link
G Sparc secreted protein acidic and cysteine rich decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of SPARC mRNA CTD PMID:12634122 NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268 		JBrowse link
G Spink1 serine peptidase inhibitor, Kazal type 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of SPINK1 mRNA CTD PMID:12634122 NCBI chr18:36,121,626...36,133,596
Ensembl chr18:36,076,399...36,133,545 		JBrowse link
G Spint2 serine peptidase inhibitor, Kunitz type, 2 decreases expression
increases expression 		ISO Methylnitronitrosoguanidine results in decreased expression of SPINT2 mRNA
Methylnitronitrosoguanidine results in increased expression of SPINT2 mRNA 		CTD PMID:12634122 NCBI chr 1:93,685,637...93,708,091
Ensembl chr 1:93,685,641...93,708,091 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of SPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SPP1 mRNA CTD PMID:19840844 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Sqle squalene epoxidase increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of SQLE mRNA
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SQLE mRNA 		CTD PMID:12634122 PMID:19840844 NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050 		JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of SRSF7 mRNA CTD PMID:12634122 NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:20,564,044...20,571,212 		JBrowse link
G Stk39 serine threonine kinase 39 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of STK39 mRNA CTD PMID:12634122 NCBI chr 3:73,321,522...73,588,397
Ensembl chr 3:73,321,522...73,586,740 		JBrowse link
G Sufu SUFU negative regulator of hedgehog signaling decreases expression EXP MNNG decreases expression of Sufu mRNA in rat stomach RGD PMID:30537251 RGD:150520178 NCBI chr 1:255,199,108...255,296,983
Ensembl chr 1:255,199,164...255,296,981 		JBrowse link
G Sumo2 small ubiquitin-like modifier 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of SUMO2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SUMO2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SUMO2 mRNA CTD PMID:19840844 NCBI chr10:101,270,899...101,283,458
Ensembl chr10:101,270,900...101,283,938
Ensembl chr 5:101,270,900...101,283,938 		JBrowse link
G Syn1 synapsin I multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of SYN1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SYN1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SYN1 mRNA CTD PMID:19840844 NCBI chr  X:3,725,745...3,780,940
Ensembl chr  X:3,725,714...3,780,938 		JBrowse link
G Tbrg4 transforming growth factor beta regulator 4 increases expression ISO Methylnitronitrosoguanidine results in increased expression of TBRG4 mRNA CTD PMID:12634122 NCBI chr14:85,696,738...85,704,691
Ensembl chr14:85,695,893...85,704,659 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of TGFB1 mRNA
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TGFB1 mRNA] 		CTD PMID:28428697 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Thbs1 thrombospondin 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of THBS1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of THBS1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of THBS1 mRNA CTD PMID:19840844 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Thbs2 thrombospondin 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of THBS2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of THBS2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of THBS2 mRNA CTD PMID:19840844 NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918 		JBrowse link
G Tiam1 TIAM Rac1 associated GEF 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of TIAM1 mRNA CTD PMID:12634122 NCBI chr11:42,517,527...42,866,280
Ensembl chr11:42,517,528...42,646,075 		JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 decreases expression
multiple interactions 		EXP
ISO 		Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA; Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of TIMP2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of TIMP2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of TIMP2 mRNA
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein] 		CTD PMID:19840844 PMID:20434464 NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214 		JBrowse link
G Tlr2 toll-like receptor 2 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of TLR2 protein
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TLR2 protein] 		CTD PMID:36403744 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tlr4 toll-like receptor 4 increases expression EXP Methylnitronitrosoguanidine results in increased expression of TLR4 mRNA CTD PMID:15120970 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007 		JBrowse link
G Tmsb4x thymosin beta 4, X-linked multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TMSB4X mRNA CTD PMID:19840844 NCBI chr  X:30,761,611...30,763,612
Ensembl chr  X:30,761,612...30,763,613 		JBrowse link
G Tnc tenascin C increases expression ISO Methylnitronitrosoguanidine results in increased expression of TNC mRNA CTD PMID:12634122 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor increases expression
multiple interactions
increases secretion 		EXP
ISO 		Methylnitronitrosoguanidine results in increased expression of TNF protein
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased secretion of TNF protein]
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TNF protein] 		CTD PMID:36403744 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfrsf25 TNF receptor superfamily member 25 increases expression ISO Methylnitronitrosoguanidine results in increased expression of TNFRSF25 mRNA CTD PMID:12634122 NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052 		JBrowse link
G Top2a DNA topoisomerase II alpha multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TOP2A mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TOP2A mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TOP2A mRNA CTD PMID:19840844 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366 		JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions
decreases expression
increases acetylation
increases response to substance
decreases response to substance 		ISO
EXP 		Methylnitronitrosoguanidine results in increased expression of TP53 mRNA; Methylnitronitrosoguanidine results in increased expression of TP53 protein
ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]; Methylnitronitrosoguanidine inhibits the reaction [TP53 protein binds to KDM8 protein]; TP53 protein mutant form inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]
Methylnitronitrosoguanidine results in increased expression of TRP53 protein
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TRP53 mRNA; Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TRP53 protein]
Methylnitronitrosoguanidine results in decreased expression of TP53 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein]; resveratrol inhibits the reaction [Methylnitronitrosoguanidine results in increased acetylation of TP53 protein]
TP53 protein results in increased susceptibility to Methylnitronitrosoguanidine
TP53 protein mutant form results in decreased susceptibility to Methylnitronitrosoguanidine 		CTD PMID:9667752 PMID:11516527 PMID:12135628 PMID:12634122 PMID:15589979 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tram1 translocation associated membrane protein 1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of TRAM1 mRNA CTD PMID:12634122 NCBI chr 5:10,425,710...10,450,669
Ensembl chr 5:10,425,633...10,470,056 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of TSC22D1 mRNA CTD PMID:12634122 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Ttc3 tetratricopeptide repeat domain 3 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of TTC3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of TTC3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of TTC3 mRNA CTD PMID:19840844 NCBI chr11:47,158,766...47,258,612
Ensembl chr11:47,158,792...47,258,418 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 multiple interactions
increases expression 		ISO KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein]
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein] 		CTD PMID:38184286 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TXN1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TXN1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TXN1 mRNA CTD PMID:19840844 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307 		JBrowse link
G Ubc ubiquitin C multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of UBC mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of UBC mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of UBC mRNA CTD PMID:19840844 NCBI chr12:36,899,673...36,905,275
Ensembl chr12:36,900,127...36,905,275 		JBrowse link
G Ubd ubiquitin D increases expression EXP Methylnitronitrosoguanidine results in increased expression of UBD mRNA CTD PMID:12082013 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of UCHL1 mRNA CTD PMID:12634122 NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417 		JBrowse link
G Ucp2 uncoupling protein 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of UCP2 mRNA CTD PMID:19840844 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression
multiple interactions 		EXP Methylnitronitrosoguanidine results in increased expression of VCAM1 protein
weifuchun inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VCAM1 protein] 		CTD PMID:36403744 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vim vimentin increases expression
multiple interactions 		ISO Methylnitronitrosoguanidine results in increased expression of VIM mRNA; Methylnitronitrosoguanidine results in increased expression of VIM protein
KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM protein]
KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA] 		CTD PMID:12634122 PMID:12773770 PMID:38184286 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of WARS1 mRNA CTD PMID:12634122 NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645 		JBrowse link
G Wnt2 Wnt family member 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of WNT2 mRNA CTD PMID:12634122 NCBI chr 4:47,294,300...47,340,284
Ensembl chr 4:47,294,300...47,421,976 		JBrowse link
G Yy1 YY1 transcription factor multiple interactions ISO Methylnitronitrosoguanidine promotes the reaction [YY1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [YY1 protein results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:133,471,562...133,497,257 		JBrowse link
N-methyl-N-nitrosourea term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abhd4 abhydrolase domain containing 4, N-acyl phospholipase B increases expression ISO Methylnitrosourea results in increased expression of ABHD4 mRNA CTD PMID:25270620 NCBI chr15:31,674,090...31,686,051
Ensembl chr15:31,674,143...31,687,007 		JBrowse link
G Acly ATP citrate lyase increases expression EXP Methylnitrosourea results in increased expression of ACLY mRNA CTD PMID:16525678 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Actb actin, beta increases mutagenesis EXP Methylnitrosourea results in increased mutagenesis of ACTB gene CTD PMID:10767621 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression EXP Methylnitrosourea results in increased expression of ADAMTS1 mRNA CTD PMID:17412507 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Afp alpha-fetoprotein decreases response to substance EXP AFP protein modified form results in decreased susceptibility to Methylnitrosourea CTD PMID:16322315 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agtr1b angiotensin II receptor, type 1b increases expression EXP Methylnitrosourea results in increased expression of AGTR1B mRNA CTD PMID:16525678 NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:104,773,930...104,849,310 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO Methylnitrosourea results in increased expression of AKR1B10 mRNA CTD PMID:25270620 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1b15 aldo-keto reductase family 1 member B15 increases expression EXP Methylnitrosourea results in increased expression of AKR1B8 protein CTD PMID:11565795 NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of AKT1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of AKT1 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of AKT1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of AKT1 protein] CTD PMID:15581186 PMID:22465879 PMID:25164625 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 multiple interactions EXP [Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein CTD PMID:22245120 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression ISO Methylnitrosourea results in decreased expression of ALDH1A1 mRNA CTD PMID:25922126 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression EXP Methylnitrosourea results in increased expression of ANGPTL4 mRNA CTD PMID:17412507 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ap3s1 adaptor related protein complex 3 subunit sigma 1 increases expression ISO Methylnitrosourea results in increased expression of AP3S1 mRNA CTD PMID:25270620 NCBI chr18:41,649,321...41,718,221
Ensembl chr18:41,648,796...41,767,641 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 increases expression ISO Methylnitrosourea results in increased expression of APAF1 mRNA CTD PMID:25270620 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apc APC regulator of WNT signaling pathway increases response to substance ISO APC gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:12096346 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Aqp1 aquaporin 1 decreases expression ISO Methylnitrosourea results in decreased expression of AQP1 mRNA CTD PMID:25270620 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Areg amphiregulin multiple interactions EXP [Methylnitrosourea co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of AREG mRNA CTD PMID:20732338 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Asip agouti signaling protein increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of A gene CTD PMID:10517996 PMID:17174358 NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression EXP Methylnitrosourea results in decreased expression of ASNS mRNA CTD PMID:17412507 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Atf1 activating transcription factor 1 decreases expression ISO Methylnitrosourea results in decreased expression of ATF1 mRNA CTD PMID:25270620 NCBI chr 7:133,240,774...133,283,488
Ensembl chr 7:133,241,197...133,283,485 		JBrowse link
G Atp6v1f ATPase H+ transporting V1 subunit F increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of ATP6V1F gene CTD PMID:16868089 NCBI chr 4:59,033,020...59,035,980 JBrowse link
G Atr ATR serine/threonine kinase affects localization
multiple interactions 		ISO Methylnitrosourea affects the localization of ATR protein
MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein] 		CTD PMID:21285353 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Aurka aurora kinase A multiple interactions
decreases expression
increases expression 		EXP
ISO 		[Estrogens co-treated with Progesterone] inhibits the reaction [Methylnitrosourea results in increased expression of AURKA mRNA]
Methylnitrosourea results in decreased expression of AURKA mRNA 		CTD PMID:12124350 PMID:27233451 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Aurkb aurora kinase B decreases phosphorylation ISO Methylnitrosourea results in decreased phosphorylation of AURKB protein CTD PMID:27233451 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G Axin1 axin 1 decreases expression EXP N-methyl-N-nitrosourea decreases expression of Axin1 mRNA in colon RGD PMID:28032729 RGD:150530464 NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092 		JBrowse link
G B3galt1 Beta-1,3-galactosyltransferase 1 increases expression EXP Methylnitrosourea results in increased expression of B3GALT1 mRNA CTD PMID:17412507 NCBI chr 3:72,661,410...73,234,447
Ensembl chr 3:72,660,801...73,235,276 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions EXP [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAD mRNA CTD PMID:20732338 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression 		EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased expression of BAX protein; [Methylnitrosourea co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of BAX mRNA; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein]; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein]
Methylnitrosourea results in increased expression of BAX mRNA; Methylnitrosourea results in increased expression of BAX protein 		CTD PMID:16011256 PMID:16047940 PMID:16168987 PMID:20732338 PMID:22465879 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl10 BCL10, immune signaling adaptor increases expression EXP Methylnitrosourea results in increased expression of BCL10 mRNA CTD PMID:17412507 NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein; [Methylnitrosourea co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of BCL2 mRNA; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein]
Methylnitrosourea results in increased expression of BCL2 mRNA 		CTD PMID:15240709 PMID:16011256 PMID:16047940 PMID:20732338 PMID:22465879 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bdnf brain-derived neurotrophic factor increases expression EXP Methylnitrosourea results in increased expression of BDNF mRNA CTD PMID:28688903 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 increases expression ISO Methylnitrosourea results in increased expression of BIRC5 mRNA CTD PMID:25270620 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bmp5 bone morphogenetic protein 5 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of BMP5 gene CTD PMID:10517996 PMID:17174358 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bpnt1 3'(2'), 5'-bisphosphate nucleotidase 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of BPNT1 gene CTD PMID:16868089 NCBI chr13:99,397,127...99,425,056
Ensembl chr13:99,400,115...99,425,053 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO Methylnitrosourea results in increased expression of BTG2 mRNA CTD PMID:21382384 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase increases expression ISO Methylnitrosourea results in increased expression of BUB1 mRNA CTD PMID:25270620 NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921 		JBrowse link
G Capn1 calpain 1 decreases activity EXP Methylnitrosourea results in decreased activity of CAPN1 protein CTD PMID:17069801 NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445 		JBrowse link
G Capn2 calpain 2 increases activity EXP Methylnitrosourea results in increased activity of CAPN2 protein CTD PMID:17069801 NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625 		JBrowse link
G Car2 carbonic anhydrase 2 increases expression EXP Methylnitrosourea results in increased expression of CAR2 mRNA CTD PMID:17341692 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP 		MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP3 protein; [Methylnitrosourea co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of CASP3 mRNA 		CTD PMID:13679151 PMID:20732338 PMID:22465879 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp6 caspase 6 increases expression EXP Methylnitrosourea results in increased expression of CASP6 mRNA CTD PMID:28688903 NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726 		JBrowse link
G Casp8 caspase 8 multiple interactions
increases expression 		EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA
Methylnitrosourea results in increased expression of CASP8 mRNA 		CTD PMID:20732338 PMID:22465879 PMID:28688903 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA CTD PMID:20732338 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase decreases activity
multiple interactions 		EXP Methylnitrosourea results in decreased activity of CAT protein
[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased activity of CAT protein 		CTD PMID:39197506 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cbr1 carbonyl reductase 1 increases expression EXP Methylnitrosourea results in increased expression of CBR1 mRNA CTD PMID:16525678 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
multiple interactions 		EXP
ISO 		Methylnitrosourea results in increased expression of CCL2 mRNA
Methylnitrosourea results in increased expression of CCL2 protein
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] 		CTD PMID:16822543 PMID:17412507 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression ISO Methylnitrosourea results in increased expression of CCL20 mRNA CTD PMID:25270620 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression EXP Methylnitrosourea results in increased expression of CCL3 mRNA CTD PMID:17412507 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression EXP Methylnitrosourea results in increased expression of CCL4 mRNA CTD PMID:17412507 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression ISO Methylnitrosourea results in increased expression of CCL5 mRNA CTD PMID:15240709 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression EXP Methylnitrosourea results in decreased expression of CCN2 mRNA CTD PMID:16525678 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn3 cellular communication network factor 3 decreases expression ISO Methylnitrosourea results in decreased expression of CCN3 mRNA CTD PMID:25270620 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Ccna2 cyclin A2 increases expression
decreases expression 		ISO Methylnitrosourea results in increased expression of CCNA2 mRNA; Methylnitrosourea results in increased expression of CCNA2 protein
Methylnitrosourea results in decreased expression of CCNA2 		CTD PMID:15870882 PMID:18593901 PMID:25270620 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 increases expression ISO Methylnitrosourea results in increased expression of CCNB1 mRNA CTD PMID:25270620 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions 		EXP Methylnitrosourea results in increased expression of CCND1 protein
[Methylnitrosourea co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of CCND1 protein; Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of CCND1 protein]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CCND1 protein] 		CTD PMID:18155124 PMID:20732338 PMID:25164625 PMID:38977090 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd3 cyclin D3 increases expression EXP Methylnitrosourea results in increased expression of CCND3 protein CTD PMID:18155124 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Cd59b CD59b molecule multiple interactions
decreases lipidation 		EXP [Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Methylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein
Methylnitrosourea results in decreased lipidation of CD59 protein 		CTD PMID:19965957 PMID:20202993 PMID:27931811 NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression 		EXP
ISO 		[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 mRNA; [Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 protein]
Methylnitrosourea results in decreased expression of CDH1 mRNA 		CTD PMID:25164625 PMID:27221058 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh2 cadherin 2 multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 mRNA; [Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 protein] CTD PMID:25164625 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh22 cadherin 22 decreases expression EXP Methylnitrosourea results in decreased expression of CDH22 mRNA CTD PMID:17341692 NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:174,264,869...174,390,142 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression
increases expression 		ISO
EXP 		Methylnitrosourea results in decreased expression of CDK1
Methylnitrosourea results in increased expression of CDK1 protein
Methylnitrosourea results in increased expression of CDK1 mRNA 		CTD PMID:15870882 PMID:16525678 PMID:18593901 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk2 cyclin dependent kinase 2 increases activity EXP Methylnitrosourea results in increased activity of CDK2 protein CTD PMID:15581186 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk5r1 cyclin-dependent kinase 5 regulatory subunit 1 increases cleavage EXP Methylnitrosourea results in increased cleavage of CDK5R1 protein CTD PMID:17069801 NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272 		JBrowse link
G Cdk5rap1 CDK5 regulatory subunit associated protein 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of CDK5RAP1 gene CTD PMID:16868089 NCBI chr 3:163,189,435...163,333,003
Ensembl chr 3:163,191,056...163,332,908 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression 		ISO
EXP 		Methylnitrosourea results in increased expression of CDKN1A mRNA
Methylnitrosourea results in decreased expression of CDKN1A protein 		CTD PMID:15581186 PMID:18593901 PMID:28688903 PMID:29110037 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cel carboxyl ester lipase increases expression ISO Methylnitrosourea results in increased expression of CEL mRNA CTD PMID:15240709 NCBI chr 3:32,281,518...32,289,019
Ensembl chr 3:32,281,518...32,289,019 		JBrowse link
G Cela2a chymotrypsin like elastase 2A increases expression ISO Methylnitrosourea results in increased expression of CELA2A mRNA CTD PMID:15240709 NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:159,409,899...159,426,208 		JBrowse link
G Cenpa centromere protein A decreases expression ISO Methylnitrosourea results in decreased expression of CENPA mRNA CTD PMID:27233451 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpe centromere protein E increases expression ISO Methylnitrosourea results in increased expression of CENPE mRNA CTD PMID:25270620 NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636 		JBrowse link
G Cep290 centrosomal protein 290 decreases expression EXP Methylnitrosourea results in decreased expression of CEP290 mRNA CTD PMID:17412507 NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955 		JBrowse link
G Chek2 checkpoint kinase 2 increases phosphorylation
multiple interactions 		ISO Methylnitrosourea results in increased phosphorylation of CHEK2 protein
MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of CHEK2 protein] 		CTD PMID:21285353 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Ckap5 cytoskeleton associated protein 5 increases expression ISO Methylnitrosourea results in increased expression of CKAP5 mRNA CTD PMID:25270620 NCBI chr 3:97,946,966...98,049,050
Ensembl chr 3:97,947,031...98,049,049 		JBrowse link
G Cldn7 claudin 7 decreases expression EXP Methylnitrosourea results in decreased expression of CLDN7 mRNA CTD PMID:16525678 NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905 		JBrowse link
G Clu clusterin increases expression EXP Methylnitrosourea results in increased expression of CLU mRNA CTD PMID:17412507 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Col4a3 collagen type IV alpha 3 chain decreases expression EXP Methylnitrosourea results in decreased expression of COL4A3 mRNA CTD PMID:16525678 NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:91,323,990...91,453,077 		JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression EXP Methylnitrosourea results in decreased expression of COL5A3 mRNA CTD PMID:17341692 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Cpt1c carnitine palmitoyltransferase 1c increases expression ISO Methylnitrosourea results in increased expression of CPT1C mRNA CTD PMID:25270620 NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:104,579,298...104,593,763 		JBrowse link
G Cradd CASP2 and RIPK1 domain containing adaptor with death domain increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of CRADD gene CTD PMID:16868089 NCBI chr 7:31,827,131...31,839,796
Ensembl chr 7:31,685,622...31,874,512 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions EXP [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein CTD PMID:34186418 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Crem cAMP responsive element modulator increases expression EXP Methylnitrosourea results in increased expression of CREM mRNA CTD PMID:17412507 NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160 		JBrowse link
G Crip2 cysteine-rich protein 2 increases expression ISO Methylnitrosourea results in increased expression of CRIP2 mRNA CTD PMID:25270620 NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
increases expression 		ISO Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] CTD PMID:16822543 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Ctcf CCCTC-binding factor decreases expression ISO Methylnitrosourea results in decreased expression of CTCF mRNA CTD PMID:25270620 NCBI chr19:50,431,478...50,481,013
Ensembl chr19:50,431,689...50,481,012 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression ISO Methylnitrosourea results in increased expression of CTNNB1 protein CTD PMID:12096346 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Cwc27 CWC27 spliceosome associated cyclophilin decreases expression ISO Methylnitrosourea results in decreased expression of CWC27 mRNA CTD PMID:25270620 NCBI chr 2:37,498,462...37,709,691
Ensembl chr 2:37,498,468...37,709,355 		JBrowse link
G Cxcr1 C-X-C motif chemokine receptor 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of CXCR1 gene CTD PMID:16868089 NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:83,215,292...83,226,872 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 increases expression EXP Methylnitrosourea results in increased expression of CYP27B1 mRNA CTD PMID:21843606 NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570 		JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 decreases expression EXP Methylnitrosourea results in decreased expression of CYP2J9 mRNA CTD PMID:17412507 NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042 		JBrowse link
G Dapk1 death associated protein kinase 1 increases expression ISO Methylnitrosourea results in increased expression of DAPK1 mRNA CTD PMID:25270620 NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581 		JBrowse link
G Dbi diazepam binding inhibitor increases expression EXP Methylnitrosourea results in increased expression of DBI mRNA CTD PMID:16525678 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor decreases expression EXP Methylnitrosourea results in decreased expression of DBP mRNA CTD PMID:16525678 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 increases expression ISO Methylnitrosourea results in increased expression of DCAF4 mRNA CTD PMID:25270620 NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression ISO Methylnitrosourea results in increased expression of DDIT4L mRNA CTD PMID:25270620 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225 		JBrowse link
G Depdc7 DEP domain containing 7 increases expression EXP Methylnitrosourea results in increased expression of DEPDC7 mRNA CTD PMID:17412507 NCBI chr 3:111,554,701...111,575,979
Ensembl chr 3:111,554,706...111,575,979 		JBrowse link
G Dio1 iodothyronine deiodinase 1 multiple interactions EXP Methylnitrosourea inhibits the reaction [Iodine results in increased expression of DIO1 mRNA] CTD PMID:15922087 NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771 		JBrowse link
G Dlgap1 DLG associated protein 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of DLGAP1 gene CTD PMID:16868089 NCBI chr 9:117,304,144...118,173,463
Ensembl chr 9:117,614,061...118,173,463 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression ISO Methylnitrosourea results in increased expression of DMBT1 mRNA CTD PMID:15240709 NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:195,047,713...195,126,704 		JBrowse link
G Dnajb5 DnaJ heat shock protein family (Hsp40) member B5 increases expression ISO Methylnitrosourea results in increased expression of DNAJB5 mRNA CTD PMID:25270620 NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:61,972,706...61,981,860 		JBrowse link
G Dnajc7 DnaJ heat shock protein family (Hsp40) member C7 decreases expression ISO Methylnitrosourea results in decreased expression of DNAJC7 mRNA CTD PMID:25270620 NCBI chr10:86,018,977...86,055,419
Ensembl chr10:86,018,961...86,055,489 		JBrowse link
G Dnpep aspartyl aminopeptidase decreases activity EXP Methylnitrosourea results in decreased activity of DNPEP protein CTD PMID:16537183 NCBI chr 9:84,248,581...84,257,484
Ensembl chr 9:84,233,486...84,256,977 		JBrowse link
G Dpysl3 dihydropyrimidinase-like 3 decreases expression EXP Methylnitrosourea results in decreased expression of DPYSL3 mRNA CTD PMID:28688903 NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152 		JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression EXP Methylnitrosourea results in increased expression of DUSP5 mRNA CTD PMID:17412507 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dym dymeclin increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of DYM gene CTD PMID:16868089 NCBI chr18:70,879,835...71,176,006
Ensembl chr18:70,880,255...71,176,004 		JBrowse link
G Ech1 enoyl-CoA hydratase 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of ECH1 gene CTD PMID:16868089 NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440 		JBrowse link
G Edf1 endothelial differentiation-related factor 1 decreases expression ISO Methylnitrosourea results in decreased expression of EDF1 mRNA CTD PMID:25270620 NCBI chr 3:28,764,906...28,779,499 JBrowse link
G Ednrb endothelin receptor type B increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of EDNRB gene CTD PMID:17174358 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Eed embryonic ectoderm development affects response to substance ISO EED protein affects the susceptibility to Methylnitrosourea CTD PMID:11803473 NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:153,280,422...153,307,500 		JBrowse link
G Efna3 ephrin A3 increases expression ISO Methylnitrosourea results in increased expression of EFNA3 mRNA CTD PMID:25270620 NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843 		JBrowse link
G Efs embryonal Fyn-associated substrate increases expression ISO Methylnitrosourea results in increased expression of EFS mRNA CTD PMID:25270620 NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743 		JBrowse link
G Egf epidermal growth factor multiple interactions
increases expression 		EXP [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of EGF mRNA
Methylnitrosourea results in increased expression of EGF mRNA 		CTD PMID:39197506 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of EGFR protein; Hexachlorobenzene promotes the reaction [Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]]; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in increased phosphorylation of EGFR protein]; Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]; Methylnitrosourea promotes the reaction [Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [Hexachlorobenzene results in increased phosphorylation of EGFR protein]; Methylnitrosourea results in increased phosphorylation of and results in decreased expression of EGFR protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of EGFR protein] CTD PMID:22245120 PMID:25164625 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 decreases expression ISO Methylnitrosourea results in decreased expression of EGLN3 mRNA CTD PMID:25270620 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015 		JBrowse link
G Eif2s2 eukaryotic translation initiation factor 2 subunit beta decreases expression ISO Methylnitrosourea results in decreased expression of EIF2S2 mRNA CTD PMID:25270620 NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions
increases phosphorylation 		EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of EIF4EBP1 protein; Methylnitrosourea promotes the reaction [sodium arsenite results in increased phosphorylation of EIF4EBP1 protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased phosphorylation of EIF4EBP1 protein] CTD PMID:22465879 PMID:38977090 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression EXP Methylnitrosourea results in increased expression of ELOVL6 mRNA CTD PMID:16525678 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Eomes eomesodermin decreases expression ISO Methylnitrosourea results in decreased expression of EOMES mRNA CTD PMID:25270620 NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression ISO Methylnitrosourea results in increased expression of EPHX1 mRNA CTD PMID:21382384 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit decreases expression
increases expression 		ISO Methylnitrosourea results in decreased expression of ERCC4 mRNA
Methylnitrosourea results in increased expression of ERCC4 mRNA 		CTD PMID:16616109 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Ergic3 ERGIC and golgi 3 increases expression ISO Methylnitrosourea results in increased expression of ERGIC3 mRNA CTD PMID:25270620 NCBI chr 3:164,985,108...164,994,897
Ensembl chr 3:164,984,853...164,994,897 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
increases expression
decreases phosphorylation
increases response to substance 		EXP [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of ESR1 mRNA; [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in decreased phosphorylation of ESR1 protein]; Methylnitrosourea inhibits the reaction [Hexachlorobenzene promotes the reaction [ESR1 protein binds to SRC protein]]
Methylnitrosourea results in increased expression of ESR1 mRNA
ESR1 protein results in increased susceptibility to Methylnitrosourea 		CTD PMID:15528971 PMID:16891317 PMID:22245120 PMID:34186418 PMID:39197506 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Ezr ezrin increases expression EXP Methylnitrosourea results in increased expression of EZR mRNA CTD PMID:17412507 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression EXP Methylnitrosourea results in increased expression of F3 mRNA CTD PMID:17412507 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Fabp3 fatty acid binding protein 3 increases expression EXP Methylnitrosourea results in increased expression of FABP3 mRNA CTD PMID:17341692 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Faim2 Fas apoptotic inhibitory molecule 2 increases expression EXP Methylnitrosourea results in increased expression of FAIM2 mRNA CTD PMID:17412507 NCBI chr 7:132,512,095...132,539,192
Ensembl chr 7:132,512,210...132,538,026 		JBrowse link
G Fam187b family with sequence similarity 187, member B decreases expression ISO Methylnitrosourea results in decreased expression of FAM187B mRNA CTD PMID:25270620 NCBI chr 1:95,329,482...95,346,940
Ensembl chr 1:95,332,631...95,371,536 		JBrowse link
G Fasn fatty acid synthase increases expression EXP Methylnitrosourea results in increased expression of FASN mRNA CTD PMID:16525678 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fbp2 fructose-bisphosphatase 2 increases expression ISO Methylnitrosourea results in increased expression of FBP2 mRNA CTD PMID:25270620 NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366 		JBrowse link
G Fbxo15 F-box protein 15 decreases expression ISO Methylnitrosourea results in decreased expression of FBXO15 mRNA CTD PMID:25270620 NCBI chr18:80,594,444...80,909,549
Ensembl chr 6:51,576,566...51,577,639
Ensembl chr18:51,576,566...51,577,639 		JBrowse link
G Fbxo5 F-box protein 5 increases expression ISO Methylnitrosourea results in increased expression of FBXO5 mRNA CTD PMID:25270620 NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781 		JBrowse link
G Fgf1 fibroblast growth factor 1 multiple interactions EXP FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein]; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] CTD PMID:16011256 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393 		JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 multiple interactions EXP Methylnitrosourea results in increased expression of and affects the localization of FGFR1 protein CTD PMID:15581186 NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 multiple interactions EXP Methylnitrosourea results in increased expression of and affects the localization of FGFR2 protein CTD PMID:15581186 NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914 		JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 multiple interactions EXP Methylnitrosourea results in increased expression of and affects the localization of FGFR4 protein CTD PMID:15581186 NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,466,692...9,481,389 		JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase increases methylation
decreases expression 		EXP Methylnitrosourea results in increased methylation of FHIT intron; Methylnitrosourea results in increased methylation of FHIT promoter
Methylnitrosourea results in decreased expression of FHIT mRNA; Methylnitrosourea results in decreased expression of FHIT protein 		CTD PMID:15937960 PMID:17412507 NCBI chr15:16,365,401...17,872,901
Ensembl chr15:16,747,338...17,872,621 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions 		EXP Methylnitrosourea results in increased expression of FOS mRNA; Methylnitrosourea results in increased expression of FOS protein
[tetramethylpyrazine affects the expression of FOS mRNA] which results in decreased susceptibility to Methylnitrosourea; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of FOS protein] 		CTD PMID:16168987 PMID:16268501 PMID:17412507 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Foxa1 forkhead box A1 decreases expression ISO Methylnitrosourea results in decreased expression of FOXA1 mRNA CTD PMID:27221058 NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191 		JBrowse link
G Foxa2 forkhead box A2 decreases expression ISO Methylnitrosourea results in decreased expression of FOXA2 mRNA CTD PMID:27221058 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions
decreases expression 		EXP Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in decreased expression of FSHB protein] CTD PMID:22245120 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of GALNT16 gene CTD PMID:16868089 NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350 		JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 increases expression ISO Methylnitrosourea results in increased expression of GALNT6 mRNA CTD PMID:25270620 NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:133,668,615...133,698,439 		JBrowse link
G Gbp2 guanylate binding protein 2 increases expression EXP Methylnitrosourea results in increased expression of GBP2 mRNA CTD PMID:17412507 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gfap glial fibrillary acidic protein increases expression
decreases expression 		EXP Methylnitrosourea results in increased expression of GFAP protein
Methylnitrosourea results in decreased expression of GFAP mRNA 		CTD PMID:18155124 PMID:28688903 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Gh1 growth hormone 1 decreases response to substance EXP GH1 gene mutant form results in decreased susceptibility to Methylnitrosourea CTD PMID:12082019 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Gjb1 gap junction protein, beta 1 decreases response to substance ISO GJB1 protein results in decreased susceptibility to Methylnitrosourea CTD PMID:17463168 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
G Glipr1l2 GLIPR1 like 2 decreases expression ISO Methylnitrosourea results in decreased expression of GLIPR1L2 mRNA CTD PMID:25270620 NCBI chr 7:49,401,847...49,432,249
Ensembl chr 7:49,401,860...49,432,267 		JBrowse link
G Gmcl1 germ cell-less 1, spermatogenesis associated increases expression ISO Methylnitrosourea results in increased expression of GMCL1 mRNA CTD PMID:25270620 NCBI chr 4:120,697,976...120,737,267
Ensembl chr 4:120,697,976...120,737,257 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression EXP Methylnitrosourea results in increased expression of GPX2 mRNA; Methylnitrosourea results in increased expression of GPX2 protein CTD PMID:18056462 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Grb14 growth factor receptor bound protein 14 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of GRB14 gene CTD PMID:16868089 NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:69,976,339...70,091,921 		JBrowse link
G Grb2 growth factor receptor bound protein 2 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 protein CTD PMID:22465879 NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138 		JBrowse link
G Grin2a glutamate ionotropic receptor NMDA type subunit 2A decreases expression
increases expression 		EXP Methylnitrosourea results in decreased expression of GRIN2A mRNA
Methylnitrosourea results in increased expression of GRIN2A mRNA 		CTD PMID:28688903 NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein] CTD PMID:25164625 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G H2ax H2A.X variant histone increases expression ISO Methylnitrosourea results in increased expression of H2AX protein modified form CTD PMID:27233451 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2bc4 H2B clustered histone 4 decreases expression ISO Methylnitrosourea results in decreased expression of H2BC4 mRNA CTD PMID:25270620 NCBI chr17:47,388,085...47,392,349
Ensembl chr17:47,404,375...47,419,020 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 increases carbamoylation ISO Methylnitrosourea results in increased carbamoylation of HBA1 protein CTD PMID:15655799 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hba-a3 hemoglobin alpha, adult chain 3 increases carbamoylation ISO Methylnitrosourea results in increased carbamoylation of HBA2 protein CTD PMID:15655799 NCBI chr10:15,816,099...15,816,943
Ensembl chr10:15,816,096...15,817,167 		JBrowse link
G Hbb hemoglobin subunit beta increases carbamoylation ISO Methylnitrosourea results in increased carbamoylation of HBB protein CTD PMID:15655799 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hdac6 histone deacetylase 6 multiple interactions EXP [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein CTD PMID:34186418 NCBI chr  X:17,222,538...17,244,373
Ensembl chr  X:17,222,856...17,244,370 		JBrowse link
G Hesx1 HESX homeobox 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of HESX1 gene CTD PMID:16868089 NCBI chr16:2,198,589...2,200,694
Ensembl chr16:2,198,589...2,200,694 		JBrowse link
G Hgf hepatocyte growth factor decreases expression
multiple interactions 		ISO Methylnitrosourea results in decreased expression of HGF mRNA
Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of HGF mRNA] 		CTD PMID:18675455 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions
increases expression 		EXP Methylnitrosourea promotes the reaction [sodium arsenite results in increased phosphorylation of HIF1A protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased phosphorylation of HIF1A protein]
Methylnitrosourea results in increased expression of HIF1A protein 		CTD PMID:38977090 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hivep2 HIVEP zinc finger 2 increases expression EXP Methylnitrosourea results in increased expression of HIVEP2 mRNA CTD PMID:17412507 NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:10,179,402...10,376,089 		JBrowse link
G Hk2 hexokinase 2 increases expression
multiple interactions 		EXP Methylnitrosourea results in increased expression of HK2 protein
Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of HK2 protein] 		CTD PMID:38977090 NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275 		JBrowse link
G Hmgb2 high mobility group box 2 increases expression EXP Methylnitrosourea results in increased expression of HMGB2 mRNA; Methylnitrosourea results in increased expression of HMGB2 protein CTD PMID:16525678 PMID:29877212 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmgb3 high mobility group box 3 decreases expression ISO Methylnitrosourea results in decreased expression of HMGB3 mRNA CTD PMID:25270620 NCBI chr  X:154,341,106...154,346,087
Ensembl chr  X:154,340,935...154,346,097 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression EXP Methylnitrosourea results in increased expression of HMOX1 mRNA CTD PMID:17412507 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases mutagenesis
increases expression 		EXP
ISO 		Methylnitrosourea results in increased mutagenesis of HPRT1 gene
Methylnitrosourea results in increased expression of HPRT1 mRNA 		CTD PMID:18249417 PMID:25270620 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions
increases response to substance
increases mutagenesis
decreases response to substance 		ISO
EXP 		limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea]
Methylnitrosourea results in increased mutagenesis of HRAS gene
HRAS protein results in decreased susceptibility to Methylnitrosourea 		CTD PMID:10767621 PMID:11182032 PMID:11376698 PMID:11802805 PMID:11973638 More... NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Id3 inhibitor of DNA binding 3 decreases expression ISO Methylnitrosourea results in decreased expression of ID3 mRNA CTD PMID:25270620 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Ier3 immediate early response 3 increases expression EXP Methylnitrosourea results in increased expression of IER3 mRNA CTD PMID:17412507 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ifng interferon gamma multiple interactions
decreases response to substance 		ISO
EXP 		IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]
IFNG protein results in decreased susceptibility to Methylnitrosourea
2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein]; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein 		CTD PMID:14736494 PMID:15240709 PMID:16080182 PMID:16822543 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 multiple interactions
increases expression 		ISO Quercetin inhibits the reaction [Methylnitrosourea results in increased expression of IFRD1 mRNA] CTD PMID:18675455 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Igdcc4 immunoglobulin superfamily, DCC subclass, member 4 increases expression ISO Methylnitrosourea results in increased expression of IGDCC4 mRNA CTD PMID:25270620 NCBI chr 8:74,517,082...74,552,834
Ensembl chr 8:74,517,086...74,552,834 		JBrowse link
G Igf1 insulin-like growth factor 1 increases response to substance ISO IGF1 protein results in increased susceptibility to Methylnitrosourea CTD PMID:15528971 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor multiple interactions
increases expression 		EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R protein; Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased expression of IGF1R protein] CTD PMID:16237195 PMID:22465879 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 decreases expression ISO Methylnitrosourea results in decreased expression of IGFBP2 mRNA CTD PMID:25270620 NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Ikzf1 IKAROS family zinc finger 1 decreases expression ISO Methylnitrosourea results in decreased expression of IKZF1 mRNA CTD PMID:16616109 NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574 		JBrowse link
G Il10 interleukin 10 multiple interactions
increases expression
decreases expression 		ISO
EXP 		Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]
Methylnitrosourea results in increased expression of IL10 mRNA; Methylnitrosourea results in increased expression of IL10 protein 		CTD PMID:14999141 PMID:16822543 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il17b interleukin 17B increases expression EXP Methylnitrosourea results in increased expression of IL17B mRNA CTD PMID:17341692 NCBI chr18:57,411,532...57,415,903
Ensembl chr18:57,411,532...57,415,903 		JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions 		ISO
EXP 		Methylnitrosourea results in increased expression of IL1B mRNA
Quercetin inhibits the reaction [Methylnitrosourea results in increased expression of IL1B mRNA] 		CTD PMID:17412507 PMID:18675455 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il2 interleukin 2 multiple interactions
increases expression 		ISO
EXP 		Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]
[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IL2 protein 		CTD PMID:14736494 PMID:16822543 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il4 interleukin 4 multiple interactions
increases expression 		ISO Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein] CTD PMID:16822543 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Insr insulin receptor increases expression EXP Methylnitrosourea results in increased expression of INSR protein CTD PMID:16237195 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803 		JBrowse link
G Irf1 interferon regulatory factor 1 decreases response to substance
increases expression 		ISO
EXP 		IRF1 protein results in decreased susceptibility to Methylnitrosourea
Methylnitrosourea results in increased expression of IRF1 mRNA 		CTD PMID:15240709 PMID:17412507 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947 		JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions
increases phosphorylation 		EXP Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased phosphorylation of IRS1 protein] CTD PMID:16237195 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Jam2 junctional adhesion molecule 2 decreases expression ISO Methylnitrosourea results in decreased expression of JAM2 mRNA CTD PMID:25270620 NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
increases phosphorylation 		EXP Methylnitrosourea results in increased expression of JUN protein
[tetramethylpyrazine affects the expression of JUN mRNA] which results in decreased susceptibility to Methylnitrosourea; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of JUN protein]; Niacinamide inhibits the reaction [Methylnitrosourea results in increased phosphorylation of JUN protein] 		CTD PMID:16168987 PMID:16268501 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression EXP Methylnitrosourea results in increased expression of JUNB mRNA CTD PMID:17412507 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218 		JBrowse link
G Kif3b kinesin family member 3B increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of KIF3B gene CTD PMID:16868089 NCBI chr 3:162,218,621...162,258,191
Ensembl chr 3:162,218,682...162,258,581 		JBrowse link
G Kitlg KIT ligand decreases expression
multiple interactions 		ISO Methylnitrosourea results in decreased expression of KITL mRNA
Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of KITL mRNA] 		CTD PMID:18675455 NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793 		JBrowse link
G Klhl22 kelch-like family member 22 increases expression ISO Methylnitrosourea results in increased expression of KLHL22 mRNA CTD PMID:25270620 NCBI chr11:96,695,168...96,736,079
Ensembl chr11:96,695,171...96,738,065 		JBrowse link
G Klk1 kallikrein 1 increases expression ISO Methylnitrosourea results in increased expression of KLK1 mRNA CTD PMID:15240709 NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270 		JBrowse link
G Kras KRAS proto-oncogene, GTPase decreases response to substance
increases mutagenesis 		EXP
ISO 		KRAS protein results in decreased susceptibility to Methylnitrosourea
Methylnitrosourea results in increased mutagenesis of KRAS gene 		CTD PMID:11973638 PMID:12483526 PMID:18062963 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320 		JBrowse link
G Lcn2 lipocalin 2 increases expression EXP Methylnitrosourea results in increased expression of LCN2 mRNA CTD PMID:17412507 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Lep leptin multiple interactions
increases expression 		ISO Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein] CTD PMID:16822543 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661 		JBrowse link
G Lgals3 galectin 3 decreases expression
increases expression 		ISO
EXP 		Methylnitrosourea results in decreased expression of LGALS3 mRNA
N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum 		CTD
RGD		 PMID:25270620 PMID:28032729 RGD:150530464 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Ltb lymphotoxin beta decreases response to substance ISO LTB protein results in decreased susceptibility to Methylnitrosourea CTD PMID:15240709 NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054 		JBrowse link
G Macrod2 mono-ADP ribosylhydrolase 2 decreases expression ISO Methylnitrosourea results in decreased expression of MACROD2 mRNA CTD PMID:25270620 NCBI chr 3:148,173,821...150,191,077
Ensembl chr 3:148,173,829...150,188,058 		JBrowse link
G Mad2l2 mitotic arrest deficient 2 like 2 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of MAD2L2 gene CTD PMID:16868089 NCBI chr 5:163,846,678...163,859,851
Ensembl chr 5:163,846,687...163,859,851 		JBrowse link
G Madcam1 mucosal vascular addressin cell adhesion molecule 1 increases expression ISO Methylnitrosourea results in increased expression of MADCAM1 mRNA CTD PMID:15240709 NCBI chr 7:10,686,920...10,690,322
Ensembl chr 7:10,686,250...10,690,322 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions EXP Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAP2K1 protein CTD PMID:12693035 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases response to substance
multiple interactions 		EXP MAPK1 protein modified form results in increased susceptibility to Methylnitrosourea; MAPK1 protein results in increased susceptibility to Methylnitrosourea
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Methylnitrosourea results in increased activity of MAPK1 protein]; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK1 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK1 protein] 		CTD PMID:12693035 PMID:15528971 PMID:22465879 PMID:25164625 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions EXP Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:12693035 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases response to substance
multiple interactions 		EXP MAPK3 protein modified form results in increased susceptibility to Methylnitrosourea; MAPK3 protein results in increased susceptibility to Methylnitrosourea
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Methylnitrosourea results in increased activity of MAPK3 protein]; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK3 protein; [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK3 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK3 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK3 protein] 		CTD PMID:12693035 PMID:15528971 PMID:22465879 PMID:25164625 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
increases activity
decreases response to substance 		ISO
EXP 		Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased activity of MAPK8 protein]; MAPK8 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]
Methylnitrosourea results in increased phosphorylation of MAPK8 protein
Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased activity of MAPK8 protein]; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK8 protein; Niacinamide inhibits the reaction [Methylnitrosourea results in increased phosphorylation of MAPK8 protein]
MAPK8 gene mutant form results in decreased susceptibility to Methylnitrosourea 		CTD PMID:12693035 PMID:16168987 PMID:18593901 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapkapk3 MAPK activated protein kinase 3 increases expression ISO Methylnitrosourea results in increased expression of MAPKAPK3 mRNA CTD PMID:25270620 NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:116,808,429...116,842,228 		JBrowse link
G Mbp myelin basic protein decreases expression EXP Methylnitrosourea results in decreased expression of MBP mRNA CTD PMID:17341692 NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174 		JBrowse link
G Mcam melanoma cell adhesion molecule increases expression ISO Methylnitrosourea results in increased expression of MCAM mRNA CTD PMID:25270620 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression EXP Methylnitrosourea results in increased expression of MDM2 mRNA CTD PMID:28688903 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Me1 malic enzyme 1 increases expression EXP Methylnitrosourea results in increased expression of ME1 mRNA CTD PMID:16525678 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase increases alkylation
increases expression
decreases response to substance
multiple interactions 		ISO
EXP 		Methylnitrosourea results in increased alkylation of MGMT protein
Methylnitrosourea results in increased expression of MGMT mRNA
MGMT protein results in decreased susceptibility to Methylnitrosourea
MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea]; MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea]
MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] 		CTD PMID:8823159 PMID:11276365 PMID:11536039 PMID:12663516 PMID:13679151 More... NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482 		JBrowse link
G Mipol1 mirror-image polydactyly 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of MIPOL1 gene CTD PMID:16868089 NCBI chr 6:80,490,330...80,825,413
Ensembl chr 6:80,490,312...80,825,413 		JBrowse link
G Mir185 microRNA 185 increases expression EXP Methylnitrosourea results in increased expression of MIR185 mRNA CTD PMID:30336191 NCBI chr11:96,169,028...96,169,107
Ensembl chr11:96,169,028...96,169,107 		JBrowse link
G Mir96 microRNA 96 increases expression EXP Methylnitrosourea results in increased expression of MIR96 mRNA CTD PMID:30336191 NCBI chr 4:59,755,841...59,755,946 JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression
multiple interactions 		ISO
EXP 		Methylnitrosourea results in increased expression of MKI67 mRNA
Methylnitrosourea results in increased expression of MKI67 protein
Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of MKI67 protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of MKI67 protein] 		CTD PMID:25270620 PMID:38977090 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mlf1 myeloid leukemia factor 1 increases expression EXP Methylnitrosourea results in increased expression of MLF1 mRNA CTD PMID:17412507 NCBI chr 2:153,958,060...153,991,705
Ensembl chr 2:153,958,546...153,994,220 		JBrowse link
G Mlh1 mutL homolog 1 multiple interactions
affects response to substance 		ISO Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]
MLH1 protein affects the susceptibility to Methylnitrosourea
MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea] 		CTD PMID:12967659 PMID:13679151 PMID:16204460 NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011 		JBrowse link
G Mlx MAX dimerization protein MLX increases expression ISO Methylnitrosourea results in increased expression of MLX mRNA CTD PMID:25270620 NCBI chr10:86,519,517...86,524,607
Ensembl chr10:86,519,864...86,524,772 		JBrowse link
G Mmp3 matrix metallopeptidase 3 increases expression EXP Methylnitrosourea results in increased expression of MMP3 mRNA CTD PMID:17412507 NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826 		JBrowse link
G Mpc1 mitochondrial pyruvate carrier 1 increases expression EXP Methylnitrosourea results in increased expression of MPC1 mRNA CTD PMID:16525678 NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:54,985,301...54,997,064 		JBrowse link
G Mpg N-methylpurine-DNA glycosylase decreases response to substance
increases response to substance 		ISO MPG protein results in decreased susceptibility to Methylnitrosourea
MPG protein results in increased susceptibility to Methylnitrosourea 		CTD PMID:15299078 PMID:16288039 PMID:17674369 NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052 		JBrowse link
G Mrpl47 mitochondrial ribosomal protein L47 decreases expression ISO Methylnitrosourea results in decreased expression of MRPL47 mRNA CTD PMID:25270620 NCBI chr 2:117,436,199...117,447,790
Ensembl chr 2:117,428,621...117,447,517 		JBrowse link
G Mrps31 mitochondrial ribosomal protein S31 decreases expression ISO Methylnitrosourea results in decreased expression of MRPS31 mRNA CTD PMID:25270620 NCBI chr16:76,303,807...76,332,970
Ensembl chr16:76,301,645...76,333,065 		JBrowse link
G Msc musculin decreases expression ISO Methylnitrosourea results in decreased expression of MSC mRNA CTD PMID:25270620 NCBI chr 5:9,330,522...9,336,391
Ensembl chr 5:9,330,544...9,336,857 		JBrowse link
G Msh2 mutS homolog 2 multiple interactions
increases response to substance
affects response to substance 		ISO Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]; Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein]
MSH2 protein results in increased susceptibility to Methylnitrosourea
MSH2 protein affects the susceptibility to Methylnitrosourea
MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of CHEK2 protein]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] 		CTD PMID:12185594 PMID:16204460 PMID:21285353 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Msh6 mutS homolog 6 multiple interactions ISO Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] CTD PMID:16204460 NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:12,316,198...12,333,844 		JBrowse link
G Mt1a metallothionein 1A multiple interactions
increases expression 		ISO [Methylnitrosourea co-treated with Carrageenan] results in increased expression of MT1 protein
Methylnitrosourea results in increased expression of MT1 protein 		CTD PMID:15928667 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase decreases expression EXP Methylnitrosourea results in decreased expression of MTHFD2 mRNA CTD PMID:17412507 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions
increases phosphorylation 		EXP
ISO 		[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MTOR protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of MTOR protein; Methylnitrosourea promotes the reaction [sodium arsenite results in increased phosphorylation of MTOR protein]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of MTOR protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased phosphorylation of MTOR protein]
Methylnitrosourea promotes the reaction [sodium arsenite results in increased phosphorylation of MTOR protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased phosphorylation of MTOR protein] 		CTD PMID:22465879 PMID:25164625 PMID:38977090 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression
multiple interactions
decreases expression 		ISO
EXP 		Methylnitrosourea results in increased expression of MYC mRNA
[bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein
Methylnitrosourea results in decreased expression of MYC mRNA 		CTD PMID:16616109 PMID:17412507 PMID:25270620 PMID:34186418 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myo5a myosin VA increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of MYO5A gene CTD PMID:10517996 PMID:17174358 NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265 		JBrowse link
G Ncor2 nuclear receptor co-repressor 2 affects expression EXP Methylnitrosourea affects the expression of NCOR2 mRNA CTD PMID:21843606 NCBI chr12:37,127,736...37,289,612
Ensembl chr12:37,127,686...37,289,612 		JBrowse link
G Nectin1 nectin cell adhesion molecule 1 decreases expression EXP Methylnitrosourea results in decreased expression of NECTIN1 mRNA CTD PMID:16525678 NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664 		JBrowse link
G Nes nestin increases expression
increases methylation 		EXP
ISO 		Methylnitrosourea results in increased expression of NES protein
Methylnitrosourea results in increased methylation of NES gene 		CTD PMID:18155124 PMID:25922126 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression 		EXP [Methylnitrosourea results in increased expression of NFKBIA protein] which affects the localization of RELA protein; tetramethylpyrazine inhibits the reaction [Methylnitrosourea results in increased expression of NFKBIA protein] CTD PMID:15960898 PMID:16098260 PMID:16762860 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nme5 NME/NM23 family member 5 decreases expression ISO Methylnitrosourea results in decreased expression of NME5 mRNA CTD PMID:25270620 NCBI chr18:26,437,705...26,454,828
Ensembl chr18:26,437,781...26,454,828 		JBrowse link
G Nnat neuronatin decreases expression EXP Methylnitrosourea results in decreased expression of NNAT mRNA CTD PMID:16525678 NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086 		JBrowse link
G Nnmt nicotinamide N-methyltransferase increases activity EXP Methylnitrosourea results in increased activity of NNMT protein CTD PMID:6652621 NCBI chr 8:57,820,156...57,851,301
Ensembl chr 8:57,825,464...57,843,174 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression ISO Methylnitrosourea results in increased expression of NOS2 protein CTD PMID:16052507 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nrxn3 neurexin 3 decreases expression EXP Methylnitrosourea results in decreased expression of NRXN3 mRNA CTD PMID:17412507 NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:113,443,524...115,002,540 		JBrowse link
G Ntm neurotrimin decreases expression ISO Methylnitrosourea results in decreased expression of NTM mRNA CTD PMID:25922126 NCBI chr 8:35,634,929...36,625,081
Ensembl chr 8:35,635,640...36,624,807 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression ISO Methylnitrosourea results in increased expression of NUSAP1 mRNA CTD PMID:25270620 NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237 		JBrowse link
G Oaf out at first homolog increases expression EXP Methylnitrosourea results in increased expression of OAF mRNA CTD PMID:17412507 NCBI chr 8:52,491,314...52,509,285
Ensembl chr 8:52,491,315...52,509,285 		JBrowse link
G Oca2 OCA2 melanosomal transmembrane protein increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of OCA2 gene CTD PMID:10517996 PMID:17174358 NCBI chr 1:116,252,026...116,581,838
Ensembl chr 1:116,251,796...116,581,838 		JBrowse link
G Ogfrl1 opioid growth factor receptor-like 1 increases expression EXP Methylnitrosourea results in increased expression of OGFRL1 mRNA CTD PMID:17412507 NCBI chr 9:33,320,501...33,338,742
Ensembl chr 9:33,324,392...33,339,237 		JBrowse link
G Opn4 opsin 4 decreases expression EXP Methylnitrosourea results in decreased expression of OPN4 mRNA; Methylnitrosourea results in decreased expression of OPN4 protein CTD PMID:16580133 NCBI chr16:9,926,638...9,935,810
Ensembl chr16:9,926,902...9,949,928 		JBrowse link
G Pafah2 platelet-activating factor acetylhydrolase 2 increases expression ISO Methylnitrosourea results in increased expression of PAFAH2 mRNA CTD PMID:25270620 NCBI chr 5:151,890,751...151,919,896
Ensembl chr 5:151,896,832...151,919,894 		JBrowse link
G Parg poly (ADP-ribose) glycohydrolase increases response to substance ISO PARG gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:15282315 NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases response to substance
multiple interactions
increases activity
affects response to substance 		ISO
EXP 		PARP1 gene mutant form results in increased susceptibility to Methylnitrosourea
Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein]
PARP1 protein affects the susceptibility to Methylnitrosourea
PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein]; PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] 		CTD PMID:11850828 PMID:15282315 PMID:16052507 PMID:16168987 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Parp2 poly (ADP-ribose) polymerase 2 increases response to substance ISO PARP2 gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:12727891 NCBI chr15:26,494,722...26,517,893
Ensembl chr15:26,494,731...26,517,891 		JBrowse link
G Patj PATJ, crumbs cell polarity complex component increases expression ISO Methylnitrosourea results in increased expression of PATJ mRNA CTD PMID:15240709 NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:118,177,565...118,480,301 		JBrowse link
G Pbk PDZ binding kinase increases expression ISO Methylnitrosourea results in increased expression of PBK mRNA CTD PMID:25270620 NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570 		JBrowse link
G Pc pyruvate carboxylase increases expression EXP Methylnitrosourea results in increased expression of PC mRNA CTD PMID:16525678 NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
increases expression 		ISO
EXP 		Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein]
[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of PCNA protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of PCNA protein; Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of PCNA protein]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of PCNA protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of PCNA protein] 		CTD PMID:16204460 PMID:18155124 PMID:25164625 PMID:38977090 PMID:39197506 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 increases expression EXP Methylnitrosourea results in increased expression of PDK1 mRNA CTD PMID:16525678 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of PDPK1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of PDPK1 protein] CTD PMID:25164625 NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181 		JBrowse link
G Perp p53 apoptosis effector related to PMP22 increases expression ISO Methylnitrosourea results in increased expression of PERP mRNA CTD PMID:21382384 PMID:25270620 NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687 		JBrowse link
G Pfkp phosphofructokinase, platelet decreases expression ISO Methylnitrosourea results in decreased expression of PFKP mRNA CTD PMID:25270620 NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752 		JBrowse link
G Pgr progesterone receptor multiple interactions EXP [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of PGR protein CTD PMID:39197506 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 increases expression ISO Methylnitrosourea results in increased expression of PHLDA3 mRNA CTD PMID:25270620 NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621 		JBrowse link
G Pias2 protein inhibitor of activated STAT, 2 increases expression ISO Methylnitrosourea results in increased expression of PIAS2 mRNA CTD PMID:25270620 NCBI chr18:72,883,008...72,989,486
Ensembl chr18:72,882,890...73,006,662 		JBrowse link
G Piezo1 piezo-type mechanosensitive ion channel component 1 increases expression EXP Methylnitrosourea results in increased expression of PIEZO1 mRNA CTD PMID:17412507 NCBI chr19:67,453,120...67,515,347
Ensembl chr19:67,453,122...67,515,037 		JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A multiple interactions
increases mutagenesis 		EXP [Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Methylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein; Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein
Methylnitrosourea results in increased mutagenesis of PIGA; Methylnitrosourea results in increased mutagenesis of PIGA gene 		CTD PMID:19965957 PMID:20202993 PMID:22923490 PMID:27931811 NCBI chr  X:33,672,832...33,687,747
Ensembl chr  X:33,674,923...33,687,636 		JBrowse link
G Pinx1 PIN2/TERF1 interacting, telomerase inhibitor 1 decreases expression ISO Methylnitrosourea results in decreased expression of PINX1 mRNA CTD PMID:25270620 NCBI chr15:42,273,805...42,333,047
Ensembl chr15:42,273,799...42,333,047 		JBrowse link
G Pkib cAMP-dependent protein kinase inhibitor beta increases expression EXP Methylnitrosourea results in increased expression of PKIB mRNA CTD PMID:17341692 NCBI chr20:37,511,564...37,608,607
Ensembl chr20:37,512,822...37,608,401 		JBrowse link
G Pkm pyruvate kinase M1/2 increases expression
multiple interactions 		EXP Methylnitrosourea results in increased expression of PKM protein
Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of PKM protein] 		CTD PMID:38977090 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO Methylnitrosourea results in increased expression of PMAIP1 mRNA CTD PMID:18593901 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pms2 PMS1 homolog 2, mismatch repair system component multiple interactions
increases response to substance
affects response to substance 		ISO Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]
PMS2 protein results in increased susceptibility to Methylnitrosourea
PMS2 protein affects the susceptibility to Methylnitrosourea 		CTD PMID:12967659 PMID:16204460 PMID:16426742 NCBI chr12:15,790,478...15,814,790
Ensembl chr12:15,790,478...15,815,248 		JBrowse link
G Polb DNA polymerase beta increases response to substance ISO POLB gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:17166880 NCBI chr16:76,081,903...76,105,174
Ensembl chr16:76,081,864...76,108,180 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma increases response to substance ISO PPARG gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:15930296 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppp1r10 protein phosphatase 1, regulatory subunit 10 decreases expression ISO Methylnitrosourea results in decreased expression of PPP1R10 mRNA CTD PMID:25270620 NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,827,802...2,842,418 		JBrowse link
G Praf2 PRA1 domain family, member 2 increases expression ISO Methylnitrosourea results in increased expression of PRAF2 mRNA CTD PMID:25270620 NCBI chr  X:17,445,313...17,447,950
Ensembl chr  X:17,445,313...17,447,950 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 increases expression ISO Methylnitrosourea results in increased expression of PRC1 mRNA CTD PMID:25270620 NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012 		JBrowse link
G Prdm14 PR/SET domain 14 decreases expression ISO Methylnitrosourea results in decreased expression of PRDM14 mRNA CTD PMID:25270620 NCBI chr 5:10,864,137...10,876,666
Ensembl chr 5:10,864,137...10,876,666 		JBrowse link
G Prl prolactin multiple interactions EXP [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of PRL protein CTD PMID:39197506 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Prune1 prune exopolyphosphatase 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of PRUNE1 gene CTD PMID:16868089 NCBI chr 2:185,519,569...185,548,402
Ensembl chr 2:185,520,781...185,548,402 		JBrowse link
G Pten phosphatase and tensin homolog decreases expression ISO Methylnitrosourea results in decreased expression of PTEN mRNA CTD PMID:16616109 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression EXP Methylnitrosourea results in increased expression of PTGS2 CTD PMID:28688903 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptpn14 protein tyrosine phosphatase, non-receptor type 14 increases expression ISO Methylnitrosourea results in increased expression of PTPN14 mRNA CTD PMID:25270620 NCBI chr13:103,799,473...103,951,708
Ensembl chr13:103,799,494...103,951,708 		JBrowse link
G Rara retinoic acid receptor, alpha increases mutagenesis
increases expression
multiple interactions 		ISO
EXP 		Methylnitrosourea results in increased mutagenesis of RARA gene
Methylnitrosourea results in increased expression of RARA mRNA
Cholecalciferol inhibits the reaction [Methylnitrosourea results in increased expression of RARA mRNA] 		CTD PMID:16868089 PMID:21843606 NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160 		JBrowse link
G Rb1 RB transcriptional corepressor 1 increases phosphorylation EXP Methylnitrosourea results in increased phosphorylation of RB1 protein CTD PMID:15581186 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbck1 RANBP2-type and C3HC4-type zinc finger containing 1 increases expression ISO Methylnitrosourea results in increased expression of RBCK1 mRNA CTD PMID:25270620 NCBI chr 3:161,249,389...161,266,321
Ensembl chr 3:161,249,390...161,266,032 		JBrowse link
G Rbm4 RNA binding motif protein 4 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of RBM4 gene CTD PMID:16868089 NCBI chr 1:211,507,845...211,516,907
Ensembl chr 1:211,506,343...211,516,891 		JBrowse link
G Rbm43 RNA binding motif protein 43 decreases expression ISO Methylnitrosourea results in decreased expression of RBM43 mRNA CTD PMID:25270620 NCBI chr 3:56,802,384...56,821,371
Ensembl chr 3:56,803,593...56,811,350 		JBrowse link
G Rbp4 retinol binding protein 4 increases expression EXP Methylnitrosourea results in increased expression of RBP4 mRNA CTD PMID:16525678 NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898 		JBrowse link
G Reg1a regenerating family member 1 alpha increases expression ISO Methylnitrosourea results in increased expression of REG1 mRNA CTD PMID:15240709 NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:112,450,468...112,453,585 		JBrowse link
G Reg3b regenerating family member 3 beta increases expression ISO Methylnitrosourea results in increased expression of REG3B mRNA CTD PMID:15240709 NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression
decreases expression
affects localization
affects activity 		EXP 3-aminobenzamide inhibits the reaction [Methylnitrosourea results in decreased expression of RELA protein modified form]; [Methylnitrosourea results in increased expression of NFKBIA protein] which affects the localization of RELA protein; tetramethylpyrazine promotes the reaction [Methylnitrosourea affects the localization of RELA protein]
Methylnitrosourea results in increased expression of RELA protein
Methylnitrosourea results in decreased expression of RELA protein; Methylnitrosourea results in decreased expression of RELA protein modified form
Methylnitrosourea affects the activity of RELA protein 		CTD PMID:15960898 PMID:16098260 PMID:16762860 PMID:17137578 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rfx4 regulatory factor X4 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of RFX4 gene CTD PMID:16868089 NCBI chr 7:20,740,760...20,903,355
Ensembl chr 7:20,741,079...20,902,851 		JBrowse link
G Rhbdf2 rhomboid 5 homolog 2 increases expression ISO Methylnitrosourea results in increased expression of RHBDF2 mRNA CTD PMID:25270620 NCBI chr10:102,331,991...102,359,117
Ensembl chr10:102,331,991...102,359,117 		JBrowse link
G Rnase1 ribonuclease A family member 1, pancreatic increases expression ISO Methylnitrosourea results in increased expression of RNASE1 mRNA CTD PMID:15240709 NCBI chr15:26,835,436...26,837,145
Ensembl chr15:26,835,463...26,837,248 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of RPS6KB1 protein; Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of RPS6KB1 protein]; Methylnitrosourea results in increased expression of and results in increased phosphorylation of RPS6KB1 protein; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of and results in increased phosphorylation of RPS6KB1 protein] CTD PMID:22465879 PMID:38977090 NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238 		JBrowse link
G RT1-A2 RT1 class Ia, locus A2 increases expression EXP Methylnitrosourea results in increased expression of RT1-A2 mRNA CTD PMID:17412507 NCBI chr20:4,872,720...4,876,425 JBrowse link
G Rxrg retinoid X receptor gamma affects expression EXP Methylnitrosourea affects the expression of RXRG mRNA CTD PMID:21843606 NCBI chr13:82,276,330...82,318,097
Ensembl chr13:82,276,291...82,318,095 		JBrowse link
G S100a3 S100 calcium binding protein A3 increases expression EXP Methylnitrosourea results in increased expression of S100A3 mRNA CTD PMID:17412507 NCBI chr 2:178,331,856...178,387,280
Ensembl chr 2:178,384,578...178,387,280 		JBrowse link
G Scarb2 scavenger receptor class B, member 2 multiple interactions EXP [Dichlorvos co-treated with Methylnitrosourea] results in increased expression of SCARB2 protein CTD PMID:37469457 NCBI chr14:15,842,583...15,894,123
Ensembl chr14:15,842,515...15,896,671 		JBrowse link
G Scg2 secretogranin II increases expression EXP Methylnitrosourea results in increased expression of SCG2 mRNA CTD PMID:17412507 NCBI chr 9:88,251,531...88,257,208
Ensembl chr 9:88,251,354...88,269,598 		JBrowse link
G Scn10a sodium voltage-gated channel alpha subunit 10 decreases expression EXP Methylnitrosourea results in decreased expression of SCN10A mRNA CTD PMID:16525678 NCBI chr 8:128,228,424...128,340,749
Ensembl chr 8:128,228,424...128,340,298 		JBrowse link
G Serpine2 serpin family E member 2 increases expression ISO Methylnitrosourea results in increased expression of SERPINE2 mRNA CTD PMID:25270620 NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression ISO Methylnitrosourea results in increased expression of SGK1 mRNA CTD PMID:29110037 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Shc1 SHC adaptor protein 1 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SHC1 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SHC1 protein CTD PMID:22465879 NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:177,135,659...177,147,914 		JBrowse link
G Slc16a12 solute carrier family 16, member 12 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of SLC16A12 gene CTD PMID:16868089 NCBI chr 1:241,597,165...241,674,821
Ensembl chr 1:241,599,066...241,674,743 		JBrowse link
G Slc25a53 solute carrier family 25, member 53 increases expression ISO Methylnitrosourea results in increased expression of SLC25A53 mRNA CTD PMID:15240709 NCBI chr  X:105,099,191...105,111,936
Ensembl chr  X:105,099,112...105,113,009 		JBrowse link
G Slc26a4 solute carrier family 26 member 4 multiple interactions EXP Methylnitrosourea promotes the reaction [Iodine results in increased expression of SLC26A4 mRNA] CTD PMID:15922087 NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:53,835,110...53,873,216 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 increases expression
multiple interactions 		EXP Methylnitrosourea results in increased expression of SLC2A1 protein
Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of SLC2A1 protein] 		CTD PMID:38977090 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742 		JBrowse link
G Slc4a1ap solute carrier family 4 member 1 adaptor protein decreases expression ISO Methylnitrosourea results in decreased expression of SLC4A1AP mRNA CTD PMID:25270620 NCBI chr 6:30,625,931...30,653,859
Ensembl chr 6:30,625,931...30,653,792 		JBrowse link
G Smad4 SMAD family member 4 increases response to substance ISO SMAD4 gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:12096346 NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684 		JBrowse link
G Smad7 SMAD family member 7 decreases expression ISO Methylnitrosourea results in decreased expression of SMAD7 mRNA CTD PMID:25270620 NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849 		JBrowse link
G Smg6 SMG6 nonsense mediated mRNA decay factor decreases expression ISO Methylnitrosourea results in decreased expression of SMG6 mRNA CTD PMID:25270620 NCBI chr10:60,284,628...60,512,738
Ensembl chr10:60,284,628...60,512,733 		JBrowse link
G Snai1 snail family transcriptional repressor 1 multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI1 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI1 mRNA] CTD PMID:25164625 NCBI chr 3:176,667,476...176,671,965 JBrowse link
G Snai2 snail family transcriptional repressor 2 multiple interactions
decreases expression 		EXP
ISO 		[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI2 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI2 mRNA]
Methylnitrosourea results in decreased expression of SNAI2 mRNA 		CTD PMID:25164625 PMID:27221058 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349 		JBrowse link
G Snrnp35 small nuclear ribonucleoprotein U11/U12 subunit 35 decreases expression ISO Methylnitrosourea results in decreased expression of SNRNP35 mRNA CTD PMID:25270620 NCBI chr12:37,773,052...37,781,635
Ensembl chr12:37,771,759...37,783,908 		JBrowse link
G Snrpc small nuclear ribonucleoprotein polypeptide C decreases expression ISO Methylnitrosourea results in decreased expression of SNRPC mRNA CTD PMID:25270620 NCBI chr20:5,890,229...5,908,410
Ensembl chr20:5,890,229...5,908,410 		JBrowse link
G Socs3 suppressor of cytokine signaling 3 decreases expression ISO Methylnitrosourea results in decreased expression of SOCS3 mRNA CTD PMID:25270620 NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825 		JBrowse link
G Sod2 superoxide dismutase 2 affects metabolic processing
multiple interactions 		ISO Methylnitrosourea affects the metabolism of SOD2 protein
PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] 		CTD PMID:16052507 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sos1 SOS Ras/Rac guanine nucleotide exchange factor 1 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SOS1 mRNA CTD PMID:22465879 NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350 		JBrowse link
G Sphk1 sphingosine kinase 1 increases expression EXP Methylnitrosourea results in increased expression of SPHK1 mRNA CTD PMID:17412507 NCBI chr10:102,257,413...102,263,086
Ensembl chr10:102,258,975...102,263,082 		JBrowse link
G Spink4 serine peptidase inhibitor, Kazal type 4 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of SPINK4 gene CTD PMID:16868089 NCBI chr 5:60,811,899...60,860,823
Ensembl chr 5:60,849,060...60,860,823 		JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression EXP Methylnitrosourea results in decreased expression of SPP1 mRNA CTD PMID:16525678 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Spry2 sprouty RTK signaling antagonist 2 increases expression EXP Methylnitrosourea results in increased expression of SPRY2 mRNA CTD PMID:17412507 NCBI chr15:89,106,809...89,111,926
Ensembl chr15:89,103,731...89,115,074 		JBrowse link
G Sptan1 spectrin, alpha, non-erythrocytic 1 increases cleavage EXP Methylnitrosourea results in increased cleavage of SPTAN1 protein CTD PMID:17069801 NCBI chr 3:33,639,020...33,703,890
Ensembl chr 3:33,607,210...33,703,889 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions
increases expression 		EXP Hexachlorobenzene promotes the reaction [Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]]; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in increased phosphorylation of SRC protein]; Methylnitrosourea inhibits the reaction [Hexachlorobenzene promotes the reaction [ESR1 protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]; Methylnitrosourea promotes the reaction [Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [Hexachlorobenzene results in increased phosphorylation of SRC protein]; Methylnitrosourea results in increased phosphorylation of and results in increased expression of SRC protein
Methylnitrosourea results in increased expression of SRC protein 		CTD PMID:22245120 NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 increases response to substance ISO STAT4 gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:11418001 NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stmn1 stathmin 1 increases expression EXP Methylnitrosourea results in increased expression of STMN1 mRNA CTD PMID:16525678 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Stmn2 stathmin 2 decreases expression ISO Methylnitrosourea results in decreased expression of STMN2 mRNA CTD PMID:25270620 NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:95,112,019...95,159,335 		JBrowse link
G Syp synaptophysin affects expression EXP Methylnitrosourea affects the expression of SYP protein CTD PMID:18155124 NCBI chr  X:17,521,348...17,536,449
Ensembl chr  X:17,521,348...17,536,984 		JBrowse link
G Tcrg T cell receptor gamma chain increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of TCRG gene CTD PMID:16868089 NCBI chr17:50,317,679...50,361,771 JBrowse link
G Terc telomerase RNA component affects response to substance ISO TERC protein affects the susceptibility to Methylnitrosourea CTD PMID:14612493 NCBI chr 2:114,744,148...114,744,535 JBrowse link
G Tff2 trefoil factor 2 increases expression ISO Methylnitrosourea results in increased expression of TFF2 mRNA CTD PMID:15240709 NCBI chr20:9,217,110...9,220,979
Ensembl chr20:9,217,121...9,220,979 		JBrowse link
G Tgif1 TGFB-induced factor homeobox 1 increases expression EXP Methylnitrosourea results in increased expression of TGIF1 mRNA CTD PMID:17412507 NCBI chr 9:118,194,735...118,204,354
Ensembl chr 9:118,194,444...118,204,442 		JBrowse link
G Thpo thrombopoietin multiple interactions
increases expression 		ISO Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein] CTD PMID:16822543 Ensembl chr11:93,686,834...93,693,320 JBrowse link
G Thra thyroid hormone receptor alpha affects expression EXP Methylnitrosourea affects the expression of THRA mRNA CTD PMID:21843606 NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657 		JBrowse link
G Thrb thyroid hormone receptor beta affects expression EXP Methylnitrosourea affects the expression of THRB mRNA CTD PMID:21843606 NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680 		JBrowse link
G Thrsp thyroid hormone responsive decreases expression
increases expression 		EXP Methylnitrosourea results in decreased expression of THRSP mRNA
Methylnitrosourea results in increased expression of THRSP mRNA 		CTD PMID:16525678 PMID:17341692 NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827 		JBrowse link
G Thumpd3 THUMP domain containing 3 decreases expression ISO Methylnitrosourea results in decreased expression of THUMPD3 mRNA CTD PMID:25270620 NCBI chr 4:147,741,288...147,764,254
Ensembl chr 4:147,741,309...147,765,579 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression EXP Methylnitrosourea results in increased expression of TIMP1 mRNA CTD PMID:17412507 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tinagl1 tubulointerstitial nephritis antigen-like 1 increases expression EXP Methylnitrosourea results in increased expression of TINAGL1 mRNA CTD PMID:17412507 NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:147,797,892...147,807,871 		JBrowse link
G Tkt transketolase increases expression EXP Methylnitrosourea results in increased expression of TKT mRNA CTD PMID:16525678 NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431 		JBrowse link
G Tmem69 transmembrane protein 69 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of TMEM69 gene CTD PMID:16868089 NCBI chr 5:135,241,557...135,247,323
Ensembl chr 5:135,241,560...135,247,215 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		ISO
EXP 		Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]
Methylnitrosourea results in increased expression of TNF mRNA 		CTD PMID:16822543 PMID:28688903 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B decreases expression EXP Methylnitrosourea results in decreased expression of TNFRSF11B mRNA CTD PMID:17341692 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075 		JBrowse link
G Tnfrsf12a TNF receptor superfamily member 12A increases expression EXP Methylnitrosourea results in increased expression of TNFRSF12A mRNA CTD PMID:17412507 NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704 		JBrowse link
G Tnip2 TNFAIP3 interacting protein 2 increases expression EXP Methylnitrosourea results in increased expression of TNIP2 mRNA CTD PMID:17412507 NCBI chr14:80,452,936...80,470,141
Ensembl chr14:80,452,845...80,470,992 		JBrowse link
G Top2a DNA topoisomerase II alpha increases expression ISO Methylnitrosourea results in increased expression of TOP2A mRNA CTD PMID:25270620 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366 		JBrowse link
G Top3b DNA topoisomerase III beta decreases expression
increases expression 		ISO Methylnitrosourea results in decreased expression of TOP3B mRNA
Methylnitrosourea results in increased expression of TOP3B mRNA 		CTD PMID:16616109 PMID:25270620 NCBI chr11:97,601,223...97,629,678
Ensembl chr11:97,601,231...97,629,597 		JBrowse link
G Tor1b torsin family 1, member B decreases expression ISO Methylnitrosourea results in decreased expression of TOR1B mRNA CTD PMID:25270620 NCBI chr 3:34,640,929...34,647,023
Ensembl chr 3:34,640,931...34,647,027 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases stability
affects response to substance
increases response to substance
increases phosphorylation
increases expression 		EXP
ISO 		[Estradiol co-treated with Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA; Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TP53 protein]
Methylnitrosourea results in increased stability of TP53 protein
Methylnitrosourea results in increased expression of and results in increased phosphorylation of TP53 protein; TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein]
TRP53 protein affects the susceptibility to Methylnitrosourea
TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea
Methylnitrosourea results in increased phosphorylation of TRP53 protein
Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; MAPK8 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein]
Methylnitrosourea results in increased expression of TP53 mRNA 		CTD PMID:11536039 PMID:11850828 PMID:12185594 PMID:17412507 PMID:18593901 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp53bp1 tumor protein p53 binding protein 1 increases expression ISO Methylnitrosourea results in increased expression of TP53BP1 protein CTD PMID:27233451 NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747 		JBrowse link
G Tp53inp1 tumor protein p53 inducible nuclear protein 1 increases expression ISO Methylnitrosourea results in increased expression of TRP53INP1 mRNA CTD PMID:25270620 NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484 		JBrowse link
G Trip6 thyroid hormone receptor interactor 6 decreases expression ISO Methylnitrosourea results in decreased expression of TRIP6 mRNA CTD PMID:25270620 NCBI chr12:25,022,959...25,027,366
Ensembl chr12:25,022,909...25,027,363 		JBrowse link
G Tspo translocator protein increases expression EXP Methylnitrosourea results in increased expression of TSPO mRNA CTD PMID:17412507 NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:116,600,210...116,610,460 		JBrowse link
G Ttk Ttk protein kinase increases expression ISO Methylnitrosourea results in increased expression of TTK mRNA CTD PMID:25270620 NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA] CTD PMID:25164625 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Tyr tyrosinase increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of TYR gene CTD PMID:17174358 NCBI chr 1:150,527,687...150,622,857
Ensembl chr 1:150,527,687...150,622,857 		JBrowse link
G Tyrp1 tyrosinase-related protein 1 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of TYRP1 gene CTD PMID:17174358 NCBI chr 5:100,327,111...100,345,657
Ensembl chr 5:100,327,125...100,345,657 		JBrowse link
G Ubac2 UBA domain containing 2 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of UBAC2 gene CTD PMID:16868089 NCBI chr15:105,366,776...105,514,435
Ensembl chr15:105,366,697...105,514,444 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C increases expression ISO Methylnitrosourea results in increased expression of UBE2C mRNA CTD PMID:25270620 NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678 		JBrowse link
G Ube2j1 ubiquitin-conjugating enzyme E2, J1 increases expression EXP Methylnitrosourea results in increased expression of UBE2J1 mRNA CTD PMID:17412507 NCBI chr 5:52,218,807...52,237,805
Ensembl chr 5:52,218,807...52,237,805 		JBrowse link
G Upp1 uridine phosphorylase 1 increases expression
decreases expression 		EXP
ISO 		Methylnitrosourea results in increased expression of UPP1 mRNA
Methylnitrosourea results in decreased expression of UPP1 mRNA 		CTD PMID:17412507 PMID:25270620 NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
increases expression 		ISO
EXP 		Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]
[Methylnitrosourea co-treated with Estradiol] results in increased expression of VEGFA mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of VEGFA mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of VEGFA mRNA 		CTD PMID:16822543 PMID:20732338 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vim vimentin multiple interactions EXP [Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM mRNA; [Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM protein] CTD PMID:25164625 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Vrk1 VRK serine/threonine kinase 1 decreases expression
multiple interactions 		ISO Methylnitrosourea results in decreased expression of VRK1 protein
TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein] 		CTD PMID:27233451 NCBI chr 6:130,679,400...130,746,089
Ensembl chr 6:130,679,515...130,746,752 		JBrowse link
G Wdr35 WD repeat domain 35 increases expression ISO Methylnitrosourea results in increased expression of WDR35 mRNA CTD PMID:25270620 NCBI chr 6:37,490,557...37,550,391
Ensembl chr 6:37,490,545...37,550,664 		JBrowse link
G Wnt5a Wnt family member 5A increases expression
increases expression 		EXP Methylnitrosourea results in increased expression of WNT5A mRNA
N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon 		CTD
RGD		 PMID:17341692 PMID:28032729 RGD:150530464 NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860 		JBrowse link
G Xiap X-linked inhibitor of apoptosis decreases response to substance ISO XIAP protein results in decreased susceptibility to Methylnitrosourea CTD PMID:12766084 NCBI chr  X:125,756,107...125,803,979
Ensembl chr  X:125,737,971...125,803,978 		JBrowse link
G Xrcc5 X-ray repair cross complementing 5 increases mutagenesis ISO Methylnitrosourea results in increased mutagenesis of XRCC5 gene CTD PMID:16868089 NCBI chr 9:81,404,507...81,493,293
Ensembl chr 9:81,375,863...81,493,293 		JBrowse link
G Zeb1 zinc finger E-box binding homeobox 1 increases expression ISO Methylnitrosourea results in increased expression of ZEB1 mRNA CTD PMID:27221058 NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745 		JBrowse link
G Zfp365 zinc finger protein 365 increases expression ISO Methylnitrosourea results in increased expression of ZFP365 mRNA CTD PMID:25270620 NCBI chr20:20,665,122...20,688,607
Ensembl chr20:20,665,046...20,690,114 		JBrowse link
G Znf8 zinc finger protein 8 increases expression EXP Methylnitrosourea results in increased expression of ZFP128 mRNA CTD PMID:16525678 NCBI chr 1:82,570,719...82,584,121
Ensembl chr 1:82,570,687...82,584,119 		JBrowse link
N-nitroso-N-methyl-4-aminobutyric acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G H2ax H2A.X variant histone multiple interactions ISO [CYP2A6 protein results in increased metabolism of 4-(N-nitroso-N-methylamino)butyric acid] which results in increased expression of H2AX protein CTD PMID:35882637 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
N-Nitrosodi-n-butylamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase increases activity ISO dibutylnitrosamine results in increased activity of ACHE protein CTD PMID:15881669 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Cyb5b cytochrome b5 type B multiple interactions ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to dibutylnitrosamine CTD PMID:11733072 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO CYP1A1 protein affects the metabolism of and results in increased activity of dibutylnitrosamine CTD PMID:11600130 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases hydroxylation EXP CYP2B1 protein results in increased hydroxylation of dibutylnitrosamine CTD PMID:8625499 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to dibutylnitrosamine; [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to dibutylnitrosamine CTD PMID:11035158 PMID:11733072 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Nras NRAS proto-oncogene, GTPase increases activity EXP dibutylnitrosamine results in increased activity of NRAS CTD PMID:3040652 NCBI chr 2:193,271,399...193,282,023
Ensembl chr 2:193,271,430...193,278,543 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO dibutylnitrosamine results in increased cleavage of PARP1 protein CTD PMID:17929238 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to dibutylnitrosamine; [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to dibutylnitrosamine CTD PMID:11035158 PMID:11733072 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809 		JBrowse link
G Tp53 tumor protein p53 increases response to substance ISO TRP53 gene mutant form results in increased susceptibility to dibutylnitrosamine CTD PMID:12706858 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
N-Nitrosodi-n-propylamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyb5a cytochrome b5 type A multiple interactions ISO CYB5A protein promotes the reaction [CYP2A6 protein results in increased activity of N-nitroso(di-n-propyl)amine]; CYB5A protein promotes the reaction [CYP2E1 protein results in increased activity of N-nitroso(di-n-propyl)amine] CTD PMID:15728263 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5b cytochrome b5 type B multiple interactions ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine CTD PMID:11733072 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 affects metabolic processing
increases hydroxylation
decreases nitrosation 		EXP CYP2B1 protein affects the metabolism of N-nitroso(di-n-propyl)amine
CYP2B1 protein results in increased hydroxylation of N-nitroso(di-n-propyl)amine
CYP2B1 protein results in decreased nitrosation of N-nitroso(di-n-propyl)amine 		CTD PMID:8625499 PMID:10910959 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 affects metabolic processing ISO CYP2B6 protein affects the metabolism of N-nitroso(di-n-propyl)amine CTD PMID:10910959 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
increases activity
affects metabolic processing 		ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine; [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine; CYB5A protein promotes the reaction [CYP2E1 protein results in increased activity of N-nitroso(di-n-propyl)amine]
CYP2E1 protein affects the metabolism of N-nitroso(di-n-propyl)amine 		CTD PMID:10910959 PMID:11035158 PMID:11733072 PMID:15728263 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases nitrosation
affects metabolic processing 		ISO CYP3A4 protein results in decreased nitrosation of N-nitroso(di-n-propyl)amine
CYP3A4 protein affects the metabolism of N-nitroso(di-n-propyl)amine 		CTD PMID:10910959 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine; [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine CTD PMID:11035158 PMID:11733072 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809 		JBrowse link
N-Nitrosodiethanolamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases metabolic processing ISO CYP2E1 protein results in increased metabolism of N-nitrosodiethanolamine CTD PMID:18616954 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G H2ax H2A.X variant histone increases phosphorylation EXP N-nitrosodiethanolamine results in increased phosphorylation of H2AX protein CTD PMID:37527026 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression EXP N-nitrosodiethanolamine results in increased expression of MKI67 protein CTD PMID:37527026 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
N-nitrosodiethylamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1bg alpha-1-B glycoprotein multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of A1BG mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of A1BG mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA] CTD PMID:18164116 PMID:22129741 NCBI chr 7:94,383,333...94,387,922
Ensembl chr 7:94,383,333...94,387,496 		JBrowse link
G A2m alpha-2-macroglobulin multiple interactions
increases expression
decreases expression 		EXP [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of A2M mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of A2M protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of A2M promoter; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of A2M mRNA; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of A2M mRNA]
Diethylnitrosamine results in increased expression of A2M mRNA; Diethylnitrosamine results in increased expression of A2M protein 		CTD PMID:20360939 PMID:20935162 PMID:25374375 PMID:27565560 PMID:28943392 More... NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G A3galt2 alpha 1,3-galactosyltransferase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of A3GALT2 mRNA CTD PMID:18164116 NCBI chr 5:146,385,725...146,398,156
Ensembl chr 5:146,385,746...146,400,043 		JBrowse link
G Aaas aladin WD repeat nucleoporin increases expression ISO Diethylnitrosamine results in increased expression of AAAS mRNA CTD PMID:21607683 NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545 		JBrowse link
G Aadat aminoadipate aminotransferase decreases expression ISO Diethylnitrosamine results in decreased expression of AADAT mRNA CTD PMID:24535843 NCBI chr16:34,520,236...34,566,388
Ensembl chr16:34,520,238...34,566,540 		JBrowse link
G Aanat aralkylamine N-acetyltransferase multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AANAT mRNA CTD PMID:20360939 NCBI chr10:102,323,647...102,330,639
Ensembl chr10:102,326,135...102,330,635 		JBrowse link
G Abca3 ATP binding cassette subfamily A member 3 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ABCA3 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ABCA3 mRNA] 		CTD PMID:17942915 NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285 		JBrowse link
G Abca5 ATP binding cassette subfamily A member 5 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ABCA5 mRNA CTD PMID:20360939 NCBI chr10:95,739,610...95,808,633
Ensembl chr10:95,739,610...95,808,424 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCB11 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ABCB11 mRNA
Diethylnitrosamine results in decreased expression of ABCB11 mRNA 		CTD PMID:17602206 PMID:19638242 PMID:28943392 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Cisplatin] results in increased expression of ABCB1 protein; [Diethylnitrosamine co-treated with Epirubicin] results in increased expression of ABCB1 protein; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCB1A mRNA
Diethylnitrosamine results in increased expression of ABCB1A mRNA
Diethylnitrosamine results in increased expression of ABCB1 protein; Diethylnitrosamine results in increased expression of ABCB1A mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCB1A mRNA 		CTD PMID:11818250 PMID:19638242 PMID:22129741 PMID:24535843 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ABCB1B mRNA
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCB1B mRNA 		CTD PMID:17602206 PMID:22129741 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCB4 mRNA CTD PMID:17602206 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of ABCC2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC2 mRNA; [Orphenadrine co-treated with Diethylnitrosamine] results in increased expression of ABCC2 mRNA CTD PMID:18544905 PMID:23665939 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression 		ISO
EXP 		[Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of ABCC3 mRNA
Diethylnitrosamine results in increased expression of ABCC3 mRNA
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ABCC3 mRNA; [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ABCC3 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCC3 mRNA 		CTD PMID:18648771 PMID:19638242 PMID:19690152 PMID:20360939 PMID:22129741 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 multiple interactions ISO
EXP 		[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCC4 mRNA; [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of ABCC4 mRNA
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCC4 mRNA 		CTD PMID:19690152 PMID:22129741 PMID:24535843 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCC5 mRNA CTD PMID:17602206 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 multiple interactions
decreases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC6 mRNA
Diethylnitrosamine results in decreased expression of ABCC6 mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCC6 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC6 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ABCC6 mRNA 		CTD PMID:17602206 PMID:17917374 PMID:18544905 PMID:19638242 PMID:28943392 NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895 		JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ABCC9 mRNA
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC9 mRNA 		CTD PMID:17917374 PMID:18164116 NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348 		JBrowse link
G Abcd1 ATP binding cassette subfamily D member 1 multiple interactions ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCD1 mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCD1 mRNA 		CTD PMID:17602206 PMID:17917374 NCBI chr  X:156,579,669...156,601,448
Ensembl chr  X:156,579,785...156,601,446 		JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 multiple interactions
increases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCD2 mRNA
Diethylnitrosamine results in increased expression of ABCD2 mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202 		JBrowse link
G Abce1 ATP binding cassette subfamily E member 1 multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCE1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ABCE1 promoter CTD PMID:25374375 NCBI chr19:45,109,880...45,134,819
Ensembl chr19:45,109,906...45,134,819 		JBrowse link
G Abcf2 ATP binding cassette subfamily F member 2 multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCF2 mRNA
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA 		CTD PMID:17602206 PMID:17917374 NCBI chr 4:11,485,865...11,500,067
Ensembl chr 4:11,487,395...11,500,053 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ABCG1 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCG1 mRNA CTD PMID:17602206 PMID:18164116 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563 		JBrowse link
G Abcg4 ATP binding cassette subfamily G member 4 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA] CTD PMID:22129741 NCBI chr 8:53,508,005...53,525,314
Ensembl chr 8:53,508,005...53,523,571 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCG5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG5 mRNA CTD PMID:17602206 PMID:22129741 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376 		JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG8 mRNA CTD PMID:22129741 NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730 		JBrowse link
G Abhd1 abhydrolase domain containing 1 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABHD1 mRNA CTD PMID:17917374 NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464 		JBrowse link
G Abhd12 abhydrolase domain containing 12, lysophospholipase multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABHD12 mRNA CTD PMID:24535843 NCBI chr 3:160,119,724...160,179,959
Ensembl chr 3:160,119,724...160,179,969 		JBrowse link
G Abhd15 abhydrolase domain containing 15 decreases expression ISO Diethylnitrosamine results in decreased expression of ABHD15 mRNA CTD PMID:24535843 NCBI chr10:62,861,335...62,866,726
Ensembl chr10:62,861,317...62,868,540 		JBrowse link
G Abhd2 abhydrolase domain containing 2, acylglycerol lipase increases expression ISO Diethylnitrosamine results in increased expression of ABHD2 mRNA CTD PMID:24535843 NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase increases expression ISO Diethylnitrosamine results in increased expression of ABHD5 mRNA CTD PMID:24535843 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Abhd8 abhydrolase domain containing 8 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA CTD PMID:22129741 NCBI chr16:18,178,441...18,185,178
Ensembl chr16:18,178,441...18,191,638 		JBrowse link
G Abi2 abl-interactor 2 multiple interactions
increases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABI2 mRNA
Diethylnitrosamine results in increased expression of ABI2 mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597 		JBrowse link
G Abi3bp ABI family member 3 binding protein multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ABI3BP mRNA
Diethylnitrosamine results in increased expression of ABI3BP mRNA 		CTD PMID:24535843 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Ablim3 actin binding LIM protein family, member 3 decreases expression ISO Diethylnitrosamine results in decreased expression of ABLIM3 mRNA CTD PMID:24535843 NCBI chr18:57,527,917...57,646,936
Ensembl chr18:57,527,917...57,646,710 		JBrowse link
G Abr ABR activator of RhoGEF and GTPase multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ABR gene CTD PMID:23968726 NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,760,743...61,959,467 		JBrowse link
G Abtb1 ankyrin repeat and BTB domain containing 1 multiple interactions
affects response to substance 		ISO [ABTB1 protein affects the susceptibility to Diethylnitrosamine] which affects the expression of GPT protein; [ABTB1 protein affects the susceptibility to Diethylnitrosamine] which affects the expression of IL1B protein CTD PMID:38866194 NCBI chr 4:122,856,558...122,862,895
Ensembl chr 4:122,856,564...122,862,789 		JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ABTB2 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ABTB2 mRNA] 		CTD PMID:17942915 NCBI chr 3:110,409,672...110,563,488
Ensembl chr 3:110,409,627...110,563,487 		JBrowse link
G Acaa1b acetyl-Coenzyme A acyltransferase 1B multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACAA1B mRNA CTD PMID:28943392 NCBI chr 8:127,750,771...127,759,589
Ensembl chr 8:127,750,743...127,759,569 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 multiple interactions EXP [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of ACAA2 mRNA CTD PMID:14656948 NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACACA mRNA CTD PMID:28943392 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACACB mRNA CTD PMID:18164116 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain decreases expression EXP Diethylnitrosamine results in decreased expression of ACADL mRNA CTD PMID:11323195 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACADM mRNA CTD PMID:17602206 NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864 		JBrowse link
G Acan aggrecan multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ACAN mRNA CTD PMID:20360939 NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779 		JBrowse link
G Acap2 ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACAP2 mRNA CTD PMID:18164116 NCBI chr11:83,043,442...83,159,105
Ensembl chr11:83,043,511...83,159,107 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 multiple interactions EXP [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ACAT1 mRNA CTD PMID:18253720 NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 increases expression
decreases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ACAT2 mRNA
Diethylnitrosamine results in decreased expression of ACAT3 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACAT2 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:20387270 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Acbd3 acyl-CoA binding domain containing 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACBD3 mRNA CTD PMID:18164116 NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355 		JBrowse link
G Acbd4 acyl-CoA binding domain containing 4 decreases expression EXP Diethylnitrosamine results in decreased expression of ACBD4 mRNA CTD PMID:19638242 NCBI chr10:88,548,146...88,558,588
Ensembl chr10:88,548,158...88,558,587 		JBrowse link
G Acbd5 acyl-CoA binding domain containing 5 increases expression EXP Diethylnitrosamine results in increased expression of ACBD5 mRNA CTD PMID:19041683 NCBI chr17:90,114,250...90,156,286
Ensembl chr17:90,114,375...90,156,286 		JBrowse link
G Ace angiotensin I converting enzyme multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACE mRNA CTD PMID:18164116 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Acer3 alkaline ceramidase 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACER3 mRNA CTD PMID:22129741 NCBI chr 1:161,915,397...162,017,802
Ensembl chr 1:161,915,397...162,017,912 		JBrowse link
G Acmsd aminocarboxymuconate semialdehyde decarboxylase multiple interactions EXP [Clofibric Acid co-treated with Diethylnitrosamine] results in decreased expression of ACMSD mRNA CTD PMID:15833021 NCBI chr13:41,752,894...41,798,427
Ensembl chr13:41,752,875...41,798,427 		JBrowse link
G Aco2 aconitase 2 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ACO2 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ACO2 mRNA] 		CTD PMID:17942915 NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of ACOT1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACOT1 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acot2 acyl-CoA thioesterase 2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ACOT2 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACOT2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT2 mRNA CTD PMID:17602206 PMID:20360939 PMID:22129741 NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502 		JBrowse link
G Acot3 acyl-CoA thioesterase 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT3 mRNA CTD PMID:22129741 NCBI chr 6:109,413,617...109,419,840
Ensembl chr 6:109,413,534...109,421,427
Ensembl chr 6:109,413,534...109,421,427 		JBrowse link
G Acot4 acyl-CoA thioesterase 4 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT4 mRNA CTD PMID:22129741 NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:109,399,578...109,405,138 		JBrowse link
G Acot5 acyl-CoA thioesterase 5 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACOT5 mRNA CTD PMID:22129741 NCBI chr 6:109,433,062...109,439,846
Ensembl chr 6:109,453,391...109,461,035
Ensembl chr 6:109,453,391...109,461,035 		JBrowse link
G Acot7 acyl-CoA thioesterase 7 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACOT7 mRNA CTD PMID:17602206 NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ACOT9 mRNA CTD PMID:24535843 NCBI chr  X:43,922,943...43,973,311
Ensembl chr  X:43,914,923...43,973,205 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACOX1 mRNA; [Diethylnitrosamine co-treated with Dietary Fats] results in increased expression of ACOX1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ACOX1 mRNA CTD PMID:17602206 PMID:18253720 PMID:18775883 PMID:30298849 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox2 acyl-CoA oxidase 2 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACOX2 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACOX2 mRNA
Diethylnitrosamine results in decreased expression of ACOX2 mRNA 		CTD PMID:17602206 PMID:19638242 PMID:28943392 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Acp3 acid phosphatase 3 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACP3 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACP3 mRNA CTD PMID:17602206 PMID:22129741 NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ACP5 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of ACSL1 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACSL1 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACSL3 mRNA
Diethylnitrosamine results in increased expression of ACSL3 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 increases expression ISO Diethylnitrosamine results in increased expression of ACSL4 mRNA CTD PMID:24535843 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:110,739,648...110,803,261 		JBrowse link
G Acsl5 acyl-CoA synthetase long-chain family member 5 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of ACSL5 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACSL5 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943 		JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 decreases expression ISO Diethylnitrosamine results in decreased expression of ACSM1 mRNA CTD PMID:24535843 NCBI chr 1:183,417,052...183,451,897
Ensembl chr 1:183,416,009...183,454,217 		JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACSM2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM2 mRNA CTD PMID:22129741 PMID:28943392 NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAH mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SAH mRNA CTD PMID:17602206 PMID:28943392 NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437 		JBrowse link
G Acsm5 acyl-CoA synthetase medium-chain family member 5 multiple interactions
decreases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSM5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA]
Diethylnitrosamine results in decreased expression of ACSM5 mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 1:183,302,241...183,328,175
Ensembl chr 1:183,294,105...183,329,925 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA CTD PMID:22129741 NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748 		JBrowse link
G Acta2 actin alpha 2, smooth muscle increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of ACTA2 protein
salvianolic acid B affects the reaction [SMAD3 protein modified form affects the reaction [Diethylnitrosamine results in increased expression of ACTA2 protein]]; salvianolic acid B inhibits the reaction [Diethylnitrosamine results in increased expression of ACTA2 protein]; SMAD3 protein modified form affects the reaction [Diethylnitrosamine results in increased expression of ACTA2 protein] 		CTD PMID:18522880 PMID:19822196 PMID:26589970 PMID:33290806 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actg1 actin, gamma 1 increases expression EXP Diethylnitrosamine results in increased expression of ACTG1 mRNA CTD PMID:19638242 NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951 		JBrowse link
G Actg2 actin gamma 2, smooth muscle decreases expression ISO Diethylnitrosamine results in decreased expression of ACTG2 mRNA CTD PMID:21527772 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn3 actinin alpha 3 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ACTN3 gene CTD PMID:23968726 NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401 		JBrowse link
G Actr10 actin related protein 10 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACTR10 mRNA CTD PMID:17602206 NCBI chr 6:95,182,082...95,208,325
Ensembl chr 6:95,182,111...95,209,021 		JBrowse link
G Acvr2b activin A receptor type 2B multiple interactions EXP [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of SCGB2A2 protein CTD PMID:20935162 NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171 		JBrowse link
G Acvrl1 activin A receptor like type 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACVRL1 mRNA CTD PMID:18164116 NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:134,118,024...134,135,305 		JBrowse link
G Acy3 aminoacylase 3 decreases expression EXP Diethylnitrosamine results in decreased expression of ACY3 mRNA CTD PMID:19638242 NCBI chr 1:210,709,238...210,715,258
Ensembl chr 1:210,709,294...210,715,633 		JBrowse link
G Adam23 ADAM metallopeptidase domain 23 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ADAM23 mRNA CTD PMID:24535843 NCBI chr 9:72,356,479...72,503,545
Ensembl chr 9:72,356,479...72,503,545 		JBrowse link
G Adam7 ADAM metallopeptidase domain 7 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ADAM7 mRNA CTD PMID:20360939 NCBI chr15:47,009,176...47,057,581
Ensembl chr15:47,009,176...47,057,581 		JBrowse link
G Adamdec1 ADAM-like, decysin 1 multiple interactions
decreases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ADAMDEC1 mRNA
Diethylnitrosamine results in decreased expression of ADAMDEC1 mRNA 		CTD PMID:24535843 NCBI chr15:47,076,011...47,097,065
Ensembl chr15:47,076,019...47,097,065 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Diethylnitrosamine results in increased expression of ADAMTS1 mRNA CTD PMID:12771043 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADAMTS2 mRNA CTD PMID:22129741 NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483 		JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 decreases expression ISO Diethylnitrosamine results in decreased expression of ADAMTS9 mRNA CTD PMID:21527772 NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876 		JBrowse link
G Adamtsl4 ADAMTS-like 4 multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADAMTSL4 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ADAMTSL4 mRNA 		CTD PMID:17602206 PMID:24535843 NCBI chr 2:185,924,582...185,936,039
Ensembl chr 2:185,924,594...185,935,796 		JBrowse link
G Adcy2 adenylate cyclase 2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ADCY2 mRNA CTD PMID:20360939 NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645 		JBrowse link
G Adcy3 adenylate cyclase 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ADCY3 mRNA CTD PMID:18164116 NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:32,843,961...32,923,173 		JBrowse link
G Adcy8 adenylate cyclase 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADCY8 mRNA CTD PMID:18164116 NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038 		JBrowse link
G Adgrb2 adhesion G protein-coupled receptor B2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB2 mRNA CTD PMID:22129741 NCBI chr 5:147,581,573...147,646,726
Ensembl chr 5:147,611,580...147,646,726 		JBrowse link
G Adgrb3 adhesion G protein-coupled receptor B3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB3 mRNA CTD PMID:22129741 NCBI chr 9:34,917,474...35,645,350
Ensembl chr 9:34,917,474...35,644,811 		JBrowse link
G Adgrg1 adhesion G protein-coupled receptor G1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ADGRG1 mRNA CTD PMID:18164116 NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124 		JBrowse link
G Adgrg2 adhesion G protein-coupled receptor G2 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ADGRG2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG2 mRNA
Diethylnitrosamine results in decreased expression of ADGRG2 mRNA 		CTD PMID:18164116 PMID:20360939 PMID:22129741 NCBI chr  X:38,106,067...38,231,286
Ensembl chr  X:38,106,067...38,231,331 		JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG6 mRNA CTD PMID:22129741 NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023 		JBrowse link
G Adgrv1 adhesion G protein-coupled receptor V1 decreases expression ISO Diethylnitrosamine results in decreased expression of ADGRV1 mRNA CTD PMID:24535843 NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:13,067,150...13,647,372 		JBrowse link
G Adh1c alcohol dehydrogenase 1C (class I), gamma polypeptide multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADH1 mRNA CTD PMID:17602206 NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide decreases expression ISO
EXP 		Diethylnitrosamine results in decreased expression of ADH4 mRNA CTD PMID:19638242 PMID:21527772 PMID:24535843 NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879 		JBrowse link
G Adh6 alcohol dehydrogenase 6 (class V) decreases expression ISO Diethylnitrosamine results in decreased expression of ADH6 mRNA CTD PMID:21527772 NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:229,576,636...229,607,914 		JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide decreases expression EXP Diethylnitrosamine results in decreased expression of ADH7 mRNA CTD PMID:19638242 NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:229,421,252...229,436,691 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of ADHFE1 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADHFE1 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835 		JBrowse link
G Adi1 acireductone dioxygenase 1 decreases expression EXP Diethylnitrosamine results in decreased expression of ADI1 mRNA CTD PMID:19041683 NCBI chr 6:51,035,267...51,042,229
Ensembl chr 6:51,034,931...51,042,855 		JBrowse link
G Adk adenosine kinase decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of ADK mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADK mRNA 		CTD PMID:17602206 PMID:20360939 NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745 		JBrowse link
G Adra1b adrenoceptor alpha 1B decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of ADRA1B mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADRA1B mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347 		JBrowse link
G Adra1d adrenoceptor alpha 1D multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ADRA1D mRNA CTD PMID:20360939 NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:139,246,323...139,262,331 		JBrowse link
G Adrb3 adrenoceptor beta 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADRB3 mRNA CTD PMID:18164116 NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420 		JBrowse link
G Adsl adenylosuccinate lyase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADSL mRNA CTD PMID:17602206 NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872 		JBrowse link
G Adtrp androgen-dependent TFPI-regulating protein multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADTRP mRNA CTD PMID:28943392 NCBI chr17:23,113,578...23,199,616
Ensembl chr17:23,135,809...23,216,622 		JBrowse link
G Aebp1 AE binding protein 1 increases expression ISO Diethylnitrosamine results in increased expression of AEBP1 mRNA CTD PMID:24535843 NCBI chr14:84,951,577...84,962,840
Ensembl chr14:84,952,822...84,962,843 		JBrowse link
G Aebp2 AE binding protein 2 multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of AEBP2 mRNA] CTD PMID:17854601 NCBI chr 4:175,258,286...175,297,149
Ensembl chr 4:175,258,887...175,326,422 		JBrowse link
G Aen apoptosis enhancing nuclease increases expression ISO Diethylnitrosamine results in increased expression of AEN mRNA CTD PMID:19100860 PMID:21607683 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Afm afamin increases expression
multiple interactions
decreases expression 		ISO
EXP 		Diethylnitrosamine results in increased expression of AFM mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AFM mRNA
Diethylnitrosamine results in decreased expression of AFM mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AFM mRNA] 		CTD PMID:17942915 PMID:19638242 PMID:28943392 NCBI chr14:17,815,194...17,848,042
Ensembl chr14:17,815,194...17,848,039 		JBrowse link
G Afp alpha-fetoprotein decreases expression
increases expression
multiple interactions
affects expression 		ISO
EXP 		Diethylnitrosamine results in decreased expression of AFP mRNA
N-nitrosodiethylamine increases expression of Afp protein in serum in rats
Diethylnitrosamine results in increased expression of AFP mRNA; Diethylnitrosamine results in increased expression of AFP protein
[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Diethylnitrosamine] results in increased expression of AFP mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AFP mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of AFP mRNA; [Phenobarbital co-treated with Pregnenolone Carbonitrile co-treated with Diethylnitrosamine] results in increased expression of AFP mRNA; Diethylnitrosamine promotes the reaction [Carbon Tetrachloride results in increased expression of AFP mRNA]; Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Losartan inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Perindopril inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Sorafenib inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]
Diethylnitrosamine results in increased expression of AFP mRNA; Diethylnitrosamine results in increased expression of AFP protein; Diethylnitrosamine results in increased expression of AFP protein alternative form
1,2,4-triazole analog inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of AFP protein; [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AFP protein; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of AFP protein; alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; alogliptin promotes the reaction [taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]]; brucine inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; carfilzomib inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; citral inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Dahuang Zhechong pill inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; formylchromone analog inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; FR 118487 inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of AFP protein]; Hesperidin inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AFP protein]; piperlongumine inhibits the reaction [[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of AFP protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AFP protein]; Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Rotenone inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]; Silymarin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; taxifolin promotes the reaction [alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]]; thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein alternative form]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]
Diethylnitrosamine affects the expression of AFP mRNA 		CTD
RGD		 PMID:11818250 PMID:15766596 PMID:19394651 PMID:19446540 PMID:19822196 More... RGD:152177911 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agap2 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AGAP2 mRNA CTD PMID:20360939 NCBI chr 7:64,782,618...64,799,624
Ensembl chr 7:64,782,612...64,799,640 		JBrowse link
G Agfg1 ArfGAP with FG repeats 1 increases expression ISO Diethylnitrosamine results in increased expression of AGFG1 mRNA CTD PMID:24535843 NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910 		JBrowse link
G Agmat agmatinase decreases expression ISO Diethylnitrosamine results in decreased expression of AGMAT mRNA CTD PMID:24535843 NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299 		JBrowse link
G Agr3 anterior gradient 3, protein disulphide isomerase family member decreases expression ISO Diethylnitrosamine results in decreased expression of AGR3 mRNA CTD PMID:21527772 NCBI chr 6:58,370,701...58,393,944
Ensembl chr 6:58,370,701...58,399,859 		JBrowse link
G Agt angiotensinogen multiple interactions ISO
EXP 		IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of AGT mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of AGT mRNA]
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of AGT mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AGT mRNA 		CTD PMID:17602206 PMID:18691550 PMID:28943392 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtpbp1 ATP/GTP binding carboxypeptidase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AGTPBP1 mRNA CTD PMID:28943392 NCBI chr17:5,092,108...5,244,414
Ensembl chr17:5,126,146...5,244,420 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of AGTR1A mRNA CTD PMID:17602206 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtrap angiotensin II receptor-associated protein multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of AGTRAP mRNA CTD PMID:17602206 NCBI chr 5:163,790,565...163,802,174
Ensembl chr 5:163,791,887...163,802,174 		JBrowse link
G Agxt alanine--glyoxylate aminotransferase increases expression
decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of AGXT mRNA
Diethylnitrosamine results in decreased expression of AGXT mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AGXT mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AGXT mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of AGXT mRNA; MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AGXT mRNA] 		CTD PMID:17942915 PMID:18164116 PMID:19041683 PMID:24535843 PMID:28943392 NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:101,122,793...101,132,745 		JBrowse link
G Ahcy adenosylhomocysteinase decreases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in decreased expression of AHCY mRNA
[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of AHCY mRNA 		CTD PMID:20360939 PMID:29127188 NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587 		JBrowse link
G Ahnak AHNAK nucleoprotein increases expression EXP Diethylnitrosamine results in increased expression of AHNAK mRNA CTD PMID:19638242 NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675 		JBrowse link
G Ahr aryl hydrocarbon receptor decreases response to substance
increases expression
decreases expression
multiple interactions 		ISO
EXP 		AHR protein results in decreased susceptibility to Diethylnitrosamine
Diethylnitrosamine results in increased expression of AHR mRNA
Diethylnitrosamine results in decreased expression of AHR protein
[Diethylnitrosamine co-treated with Hexachlorobenzene] results in increased expression of AHR protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AHR protein; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of TP53 protein]]
[Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein affects the reaction [Diethylnitrosamine affects the expression of APAF1 mRNA]; AHR protein affects the reaction [Diethylnitrosamine results in increased expression of IL6 protein]; AHR protein affects the reaction [Diethylnitrosamine results in increased expression of TNF mRNA]; AHR protein affects the reaction [Diethylnitrosamine results in increased expression of TNF protein]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of APAF1 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2C mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DNMT1 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of HDAC1 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of MCM7 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of SIRT1 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TRP53 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TRP73 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDC25B mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in increased expression of SERPINE1 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in increased expression of TGFB2 mRNA]; AHR protein promotes the reaction [Diethylnitrosamine results in increased expression of IL6 mRNA]; Diethylnitrosamine promotes the reaction [AHR protein binds to CYP1A1 promoter]
Diethylnitrosamine results in decreased expression of AHR mRNA 		CTD PMID:15459018 PMID:15535986 PMID:18282651 PMID:19690152 PMID:19996281 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AHRR mRNA CTD PMID:18164116 NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Ahsa1 activator of Hsp90 ATPase activity 1 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of AHSA1 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AHSA1 mRNA] 		CTD PMID:17942915 NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:112,644,479...112,655,595 		JBrowse link
G Aifm3 AIF family member 3 decreases expression ISO Diethylnitrosamine results in decreased expression of AIFM3 mRNA CTD PMID:24535843 NCBI chr11:97,009,100...97,030,601
Ensembl chr11:97,008,426...97,023,334 		JBrowse link
G Ajuba ajuba LIM protein increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of AJUBA mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AJUBA mRNA 		CTD PMID:24535843 NCBI chr15:31,989,796...32,000,042
Ensembl chr15:31,989,799...32,000,042 		JBrowse link
G Ak4 adenylate kinase 4 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of AK4 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AK4 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401 		JBrowse link
G Akap8 A-kinase anchoring protein 8 increases expression EXP Diethylnitrosamine results in increased expression of AKAP8 mRNA CTD PMID:20360939 NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900 		JBrowse link
G Akap9 A-kinase anchoring protein 9 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AKAP9 mRNA
Diethylnitrosamine results in increased expression of AKAP9 mRNA 		CTD PMID:19041683 PMID:20360939 NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions
increases response to substance 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of AKR1A1 mRNA
AKR1A1 gene mutant form results in increased susceptibility to Diethylnitrosamine
[AKR1A1 gene mutant form results in increased susceptibility to Diethylnitrosamine] which results in decreased abundance of Ascorbic Acid; AKR1A1 gene mutant form promotes the reaction [Diethylnitrosamine results in decreased abundance of Ascorbic Acid] 		CTD PMID:17602206 PMID:32805337 NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 increases expression EXP
ISO 		Diethylnitrosamine results in increased expression of AKR1B1 mRNA CTD PMID:19638242 PMID:24535843 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 multiple interactions EXP [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA CTD PMID:14656948 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1b15 aldo-keto reductase family 1 member B15 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR1B8 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR1B8 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR1B8 mRNA
Diethylnitrosamine results in increased expression of AKR1B8 mRNA; Diethylnitrosamine results in increased expression of AKR1B8 protein 		CTD PMID:11565795 PMID:18164116 PMID:19638242 PMID:22129741 PMID:28943392 NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349 		JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of AKR1B7 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AKR1B7 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR1B7 mRNA 		CTD PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909 		JBrowse link
G Akr1b8-ps1 aldo-keto reductase family 1, member B8, pseudogene 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR1B8-PS1 mRNA CTD PMID:28943392 NCBI chr 1:240,221,768...240,222,776 JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AKR1C6 mRNA CTD PMID:28943392 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c12 aldo-keto reductase family 1, member C12 multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AKR1C12 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1C12 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR1C12 mRNA CTD PMID:14656948 PMID:16158176 PMID:28943392 NCBI chr17:70,955,288...70,971,412
Ensembl chr17:70,955,294...70,971,431 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AKR1C18 mRNA
Diethylnitrosamine results in increased expression of AKR1C18 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr1c3l1 aldo-keto reductase family 1 member C3-like 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AKR1C3L1 mRNA CTD PMID:28943392 NCBI chr17:70,745,496...70,791,411
Ensembl chr17:70,745,496...70,791,322 		JBrowse link
G Akr1c8 aldo-keto reductase family 1 member C8 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR1CL mRNA CTD PMID:28943392 NCBI chr17:71,091,398...71,117,985
Ensembl chr17:71,083,080...71,117,957 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 decreases expression EXP Diethylnitrosamine results in decreased expression of AKR1D1 mRNA CTD PMID:20360939 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Akr1e2 aldo-keto reductase family 1, member E2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR1E1 mRNA CTD PMID:18164116 NCBI chr17:70,645,835...70,660,366
Ensembl chr17:70,645,869...70,660,360 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 multiple interactions
increases expression
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA; [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA; [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of AKR7A3 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR7A3 mRNA; [ethofenprox co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA; [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA; [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA; Melatonin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of AKR7A3 mRNA]
Diethylnitrosamine results in increased expression of AKR7A3 mRNA
Diethylnitrosamine results in decreased expression of AKR7A3 mRNA 		CTD PMID:11323195 PMID:18164116 PMID:18754104 PMID:19638242 PMID:20033131 More... NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases expression
increases phosphorylation 		ISO
EXP 		CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein]; Diethylnitrosamine inhibits the reaction [Cholic Acid results in increased activity of and results in increased phosphorylation of AKT1 protein]
N-nitrosodiethylamine increases expression of Akt1 protein in liver in rats
[Diethylnitrosamine co-treated with N-nitrosomorpholine] results in increased expression of and results in increased phosphorylation of AKT1 protein; [Sorafenib co-treated with Methionine] inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein]; Chloroquine inhibits the reaction [[Diethylnitrosamine co-treated with N-nitrosomorpholine] results in increased expression of and results in increased phosphorylation of AKT1 protein]; Hesperidin inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein]; neferine inhibits the reaction [Diethylnitrosamine results in increased expression of AKT1 mRNA]
Diethylnitrosamine results in increased expression of AKT1; Diethylnitrosamine results in increased expression of AKT1 mRNA 		CTD
RGD		 PMID:17055752 PMID:20583210 PMID:24990399 PMID:27151938 PMID:30423403 More... RGD:152177911 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 increases phosphorylation ISO N-nitrosodiethylamine increases phosphorylation of Akt2 protein in liver RGD PMID:28100771 RGD:127285675 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Alad aminolevulinate dehydratase decreases expression EXP Diethylnitrosamine results in decreased expression of ALAD mRNA CTD PMID:19638242 NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041 		JBrowse link
G Alas2 5'-aminolevulinate synthase 2 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALAS2 mRNA
Diethylnitrosamine results in decreased expression of ALAS2 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr  X:22,890,650...22,914,046
Ensembl chr  X:22,890,689...22,914,043 		JBrowse link
G Alb albumin decreases expression
multiple interactions
increases expression 		EXP Diethylnitrosamine results in decreased expression of ALB mRNA; Diethylnitrosamine results in decreased expression of ALB protein
[Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of ALB protein; piperlongumine inhibits the reaction [[Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of ALB protein]; Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of ALB protein]
Diethylnitrosamine results in increased expression of ALB mRNA; Diethylnitrosamine results in increased expression of ALB protein 		CTD PMID:20360939 PMID:28804948 PMID:29698782 PMID:35113675 PMID:38369053 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression ISO Diethylnitrosamine results in increased expression of ALCAM mRNA CTD PMID:24535843 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALDH18A1 mRNA
Diethylnitrosamine results in increased expression of ALDH18A1 mRNA 		CTD PMID:17602206 PMID:24535843 NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of ALDH1A1 mRNA
Diethylnitrosamine results in increased expression of ALDH1A1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH1A1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ALDH1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA; [Mastic Resin co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA; [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA 		CTD PMID:17602206 PMID:18977376 PMID:21295105 PMID:21527772 PMID:21813463 More... NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ALDH1A2 mRNA CTD PMID:20360939 NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 multiple interactions EXP [Mastic Resin co-treated with Diethylnitrosamine] results in decreased expression of ALDH1A3 mRNA CTD PMID:18977376 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH1A7 mRNA CTD PMID:22129741 NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:227,627,448...227,672,523 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ALDH1B1 mRNA
Diethylnitrosamine results in increased expression of ALDH1B1 mRNA 		CTD PMID:24535843 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ALDH3A1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH3A1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ALDH3A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH3A1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:22129741 PMID:28943392 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ALDH3A2 mRNA CTD PMID:24535843 NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648 		JBrowse link
G Aldh3b1 aldehyde dehydrogenase 3 family, member B1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH3B1 mRNA CTD PMID:18164116 NCBI chr 1:210,574,545...210,605,188
Ensembl chr 1:210,573,661...210,610,538 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALDOA mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ALDOA mRNA
Diethylnitrosamine results in increased expression of ALDOA mRNA 		CTD PMID:17602206 PMID:19638242 PMID:28943392 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211 		JBrowse link
G Aldob aldolase, fructose-bisphosphate B multiple interactions ISO [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of ALDOB protein CTD PMID:23457121 NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO Diethylnitrosamine results in increased expression of ALOX5 mRNA CTD PMID:24535843 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Alpg alkaline phosphatase, germ cell decreases expression ISO Diethylnitrosamine results in decreased expression of ALPG mRNA CTD PMID:21527772 NCBI chr 9:95,187,995...95,205,127
Ensembl chr 9:95,198,334...95,205,742 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALPL mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALPL mRNA; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; Tocotrienols affects the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein] CTD PMID:15548946 PMID:15554553 PMID:17602206 PMID:18164116 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Alpp alkaline phosphatase, placental multiple interactions
increases activity 		EXP Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased activity of ALPP protein] CTD PMID:15563447 NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of AMACR mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AMACR mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379 		JBrowse link
G Amot angiomotin increases expression ISO Diethylnitrosamine results in increased expression of AMOT mRNA CTD PMID:24535843 NCBI chr  X:113,778,990...113,837,846
Ensembl chr  X:113,781,526...113,837,482 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AMPD3 mRNA
Diethylnitrosamine results in increased expression of AMPD3 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608 		JBrowse link
G Amy1 amylase alpha 1 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of AMY1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AMY1 mRNA
Diethylnitrosamine results in decreased expression of AMY1 mRNA 		CTD PMID:17602206 PMID:19638242 PMID:28943392 NCBI chr 2:204,071,101...204,085,910
Ensembl chr 2:204,071,098...204,086,239 		JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ANAPC5 mRNA] CTD PMID:17854601 NCBI chr12:39,409,519...39,442,518
Ensembl chr12:39,385,399...39,442,762 		JBrowse link
G Ang angiogenin multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ANG mRNA
Diethylnitrosamine results in decreased expression of ANG mRNA 		CTD PMID:17602206 PMID:19638242 PMID:24535843 NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106 		JBrowse link
G Angpt1 angiopoietin 1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ANGPT1 mRNA
Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of ANGPT1 mRNA] 		CTD PMID:17034775 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Angpt2 angiopoietin 2 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ANGPT2 mRNA
Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of ANGPT2 mRNA] 		CTD PMID:17034775 NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239 		JBrowse link
G Angptl2 angiopoietin-like 2 multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ANGPTL2 mRNA] CTD PMID:17854601 NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876 		JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ANGPTL4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANGPTL4 mRNA CTD PMID:17602206 PMID:22129741 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Angptl8 angiopoietin-like 8 decreases expression
increases expression 		ISO Diethylnitrosamine results in decreased expression of ANGPTL8 mRNA
Diethylnitrosamine results in increased expression of ANGPTL8 mRNA 		CTD PMID:21527772 PMID:24535843 NCBI chr 8:28,652,555...28,654,581
Ensembl chr 8:28,652,555...28,654,581 		JBrowse link
G Ankrd17 ankyrin repeat domain 17 multiple interactions
increases expression 		EXP caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of ANKRD17 mRNA] CTD PMID:20360939 NCBI chr14:18,007,342...18,145,980
Ensembl chr14:18,008,859...18,145,980 		JBrowse link
G Ankrd29 ankyrin repeat domain 29 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANKRD29 mRNA CTD PMID:22129741 NCBI chr18:3,711,052...3,768,997
Ensembl chr18:3,711,059...3,769,098 		JBrowse link
G Anln anillin, actin binding protein increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of ANLN mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ANLN mRNA] 		CTD PMID:17854601 PMID:19041683 NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANP32A mRNA CTD PMID:18164116 NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922 		JBrowse link
G Anp32b acidic nuclear phosphoprotein 32 family member B multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ANP32B mRNA CTD PMID:17602206 NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437 		JBrowse link
G Anxa1 annexin A1 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA1 protein; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA1 mRNA
Diethylnitrosamine results in increased expression of ANXA1 mRNA; Diethylnitrosamine results in increased expression of ANXA1 protein 		CTD PMID:18164116 PMID:19638242 PMID:20935162 PMID:28943392 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa2 annexin A2 increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of ANXA2 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA2 mRNA 		CTD PMID:12771043 PMID:19638242 PMID:21813463 PMID:24535843 PMID:28943392 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Anxa3 annexin A3 increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of ANXA3 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA3 mRNA 		CTD PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Anxa5 annexin A5 multiple interactions
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA
Diethylnitrosamine results in increased expression of ANXA5 mRNA; Diethylnitrosamine results in increased expression of ANXA5 protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA5 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA5 protein; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA5 mRNA 		CTD PMID:17917374 PMID:18164116 PMID:19638242 PMID:20935162 PMID:28943392 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Anxa7 annexin A7 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ANXA7 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA7 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891 		JBrowse link
G Anxa8 annexin A8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA8 mRNA CTD PMID:18164116 NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310 		JBrowse link
G Aoc1 amine oxidase, copper containing 1 increases expression EXP Diethylnitrosamine results in increased expression of AOC1 mRNA CTD PMID:19638242 NCBI chr 4:79,143,126...79,162,705
Ensembl chr 4:79,143,126...79,162,704 		JBrowse link
G Aox1 aldehyde oxidase 1 multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AOX1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AOX1 mRNA CTD PMID:14656948 PMID:16158176 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ap1m1 adaptor related protein complex 1 subunit mu 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of AP1M1 gene CTD PMID:23968726 NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462 		JBrowse link
G Ap2b1 adaptor related protein complex 2 subunit beta 1 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of AP2B1 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AP2B1 mRNA] 		CTD PMID:17942915 NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions
affects expression 		ISO
EXP 		AHR protein affects the reaction [Diethylnitrosamine affects the expression of APAF1 mRNA]; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of APAF1 mRNA]
[3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of APAF1 mRNA 		CTD PMID:19996281 PMID:27048571 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in decreased expression of APC mRNA
epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in decreased expression of APC mRNA]; epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in decreased expression of APC protein]; theaflavin inhibits the reaction [Diethylnitrosamine results in decreased expression of APC mRNA]; theaflavin inhibits the reaction [Diethylnitrosamine results in decreased expression of APC protein]
Diethylnitrosamine results in decreased expression of APC mRNA; Diethylnitrosamine results in decreased expression of APC protein 		CTD PMID:20360939 PMID:27058323 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apcs amyloid P component, serum multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of APCS mRNA CTD PMID:18164116 NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824 		JBrowse link
G Apeg3 antisense paternally expressed gene 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of APEG3 mRNA CTD PMID:22129741 NCBI chr 1:76,154,484...76,155,415
Ensembl chr 1:76,154,982...76,155,263 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APEX1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of APEX1 mRNA
Diethylnitrosamine results in decreased expression of APEX1 mRNA 		CTD PMID:11323195 PMID:17602206 PMID:18253720 PMID:18775883 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Aph1b aph-1 homolog B, gamma secretase subunit increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of APH1B mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APH1B mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of APH1B mRNA 		CTD PMID:17602206 PMID:19638242 PMID:22129741 PMID:24535843 NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:76,310,380...76,331,428 		JBrowse link
G Apln apelin multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of APLN mRNA
Diethylnitrosamine results in increased expression of APLN mRNA 		CTD PMID:18164116 PMID:19041683 NCBI chr  X:132,058,739...132,091,518
Ensembl chr  X:132,081,759...132,091,246 		JBrowse link
G Aplnr apelin receptor increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of APLNR mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of APLNR mRNA 		CTD PMID:24535843 NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908 		JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions EXP [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOA1 protein CTD PMID:20935162 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa2 apolipoprotein A2 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of APOA2 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of APOA2 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410 		JBrowse link
G Apoa4 apolipoprotein A4 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of APOA4 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of APOA4 mRNA
Diethylnitrosamine results in increased expression of APOA4 mRNA 		CTD PMID:18164116 PMID:24535843 PMID:28943392 NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164 		JBrowse link
G Apoc2 apolipoprotein C2 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of APOC2 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of APOC2 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 1:88,457,397...88,462,365
Ensembl chr 1:88,457,396...88,463,438 		JBrowse link
G Apoc3 apolipoprotein C3 decreases expression ISO Diethylnitrosamine results in decreased expression of APOC3 mRNA CTD PMID:21527772 NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679 		JBrowse link
G Apoe apolipoprotein E multiple interactions EXP [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOE protein CTD PMID:20935162 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Apof apolipoprotein F multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of APOF mRNA CTD PMID:28943392 NCBI chr 7:1,285,222...1,286,659
Ensembl chr 7:1,285,222...1,286,659 		JBrowse link
G Apol2 apolipoprotein L2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APOL3 mRNA CTD PMID:17602206 NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:111,211,893...111,217,223 		JBrowse link
G Apol9a apolipoprotein L9a increases expression EXP Diethylnitrosamine results in increased expression of APOL9A mRNA CTD PMID:19638242 NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213 		JBrowse link
G Apom apolipoprotein M multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of APOM mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of APOM mRNA
Diethylnitrosamine results in increased expression of APOM mRNA
Diethylnitrosamine results in decreased expression of APOM mRNA 		CTD PMID:18164116 PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218 		JBrowse link
G Apon apolipoprotein N multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of APON mRNA CTD PMID:28943392 NCBI chr 7:1,271,514...1,272,917
Ensembl chr 7:1,271,515...1,272,917 		JBrowse link
G App amyloid beta precursor protein increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of APP mRNA; Diethylnitrosamine results in increased expression of APP protein
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APP mRNA 		CTD PMID:17602206 PMID:19542621 PMID:19638242 PMID:20387270 PMID:24535843 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aprt adenine phosphoribosyl transferase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APRT mRNA CTD PMID:17602206 NCBI chr19:67,534,737...67,537,027 JBrowse link
G Aqp1 aquaporin 1 increases expression EXP Diethylnitrosamine results in increased expression of AQP1 mRNA CTD PMID:19638242 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp4 aquaporin 4 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of AQP4 mRNA CTD PMID:24535843 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Aqp7 aquaporin 7 increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of AQP7 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AQP7 mRNA 		CTD PMID:19638242 PMID:24535843 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Aqp9 aquaporin 9 decreases expression EXP Diethylnitrosamine results in decreased expression of AQP9 mRNA CTD PMID:19638242 NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240 		JBrowse link
G Arap1 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ARAP1 gene CTD PMID:23968726 NCBI chr 1:165,160,701...165,226,219
Ensembl chr 1:165,160,678...165,226,218 		JBrowse link
G Arfip1 ARF interacting protein 1 increases expression EXP Diethylnitrosamine results in increased expression of ARFIP1 mRNA CTD PMID:20360939 NCBI chr 2:172,141,862...172,224,464
Ensembl chr 2:172,141,859...172,221,280 		JBrowse link
G Arg1 arginase 1 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ARG1 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARG1 mRNA] 		CTD PMID:17942915 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713 		JBrowse link
G Arg2 arginase 2 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ARG2 mRNA CTD PMID:24535843 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arhgap19 Rho GTPase activating protein 19 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ARHGAP19 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP19 mRNA] 		CTD PMID:17942915 NCBI chr 1:250,519,703...250,566,705
Ensembl chr 1:250,530,214...250,580,190 		JBrowse link
G Arhgap22 Rho GTPase activating protein 22 increases expression ISO Diethylnitrosamine results in increased expression of ARHGAP22 mRNA CTD PMID:24535843 NCBI chr16:8,480,222...8,637,823
Ensembl chr16:8,479,956...8,637,822 		JBrowse link
G Arhgap24 Rho GTPase activating protein 24 increases expression EXP Diethylnitrosamine results in increased expression of ARHGAP24 mRNA CTD PMID:19638242 NCBI chr14:7,105,200...7,488,437
Ensembl chr14:7,105,200...7,528,950 		JBrowse link
G Arhgap29 Rho GTPase activating protein 29 increases expression ISO Diethylnitrosamine results in increased expression of ARHGAP29 mRNA CTD PMID:21527772 NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ARHGAP5 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP5 mRNA] 		CTD PMID:17942915 NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636 		JBrowse link
G Arhgef19 Rho guanine nucleotide exchange factor 19 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ARHGEF19 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGEF19 mRNA] 		CTD PMID:17942915 NCBI chr 5:158,818,840...158,837,196
Ensembl chr 5:158,818,932...158,837,196 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA CTD PMID:18164116 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646 		JBrowse link
G Arhgef37 Rho guanine nucleotide exchange factor 37 decreases expression ISO Diethylnitrosamine results in decreased expression of ARHGEF37 mRNA CTD PMID:24535843 NCBI chr18:57,205,621...57,271,284
Ensembl chr18:57,230,117...57,271,031 		JBrowse link
G Arl13a ARF like GTPase 13A multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARL13A mRNA CTD PMID:22129741 NCBI chr  X:101,673,637...101,699,986
Ensembl chr  X:101,673,652...101,699,984 		JBrowse link
G Arl3 ARF like GTPase 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ARL3 mRNA CTD PMID:18164116 NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279 		JBrowse link
G Arl5a ARF like GTPase 5A increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ARL5A mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARL5A mRNA] 		CTD PMID:17942915 NCBI chr 3:57,287,599...57,312,488
Ensembl chr 3:57,289,846...57,312,488 		JBrowse link
G Armcx1 armadillo repeat containing, X-linked 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ARMCX1 mRNA CTD PMID:22129741 NCBI chr  X:102,192,225...102,196,130
Ensembl chr  X:102,192,015...102,199,115 		JBrowse link
G Armcx3 armadillo repeat containing, X-linked 3 increases expression ISO Diethylnitrosamine results in increased expression of ARMCX3 mRNA CTD PMID:24535843 NCBI chr  X:102,230,464...102,234,017
Ensembl chr  X:102,219,848...102,263,297 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of ARNT mRNA; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of ARNT mRNA] CTD PMID:19182440 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B increases expression ISO Diethylnitrosamine results in increased expression of ARPC1B mRNA CTD PMID:24535843 NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504 		JBrowse link
G Arrb1 arrestin, beta 1 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of ARRB1 mRNA
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ARRB1 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB1 mRNA] 		CTD PMID:17942915 PMID:20360939 NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:163,250,157...163,340,859 		JBrowse link
G Arrb2 arrestin, beta 2 multiple interactions
increases expression 		EXP chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 protein]; Plant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 protein]
Diethylnitrosamine results in increased expression of ARRB2 mRNA; Diethylnitrosamine results in increased expression of ARRB2 protein 		CTD PMID:21167192 PMID:22393308 NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487 		JBrowse link
G Arrdc2 arrestin domain containing 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARRDC2 mRNA CTD PMID:18164116 NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158 		JBrowse link
G Arrdc3 arrestin domain containing 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARRDC3 mRNA CTD PMID:22129741 NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875 		JBrowse link
G Arsb arylsulfatase B multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ARSB gene CTD PMID:23968726 NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611 		JBrowse link
G Art1 ADP-ribosyltransferase 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ART1 gene CTD PMID:23968726 NCBI chr 1:165,890,032...165,899,154
Ensembl chr 1:165,890,086...165,899,146 		JBrowse link
G As3mt arsenite methyltransferase multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of AS3MT mRNA CTD PMID:24535843 NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression EXP Diethylnitrosamine results in increased expression of ASAH1 mRNA CTD PMID:19638242 NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305 		JBrowse link
G Asb10 ankyrin repeat and SOCS box-containing 10 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ASB10 mRNA CTD PMID:22129741 NCBI chr 4:11,522,531...11,531,946
Ensembl chr 4:11,522,887...11,531,505 		JBrowse link
G Asb14 ankyrin repeat and SOCS box-containing 14 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ASB14 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASB14 mRNA] 		CTD PMID:17942915 NCBI chr16:2,102,303...2,131,379
Ensembl chr16:2,102,363...2,130,590 		JBrowse link
G Asb5 ankyrin repeat and SOCS box-containing 5 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ASB5 mRNA CTD PMID:22129741 NCBI chr16:43,970,940...44,038,318
Ensembl chr16:43,970,940...44,010,437 		JBrowse link
G Asf1b anti-silencing function 1B histone chaperone increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ASF1B mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASF1B mRNA] 		CTD PMID:17854601 NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352 		JBrowse link
G Asic5 acid sensing ion channel subunit family member 5 decreases expression ISO Diethylnitrosamine results in decreased expression of ASIC5 mRNA CTD PMID:24535843 NCBI chr 2:169,606,059...169,634,885
Ensembl chr 2:169,606,059...169,634,885 		JBrowse link
G Asip agouti signaling protein increases response to substance ISO A protein results in increased susceptibility to Diethylnitrosamine CTD PMID:15175105 NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of ASNS mRNA
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASNS mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASNS mRNA] 		CTD PMID:17942915 PMID:19638242 PMID:22129741 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspg asparaginase multiple interactions ISO
EXP 		[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ASPG mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ASPG mRNA 		CTD PMID:24535843 PMID:28943392 NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417 		JBrowse link
G Aspm assembly factor for spindle microtubules multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ASPM mRNA CTD PMID:24535843 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Asrgl1 asparaginase and isoaspartyl peptidase 1 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ASRGL1 mRNA
Diethylnitrosamine results in decreased expression of ASRGL1 mRNA 		CTD PMID:17602206 PMID:19638242 NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198 		JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ASS1 protein
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ASS1 mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of ASS1 protein 		CTD PMID:20935162 PMID:28943392 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627 		JBrowse link
G Astl astacin like metalloendopeptidase multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASTL mRNA CTD PMID:22129741 NCBI chr 3:135,016,444...135,032,177
Ensembl chr 3:135,016,444...135,032,177 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ATAD1 mRNA CTD PMID:28943392 NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822 		JBrowse link
G Atf2 activating transcription factor 2 multiple interactions ISO [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ATF2 mRNA CTD PMID:19690152 NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ATF3 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ATF3 mRNA CTD PMID:18978307 PMID:19690152 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATF4 mRNA CTD PMID:17602206 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf5 activating transcription factor 5 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATF5 mRNA CTD PMID:17602206 NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183 		JBrowse link
G Atic 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATIC mRNA CTD PMID:17602206 NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756 		JBrowse link
G Atl2 atlastin GTPase 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATL2 mRNA CTD PMID:17602206 NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320 		JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
decreases expression
decreases activity
increases phosphorylation
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ATM mRNA; ATM protein inhibits the reaction [Diethylnitrosamine results in increased cleavage of and results in increased activity of CASP3 protein]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR mRNA]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR protein]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDKN2A protein]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 mRNA]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 protein]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRP53 protein]; ATM protein promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; ATM protein promotes the reaction [Diethylnitrosamine results in increased expression of TERT protein]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATM mRNA]; XRCC6 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of ATM protein]
Diethylnitrosamine results in decreased expression of ATM protein
Diethylnitrosamine results in decreased activity of ATM protein
ATM protein affects the reaction [Diethylnitrosamine results in increased expression of TP53 protein] 		CTD PMID:11751435 PMID:17854601 PMID:17917374 PMID:18506893 PMID:19919837 NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ATOX1 mRNA
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of ATOX1 mRNA] 		CTD PMID:20360939 NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585 		JBrowse link
G Atp11c ATPase phospholipid transporting 11C multiple interactions
increases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATP11C mRNA] CTD PMID:17942915 NCBI chr  X:143,600,763...143,788,407
Ensembl chr  X:143,600,767...143,788,432 		JBrowse link
G Atp13a1 ATPase 13A1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP13A1 mRNA CTD PMID:17602206 NCBI chr16:19,649,065...19,665,126
Ensembl chr16:19,649,066...19,665,120 		JBrowse link
G Atp13a4 ATPase 13A4 decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of ATP13A4 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ATP13A4 mRNA] 		CTD PMID:17942915 NCBI chr11:84,727,014...84,864,747
Ensembl chr11:84,731,041...84,864,747 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP1A1 mRNA CTD PMID:17602206 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp1a4 ATPase Na+/K+ transporting subunit alpha 4 decreases expression EXP Diethylnitrosamine results in decreased expression of ATP1A4 mRNA CTD PMID:20360939 NCBI chr13:87,216,139...87,252,155
Ensembl chr13:87,216,139...87,251,724 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP1B1 mRNA
Diethylnitrosamine results in increased expression of ATP1B1 mRNA 		CTD PMID:17602206 PMID:19638242 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549 		JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 decreases expression EXP Diethylnitrosamine results in decreased expression of ATP1B3 mRNA CTD PMID:11323195 NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 multiple interactions
decreases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ATP2A1 mRNA] CTD PMID:17942915 NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423 		JBrowse link
G Atp2b2 ATPase plasma membrane Ca2+ transporting 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP2B2 mRNA CTD PMID:18164116 NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:148,450,207...148,696,239 		JBrowse link
G Atp2c1 ATPase secretory pathway Ca2+ transporting 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP2C1 mRNA CTD PMID:17602206 NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein; [Diethylnitrosamine co-treated with Methapyrilene] results in decreased expression of ATP5F1B protein; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ATP5F1B protein CTD PMID:28903497 NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462 		JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ATP5IF1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ATP5IF1 promoter; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ATP5IF1 mRNA
Diethylnitrosamine results in increased expression of ATP5IF1 mRNA 		CTD PMID:19638242 PMID:25374375 PMID:28943392 NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677 		JBrowse link
G Atp5po ATP synthase peripheral stalk subunit OSCP multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP5PO mRNA
Diethylnitrosamine results in decreased expression of ATP5PO mRNA 		CTD PMID:17602206 PMID:20360939 NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520 		JBrowse link
G Atp6v0d2 ATPase H+ transporting V0 subunit D2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA CTD PMID:22129741 NCBI chr 5:38,133,151...38,182,245
Ensembl chr 5:38,133,158...38,182,245 		JBrowse link
G Atp6v0e2 ATPase, H+ transporting V0 subunit e2 increases expression EXP Diethylnitrosamine results in increased expression of ATP6V0E2 mRNA CTD PMID:19638242 NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680 		JBrowse link
G Atp6v1c2 ATPase H+ transporting V1 subunit C2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1C2 mRNA CTD PMID:17602206 NCBI chr 6:45,809,269...45,872,914
Ensembl chr 6:45,809,271...45,848,747 		JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA CTD PMID:17602206 NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346 		JBrowse link
G Atp7b ATPase copper transporting beta affects response to substance EXP ATP7B protein affects the susceptibility to Diethylnitrosamine CTD PMID:11509115 NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801 		JBrowse link
G Atp8b2 ATPase phospholipid transporting 8B2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ATP8B2 mRNA CTD PMID:22129741 NCBI chr 2:177,676,205...177,699,575
Ensembl chr 2:177,676,208...177,699,575 		JBrowse link
G Atp8b3 ATPase phospholipid transporting 8B3 increases expression ISO Diethylnitrosamine results in increased expression of ATP8B3 mRNA CTD PMID:21527772 NCBI chr 7:9,823,496...9,846,137
Ensembl chr 7:9,826,275...9,846,195 		JBrowse link
G Atp8b4 ATPase phospholipid transporting 8B4 (putative) multiple interactions
decreases expression
increases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATP8B4 mRNA]
Diethylnitrosamine results in decreased expression of ATP8B4 mRNA 		CTD PMID:17942915 PMID:24535843 NCBI chr 3:134,008,367...134,212,394
Ensembl chr 3:134,009,580...134,210,260 		JBrowse link
G Atr ATR serine/threonine kinase multiple interactions
increases expression 		ISO ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR mRNA]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR protein]
Diethylnitrosamine results in increased expression of ATR mRNA; Diethylnitrosamine results in increased expression of ATR protein 		CTD PMID:19919837 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Atrn attractin decreases expression EXP Diethylnitrosamine results in decreased expression of ATRN mRNA CTD PMID:19638242 NCBI chr 3:138,563,271...138,697,360
Ensembl chr 3:138,563,312...138,697,360 		JBrowse link
G Atrnl1 attractin like 1 multiple interactions
decreases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ATRNL1 mRNA
Diethylnitrosamine results in decreased expression of ATRNL1 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ATRNL1 mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 1:266,676,051...267,216,847
Ensembl chr 1:266,675,852...267,216,842 		JBrowse link
G Atxn10 ataxin 10 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ATXN10 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATXN10 mRNA CTD PMID:17602206 PMID:18164116 NCBI chr 7:118,321,516...118,444,967
Ensembl chr 7:118,319,490...118,445,636 		JBrowse link
G Aurka aurora kinase A multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AURKA mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of AURKA mRNA]; XRCC6 protein inhibits the reaction [Diethylnitrosamine results in increased expression of AURKA mRNA] CTD PMID:17854601 PMID:18506893 PMID:24535843 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Aurkb aurora kinase B multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AURKB mRNA CTD PMID:22129741 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G Avil advillin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AVIL mRNA CTD PMID:18164116 NCBI chr 7:64,711,294...64,729,436
Ensembl chr 7:64,711,403...64,729,436 		JBrowse link
G Avpr1a arginine vasopressin receptor 1A decreases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in decreased expression of AVPR1A mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AVPR1A mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of AVPR1A mRNA 		CTD PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837 		JBrowse link
G Axin2 axin 2 multiple interactions ISO [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of AXIN2 mRNA; [Phenobarbital co-treated with Pregnenolone Carbonitrile co-treated with Diethylnitrosamine] results in increased expression of AXIN2 mRNA CTD PMID:33398415 NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575 		JBrowse link
G Axl Axl receptor tyrosine kinase multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AXL mRNA CTD PMID:20360939 NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of AZGP1 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of AZGP1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of AZGP1 promoter; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AZGP1 mRNA 		CTD PMID:19041683 PMID:19638242 PMID:25374375 PMID:28943392 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G B2m beta-2 microglobulin increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of B2M mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of B2M mRNA] 		CTD PMID:17942915 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3galnt1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of B3GALNT1 mRNA
Diethylnitrosamine results in increased expression of B3GALNT1 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr 2:156,157,234...156,187,037
Ensembl chr 2:156,156,265...156,188,404 		JBrowse link
G B3galt5 Beta-1,3-galactosyltransferase 5 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GALT5 mRNA CTD PMID:22129741 NCBI chr11:49,053,959...49,100,398
Ensembl chr11:49,006,560...49,101,283 		JBrowse link
G B3gat1 beta-1,3-glucuronyltransferase 1 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of B3GAT1 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of B3GAT1 mRNA] 		CTD PMID:17942915 NCBI chr 8:33,362,791...33,390,446
Ensembl chr 8:33,363,048...33,390,443 		JBrowse link
G B3gnt9 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GNT9 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of B3GNT9 mRNA CTD PMID:22129741 NCBI chr19:50,039,649...50,042,206
Ensembl chr19:50,030,866...50,043,339 		JBrowse link
G B4galnt1 beta-1,4-N-acetyl-galactosaminyl transferase 1 increases expression ISO Diethylnitrosamine results in increased expression of B4GALNT1 mRNA CTD PMID:21527772 NCBI chr 7:64,873,909...64,881,512
Ensembl chr 7:64,874,022...64,881,516 		JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 increases expression EXP
ISO 		Diethylnitrosamine results in increased expression of B4GALT6 mRNA CTD PMID:19638242 PMID:24535843 NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204 		JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of BAAT mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of BAAT mRNA 		CTD PMID:12771043 PMID:19638242 PMID:28943392 NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
decreases expression 		EXP [3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of BAD mRNA; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD protein]
Diethylnitrosamine results in decreased expression of BAD mRNA; Diethylnitrosamine results in decreased expression of BAD protein 		CTD PMID:27048571 PMID:31129132 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag3 BAG cochaperone 3 decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of BAG3 mRNA
IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of BAG3 mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in decreased expression of BAG3 mRNA] 		CTD PMID:18691550 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Bag4 BAG cochaperone 4 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of BAG4 gene CTD PMID:23968726 NCBI chr16:72,991,407...73,008,620
Ensembl chr16:72,991,362...73,013,273 		JBrowse link
G Bahd1 bromo adjacent homology domain containing 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of BAHD1 gene CTD PMID:23968726 NCBI chr 3:126,341,853...126,368,281
Ensembl chr 3:126,345,371...126,368,278 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions EXP 3,4,5,4'-tetramethoxystilbene inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BAK1 mRNA]; [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BAK1 mRNA CTD PMID:27048571 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Banf1 barrier to autointegration nuclear assembly factor 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BANF1 mRNA CTD PMID:17602206 NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:212,101,523...212,103,552 		JBrowse link
G Barx2 BARX homeobox 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BARX2 mRNA CTD PMID:22129741 NCBI chr 8:38,509,277...38,576,978
Ensembl chr 8:38,509,277...38,576,978 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of BASP1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BASP1 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
decreases expression
increases expression 		EXP
ISO 		[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BAX protein; [5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of BAX protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein; [Diethylnitrosamine co-treated with Cyclohexanols] results in decreased expression of BAX protein; [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of BAX mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BAX mRNA; chrysin promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein]; morin inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]; neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]; Plant Oils inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; Plant Oils inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]; Resveratrol promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; zerumbone promotes the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BAX protein]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]
Diethylnitrosamine results in increased expression of BAX mRNA; Diethylnitrosamine results in increased expression of BAX protein
Diethylnitrosamine results in decreased expression of BAX mRNA; Diethylnitrosamine results in decreased expression of BAX protein
CYP2E1 protein promotes the reaction [Diethylnitrosamine results in increased expression of BAX mRNA]; maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]; Quercetin inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein] 		CTD PMID:11915028 PMID:17393424 PMID:18056438 PMID:19073162 PMID:19100860 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bbc3 Bcl-2 binding component 3 increases expression ISO N-nitrosodiethylamine increases expression of Bbc3 mRNA in liver RGD PMID:28100771 RGD:127285675 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 decreases expression EXP Diethylnitrosamine results in decreased expression of BBOX1 mRNA CTD PMID:19041683 NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064 		JBrowse link
G Bbs7 Bardet-Biedl syndrome 7 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BBS7 mRNA CTD PMID:22129741 NCBI chr 2:121,362,884...121,402,473
Ensembl chr 2:121,362,885...121,402,473 		JBrowse link
G Bcas1 brain enriched myelin associated protein 1 multiple interactions
increases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCAS1 mRNA
Diethylnitrosamine results in increased expression of BCAS1 mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 3:179,554,754...179,637,800
Ensembl chr 3:179,551,704...179,637,743 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BCAT2 mRNA CTD PMID:17602206 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bckdhb branched chain keto acid dehydrogenase E1 subunit beta increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of BCKDHB mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of BCKDHB mRNA] 		CTD PMID:17942915 NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798 		JBrowse link
G Bckdk branched chain ketoacid dehydrogenase kinase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BCKDK mRNA CTD PMID:17602206 NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453 		JBrowse link
G Bcl10 BCL10, immune signaling adaptor increases expression ISO Diethylnitrosamine results in increased expression of BCL10 mRNA CTD PMID:24535843 NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression
decreases response to substance 		ISO
EXP 		BCL2 protein inhibits the reaction [TGFA protein results in increased susceptibility to Diethylnitrosamine]; maculosin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; Quercetin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]
N-nitrosodiethylamine increases expression of Bcl2 mRNA in liver
Diethylnitrosamine results in increased expression of BCL2 mRNA; Diethylnitrosamine results in increased expression of BCL2 protein
[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA; [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; fumagillin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; neferine inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; neferine inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]; Plant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; Plant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; Silymarin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]; Thioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA]; thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; zerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]
BCL2 protein results in decreased susceptibility to Diethylnitrosamine 		CTD
RGD		 PMID:11915028 PMID:12000706 PMID:15682466 PMID:19073162 PMID:19931519 More... RGD:127285675 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
increases expression 		EXP
ISO 		5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein]; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein; [Diethylnitrosamine co-treated with Colchicine] results in decreased expression of BCL2L1 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BCL2L1 protein; [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein]; Plant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; Plant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein]
N-nitrosodiethylamine increases expression of Bcl2l1 mRNA in liver
Diethylnitrosamine results in increased expression of BCL2L1 mRNA; Diethylnitrosamine results in increased expression of BCL2L1 protein 		CTD
RGD		 PMID:11749691 PMID:11915028 PMID:21167192 PMID:21554863 PMID:21607683 More... RGD:127285675 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l11 Bcl2-like 11 increases expression ISO Diethylnitrosamine results in increased expression of BCL2L11 mRNA CTD PMID:24535843 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l14 Bcl2-like 14 increases expression ISO Diethylnitrosamine results in increased expression of BCL2L14 mRNA CTD PMID:24535843 NCBI chr 4:168,948,919...168,989,450
Ensembl chr 4:168,948,946...168,990,079 		JBrowse link
G Bcl2l2 Bcl2-like 2 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA CTD PMID:17917374 NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379 		JBrowse link
G Bcl6 BCL6, transcription repressor multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA CTD PMID:22129741 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bco1 beta-carotene oxygenase 1 increases expression ISO Diethylnitrosamine results in increased expression of BCO1 mRNA CTD PMID:24535843 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917 		JBrowse link
G Bco2 beta-carotene oxygenase 2 decreases expression ISO Diethylnitrosamine results in decreased expression of BCO2 mRNA CTD PMID:24535843 NCBI chr 8:59,778,571...59,803,597
Ensembl chr 8:59,778,575...59,799,168 		JBrowse link
G Bcor BCL6 co-repressor multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of BCOR gene CTD PMID:23968726 NCBI chr  X:13,282,431...13,402,254
Ensembl chr  X:13,360,376...13,402,254 		JBrowse link
G Bcr BCR activator of RhoGEF and GTPase multiple interactions EXP [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of BCR mRNA CTD PMID:18253720 NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333 		JBrowse link
G Bcs1l BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BCS1L mRNA CTD PMID:17602206 NCBI chr 9:83,614,045...83,618,052
Ensembl chr 9:83,613,975...83,618,257 		JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase 1 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of BDH1 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of BDH1 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636 		JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase 2 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BDH2 mRNA
Diethylnitrosamine results in decreased expression of BDH2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BDH2 mRNA 		CTD PMID:17602206 PMID:24535843 NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006 		JBrowse link
G Becn1 beclin 1 multiple interactions EXP [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of BECN1 protein; alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of BECN1 protein]; alogliptin promotes the reaction [taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of BECN1 protein]]; taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of BECN1 protein]; taxifolin promotes the reaction [alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of BECN1 protein]] CTD PMID:33840231 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bend5 BEN domain containing 5 increases expression EXP Diethylnitrosamine results in increased expression of BEND5 mRNA CTD PMID:19638242 NCBI chr 5:131,519,214...131,565,228
Ensembl chr 5:131,519,214...131,762,906 		JBrowse link
G Bex1 brain expressed X-linked 1 increases expression ISO Diethylnitrosamine results in increased expression of BEX2 mRNA CTD PMID:24535843 NCBI chr  X:104,010,639...104,012,143
Ensembl chr  X:104,010,371...104,011,236 		JBrowse link
G Bex2 brain expressed X-linked 2 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of BEX1 mRNA
Diethylnitrosamine promotes the reaction [Carbon Tetrachloride results in increased expression of BEX1 mRNA]
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BEX1 mRNA 		CTD PMID:19638242 PMID:23288052 PMID:24535843 PMID:28943392 NCBI chr  X:103,811,458...103,812,986
Ensembl chr  X:103,808,935...103,812,092 		JBrowse link
G Bex3 brain expressed X-linked 3 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BEX3 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BEX3 mRNA
Diethylnitrosamine results in increased expression of BEX3 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr  X:104,064,896...104,066,425
Ensembl chr  X:104,064,515...104,075,906 		JBrowse link
G Bex4 brain expressed, X-linked 4 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of BEX4 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BEX4 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr  X:103,923,609...103,925,041
Ensembl chr  X:103,923,338...103,925,496 		JBrowse link
G Bgn biglycan multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of BGN mRNA CTD PMID:20360939 NCBI chr  X:156,348,633...156,360,797
Ensembl chr  X:156,348,615...156,360,799 		JBrowse link
G Bhlhe41 basic helix-loop-helix family, member e41 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BHLHE41 mRNA CTD PMID:18164116 NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of BHMT mRNA
[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of BHMT mRNA 		CTD PMID:28943392 PMID:29127188 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715 		JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of BHMT2 mRNA CTD PMID:28943392 NCBI chr 2:26,630,502...26,647,450
Ensembl chr 2:26,630,510...26,651,326 		JBrowse link
G Bicc1 BicC family RNA binding protein 1 increases expression ISO Diethylnitrosamine results in increased expression of BICC1 mRNA CTD PMID:24535843 NCBI chr20:17,448,745...17,685,887
Ensembl chr20:17,448,765...17,685,885 		JBrowse link
G Bid BH3 interacting domain death agonist affects response to substance ISO BID protein affects the susceptibility to Diethylnitrosamine CTD PMID:15904428 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Bik BCL2-interacting killer multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BIK mRNA CTD PMID:24535843 NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions EXP [3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BIRC3 mRNA CTD PMID:27048571 NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of BIRC5 mRNA
Diethylnitrosamine affects the localization of and results in increased expression of BIRC5 protein
Diethylnitrosamine results in increased expression of BIRC5 mRNA; Diethylnitrosamine results in increased expression of BIRC5 protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BIRC5 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BIRC5 mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of BIRC5 mRNA; [Phenobarbital co-treated with Pregnenolone Carbonitrile co-treated with Diethylnitrosamine] results in increased expression of BIRC5 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BIRC5 mRNA] 		CTD PMID:17854601 PMID:18164116 PMID:20514400 PMID:21776270 PMID:24535843 More... NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Blnk B-cell linker multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BLNK mRNA
Diethylnitrosamine results in increased expression of BLNK mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr 1:249,703,064...249,770,533
Ensembl chr 1:249,703,072...249,770,533 		JBrowse link
G Bloc1s2 biogenesis of lysosomal organelles complex-1, subunit 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BLOC1S2 mRNA CTD PMID:17602206 NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:252,973,202...252,980,873 		JBrowse link
G Bltp1 bridge-like lipid transfer protein family member 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BLTP1 mRNA CTD PMID:17602206 NCBI chr 2:121,636,181...121,852,802
Ensembl chr 2:121,636,323...121,852,802 		JBrowse link
G Blvrb biliverdin reductase B multiple interactions ISO [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of BLVRB protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BLVRB mRNA CTD PMID:23457121 PMID:24535843 NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of BMAL1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA CTD PMID:18164116 PMID:22129741 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmal2 basic helix-loop-helix ARNT like 2 increases expression ISO Diethylnitrosamine results in increased expression of BMAL2 mRNA CTD PMID:24535843 NCBI chr 4:181,429,097...181,478,384
Ensembl chr 4:181,430,159...181,478,382 		JBrowse link
G Bmf Bcl2 modifying factor decreases expression ISO Diethylnitrosamine results in decreased expression of BMF mRNA CTD PMID:24535843 NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258 		JBrowse link
G Bmp1 bone morphogenetic protein 1 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BMP1 mRNA
Diethylnitrosamine results in increased expression of BMP1 mRNA 		CTD PMID:17602206 PMID:20360939 NCBI chr15:51,961,310...52,005,597
Ensembl chr15:51,961,310...52,005,485 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BMP2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP2 mRNA 		CTD PMID:17602206 PMID:24535843 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmp2k BMP-2 inducible kinase multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BMP2K mRNA CTD PMID:22129741 NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657 		JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions
decreases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA
Diethylnitrosamine results in decreased expression of BMP5 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bmp7 bone morphogenetic protein 7 increases expression ISO Diethylnitrosamine results in increased expression of BMP7 mRNA CTD PMID:24535843 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bok BCL2 family apoptosis regulator BOK multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BOK mRNA CTD PMID:18164116 NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833 		JBrowse link
G Bphl biphenyl hydrolase like multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BPHL mRNA CTD PMID:17602206 NCBI chr17:31,006,283...31,042,631
Ensembl chr17:31,004,972...31,042,632 		JBrowse link
G Bpifb4 BPI fold containing family B, member 4 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of BPIFB4 gene CTD PMID:23968726 NCBI chr 3:162,881,478...162,908,207
Ensembl chr 3:162,881,437...162,908,207 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase increases mutagenesis ISO Diethylnitrosamine results in increased mutagenesis of BRAF gene CTD PMID:15592514 PMID:25319454 NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931 		JBrowse link
G Brca1 BRCA1, DNA repair associated increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of BRCA1 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA1 mRNA] 		CTD PMID:17854601 NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763 		JBrowse link
G Brca2 BRCA2, DNA repair associated increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of BRCA2 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA2 mRNA] 		CTD PMID:17854601 NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194 		JBrowse link
G Brf1 BRF1 general transcription factor IIIB subunit decreases expression EXP Diethylnitrosamine results in decreased expression of BRF1 protein CTD PMID:37021545 NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386 		JBrowse link
G Bri3 brain protein I3 decreases expression EXP Diethylnitrosamine results in decreased expression of BRI3 mRNA CTD PMID:19638242 NCBI chr12:15,454,673...15,478,319
Ensembl chr12:15,454,673...15,478,319 		JBrowse link
G Brinp3 BMP/retinoic acid inducible neural specific 3 increases expression EXP Diethylnitrosamine results in increased expression of BRINP3 mRNA CTD PMID:20360939 NCBI chr13:60,964,127...61,397,044
Ensembl chr13:60,966,100...61,397,039 		JBrowse link
G Bspry B-box and SPRY domain containing multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BSPRY mRNA CTD PMID:18164116 NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of BST2 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of BST2 mRNA] 		CTD PMID:17942915 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btaf1 B-TFIID TATA-box binding protein associated factor 1 increases expression EXP Diethylnitrosamine results in increased expression of BTAF1 mRNA CTD PMID:19041683 NCBI chr 1:244,065,728...244,156,457
Ensembl chr 1:244,065,743...244,156,457 		JBrowse link
G Btf3 basic transcription factor 3 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BTF3 mRNA CTD PMID:17602206 NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125
Ensembl chr13:31,394,011...31,401,125 		JBrowse link
G Btf3l4 basic transcription factor 3-like 4 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BTF3L4 mRNA CTD PMID:22129741 NCBI chr 5:128,796,594...128,816,219
Ensembl chr 5:128,796,594...128,816,602 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 decreases response to substance
increases expression
decreases expression
multiple interactions 		ISO
EXP 		BTG2 protein results in decreased susceptibility to Diethylnitrosamine
Diethylnitrosamine results in increased expression of BTG2 mRNA
Diethylnitrosamine results in decreased expression of BTG2 mRNA
Diethylnitrosamine affects the localization of and results in increased expression of BTG2 protein 		CTD PMID:18393292 PMID:19100860 PMID:19254457 PMID:19638242 PMID:21607683 More... NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BTG3 mRNA CTD PMID:18164116 NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082 		JBrowse link
G Btn1a1 butyrophilin, subfamily 1, member A1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BTN1A1 mRNA CTD PMID:22129741 NCBI chr17:42,080,217...42,092,286
Ensembl chr17:42,081,527...42,092,276 		JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BUB1 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BUB1 mRNA] CTD PMID:17854601 PMID:24535843 NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921 		JBrowse link
G C1galt1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of C1GALT1 mRNA CTD PMID:17602206 NCBI chr 4:36,894,440...36,932,434
Ensembl chr 4:36,894,488...36,932,441 		JBrowse link
G C1qa complement C1q A chain multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of C1QA mRNA CTD PMID:28943392 NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732 		JBrowse link
G C1qb complement C1q B chain multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of C1QB mRNA CTD PMID:28943392 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1qc complement C1q C chain multiple interactions
increases expression 		ISO
EXP 		MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of C1QC mRNA] CTD PMID:17942915 PMID:19638242 NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468 		JBrowse link
G C1qtnf3 C1q and TNF related 3 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of C1QTNF3 gene CTD PMID:23968726 NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559 		JBrowse link
G C1s complement C1s decreases expression EXP Diethylnitrosamine results in decreased expression of C1S mRNA CTD PMID:19638242 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C4b complement C4B decreases expression ISO Diethylnitrosamine results in decreased expression of C4B mRNA CTD PMID:24535843 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289 		JBrowse link
G C4bpb complement component 4 binding protein, beta decreases expression EXP Diethylnitrosamine results in decreased expression of C4BPB mRNA CTD PMID:19638242 NCBI chr13:44,673,064...44,683,781
Ensembl chr13:44,673,065...44,683,793 		JBrowse link
G C5 complement C5 decreases expression EXP Diethylnitrosamine results in decreased expression of C5 mRNA CTD PMID:19638242 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C6 complement C6 decreases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in decreased expression of C6 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of C6 mRNA 		CTD PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120 		JBrowse link
G C7h19orf25 similar to human chromosome 19 open reading frame 25 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of C7H19ORF25 mRNA CTD PMID:17602206 NCBI chr 7:10,040,929...10,043,057
Ensembl chr 7:10,040,893...10,043,042 		JBrowse link
G C8b complement C8 beta chain decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of C8B mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of C8B mRNA 		CTD PMID:24535843 PMID:28943392 NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:124,761,790...124,801,516 		JBrowse link
G C8g complement C8 gamma chain multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of C8G mRNA CTD PMID:28943392 NCBI chr 3:28,718,648...28,720,232 JBrowse link
G C9 complement C9 decreases expression ISO Diethylnitrosamine results in decreased expression of C9 mRNA CTD PMID:12771043 NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:57,300,427...57,348,752 		JBrowse link
G Ca1 carbonic anhydrase 1 decreases expression ISO Diethylnitrosamine results in decreased expression of CAR1 mRNA CTD PMID:24535843 NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454 		JBrowse link
G Ca11 carbonic anhydrase 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAR11 mRNA CTD PMID:18164116 NCBI chr 1:105,306,347...105,311,651
Ensembl chr 1:105,302,289...105,311,832 		JBrowse link
G Ca14 carbonic anhydrase 14 decreases expression ISO Diethylnitrosamine results in decreased expression of CAR14 mRNA CTD PMID:24535843 NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CA3 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CA3 mRNA; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CAR3 mRNA]
Diethylnitrosamine results in decreased expression of CA3 mRNA; Diethylnitrosamine results in decreased expression of CAR3 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:20360939 PMID:28943392 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Ca4 carbonic anhydrase 4 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CAR4 mRNA CTD PMID:20360939 NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916 		JBrowse link
G Ca5a carbonic anhydrase 5A decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of CA5A mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CA5A mRNA
Diethylnitrosamine results in decreased expression of CAR5A mRNA 		CTD PMID:19638242 PMID:21527772 PMID:24535843 PMID:28943392 NCBI chr19:66,881,678...66,911,486
Ensembl chr19:66,881,693...66,911,486 		JBrowse link
G Cab39l calcium binding protein 39-like multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CAB39L mRNA CTD PMID:18164116 NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742 		JBrowse link
G Cables1 Cdk5 and Abl enzyme substrate 1 decreases expression ISO Diethylnitrosamine results in decreased expression of CABLES1 mRNA CTD PMID:21527772 NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956 		JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CACNA1A mRNA CTD PMID:20360939 NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599 		JBrowse link
G Cacna1b calcium voltage-gated channel subunit alpha1 B increases expression ISO Diethylnitrosamine results in increased expression of CACNA1B mRNA CTD PMID:24535843 NCBI chr 3:27,779,133...27,944,292
Ensembl chr 3:27,779,166...27,944,285 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C increases expression ISO Diethylnitrosamine results in increased expression of CACNA1C mRNA CTD PMID:24535843 NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762 		JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA CTD PMID:22129741 NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634 		JBrowse link
G Cacna1h calcium voltage-gated channel subunit alpha1 H multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CACNA1H mRNA CTD PMID:20360939 NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,894,641...14,952,771 		JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CACNA2D1 mRNA CTD PMID:18164116 NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147 		JBrowse link
G Cacnb1 calcium voltage-gated channel auxiliary subunit beta 1 decreases expression EXP Diethylnitrosamine results in decreased expression of CACNB1 mRNA CTD PMID:20360939 NCBI chr10:83,494,509...83,515,164
Ensembl chr10:83,494,509...83,515,146 		JBrowse link
G Cacng5 calcium voltage-gated channel auxiliary subunit gamma 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CACNG5 mRNA CTD PMID:18164116 NCBI chr10:93,327,142...93,369,244
Ensembl chr10:93,327,150...93,336,667 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CAD mRNA CTD PMID:17602206 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297 		JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions
decreases expression
increases methylation 		EXP [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of CADM1 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of CADM1 gene
Diethylnitrosamine results in decreased expression of CADM1 mRNA; Diethylnitrosamine results in decreased expression of CADM1 protein
Diethylnitrosamine results in increased methylation of CADM1 5' UTR 		CTD PMID:17428255 PMID:21163286 NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192 		JBrowse link
G Cadps calcium dependent secretion activator multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CADPS mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of CADPS promoter CTD PMID:25374375 NCBI chr15:14,719,078...15,173,218
Ensembl chr15:14,720,726...15,173,211 		JBrowse link
G Cadps2 calcium dependent secretion activator 2 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CADPS2 mRNA CTD PMID:24535843 NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004 		JBrowse link
G Calcb calcitonin-related polypeptide, beta increases expression ISO Diethylnitrosamine results in increased expression of CALCB mRNA CTD PMID:21527772 NCBI chr 1:178,399,634...178,404,654
Ensembl chr 1:178,399,785...178,404,654 		JBrowse link
G Cald1 caldesmon 1 multiple interactions
increases expression 		EXP Dahuang Zhechong pill inhibits the reaction [Diethylnitrosamine results in increased expression of CALD1 protein]; Sorafenib inhibits the reaction [Diethylnitrosamine results in increased expression of CALD1 protein] CTD PMID:36731809 NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085 		JBrowse link
G Calm2 calmodulin 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALM2 mRNA CTD PMID:17602206 NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657 		JBrowse link
G Calml4 calmodulin-like 4 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CALML4 mRNA
Diethylnitrosamine results in increased expression of CALML4 mRNA 		CTD PMID:24535843 NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650 		JBrowse link
G Calr calreticulin multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALR mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA CTD PMID:17602206 PMID:18544905 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CAMK2A gene CTD PMID:23968726 NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CAMK2D mRNA CTD PMID:20360939 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camkv CaM kinase-like vesicle-associated increases expression ISO Diethylnitrosamine results in increased expression of CAMKV mRNA CTD PMID:21527772 NCBI chr 8:117,505,439...117,519,785
Ensembl chr 8:117,505,408...117,519,797 		JBrowse link
G Capg capping actin protein, gelsolin like multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CAPG gene CTD PMID:23968726 NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672 		JBrowse link
G Capn10 calpain 10 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CAPN10 mRNA CTD PMID:17602206 NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912 		JBrowse link
G Capn8 calpain 8 multiple interactions
decreases expression 		EXP caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CAPN8 mRNA] CTD PMID:20360939 NCBI chr13:96,783,640...96,847,825
Ensembl chr13:96,783,667...96,847,820 		JBrowse link
G Capn9 calpain 9 decreases expression ISO Diethylnitrosamine results in decreased expression of CAPN9 mRNA CTD PMID:21527772 NCBI chr19:69,446,847...69,483,810
Ensembl chr19:69,446,847...69,483,810 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CAPZA2 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CAPZA2 mRNA] 		CTD PMID:17942915 NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938 		JBrowse link
G Car2 carbonic anhydrase 2 increases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in increased expression of CA2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CAR2 mRNA
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CAR2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CAR2 mRNA; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CA2 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CA2 mRNA 		CTD PMID:14656948 PMID:16158176 PMID:18164116 PMID:19638242 PMID:24535843 More... NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Card10 caspase recruitment domain family, member 10 multiple interactions
increases expression 		ISO IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of CARD10 mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CARD10 mRNA] CTD PMID:18691550 NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:112,210,776...112,239,806 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CARS1 gene CTD PMID:23968726 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Cask calcium/calmodulin dependent serine protein kinase increases expression EXP Diethylnitrosamine results in increased expression of CASK mRNA CTD PMID:20360939 NCBI chr  X:11,572,328...11,915,831
Ensembl chr  X:11,572,636...11,911,948 		JBrowse link
G Caskin1 CASK interacting protein 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CASKIN1 gene CTD PMID:23968726 NCBI chr10:14,016,780...14,037,927
Ensembl chr10:14,018,012...14,037,924 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CASP1 mRNA CTD PMID:24535843 NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp12 caspase 12 multiple interactions
increases expression 		EXP
ISO 		[3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP12 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CASP12 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CASP12 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CASP12 mRNA
Diethylnitrosamine results in increased expression of CASP12 mRNA 		CTD PMID:17602206 PMID:23830814 PMID:24535843 PMID:27048571 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression
increases cleavage
increases expression
decreases activity
increases activity 		ISO
EXP 		ATM protein inhibits the reaction [Diethylnitrosamine results in increased cleavage of and results in increased activity of CASP3 protein]; Cholic Acid inhibits the reaction [Diethylnitrosamine results in increased cleavage of CASP3 protein]; CLOCK protein promotes the reaction [Diethylnitrosamine results in increased activity of CASP3 protein]; CYP2E1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 mRNA]; Diethylnitrosamine results in increased cleavage of and results in increased activity of CASP3 protein; eumelanin inhibits the reaction [Diethylnitrosamine results in increased expression of CASP3 protein]; maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; Quercetin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]
Diethylnitrosamine results in decreased expression of CASP3 mRNA; Diethylnitrosamine results in decreased expression of CASP3 protein
Diethylnitrosamine results in increased expression of CASP3 mRNA; Diethylnitrosamine results in increased expression of CASP3 protein
5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 protein]; [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP3 protein; [Diethylnitrosamine co-treated with chrysin] results in increased expression of CASP3 protein; [Diethylnitrosamine co-treated with lanreotide] results in increased activity of CASP3 protein; [Diethylnitrosamine co-treated with thiosalicylic acid] results in increased activity of CASP3 protein; [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP3 protein; [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP3 mRNA; [Sodium Fluoride results in increased abundance of Fluorides] promotes the reaction [Diethylnitrosamine results in increased activity of CASP3 protein]; alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP3 protein]; alogliptin promotes the reaction [taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP3 protein]]; Diethylnitrosamine promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in increased activity of CASP3 protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; formylchromone analog inhibits the reaction [Diethylnitrosamine results in decreased activity of CASP3 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP3 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP3 mRNA]; Hesperidin promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 protein]; morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; Plant Oils inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; Plant Oils inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein modified form]; Polyphenols inhibits the reaction [Diethylnitrosamine results in increased activity of CASP3 protein]; taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP3 protein]; taxifolin promotes the reaction [alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP3 protein]]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]
Diethylnitrosamine results in decreased expression of CASP3 mRNA; Diethylnitrosamine results in decreased expression of CASP3 protein; Diethylnitrosamine results in decreased expression of CASP3 protein modified form 		CTD PMID:18056438 PMID:19427195 PMID:19602430 PMID:19874807 PMID:19919837 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 multiple interactions
increases expression 		EXP
ISO 		3,4,5,4'-tetramethoxystilbene affects the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CASP4 mRNA]; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CASP4 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CASP4 mRNA; [kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA]
Diethylnitrosamine results in increased expression of CASP4 mRNA 		CTD PMID:17602206 PMID:18544905 PMID:24535843 PMID:27048571 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp7 caspase 7 multiple interactions
increases activity 		ISO CLOCK protein promotes the reaction [Diethylnitrosamine results in increased activity of CASP7 protein] CTD PMID:21167249 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 multiple interactions
decreases activity 		EXP
ISO 		[3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP8 mRNA; [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA; [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of CASP8 mRNA; [Diethylnitrosamine co-treated with thiosalicylic acid] results in increased activity of CASP8 protein; [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein; [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA]
S-allylcysteine inhibits the reaction [Diethylnitrosamine results in decreased activity of CASP8 protein] 		CTD PMID:18544905 PMID:19427195 PMID:21907755 PMID:23830814 PMID:27048571 More... NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp8ap2 caspase 8 associated protein 2 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CASP8AP2 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP8AP2 mRNA] 		CTD PMID:17854601 NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632 		JBrowse link
G Casp9 caspase 9 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Diethylnitrosamine results in increased expression of CASP9 mRNA
[3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP9 mRNA; [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP9 protein; [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CASP9 mRNA; [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein; [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA; alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP9 protein]; alogliptin promotes the reaction [taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP9 protein]]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein]; geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA]; morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein]; neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA]; neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein]; taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP9 protein]; taxifolin promotes the reaction [alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CASP9 protein]]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA]; zolmitriptan inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein]
Diethylnitrosamine results in decreased expression of CASP9 mRNA; Diethylnitrosamine results in decreased expression of CASP9 protein
MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP9 mRNA] 		CTD PMID:18691550 PMID:19931519 PMID:21907755 PMID:23830814 PMID:27048571 More... Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase decreases expression
decreases abundance
affects activity
decreases activity
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of CAT mRNA
Diethylnitrosamine results in decreased abundance of CAT protein
Diethylnitrosamine affects the activity of CAT protein
Diethylnitrosamine results in decreased activity of CAT protein
Diethylnitrosamine results in decreased expression of CAT mRNA; Diethylnitrosamine results in decreased expression of CAT protein
[3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CAT mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of CAT protein; [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased activity of CAT protein; [Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of CAT mRNA; [Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in decreased activity of CAT protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CAT mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in decreased activity of CAT protein; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CAT mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CAT protein; [Fenofibrate co-treated with Diethylnitrosamine] results in increased activity of CAT protein; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CAT mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of CAT protein; [Sodium Fluoride results in increased abundance of Fluorides] promotes the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; brucine inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Carnitine inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; citral inhibits the reaction [Diethylnitrosamine results in decreased expression of CAT protein]; Hesperidin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; neferine inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Plant Oils inhibits the reaction [Diethylnitrosamine affects the activity of CAT protein]; Quercetin inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Silymarin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CAT mRNA]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; eumelanin inhibits the reaction [Diethylnitrosamine results in decreased abundance of CAT protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; indoleacetic acid inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; indoleacetic acid inhibits the reaction [Diethylnitrosamine results in decreased expression of CAT mRNA]; maculosin inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] 		CTD PMID:11323195 PMID:16144695 PMID:16188247 PMID:17761372 PMID:18253720 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Catsperd cation channel sperm associated auxiliary subunit delta increases expression ISO Diethylnitrosamine results in increased expression of CATSPERD mRNA CTD PMID:24535843 NCBI chr 9:1,546,903...1,585,470
Ensembl chr 9:1,548,205...1,585,467 		JBrowse link
G Cav1 caveolin 1 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CAV1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA 		CTD PMID:18164116 PMID:21527772 PMID:24535843 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav2 caveolin 2 increases expression ISO Diethylnitrosamine results in increased expression of CAV2 mRNA CTD PMID:24535843 NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425 		JBrowse link
G Cavin2 caveolae associated protein 2 increases expression ISO Diethylnitrosamine results in increased expression of CAVIN2 mRNA CTD PMID:21527772 PMID:24535843 NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:57,794,019...57,806,024 		JBrowse link
G Cavin3 caveolae associated protein 3 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CAVIN3 mRNA
Diethylnitrosamine results in increased expression of CAVIN3 mRNA 		CTD PMID:14656948 PMID:19638242 NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981 		JBrowse link
G Cbarp CACN subunit beta associated regulatory protein multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CBARP gene CTD PMID:23968726 NCBI chr 7:10,217,314...10,225,855
Ensembl chr 7:10,217,328...10,225,854 		JBrowse link
G Cblc Cbl proto-oncogene C multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CBLC mRNA CTD PMID:18164116 NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709 		JBrowse link
G Cbr1 carbonyl reductase 1 increases expression ISO
EXP 		Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:12771043 PMID:19638242 PMID:21607683 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Cbs cystathionine beta synthase multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CBS mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CBS mRNA
Diethylnitrosamine results in decreased expression of CBS mRNA 		CTD PMID:17602206 PMID:19638242 PMID:28943392 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066 		JBrowse link
G Cbx3 chromobox 3 increases expression EXP Diethylnitrosamine results in increased expression of CBX3 mRNA CTD PMID:19638242 NCBI chr 4:81,876,155...81,889,912
Ensembl chr 4:81,876,649...81,889,911 		JBrowse link
G Cbx5 chromobox 5 multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CBX5 mRNA] CTD PMID:17854601 NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118 		JBrowse link
G Cbx6 chromobox 6 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CBX6 mRNA CTD PMID:17602206 NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413 		JBrowse link
G Ccar1 cell division cycle and apoptosis regulator 1 increases expression EXP Diethylnitrosamine results in increased expression of CCAR1 mRNA CTD PMID:19041683 NCBI chr20:31,228,624...31,271,233
Ensembl chr20:31,228,624...31,271,227 		JBrowse link
G Ccdc120 coiled-coil domain containing 120 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CCDC120 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCDC120 mRNA 		CTD PMID:24535843 NCBI chr  X:17,437,219...17,443,716
Ensembl chr  X:17,425,624...17,444,717 		JBrowse link
G Ccdc121 coiled-coil domain containing 121 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCDC121 mRNA CTD PMID:22129741 NCBI chr 6:30,690,831...30,693,437
Ensembl chr 6:30,690,831...30,693,437 		JBrowse link
G Ccdc136 coiled-coil domain containing 136 increases expression ISO Diethylnitrosamine results in increased expression of CCDC136 mRNA CTD PMID:21527772 NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:58,962,908...58,992,975 		JBrowse link
G Ccdc149 coiled-coil domain containing 149 increases expression ISO Diethylnitrosamine results in increased expression of CCDC149 mRNA CTD PMID:24535843 NCBI chr14:62,722,567...62,817,778
Ensembl chr14:62,722,600...62,817,777 		JBrowse link
G Ccdc158 coiled-coil domain containing 158 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCDC158 mRNA CTD PMID:22129741 NCBI chr14:15,695,456...15,752,896
Ensembl chr14:15,695,512...15,752,941 		JBrowse link
G Ccdc162 coiled-coil domain containing 162 decreases expression ISO Diethylnitrosamine results in decreased expression of CCDC162 mRNA CTD PMID:24535843 NCBI chr20:46,627,277...46,820,216
Ensembl chr20:46,627,277...46,818,249 		JBrowse link
G Ccdc33 coiled-coil domain containing 33 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CCDC33 gene CTD PMID:23968726 NCBI chr 8:67,331,519...67,430,194
Ensembl chr 8:67,331,519...67,413,485 		JBrowse link
G Ccdc68 coiled-coil domain containing 68 increases expression ISO Diethylnitrosamine results in increased expression of CCDC68 mRNA CTD PMID:24535843 NCBI chr18:65,817,232...65,859,529
Ensembl chr18:65,786,926...65,859,526 		JBrowse link
G Ccdc80 coiled-coil domain containing 80 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCDC80 mRNA CTD PMID:17602206 NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844 		JBrowse link
G Cckbr cholecystokinin B receptor multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCKBR mRNA CTD PMID:18164116 NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCL11 mRNA CTD PMID:22129741 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression 		EXP [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA; [Iron co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA; Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA]; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA]
Diethylnitrosamine results in increased expression of CCL2 mRNA; Diethylnitrosamine results in increased expression of CCL2 protein 		CTD PMID:20302851 PMID:21295105 PMID:25051504 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl21 C-C motif chemokine ligand 21 multiple interactions
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL21A mRNA
Diethylnitrosamine results in increased expression of CCL21B mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL21B mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CCL21B mRNA 		CTD PMID:17917374 PMID:18164116 PMID:19638242 PMID:28943392 NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 decreases expression EXP Diethylnitrosamine results in decreased expression of CCL28 mRNA CTD PMID:20360939 NCBI chr 2:53,334,071...53,358,709
Ensembl chr 2:53,334,071...53,358,709 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL3 mRNA; CCL3 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 mRNA]; CCL3 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] CTD PMID:16284949 PMID:17917374 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
increases expression
decreases expression 		EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA
Diethylnitrosamine results in increased expression of CCL5 protein
Diethylnitrosamine results in decreased expression of CCL5 protein 		CTD PMID:20360939 PMID:25051504 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CCL6 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCL6 mRNA CTD PMID:17602206 PMID:18164116 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877 		JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCN1 mRNA
[Phenobarbital co-treated with Pregnenolone Carbonitrile co-treated with Diethylnitrosamine] results in increased expression of CCN1 mRNA 		CTD PMID:18164116 PMID:33398415 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCN2 mRNA
[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Diethylnitrosamine] results in increased expression of CCN2 mRNA
Diethylnitrosamine results in increased expression of CCN2 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:21391223 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn3 cellular communication network factor 3 increases expression ISO Diethylnitrosamine results in increased expression of CCN3 mRNA CTD PMID:21527772 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Ccn4 cellular communication network factor 4 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCN4 mRNA CTD PMID:24535843 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCN5 mRNA CTD PMID:18164116 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna2 cyclin A2 multiple interactions
increases expression 		ISO
EXP 		RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNA2 mRNA]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNA2 protein]
Diethylnitrosamine results in increased expression of CCNA2 mRNA; Diethylnitrosamine results in increased expression of CCNA2 protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCNA2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCNA2 mRNA 		CTD PMID:17854601 PMID:18164116 PMID:19638242 PMID:22129741 PMID:24535843 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCNB1 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNB1 mRNA]
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCNB1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CCNB1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CCNB1 protein; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CCNB1 mRNA; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CCNB1 protein; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCNB1 mRNA 		CTD PMID:12616621 PMID:17854601 PMID:18164116 PMID:19996281 PMID:22129741 More... NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 multiple interactions
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCNB2 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNB2 mRNA] CTD PMID:17854601 PMID:24535843 PMID:25242409 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnc cyclin C multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNC mRNA CTD PMID:17917374 NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Cholic Acid] results in increased expression of CCND1 protein; [Diethylnitrosamine co-treated with Dietary Fats] affects the expression of CCND1 mRNA; [Diethylnitrosamine co-treated with Dietary Fats] affects the expression of CCND1 protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CCND1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CCND1 mRNA; ATM protein promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; Losartan inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; Perindopril inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; Sorafenib inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; XRCC6 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]
N-nitrosodiethylamine increases expression of CcnD1 protein in rat liver
N-nitrosodiethylamine increases expression of Ccnd1 protein in liver
Diethylnitrosamine results in increased expression of CCND1 mRNA; Diethylnitrosamine results in increased expression of CCND1 protein
Diethylnitrosamine results in increased expression of CCND1; Diethylnitrosamine results in increased expression of CCND1 mRNA; Diethylnitrosamine results in increased expression of CCND1 protein
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; [Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CCND1 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CCND1 protein; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CCND1 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of CCND1 promoter; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CCND1 mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA]; lycopene inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CCND1 protein]; malachite green promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; metanil yellow promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; Orphenadrine promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; Phenobarbital promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; Plant Extracts inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CCND1 protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 protein] 		CTD
RGD		 PMID:10906429 PMID:11831363 PMID:12175673 PMID:12616621 PMID:14633663 More... RGD:151356973, RGD:127285675 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccndbp1 cyclin D1 binding protein 1 decreases response to substance ISO CCNDBP1 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:16501603 NCBI chr 3:128,416,105...128,427,985
Ensembl chr 3:128,416,054...128,436,008 		JBrowse link
G Ccne1 cyclin E1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA]; malachite green promotes the reaction [Diethylnitrosamine results in increased expression of CCNE1 protein]; metanil yellow promotes the reaction [Diethylnitrosamine results in increased expression of CCNE1 protein]; Phenobarbital promotes the reaction [Diethylnitrosamine results in increased expression of CCNE1 protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of CCNE1 protein]
N-nitrosodiethylamine increases expression of CcnE protein in rat liver
N-nitrosodiethylamine increases expression of Ccne1 mRNA in liver
[Diethylnitrosamine co-treated with Dietary Fats] affects the expression of CCNE1 protein
Diethylnitrosamine results in increased expression of CCNE1 mRNA
Diethylnitrosamine results in increased expression of CCNE1 mRNA; Diethylnitrosamine results in increased expression of CCNE1 protein 		CTD
RGD		 PMID:10906429 PMID:11831363 PMID:14633663 PMID:19254457 PMID:24012840 More... RGD:151356973, RGD:127285675 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccne2 cyclin E2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCNE2 mRNA CTD PMID:22129741 NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882 		JBrowse link
G Ccnf cyclin F increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CCNF mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNF mRNA] 		CTD PMID:17854601 NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837 		JBrowse link
G Ccng1 cyclin G1 multiple interactions
increases expression
affects response to substance 		ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNG1 mRNA
Diethylnitrosamine results in increased expression of CCNG1 mRNA
CCNG1 protein affects the susceptibility to Diethylnitrosamine
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of CCNG1 mRNA 		CTD PMID:12668979 PMID:17602206 PMID:17917374 PMID:18544905 PMID:19100860 More... NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccnh cyclin H increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CCNH mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCNH mRNA
MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNH mRNA] 		CTD PMID:17602206 PMID:18691550 NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 multiple interactions ISO CCR1 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 mRNA]; CCR1 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] CTD PMID:16284949 NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374 		JBrowse link
G Ccr4 C-C motif chemokine receptor 4 increases expression EXP Diethylnitrosamine results in increased expression of CCR4 mRNA CTD PMID:20360939 NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642 		JBrowse link
G Ccs copper chaperone for superoxide dismutase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCS mRNA CTD PMID:17602206 NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCT2 mRNA CTD PMID:17602206 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cct3 chaperonin containing TCP1 subunit 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCT3 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCT3 mRNA CTD PMID:17602206 PMID:18164116 NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925 		JBrowse link
G Cd14 CD14 molecule multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CD14 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CD14 mRNA
Diethylnitrosamine results in increased expression of CD14 mRNA 		CTD PMID:17602206 PMID:20360939 PMID:24535843 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CD151 mRNA CTD PMID:20360939 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd163 CD163 molecule decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of CD163 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CD163 mRNA 		CTD PMID:24535843 NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146 		JBrowse link
G Cd24 CD24 molecule multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD24 mRNA
Diethylnitrosamine results in increased expression of CD24 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd276 Cd276 molecule multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD276 mRNA
Diethylnitrosamine results in increased expression of CD276 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:24535843 NCBI chr 8:67,833,587...67,863,918
Ensembl chr 8:67,829,048...67,864,505 		JBrowse link
G Cd2ap CD2-associated protein increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CD2AP mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CD2AP mRNA 		CTD PMID:24535843 NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968 		JBrowse link
G Cd36 CD36 molecule increases expression EXP
ISO 		Diethylnitrosamine results in increased expression of CD36 mRNA CTD PMID:12771043 PMID:19638242 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd37 CD37 molecule multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CD37 gene CTD PMID:23968726 NCBI chr 1:104,855,622...104,861,111
Ensembl chr 1:104,849,166...104,861,276 		JBrowse link
G Cd38 CD38 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD38 mRNA CTD PMID:18164116 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd4 Cd4 molecule multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD4 mRNA CTD PMID:23830814 NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461 		JBrowse link
G Cd40 CD40 molecule increases expression ISO Diethylnitrosamine results in increased expression of CD40 mRNA CTD PMID:24535843 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd44 CD44 molecule increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CD44 mRNA
epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CD44 protein]; theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CD44 protein] 		CTD PMID:19638242 PMID:21527772 PMID:27058323 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd46 CD46 molecule multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CD46 mRNA CTD PMID:17602206 NCBI chr13:109,104,122...109,134,903 JBrowse link
G Cd47 Cd47 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CD47 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CD47 mRNA CTD PMID:17602206 PMID:18164116 NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272 		JBrowse link
G Cd48 Cd48 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD48 mRNA CTD PMID:18164116 NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942 		JBrowse link
G Cd52 CD52 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD52 mRNA CTD PMID:18164116 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd63 Cd63 molecule multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD63 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD63 mRNA
Diethylnitrosamine results in increased expression of CD63 mRNA 		CTD PMID:12771043 PMID:18164116 PMID:28943392 NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938 		JBrowse link
G Cd68 Cd68 molecule multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD68 mRNA CTD PMID:28943392 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cd74 CD74 molecule increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of CD74 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD74 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd80 Cd80 molecule decreases expression EXP Diethylnitrosamine results in decreased expression of CD80 mRNA CTD PMID:20360939 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd86 CD86 molecule multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CD86 mRNA CTD PMID:20360939 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cd8a CD8 subunit alpha multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CD8A mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD8A mRNA CTD PMID:23830814 NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358 		JBrowse link
G Cd9 CD9 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD9 mRNA CTD PMID:18164116 NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444 		JBrowse link
G Cd93 CD93 molecule increases expression ISO Diethylnitrosamine results in increased expression of CD93 mRNA CTD PMID:24535843 NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537 		JBrowse link
G Cdc20 cell division cycle 20 multiple interactions
increases expression 		ISO
EXP 		RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDC20 mRNA]
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDC20 mRNA 		CTD PMID:17854601 PMID:18164116 PMID:19638242 PMID:21295105 PMID:24535843 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdc25b cell division cycle 25B multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDC25B protein; AHR protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDC25B mRNA]; FOXM1 protein affects the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDC25B protein] CTD PMID:15082532 PMID:19996281 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492 		JBrowse link
G Cdc25c cell division cycle 25C increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CDC25C mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDC25C protein; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDC25C mRNA] 		CTD PMID:15082532 PMID:17854601 NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292 		JBrowse link
G Cdc34 cell division cycle 34, ubiquitin conjugating enzyme multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CDC34 gene CTD PMID:23968726 NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526 		JBrowse link
G Cdc37 cell division cycle 37, HSP90 cochaperone multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 mRNA; [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 protein; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDC37 mRNA CTD PMID:16317707 PMID:17602206 NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931 		JBrowse link
G Cdc42bpa CDC42 binding protein kinase alpha multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDC42BPA mRNA CTD PMID:18164116 NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CDC42BPB gene CTD PMID:23968726 NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570 		JBrowse link
G Cdc45 cell division cycle 45 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CDC45 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDC45 mRNA] 		CTD PMID:17854601 NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981 		JBrowse link
G Cdc5l cell division cycle 5-like increases expression EXP Diethylnitrosamine results in increased expression of CDC5L mRNA CTD PMID:20360939 NCBI chr 9:23,062,397...23,100,901
Ensembl chr 9:23,062,205...23,100,899 		JBrowse link
G Cdc6 cell division cycle 6 multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDC6 mRNA] CTD PMID:17854601 NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241 		JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDCA3 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA3 mRNA] CTD PMID:17854601 PMID:24535843 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068 		JBrowse link
G Cdca5 cell division cycle associated 5 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CDCA5 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA5 mRNA] 		CTD PMID:17854601 NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309 		JBrowse link
G Cdca7 cell division cycle associated 7 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CDCA7 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA7 mRNA] 		CTD PMID:17854601 NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947 		JBrowse link
G Cdca8 cell division cycle associated 8 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CDCA8 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDCA8 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDCA8 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDCA8 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA8 mRNA] 		CTD PMID:17854601 PMID:18164116 PMID:22129741 PMID:24535843 NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283 		JBrowse link
G Cdh1 cadherin 1 increases expression
increases expression
multiple interactions
decreases expression 		ISO Diethylnitrosamine results in increased expression of CDH1 mRNA; Diethylnitrosamine results in increased expression of CDH1 protein
N-nitrosodiethylamine co-treated with atorvastatin increases expression of Cdh1 mRNA in liver
epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in decreased expression of CDH1 mRNA]; theaflavin inhibits the reaction [Diethylnitrosamine results in decreased expression of CDH1 mRNA] 		CTD
RGD		 PMID:24535843 PMID:25319454 PMID:27058323 PMID:25319454 RGD:152995431 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh11 cadherin 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDH11 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDH11 mRNA CTD PMID:18164116 PMID:22129741 NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140 		JBrowse link
G Cdh13 cadherin 13 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDH13 mRNA CTD PMID:18164116 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdh17 cadherin 17 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDH17 mRNA
Diethylnitrosamine results in increased expression of CDH17 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:30,060,090...30,112,226 		JBrowse link
G Cdh2 cadherin 2 multiple interactions EXP [Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of CDH2 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased expression of CDH2 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of CDH2 gene CTD PMID:21163286 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh3 cadherin 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDH3 mRNA CTD PMID:18164116 NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257 		JBrowse link
G Cdh4 cadherin 4 increases expression EXP Diethylnitrosamine results in increased expression of CDH4 mRNA CTD PMID:20360939 NCBI chr 3:186,902,763...187,381,020
Ensembl chr 3:186,902,751...187,381,020 		JBrowse link
G Cdhr2 cadherin-related family member 2 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDHR2 mRNA
Diethylnitrosamine results in increased expression of CDHR2 mRNA 		CTD PMID:24535843 NCBI chr17:9,881,979...9,917,698
Ensembl chr17:9,881,979...9,917,698 		JBrowse link
G Cdhr5 cadherin-related family member 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDHR5 mRNA CTD PMID:18164116 NCBI chr 1:205,802,686...205,811,184
Ensembl chr 1:205,802,686...205,811,093 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CDK1 mRNA; Diethylnitrosamine results in increased expression of CDK1 protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDK1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK1 protein; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CDK1 mRNA; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CDK1 protein
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK1 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDK1 mRNA] 		CTD PMID:12616621 PMID:17854601 PMID:18164116 PMID:19638242 PMID:19887370 More... NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk2 cyclin dependent kinase 2 increases expression
multiple interactions
affects expression 		EXP
ISO 		Diethylnitrosamine results in increased expression of CDK2 protein
Hesperidin inhibits the reaction [Diethylnitrosamine results in increased expression of CDK2 protein]
Diethylnitrosamine affects the expression of CDK2 protein
Diethylnitrosamine results in increased expression of CDK2 mRNA; Diethylnitrosamine results in increased expression of CDK2 protein
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein; CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDK2 mRNA] 		CTD PMID:11831363 PMID:17620307 PMID:17854601 PMID:26589970 PMID:30779474 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk2ap2 cyclin-dependent kinase 2 associated protein 2 multiple interactions
increases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDK2AP2 mRNA] CTD PMID:17942915 NCBI chr 1:210,819,155...210,822,604
Ensembl chr 1:210,820,507...210,823,010 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDK4 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 protein; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CDK4 mRNA; [Diethylnitrosamine co-treated with metanil yellow] results in increased expression of CDK4 protein; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of CDK4 protein] CTD PMID:11831363 PMID:12616621 PMID:17602206 PMID:19822196 PMID:24012840 More... NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 increases expression EXP Diethylnitrosamine results in increased expression of CDK5RAP2 mRNA CTD PMID:19041683 NCBI chr 5:88,807,402...88,976,005
Ensembl chr 5:88,807,402...88,976,069 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDK6 mRNA CTD PMID:22129741 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdkl3 cyclin-dependent kinase-like 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDKL3 mRNA CTD PMID:22129741 NCBI chr10:36,755,413...36,850,197
Ensembl chr10:36,764,377...36,878,660 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Cholic Acid] results in decreased expression of CDKN1A protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A mRNA]; RB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CDKN1A mRNA]; salvianolic acid B inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]; salvianolic acid B inhibits the reaction [SMAD3 protein modified form affects the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]]; SMAD3 protein modified form affects the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]
Diethylnitrosamine results in increased expression of CDKN1A mRNA; Diethylnitrosamine results in increased expression of CDKN1A protein
2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of CDKN1A protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDKN1A mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1A mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDKN1A mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA]; lanreotide promotes the reaction [Diethylnitrosamine results in increased expression of CDKN1A mRNA]; Pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]]; Pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]; pyrazolanthrone promotes the reaction [Diethylnitrosamine results in increased expression of CDKN1A protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]
Diethylnitrosamine results in decreased expression of CDKN1A mRNA; Diethylnitrosamine results in decreased expression of CDKN1A protein 		CTD PMID:11003613 PMID:14633663 PMID:17582756 PMID:17917374 PMID:18164116 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions
decreases expression 		EXP
ISO 		2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]; [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; Pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]]; Pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]
CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein]; CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] 		CTD PMID:17582756 PMID:17602206 PMID:17620307 PMID:18253720 PMID:18544905 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CDKN1C mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDKN1C mRNA] 		CTD PMID:17854601 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions
decreases expression
increases methylation
increases expression 		ISO
EXP 		[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN2A protein; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDKN2A protein]
Diethylnitrosamine results in decreased expression of CDKN2A mRNA
Diethylnitrosamine results in increased methylation of CDKN2A promoter
Diethylnitrosamine results in increased expression of CDKN2A mRNA; Diethylnitrosamine results in increased expression of CDKN2A protein
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA; [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A protein; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN2A mRNA; Betaine promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN2A mRNA]; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2A mRNA] 		CTD PMID:15082532 PMID:16317707 PMID:17602206 PMID:19642983 PMID:19919837 More... NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B decreases expression
increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of CDKN2B mRNA
Diethylnitrosamine results in increased expression of CDKN2B mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA]
IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2B mRNA] 		CTD PMID:18691550 PMID:21295105 PMID:24535843 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN2C mRNA; AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2C mRNA]
Diethylnitrosamine results in increased expression of CDKN2C mRNA
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CDKN2C mRNA 		CTD PMID:18282651 PMID:19996281 PMID:20360939 PMID:24535843 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of CDKN2D mRNA
RB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN2D mRNA] 		CTD PMID:18282651 NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN3 mRNA
Diethylnitrosamine results in increased expression of CDKN3 mRNA 		CTD PMID:24535843 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdo1 cysteine dioxygenase type 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CDO1 mRNA CTD PMID:28943392 NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891 		JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDR2 mRNA CTD PMID:18164116 NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CDT1 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDT1 mRNA] 		CTD PMID:17854601 NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194 		JBrowse link
G Cdx2 caudal type homeo box 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDX2 mRNA CTD PMID:18164116 NCBI chr12:12,762,769...12,769,246
Ensembl chr12:12,762,904...12,769,246 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CEACAM1 mRNA CTD PMID:18164116 NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798 		JBrowse link
G Ceacam20 CEA cell adhesion molecule 20 multiple interactions
increases expression 		EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM20 mRNA; citral inhibits the reaction [Diethylnitrosamine results in increased expression of CEACAM20 protein] CTD PMID:22129741 PMID:32302048 NCBI chr 1:88,750,010...88,771,679
Ensembl chr 1:88,750,000...88,772,779 		JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of CEACAM10 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM10 mRNA CTD PMID:20360939 PMID:22129741 NCBI chr 1:89,504,555...89,510,831
Ensembl chr 1:89,504,555...89,510,831 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression ISO
EXP 		Diethylnitrosamine results in decreased expression of CEBPA mRNA CTD PMID:19638242 PMID:21527772 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta increases expression EXP Diethylnitrosamine results in increased expression of CEBPZ mRNA CTD PMID:19041683 NCBI chr 6:21,872,071...21,889,755
Ensembl chr 6:21,872,025...21,889,749 		JBrowse link
G Cela1 chymotrypsin like elastase 1 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CELA1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CELA1 mRNA
Diethylnitrosamine results in decreased expression of CELA1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:28943392 NCBI chr 7:133,651,939...133,665,136
Ensembl chr 7:133,651,941...133,665,061 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CELSR1 mRNA CTD PMID:18164116 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 increases expression ISO Diethylnitrosamine results in increased expression of CELSR2 mRNA CTD PMID:24535843 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Cenpa centromere protein A multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CENPA mRNA] CTD PMID:17854601 PMID:24535843 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpc centromere protein C increases expression EXP Diethylnitrosamine results in increased expression of CENPC1 mRNA CTD PMID:19041683 NCBI chr14:22,342,910...22,401,522
Ensembl chr14:22,342,927...22,438,590 		JBrowse link
G Cenpf centromere protein F multiple interactions EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CENPF mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CENPF mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cenpi centromere protein I multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CENPI mRNA CTD PMID:18164116 NCBI chr  X:101,809,192...101,860,935
Ensembl chr  X:101,809,659...101,860,934 		JBrowse link
G Cenpk centromere protein K multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CENPK mRNA CTD PMID:22129741 NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488 		JBrowse link
G Cenpl centromere protein L multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CENPL mRNA CTD PMID:24535843 NCBI chr13:75,870,479...75,885,466
Ensembl chr13:75,870,489...75,905,250 		JBrowse link
G Cenpp centromere protein P multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CENPP mRNA CTD PMID:24535843 NCBI chr17:15,220,521...15,395,741
Ensembl chr17:15,220,291...15,395,739 		JBrowse link
G Cep55 centrosomal protein 55 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CEP55 mRNA CTD PMID:24535843 NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890 		JBrowse link
G Cep76 centrosomal protein 76 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA CTD PMID:22129741 NCBI chr18:63,444,389...63,478,358
Ensembl chr18:63,443,746...63,478,358 		JBrowse link
G Cers2 ceramide synthase 2 increases expression EXP Diethylnitrosamine results in increased expression of CERS2 mRNA CTD PMID:20387270 NCBI chr 2:185,579,511...185,587,789
Ensembl chr 2:185,579,119...185,588,839 		JBrowse link
G Cers4 ceramide synthase 4 increases expression EXP Diethylnitrosamine results in increased expression of CERS4 mRNA CTD PMID:20387270 NCBI chr12:7,649,610...7,688,066
Ensembl chr12:7,649,610...7,688,070 		JBrowse link
G Cers6 ceramide synthase 6 increases expression ISO Diethylnitrosamine results in increased expression of LASS6 mRNA CTD PMID:24535843 NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544 		JBrowse link
G Ces1d carboxylesterase 1D multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CES1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CES1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CES1 mRNA
Diethylnitrosamine results in decreased expression of CES1D mRNA
[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of CES1D protein; [3,4,5,3',4'-pentachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of CES1D protein 		CTD PMID:17602206 PMID:18253720 PMID:18544905 PMID:19041683 PMID:23457121 NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449 		JBrowse link
G Ces1e carboxylesterase 1E multiple interactions EXP [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of CES1E protein CTD PMID:20935162 NCBI chr19:30,006,173...30,042,628
Ensembl chr19:30,006,153...30,042,626 		JBrowse link
G Ces2a carboxylesterase 2A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CES2A mRNA CTD PMID:18164116 NCBI chr19:135,885...142,935
Ensembl chr19:135,885...142,935 		JBrowse link
G Ces2c carboxylesterase 2C multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CES2C mRNA CTD PMID:22129741 NCBI chr 1:270,377,201...270,384,768
Ensembl chr 1:270,374,913...270,384,801 		JBrowse link
G Ces2e carboxylesterase 2E increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CES2E mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CES2E mRNA 		CTD PMID:18164116 PMID:21607683 PMID:24535843 NCBI chr19:163,899...179,274
Ensembl chr19:163,859...179,308 		JBrowse link
G Ces2h carboxylesterase 2H increases expression EXP Diethylnitrosamine results in increased expression of CES2 mRNA CTD PMID:21813463 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Cfap45 cilia and flagella associated protein 45 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CFAP45 mRNA CTD PMID:18164116 NCBI chr13:87,521,831...87,545,236
Ensembl chr13:87,521,518...87,545,234 		JBrowse link
G Cfb complement factor B decreases expression EXP Diethylnitrosamine results in decreased expression of CFB mRNA CTD PMID:19638242 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Cfdp1 craniofacial development protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CFDP1 mRNA CTD PMID:18164116 NCBI chr19:56,627,596...56,733,099
Ensembl chr19:56,626,963...56,733,098 		JBrowse link
G Cfh complement factor H decreases expression EXP Diethylnitrosamine results in decreased expression of CFH mRNA CTD PMID:19638242 NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532 		JBrowse link
G Cfhr1 complement factor H-related 1 decreases expression EXP
ISO 		Diethylnitrosamine results in decreased expression of CFHR1 mRNA CTD PMID:19638242 PMID:24535843 NCBI chr13:53,946,298...53,961,282
Ensembl chr13:53,919,927...53,961,303 		JBrowse link
G Cfl1 cofilin 1 increases expression EXP Diethylnitrosamine results in increased expression of CFL1 mRNA CTD PMID:19638242 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cgm4 carcinoembryonic antigen gene family 4 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CGM4 mRNA CTD PMID:20360939 NCBI chr 1:86,904,526...86,917,487
Ensembl chr 1:86,904,526...86,917,475 		JBrowse link
G Cgn cingulin multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CGN gene CTD PMID:23968726 NCBI chr 2:184,997,425...185,024,785
Ensembl chr 2:184,997,425...185,023,635 		JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression ISO Diethylnitrosamine results in increased expression of CGREF1 mRNA CTD PMID:24535843 NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800 		JBrowse link
G Ch25h cholesterol 25-hydroxylase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CH25H mRNA CTD PMID:18164116 NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHAF1B mRNA] CTD PMID:17854601 NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733 		JBrowse link
G Champ1 chromosome alignment maintaining phosphoprotein 1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CHAMP1 gene CTD PMID:23968726 NCBI chr16:82,436,172...82,447,144
Ensembl chr16:82,434,823...82,458,984 		JBrowse link
G Chat choline O-acetyltransferase decreases expression EXP Diethylnitrosamine results in decreased expression of CHAT mRNA CTD PMID:19542621 NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416 		JBrowse link
G Chchd3 coiled-coil-helix-coiled-coil-helix domain containing 3 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHCHD3 mRNA CTD PMID:17602206 NCBI chr 4:62,327,574...62,584,085
Ensembl chr 4:62,327,576...62,584,035 		JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHCHD6 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA CTD PMID:17602206 PMID:22129741 NCBI chr 4:123,360,729...123,581,429
Ensembl chr 4:123,349,187...123,581,421 		JBrowse link
G Chdh choline dehydrogenase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CHDH mRNA CTD PMID:18164116 NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,200,763...5,232,997 		JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions
increases expression 		ISO
EXP 		ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 mRNA]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 protein]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 mRNA]
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK1 mRNA
Diethylnitrosamine results in increased expression of CHEK1 mRNA; Diethylnitrosamine results in increased expression of CHEK1 protein 		CTD PMID:17854601 PMID:19919837 PMID:22129741 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions EXP [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CHEK2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA; [kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA] CTD PMID:18253720 PMID:18544905 PMID:22129741 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Cherp calcium homeostasis endoplasmic reticulum protein multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHERP mRNA CTD PMID:17602206 NCBI chr16:17,401,497...17,414,549
Ensembl chr16:17,401,497...17,414,549 		JBrowse link
G Chka choline kinase alpha multiple interactions
increases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHKA mRNA
Diethylnitrosamine results in increased expression of CHKA mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chmp4c charged multivesicular body protein 4C increases expression ISO Diethylnitrosamine results in increased expression of CHMP4C mRNA CTD PMID:24535843 NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:93,299,157...93,360,850 		JBrowse link
G Chpf chondroitin polymerizing factor multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CHPF mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CHPF mRNA CTD PMID:18164116 PMID:28943392 NCBI chr 9:84,411,824...84,416,523
Ensembl chr 9:84,411,829...84,416,523 		JBrowse link
G Chrdl1 chordin-like 1 increases expression EXP Diethylnitrosamine results in increased expression of CHRDL1 mRNA CTD PMID:19638242 NCBI chr  X:111,685,864...111,789,684
Ensembl chr  X:111,685,866...111,789,661 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHRM2 mRNA CTD PMID:22129741 NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464 		JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CHRNA2 mRNA CTD PMID:20360939 NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit increases expression ISO Diethylnitrosamine results in increased expression of CHRNA4 mRNA CTD PMID:24535843 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit increases expression EXP Diethylnitrosamine results in increased expression of CHRNA7 mRNA CTD PMID:20360939 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858 		JBrowse link
G Chrnb1 cholinergic receptor nicotinic beta 1 subunit multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CHRNB1 mRNA CTD PMID:18164116 NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107 		JBrowse link
G Chrne cholinergic receptor nicotinic epsilon subunit multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of CHRNE mRNA CTD PMID:20360939 NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154 		JBrowse link
G Chst12 carbohydrate sulfotransferase 12 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CHST12 gene CTD PMID:23968726 NCBI chr12:19,224,545...19,243,012
Ensembl chr12:19,220,141...19,243,047 		JBrowse link
G Chst13 carbohydrate sulfotransferase 13 decreases expression ISO Diethylnitrosamine results in decreased expression of CHST13 mRNA CTD PMID:21527772 NCBI chr 4:124,381,226...124,395,143
Ensembl chr 4:124,381,226...124,395,143 		JBrowse link
G Chst14 carbohydrate sulfotransferase 14 multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in decreased methylation of CHST14 promoter; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CHST14 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHST14 mRNA CTD PMID:22129741 PMID:25374375 NCBI chr 3:126,370,348...126,372,405
Ensembl chr 3:126,370,348...126,372,777 		JBrowse link
G Chst4 carbohydrate sulfotransferase 4 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CHST4 mRNA CTD PMID:17917374 NCBI chr19:54,900,914...54,911,735
Ensembl chr19:54,882,719...54,916,648 		JBrowse link
G Chst6 carbohydrate sulfotransferase 6 increases expression ISO Diethylnitrosamine results in increased expression of CHST6 mRNA CTD PMID:21527772 NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306 		JBrowse link
G Chst8 carbohydrate sulfotransferase 8 multiple interactions EXP [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CHST8 mRNA CTD PMID:18253720 NCBI chr 1:96,431,144...96,572,880
Ensembl chr 1:96,431,145...96,572,880 		JBrowse link
G Chsy3 chondroitin sulfate synthase 3 increases expression ISO Diethylnitrosamine results in increased expression of CHSY3 mRNA CTD PMID:24535843 NCBI chr18:54,842,260...55,096,008
Ensembl chr18:54,842,180...55,095,981 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex increases activity ISO Diethylnitrosamine results in increased activity of CHUK protein CTD PMID:15989949 NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273 		JBrowse link
G Cib2 calcium and integrin binding family member 2 decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of CIB2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CIB2 mRNA 		CTD PMID:24535843 NCBI chr 8:63,826,410...63,843,301
Ensembl chr 8:63,826,411...63,843,277 		JBrowse link
G Cib3 calcium and integrin binding family member 3 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CIB3 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CIB3 mRNA] 		CTD PMID:17942915 NCBI chr16:17,656,453...17,665,848
Ensembl chr16:17,656,453...17,665,848 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a multiple interactions
increases expression 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA
Diethylnitrosamine results in increased expression of CIDEA mRNA 		CTD PMID:22129741 PMID:24535843 NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cidec cell death-inducing DFFA-like effector c increases expression ISO Diethylnitrosamine results in increased expression of CIDEC mRNA CTD PMID:24535843 NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806 		JBrowse link
G Cimap1a ciliary microtubule associated protein 1A multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIMAP1A mRNA CTD PMID:22129741 NCBI chr 1:205,355,601...205,358,882
Ensembl chr 1:205,355,675...205,358,882 		JBrowse link
G Cimap1b ciliary microtubule associated protein 1B multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CIMAP1B mRNA CTD PMID:24535843 NCBI chr 7:122,323,860...122,326,921
Ensembl chr 7:122,323,860...122,326,876 		JBrowse link
G Cish cytokine inducible SH2-containing protein multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CISH mRNA CTD PMID:22129741 NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986 		JBrowse link
G Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CITED1 mRNA CTD PMID:28943392 NCBI chr  X:71,390,328...71,395,023
Ensembl chr  X:71,390,331...71,393,649 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CITED2 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CITED2 mRNA
MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CITED2 mRNA] 		CTD PMID:18164116 PMID:18691550 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782 		JBrowse link
G Cited4 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 decreases expression ISO Diethylnitrosamine results in decreased expression of CITED4 mRNA CTD PMID:21527772 NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CKAP2 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKAP2 mRNA] CTD PMID:17854601 PMID:24535843 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CKAP4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CKAP4 mRNA CTD PMID:22129741 PMID:28943392 NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CKS1B mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKS1B mRNA] 		CTD PMID:17854601 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CKS2 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKS2 mRNA] 		CTD PMID:17854601 PMID:25242409 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 increases expression ISO Diethylnitrosamine results in increased expression of CLCF1 mRNA CTD PMID:24535843 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064 		JBrowse link
G Clcn1 chloride voltage-gated channel 1 multiple interactions
increases expression 		EXP caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of CLCN1 mRNA] CTD PMID:20360939 NCBI chr 4:72,138,739...72,168,113
Ensembl chr 4:72,139,162...72,168,128 		JBrowse link
G Clcn2 chloride voltage-gated channel 2 decreases expression ISO Diethylnitrosamine results in decreased expression of CLCN2 mRNA CTD PMID:24535843 NCBI chr11:93,702,382...93,716,059
Ensembl chr11:93,702,360...93,716,059 		JBrowse link
G Clcn5 chloride voltage-gated channel 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLCN5 mRNA CTD PMID:18164116 NCBI chr  X:17,857,260...18,011,844
Ensembl chr  X:17,857,260...18,011,844 		JBrowse link
G Cldn1 claudin 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLDN1 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLDN1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLDN1 mRNA CTD PMID:17602206 PMID:18164116 PMID:22129741 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn15 claudin 15 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CLDN15 gene CTD PMID:23968726 NCBI chr12:25,334,849...25,345,104
Ensembl chr12:25,334,849...25,343,477 		JBrowse link
G Cldn16 claudin 16 increases expression ISO Diethylnitrosamine results in increased expression of CLDN16 mRNA CTD PMID:21527772 NCBI chr11:87,795,106...87,814,396
Ensembl chr11:87,795,106...87,814,396 		JBrowse link
G Cldn7 claudin 7 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CLDN7 mRNA; [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLDN7 mRNA
Diethylnitrosamine results in increased expression of CLDN7 mRNA 		CTD PMID:18164116 PMID:20360939 PMID:24535843 NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905 		JBrowse link
G Clec1b C-type lectin domain family 1, member B decreases expression ISO Diethylnitrosamine results in decreased expression of CLEC1B mRNA CTD PMID:24535843 NCBI chr 4:164,533,987...164,542,320
Ensembl chr 4:164,534,055...164,542,867 		JBrowse link
G Clec4a3 C-type lectin domain family 4, member A3 increases expression EXP Diethylnitrosamine results in increased expression of CLEC4A3 mRNA CTD PMID:19638242 NCBI chr 4:157,885,899...157,896,728
Ensembl chr 4:157,885,895...157,896,727 		JBrowse link
G Clec4f C-type lectin domain family 4, member F decreases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in decreased expression of CLEC4F mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CLEC4F mRNA 		CTD PMID:19041683 PMID:24535843 NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438 		JBrowse link
G Clec9a C-type lectin domain containing 9A multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLEC9A mRNA CTD PMID:22129741 NCBI chr 4:164,546,323...164,561,380
Ensembl chr 4:164,546,311...164,561,380 		JBrowse link
G Clic1 chloride intracellular channel 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CLIC1 mRNA CTD PMID:28943392 NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367 		JBrowse link
G Clic2 chloride intracellular channel 2 increases expression EXP Diethylnitrosamine results in increased expression of CLIC2 mRNA CTD PMID:19638242 NCBI chr20:154,630...169,655
Ensembl chr20:154,255...169,648 		JBrowse link
G Clic5 chloride intracellular channel 5 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLIC5 mRNA CTD PMID:20360939 NCBI chr 9:24,208,455...24,310,964
Ensembl chr 9:24,208,456...24,358,780 		JBrowse link
G Clns1a chloride nucleotide-sensitive channel 1A multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLNS1A mRNA CTD PMID:17602206 NCBI chr 1:161,429,437...161,450,904
Ensembl chr 1:161,421,808...161,450,902 		JBrowse link
G Clock clock circadian regulator multiple interactions
increases response to substance
increases expression 		ISO
EXP 		CLOCK protein promotes the reaction [Diethylnitrosamine results in increased activity of CASP3 protein]; CLOCK protein promotes the reaction [Diethylnitrosamine results in increased activity of CASP7 protein]; CLOCK protein promotes the reaction [Diethylnitrosamine results in increased expression of and results in increased phosphorylation of TRP53 protein]; MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CLOCK mRNA]
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLOCK mRNA
CLOCK protein results in increased susceptibility to Diethylnitrosamine 		CTD PMID:17942915 PMID:20360939 PMID:21167249 NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872 		JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit X multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLPX mRNA CTD PMID:18164116 NCBI chr 8:74,700,602...74,740,244
Ensembl chr 8:74,700,662...74,744,762 		JBrowse link
G Clu clusterin multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CLU mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CLU mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CLU mRNA CTD PMID:14656948 PMID:16158176 PMID:18544905 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Clybl citramalyl-CoA lyase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA CTD PMID:17602206 PMID:18164116 NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345 		JBrowse link
G Cma1 chymase 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CMA1 mRNA CTD PMID:22129741 NCBI chr15:33,387,351...33,390,133
Ensembl chr15:33,387,351...33,390,133 		JBrowse link
G Cmbl carboxymethylenebutenolidase homolog decreases expression ISO Diethylnitrosamine results in decreased expression of CMBL mRNA CTD PMID:24535843 NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880 		JBrowse link
G Cmtm6 CKLF-like MARVEL transmembrane domain containing 6 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the expression of and affects the localization of CMTM6 protein; [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CMTM6 gene CTD PMID:23968726 NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:123,300,918...123,319,230 		JBrowse link
G Cnmd chondromodulin decreases expression ISO Diethylnitrosamine results in decreased expression of CNMD mRNA CTD PMID:24535843 NCBI chr15:61,450,617...61,475,382
Ensembl chr15:61,450,450...61,475,350 		JBrowse link
G Cnn3 calponin 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CNN3 mRNA CTD PMID:18164116 NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815 		JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CNP1 mRNA CTD PMID:18164116 NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063 		JBrowse link
G Cntnap2 contactin associated protein 2 increases expression ISO Diethylnitrosamine results in increased expression of CNTNAP2 mRNA CTD PMID:21527772 NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258 		JBrowse link
G Cobl cordon-bleu WH2 repeat protein increases expression ISO Diethylnitrosamine results in increased expression of COBL mRNA CTD PMID:24535843 NCBI chr14:91,041,721...91,274,272
Ensembl chr14:91,041,721...91,274,257 		JBrowse link
G Col16a1 collagen type XVI alpha 1 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL16A1 mRNA CTD PMID:18164116 NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011 		JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL18A1 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of COL18A1 mRNA
Diethylnitrosamine results in decreased expression of COL18A1 mRNA 		CTD PMID:17602206 PMID:18164116 PMID:19638242 NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of COL1A1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL1A1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of COL1A1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of COL1A1 promoter; [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] affects the expression of COL1A1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COL1A1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:20045035 PMID:21295105 PMID:23830814 More... NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of COL1A2 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COL1A2 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col26a1 collagen type XXVI alpha 1 chain multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of COL26A1 gene CTD PMID:23968726 NCBI chr12:25,429,362...25,575,205
Ensembl chr12:25,429,387...25,575,206 		JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL27A1 mRNA CTD PMID:18164116 NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502 		JBrowse link
G Col3a1 collagen type III alpha 1 chain increases expression EXP Diethylnitrosamine results in increased expression of COL3A1 mRNA CTD PMID:19638242 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL4A1 mRNA
Diethylnitrosamine results in increased expression of COL4A1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:24535843 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain increases expression ISO Diethylnitrosamine results in increased expression of COL4A2 mRNA CTD PMID:12771043 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520 		JBrowse link
G Col4a3 collagen type IV alpha 3 chain increases expression ISO Diethylnitrosamine results in increased expression of COL4A3 mRNA CTD PMID:24535843 NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:91,323,990...91,453,077 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain increases expression ISO Diethylnitrosamine results in increased expression of COL4A4 mRNA CTD PMID:24535843 NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577 		JBrowse link
G Col4a5 collagen type IV alpha 5 chain increases expression ISO Diethylnitrosamine results in increased expression of COL4A5 mRNA CTD PMID:24535843 NCBI chr  X:109,907,251...110,111,214
Ensembl chr  X:109,907,346...110,111,214 		JBrowse link
G Col5a2 collagen type V alpha 2 chain increases expression EXP Diethylnitrosamine results in increased expression of COL5A2 mRNA CTD PMID:19638242 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain multiple interactions
increases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of COL6A1 mRNA] CTD PMID:17942915 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL6A2 mRNA CTD PMID:18164116 NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042 		JBrowse link
G Colec10 collectin subfamily member 10 multiple interactions
decreases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of COLEC10 mRNA
Diethylnitrosamine results in decreased expression of COLEC10 mRNA 		CTD PMID:24535843 NCBI chr 7:87,634,686...87,695,465
Ensembl chr 7:87,634,654...87,699,534 		JBrowse link
G Colec11 collectin sub-family member 11 increases expression ISO Diethylnitrosamine results in increased expression of COLEC11 mRNA CTD PMID:24535843 NCBI chr 6:50,952,357...50,984,845
Ensembl chr 6:50,952,357...50,999,493 		JBrowse link
G Colec12 collectin sub-family member 12 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COLEC12 mRNA CTD PMID:18164116 NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297 		JBrowse link
G Colq collagen like tail subunit of asymmetric acetylcholinesterase multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of COLQ mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA] CTD PMID:22129741 NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501 		JBrowse link
G Commd3 COMM domain containing 3 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of COMMD3 gene CTD PMID:23968726 NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA CTD PMID:18544905 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Coq3 coenzyme Q3 methyltransferase decreases expression EXP Diethylnitrosamine results in decreased expression of COQ3 mRNA CTD PMID:20360939 NCBI chr 5:40,226,313...40,257,383
Ensembl chr 5:40,226,368...40,257,617 		JBrowse link
G Coq6 coenzyme Q6 monooxygenase multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of COQ6 mRNA CTD PMID:16158176 NCBI chr 6:109,738,934...109,750,315
Ensembl chr 6:109,738,951...109,750,310 		JBrowse link
G Coq8a coenzyme Q8A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of COQ8A mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of COQ8A mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of COQ8A mRNA CTD PMID:17602206 PMID:18164116 PMID:28943392 NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378 		JBrowse link
G Coq8b coenzyme Q8B increases expression ISO Diethylnitrosamine results in increased expression of COQ8B mRNA CTD PMID:24535843 NCBI chr 1:91,653,241...91,676,822
Ensembl chr 1:91,654,225...91,676,819 		JBrowse link
G Corin corin, serine peptidase decreases expression ISO Diethylnitrosamine results in decreased expression of CORIN mRNA CTD PMID:24535843 NCBI chr14:36,034,613...36,264,671
Ensembl chr14:36,034,993...36,264,649 		JBrowse link
G Coro1a coronin 1A multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CORO1A mRNA CTD PMID:28943392 NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102 		JBrowse link
G Coro6 coronin 6 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CORO6 mRNA CTD PMID:22129741 NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COTL1 mRNA CTD PMID:28943392 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox4i2 cytochrome c oxidase subunit 4i2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of COX4I2 mRNA CTD PMID:20360939 NCBI chr 3:161,686,193...161,699,605
Ensembl chr 3:161,689,017...161,699,602 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B increases expression ISO Diethylnitrosamine results in increased expression of COX5B mRNA CTD PMID:24535843 NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of COX6A2 mRNA CTD PMID:20360939 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Cox6b2 cytochrome c oxidase subunit 6B2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COX6B2 mRNA CTD PMID:18164116 NCBI chr 1:78,122,871...78,124,096
Ensembl chr 1:78,122,453...78,124,094 		JBrowse link
G Cox6c cytochrome c oxidase subunit 6C increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of COX6C protein
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of COX6C protein 		CTD PMID:20935162 NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166 		JBrowse link
G Cox7a2 cytochrome c oxidase subunit 7A2 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of COX7A2 mRNA; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of COX7A2 mRNA] CTD PMID:17602206 PMID:20360939 NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512
Ensembl chr 8:55,514,261...55,514,512 		JBrowse link
G Cp ceruloplasmin multiple interactions
increases expression
decreases expression 		ISO
EXP 		Diethylnitrosamine results in increased expression of and results in increased activity of CP protein; Iron inhibits the reaction [Diethylnitrosamine results in increased expression of CP protein]
Diethylnitrosamine results in increased expression of CP mRNA
Diethylnitrosamine results in decreased expression of CP mRNA
[Copper co-treated with Diethylnitrosamine] results in increased expression of CP protein 		CTD PMID:19061943 PMID:19638242 PMID:20302851 PMID:24535843 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Cpa1 carboxypeptidase A1 increases expression EXP Diethylnitrosamine results in increased expression of CPA1 mRNA CTD PMID:19638242 NCBI chr 4:60,224,801...60,230,928
Ensembl chr 4:60,224,801...60,230,928 		JBrowse link
G Cpe carboxypeptidase E multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPE mRNA CTD PMID:18164116 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CPEB2 mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPEB2 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CPEB2 mRNA] 		CTD PMID:17602206 PMID:17942915 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cpeb4 cytoplasmic polyadenylation element binding protein 4 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPEB4 mRNA CTD PMID:17602206 NCBI chr10:16,222,271...16,284,248
Ensembl chr10:16,225,672...16,283,787 		JBrowse link
G Cplx1 complexin 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPLX1 mRNA CTD PMID:22129741 NCBI chr14:1,329,073...1,360,781
Ensembl chr14:1,329,032...1,360,769 		JBrowse link
G Cpne8 copine 8 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPNE8 mRNA CTD PMID:17602206 NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060 		JBrowse link
G Cpq carboxypeptidase Q decreases expression EXP Diethylnitrosamine results in decreased expression of CPQ mRNA CTD PMID:19041683 PMID:19638242 NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137 		JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 multiple interactions EXP
ISO 		[Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of CPS1 protein
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CPS1 mRNA 		CTD PMID:20935162 PMID:24535843 NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734 		JBrowse link
G Cpsf3 cleavage and polyadenylation specific factor 3 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPSF3 mRNA CTD PMID:17602206 NCBI chr 6:46,564,855...46,592,776
Ensembl chr 6:46,564,735...46,594,136 		JBrowse link
G Cpt1b carnitine palmitoyltransferase 1B multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA CTD PMID:22129741 NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036 		JBrowse link
G Cpz carboxypeptidase Z multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPZ mRNA CTD PMID:18164116 NCBI chr14:79,448,242...79,471,557
Ensembl chr14:79,448,139...79,471,556 		JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CRABP1 mRNA] CTD PMID:17854601 NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO Diethylnitrosamine results in increased expression of CRABP2 mRNA CTD PMID:21527772 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Crat carnitine O-acetyltransferase increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CRAT mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRAT mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased activity of CRAT protein; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA 		CTD PMID:12771043 PMID:18164116 PMID:18253720 PMID:22129741 NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions EXP [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of CREB1 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased phosphorylation of CREB1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [bisphenol A co-treated with Diethylnitrosamine] results in increased expression of and results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of and results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of CREB1 mRNA; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; bisphenol A promotes the reaction [[Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of CREB1 protein] CTD PMID:34186418 PMID:36608567 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CREG mRNA CTD PMID:17602206 NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272 		JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CRELD2 mRNA CTD PMID:17602206 NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:121,788,745...121,796,228 		JBrowse link
G Crem cAMP responsive element modulator multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CREM mRNA CTD PMID:18164116 NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160 		JBrowse link
G Crisp2 cysteine-rich secretory protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRISP2 mRNA CTD PMID:18164116 NCBI chr 9:27,604,024...27,628,520
Ensembl chr 9:27,604,257...27,629,870 		JBrowse link
G Crmp1 collapsin response mediator protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CRMP1 mRNA CTD PMID:20360939 NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916 		JBrowse link
G Crot carnitine O-octanoyltransferase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CROT mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CROT mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CROT mRNA CTD PMID:17602206 PMID:18164116 PMID:28943392 NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064 		JBrowse link
G Crp C-reactive protein multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CRP mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CRP mRNA
[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of CRP protein; [Gemcitabine co-treated with olsalazine] inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of CRP protein]; Gemcitabine inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of CRP protein] 		CTD PMID:17602206 PMID:28943392 PMID:38798245 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cryab crystallin, alpha B multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CRYAB mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CRYAB mRNA
Diethylnitrosamine results in increased expression of CRYAB mRNA 		CTD PMID:18164116 PMID:19638242 PMID:28943392 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CRYBG2 mRNA CTD PMID:28943392 NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163 		JBrowse link
G Cryga crystallin, gamma A multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRYGA mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA] CTD PMID:22129741 NCBI chr 9:73,975,914...74,006,614
Ensembl chr 9:73,975,914...74,003,290 		JBrowse link
G Cryge crystallin, gamma E multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CRYGE mRNA CTD PMID:20360939 NCBI chr 9:73,923,661...73,926,258
Ensembl chr 9:73,923,661...73,927,011 		JBrowse link
G Crygn crystallin, gamma N decreases expression ISO Diethylnitrosamine results in decreased expression of CRYGN mRNA CTD PMID:24535843 NCBI chr 4:11,286,475...11,294,002
Ensembl chr 4:11,286,475...11,294,002 		JBrowse link
G Cryl1 crystallin, lambda 1 multiple interactions
increases expression 		EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CRYL1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CRYL1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CRYL1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYL1 mRNA
Diethylnitrosamine results in increased expression of CRYL1 mRNA 		CTD PMID:14656948 PMID:16158176 PMID:19638242 PMID:22129741 PMID:28943392 NCBI chr15:35,542,628...35,661,563
Ensembl chr15:35,542,628...35,661,563 		JBrowse link
G Crym crystallin, mu decreases expression EXP Diethylnitrosamine results in decreased expression of CRYM mRNA CTD PMID:19638242 NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:183,991,745...184,006,962 		JBrowse link
G Csad cysteine sulfinic acid decarboxylase multiple interactions
decreases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CSAD mRNA
Diethylnitrosamine results in decreased expression of CSAD mRNA 		CTD PMID:24535843 NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions EXP [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CSF2 mRNA CTD PMID:18253720 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csk C-terminal Src kinase multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CSK mRNA CTD PMID:20360939 NCBI chr 8:66,925,650...66,944,861
Ensembl chr 8:66,925,651...66,930,274 		JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CSMD1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA CTD PMID:18164116 PMID:22129741 NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944 		JBrowse link
G Csn3 casein kappa increases expression ISO Diethylnitrosamine results in increased expression of CSN3 mRNA CTD PMID:24535843 NCBI chr14:20,433,277...20,439,830
Ensembl chr14:20,433,277...20,439,832 		JBrowse link
G Csnk2b casein kinase 2 beta increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of CSNK2B mRNA; Diethylnitrosamine results in increased expression of CSNK2B protein
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CSNK2B mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CSNK2B protein] 		CTD PMID:21554863 NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,704,904...3,710,525 		JBrowse link
G Cspg4 chondroitin sulfate proteoglycan 4 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CSPG4 mRNA CTD PMID:20360939 NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 decreases expression ISO Diethylnitrosamine results in decreased expression of CSRP2 mRNA CTD PMID:24535843 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 decreases expression ISO Diethylnitrosamine results in decreased expression of CSRP3 mRNA CTD PMID:24535843 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Cst6 cystatin E/M increases expression ISO Diethylnitrosamine results in increased expression of CST6 mRNA CTD PMID:21527772 NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384 		JBrowse link
G Cstb cystatin B multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CSTB mRNA CTD PMID:24535843 NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199 		JBrowse link
G Cth cystathionine gamma-lyase multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CTH mRNA
[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of CTH mRNA 		CTD PMID:28943392 PMID:29127188 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Cthrc1 collagen triple helix repeat containing 1 increases expression ISO Diethylnitrosamine results in increased expression of CTHRC1 mRNA CTD PMID:21527772 NCBI chr 7:72,007,372...72,017,654
Ensembl chr 7:72,007,372...72,017,654 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions
increases expression
affects localization
increases mutagenesis
decreases response to substance 		ISO
EXP 		[Diethylnitrosamine co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of CTNNB1 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased mutagenesis of CTNNB1 gene; [Diethylnitrosamine promotes the reaction [TGFB1 protein affects the susceptibility to Dietary Fats]] which results in increased expression of CTNNB1 protein; [Phenobarbital co-treated with Diethylnitrosamine] results in increased mutagenesis of CTNNB1 gene; CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MYC protein]; CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein]; CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein]; CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein]; CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of PDK1 protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of EGFR protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of HGF protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of HGFAC protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of MET protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of FAS protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of NFKB1 protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of NFKBIA protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of RELA protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of TRAF1 protein]; epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA]; epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 protein]; theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA]; theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 protein]
Diethylnitrosamine results in increased expression of CTNNB1 mRNA; Diethylnitrosamine results in increased expression of CTNNB1 protein
Diethylnitrosamine affects the localization of CTNNB1 protein modified form
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine affects the localization of CTNNB1 protein modified form]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA]
Diethylnitrosamine results in increased mutagenesis of CTNNB1
CTNNB1 protein results in decreased susceptibility to Diethylnitrosamine 		CTD PMID:10463579 PMID:20583210 PMID:21047994 PMID:21554863 PMID:24535843 More... NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctps2 CTP synthase 2 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CTPS2 mRNA
Diethylnitrosamine results in increased expression of CTPS2 mRNA 		CTD PMID:24535843 NCBI chr  X:35,277,658...35,418,505
Ensembl chr  X:35,277,658...35,418,505 		JBrowse link
G Ctrc chymotrypsin C multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CTRC mRNA CTD PMID:22129741 NCBI chr 5:159,430,333...159,439,557
Ensembl chr 5:159,430,335...159,439,545 		JBrowse link
G Ctrl chymotrypsin-like increases expression EXP Diethylnitrosamine results in increased expression of CTRB1 mRNA CTD PMID:20360939 NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979 		JBrowse link
G Ctsb cathepsin B increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CTSB mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CTSB mRNA 		CTD PMID:12771043 PMID:17602206 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsc cathepsin C decreases expression
increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of CTSC mRNA
Diethylnitrosamine results in increased expression of CTSC mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CTSC mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CTSC mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CTSC mRNA; MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CTSC mRNA] 		CTD PMID:17602206 PMID:17942915 PMID:18164116 PMID:24535843 NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082 		JBrowse link
G Ctse cathepsin E increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of CTSE mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CTSE mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr13:45,644,168...45,666,722
Ensembl chr13:45,644,147...45,666,722 		JBrowse link
G Ctsk cathepsin K multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CTSK mRNA CTD PMID:20360939 NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582 		JBrowse link
G Ctsl cathepsin L increases expression ISO
EXP 		Diethylnitrosamine results in increased expression of CTSL mRNA CTD PMID:12771043 PMID:20360939 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Ctsm cathepsin M multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of CTSM mRNA CTD PMID:20360939 NCBI chr17:3,242,488...3,247,896
Ensembl chr17:3,242,488...3,247,896 		JBrowse link
G Ctsr cathepsin R multiple interactions
increases expression 		EXP caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of CTSR mRNA] CTD PMID:20360939 NCBI chr17:3,527,990...3,536,753
Ensembl chr17:3,527,990...3,536,746 		JBrowse link
G Ctss cathepsin S increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of CTSS mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CTSS mRNA] 		CTD PMID:17942915 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440 		JBrowse link
G Ctxn1 cortexin 1 decreases expression EXP Diethylnitrosamine results in decreased expression of CTXN1 mRNA CTD PMID:20360939 NCBI chr12:7,408,308...7,409,919
Ensembl chr12:7,408,309...7,409,919 		JBrowse link
G Cul5 cullin 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CUL5 mRNA CTD PMID:18164116 NCBI chr 8:62,909,150...62,974,641
Ensembl chr 8:62,912,193...62,965,463 		JBrowse link
G Cuta cutA divalent cation tolerance homolog multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CUTA mRNA CTD PMID:17602206 NCBI chr20:5,024,816...5,026,446
Ensembl chr20:5,024,816...5,026,631 		JBrowse link
G Cux2 cut-like homeobox 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] CTD PMID:22129741 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CX3CL1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CX3CL1 mRNA CTD PMID:18164116 PMID:23830814 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxadr CXADR, Ig-like cell adhesion molecule increases expression EXP
ISO 		Diethylnitrosamine results in increased expression of CXADR mRNA CTD PMID:19638242 PMID:24535843 NCBI chr11:30,469,778...30,516,990
Ensembl chr11:30,469,526...30,516,988 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases expression
multiple interactions
increases expression 		EXP
ISO 		Diethylnitrosamine results in decreased expression of CXCL10 protein
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CXCL10 mRNA
Diethylnitrosamine results in increased expression of CXCL10 protein 		CTD PMID:24535843 PMID:25051504 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CXCL11 mRNA CTD PMID:18164116 NCBI chr14:15,973,728...15,976,503
Ensembl chr14:15,973,720...15,976,567 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CXCL12 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CXCL12 mRNA
Diethylnitrosamine results in decreased expression of CXCL12 mRNA 		CTD PMID:12771043 PMID:17602206 PMID:19041683 PMID:19638242 PMID:28943392 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 increases expression ISO Diethylnitrosamine results in increased expression of CXCL14 mRNA CTD PMID:24535843 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcl16 C-X-C motif chemokine ligand 16 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CXCL16 mRNA CTD PMID:18164116 NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,664,742...55,670,226 		JBrowse link
G Cxcl17 C-X-C motif chemokine ligand 17 increases expression ISO Diethylnitrosamine results in increased expression of CXCL17 mRNA CTD PMID:24535843 NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO Diethylnitrosamine results in increased expression of CXCL1 mRNA CTD PMID:19919837 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcr3 C-X-C motif chemokine receptor 3 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CXCR3 mRNA CTD PMID:20360939 NCBI chr  X:70,884,293...70,886,944
Ensembl chr  X:70,883,958...70,886,871 		JBrowse link
G Cyb561 cytochrome b-561 increases expression ISO Diethylnitrosamine results in increased expression of CYB561 mRNA CTD PMID:24535843 NCBI chr10:91,377,866...91,388,548
Ensembl chr10:91,377,866...91,385,097 		JBrowse link
G Cyb5a cytochrome b5 type A multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYB5A protein; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of CYB5A protein; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CYB5A mRNA]; citral inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A protein]
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A mRNA]
CYB5A protein promotes the reaction [CYP2A6 protein results in increased activity of Diethylnitrosamine]; CYB5A protein promotes the reaction [CYP2E1 protein results in increased activity of Diethylnitrosamine] 		CTD PMID:15728263 PMID:17942915 PMID:19409407 PMID:20360939 PMID:20935162 More... NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5b cytochrome b5 type B multiple interactions ISO [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Diethylnitrosamine CTD PMID:11733072 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYB5R3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYB5R3 mRNA CTD PMID:18544905 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cyb5r4 cytochrome b5 reductase 4 decreases expression EXP Diethylnitrosamine results in decreased expression of CYB5R4 mRNA CTD PMID:20360939 NCBI chr 8:96,860,415...96,925,789
Ensembl chr 8:96,861,090...96,926,094 		JBrowse link
G Cyba cytochrome b-245 alpha chain multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid] results in increased expression of CYBA mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CYBA mRNA; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of CYBA mRNA] CTD PMID:20360939 PMID:28943392 PMID:30298849 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cycs cytochrome c, somatic multiple interactions
decreases expression 		EXP morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CYCS protein] CTD PMID:19931519 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA CTD PMID:22129741 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cygb cytoglobin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYGB mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CYGB mRNA CTD PMID:18164116 PMID:28943392 NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases activity
multiple interactions 		EXP Diethylnitrosamine results in decreased activity of CYP11A1 protein
[nodularin co-treated with Diethylnitrosamine] results in decreased activity of CYP11A1 protein 		CTD PMID:12112309 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases activity 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA; [nodularin co-treated with Diethylnitrosamine] results in decreased activity of CYP17A1 protein
Diethylnitrosamine results in increased expression of CYP17A1 mRNA
Diethylnitrosamine results in decreased activity of CYP17A1 protein 		CTD PMID:12112309 PMID:17602206 PMID:24535843 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO
EXP 		2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [[3,4,5,3',4'-pentachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA]; [3,4,5,3',4'-pentachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA] which results in increased abundance of Reactive Oxygen Species; [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP1A1 mRNA; Diethylnitrosamine promotes the reaction [AHR protein binds to CYP1A1 promoter]; Plant Extracts inhibits the reaction [[[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA] which results in increased abundance of Reactive Oxygen Species]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of CYP1A1 mRNA]
Diethylnitrosamine results in increased expression of CYP1A1 mRNA; Diethylnitrosamine results in increased expression of CYP1A1 protein
[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP1A1 protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 mRNA; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 protein; [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A1 mRNA; [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A1 mRNA; [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [Mastic Resin co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [Orphenadrine co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 protein; allyl sulfide inhibits the reaction [Diethylnitrosamine results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [Diethylnitrosamine results in increased expression of CYP1A1 mRNA]; Diethylnitrosamine results in increased expression of and results in increased activity of CYP1A1 protein; Melatonin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A1 mRNA] 		CTD PMID:11165752 PMID:15535986 PMID:17162532 PMID:18164116 PMID:18648771 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
decreases expression 		ISO
EXP 		[[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species; [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA
Diethylnitrosamine results in decreased expression of CYP1A2 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA; [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA; [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA; [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA; [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A2 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP1A2 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA]; allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP1A2 protein]; allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP1A2 mRNA]; Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP1A2 protein 		CTD PMID:18164116 PMID:18253720 PMID:18754104 PMID:19638242 PMID:20033131 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1B1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA]
Diethylnitrosamine results in increased expression of CYP1B1 mRNA 		CTD PMID:18164116 PMID:20045035 PMID:22129741 PMID:27565560 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp21a1 cytochrome P450, family 21, subfamily a, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP21A1 mRNA CTD PMID:18164116 NCBI chr20:4,028,323...4,031,549
Ensembl chr20:4,028,391...4,031,543 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP26A1 mRNA
Diethylnitrosamine results in decreased expression of CYP26A1 mRNA 		CTD PMID:12771043 PMID:18164116 PMID:24535843 NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657 		JBrowse link
G Cyp26c1 cytochrome P450, family 26, subfamily C, polypeptide 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP26C1 mRNA CTD PMID:22129741 NCBI chr 1:244,870,412...244,881,610
Ensembl chr 1:244,871,612...244,880,297 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 increases expression
decreases expression 		EXP
ISO 		Diethylnitrosamine results in increased expression of CYP27A1 mRNA
Diethylnitrosamine results in decreased expression of CYP27A1 mRNA 		CTD PMID:20360939 PMID:24535843 NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased activity of CYP2A1 protein
Diethylnitrosamine results in increased expression of CYP2A22 mRNA 		CTD PMID:16246485 PMID:21607683 NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730 		JBrowse link
G Cyp2a2 cytochrome P450, family 2, subfamily a, polypeptide 2 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP2A2 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2A2 mRNA
Diethylnitrosamine results in decreased expression of CYP2A2 mRNA 		CTD PMID:19638242 PMID:20360939 PMID:28943392 NCBI chr 1:91,391,492...91,417,158
Ensembl chr 1:91,391,502...91,417,158 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 multiple interactions EXP [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP2A3 mRNA CTD PMID:18253720 NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 multiple interactions
increases expression 		EXP [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein; [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP2B1 mRNA; [DDT co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased activity of CYP2B1 protein; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2B1 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2B1 protein; [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP2B1 mRNA; [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP2B1 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP2B1 protein; [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein
Diethylnitrosamine results in increased expression of CYP2B1 mRNA 		CTD PMID:9744545 PMID:10550479 PMID:11165752 PMID:12115560 PMID:15885732 More... NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b12 cytochrome P450, family 2, subfamily b, polypeptide 12 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2B12 mRNA CTD PMID:22129741 NCBI chr 1:91,135,294...91,147,094
Ensembl chr 1:91,135,294...91,208,159 		JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2B15 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2B15 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP2B15 mRNA
Diethylnitrosamine results in decreased expression of CYP2B15 mRNA 		CTD PMID:18253720 PMID:18544905 PMID:19638242 NCBI chr 1:91,221,865...91,234,169
Ensembl chr 1:91,221,865...91,234,169 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 multiple interactions
increases expression 		EXP
ISO 		[Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP2B2 mRNA; [DDT co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP2B2 protein; [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP2B2 mRNA; [ethofenprox co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [Mastic Resin co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP2B2 mRNA]; Melatonin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP2B2 mRNA]
Diethylnitrosamine results in increased expression of CYP2B13 mRNA
Diethylnitrosamine results in increased expression of CYP2B2 mRNA 		CTD PMID:10550479 PMID:12115560 PMID:15885732 PMID:18977376 PMID:20033131 More... NCBI chr 1:90,722,243...90,736,272 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of CYP2B10 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA; [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B10 mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of CYP2B10 mRNA; NR1I3 protein affects the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA] CTD PMID:15492232 PMID:17917374 PMID:19690152 PMID:20101389 PMID:23457121 More... NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2C11 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2C11 protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP2C mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2C mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA
Diethylnitrosamine results in decreased expression of CYP2C mRNA; Diethylnitrosamine results in decreased expression of CYP2C11 mRNA; Diethylnitrosamine results in decreased expression of CYP2C11 protein 		CTD PMID:14965361 PMID:16246485 PMID:17602206 PMID:18164116 PMID:18253720 More... NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853 		JBrowse link
G Cyp2c12 cytochrome P450, family 2, subfamily c, polypeptide 12 decreases expression
multiple interactions
increases expression 		EXP Diethylnitrosamine results in decreased expression of CYP2C12 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CYP2C40 mRNA
Diethylnitrosamine results in increased expression of CYP2C40 mRNA 		CTD PMID:19638242 PMID:20360939 PMID:28943392 NCBI chr 1:248,619,887...248,681,945
Ensembl chr 1:248,619,882...248,677,042 		JBrowse link
G Cyp2c13 cytochrome P450, family 2, subfamily c, polypeptide 13 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C13 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2C13 mRNA; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP2C13 mRNA] CTD PMID:11323195 PMID:18544905 PMID:19638242 PMID:20360939 PMID:28943392 NCBI chr 1:248,706,787...248,787,239
Ensembl chr 1:248,706,788...248,787,210 		JBrowse link
G Cyp2c22 cytochrome P450, family 2, subfamily c, polypeptide 22 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP2C22 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C70 mRNA 		CTD PMID:18544905 PMID:20360939 NCBI chr 1:248,941,143...248,980,767
Ensembl chr 1:248,904,062...248,971,182 		JBrowse link
G Cyp2c23 cytochrome P450, family 2, subfamily c, polypeptide 23 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP2C23 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP2C23 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2C23 mRNA
Diethylnitrosamine results in decreased expression of CYP2C23 mRNA 		CTD PMID:11323195 PMID:17602206 PMID:18164116 PMID:28943392 NCBI chr 1:252,838,427...252,863,081
Ensembl chr 1:252,838,433...252,863,067 		JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP2C55 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CYP2C55 mRNA 		CTD PMID:20360939 PMID:28943392 NCBI chr 1:246,286,341...246,348,607
Ensembl chr 1:246,286,341...246,348,607 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2C6 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP2C6 protein; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2C6 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2C6 mRNA
Diethylnitrosamine results in decreased expression of CYP2C29 mRNA
Diethylnitrosamine results in decreased expression of CYP2C6 mRNA 		CTD PMID:9744545 PMID:12771043 PMID:16246485 PMID:20360939 PMID:22129741 More... NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2c7 cytochrome P450, family 2, subfamily c, polypeptide 7 multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C7 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C7 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2C7 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2C7 mRNA
Diethylnitrosamine results in decreased expression of CYP2C7 mRNA 		CTD PMID:18164116 PMID:18253720 PMID:18544905 PMID:19638242 PMID:28943392 NCBI chr 1:247,966,295...248,022,393
Ensembl chr 1:247,966,346...248,022,388 		JBrowse link
G Cyp2d2 cytochrome P450, family 2, subfamily d, polypeptide 2 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP2D2 mRNA; Diethylnitrosamine results in decreased expression of CYP2D26 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2D26 mRNA 		CTD PMID:19638242 PMID:20360939 PMID:28943392 NCBI chr 7:115,815,212...115,819,281
Ensembl chr 7:115,815,212...115,819,281 		JBrowse link
G Cyp2d3 cytochrome P450, family 2, subfamily d, polypeptide 3 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP2D13 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2D13 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2D13 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2D13 mRNA 		CTD PMID:18253720 PMID:18544905 PMID:19638242 PMID:28943392 NCBI chr 7:115,797,785...115,802,142
Ensembl chr 7:115,797,789...115,802,158 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of CYP2D22 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP2D22 mRNA]
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2D22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2D22 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2D22 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2D22 mRNA 		CTD PMID:17942915 PMID:18253720 PMID:18544905 PMID:28943392 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2d5 cytochrome P450, family 2, subfamily d, polypeptide 5 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP2D10 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2D10 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 7:115,779,981...115,784,554 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
increases expression
decreases expression
increases response to substance
increases activity
affects metabolic processing 		ISO
EXP 		[CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Diethylnitrosamine; [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to Diethylnitrosamine; CYB5A protein promotes the reaction [CYP2E1 protein results in increased activity of Diethylnitrosamine]; CYP2E1 protein affects the metabolism of and results in increased activity of Diethylnitrosamine
Diethylnitrosamine results in increased expression of CYP2E1 protein
Diethylnitrosamine results in increased expression of CYP2E1 mRNA; Diethylnitrosamine results in increased expression of CYP2E1 protein
Diethylnitrosamine results in decreased expression of CYP2E1 mRNA; Diethylnitrosamine results in decreased expression of CYP2E1 protein
CYP2E1 protein results in increased susceptibility to Diethylnitrosamine
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA; [Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CYP2E1 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CYP2E1 protein; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2E1 protein; [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of CYP2E1 protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2E1 mRNA; allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP2E1 protein]; allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP2E1 mRNA]; Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP2E1 protein; neferine inhibits the reaction [Diethylnitrosamine results in increased expression of CYP2E1 mRNA]; Plant Extracts inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CYP2E1 protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP2E1 protein]
CYP2E1 protein promotes the reaction [Diethylnitrosamine results in increased expression of BAX mRNA]; CYP2E1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 mRNA]; Vitamin D inhibits the reaction [Diethylnitrosamine results in increased expression of CYP2E1 protein]
CYP2E1 protein affects the metabolism of Diethylnitrosamine 		CTD PMID:2655891 PMID:11035158 PMID:11733072 PMID:11774366 PMID:14656948 More... NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2f4 cytochrome P450, family 2, subfamily f, polypeptide 4 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2F2 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA
Diethylnitrosamine results in decreased expression of CYP2F2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CYP2F2 mRNA 		CTD PMID:18253720 PMID:18544905 PMID:24535843 NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553 		JBrowse link
G Cyp2g1 cytochrome P450, family 2, subfamily g, polypeptide 1 decreases expression ISO Diethylnitrosamine results in decreased expression of CYP2G1 mRNA CTD PMID:24535843 NCBI chr 1:91,273,309...91,284,499
Ensembl chr 1:91,272,680...91,284,498 		JBrowse link
G Cyp2j3 cytochrome P450, family 2, subfamily j, polypeptide 3 decreases expression EXP Diethylnitrosamine results in decreased expression of CYP2J3 mRNA CTD PMID:19041683 PMID:20360939 NCBI chr 5:116,335,755...116,360,677
Ensembl chr 5:116,335,755...116,360,499 		JBrowse link
G Cyp2u1 cytochrome P450, family 2, subfamily u, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2U1 mRNA CTD PMID:18164116 NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:222,523,518...222,541,124 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 increases expression ISO Diethylnitrosamine results in increased expression of CYP39A1 mRNA CTD PMID:24535843 NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:24,727,817...24,804,060 		JBrowse link
G Cyp3a18 cytochrome P450, family 3, subfamily a, polypeptide 18 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP3A18 mRNA
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP3A18 mRNA] 		CTD PMID:19638242 PMID:20360939 NCBI chr12:13,994,312...14,044,185
Ensembl chr12:13,994,311...14,045,788 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
decreases expression 		EXP [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP3A2 mRNA; [DDT co-treated with Diethylnitrosamine] results in increased expression of CYP3A2 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in decreased expression of CYP3A2 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased activity of CYP3A2 protein; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP3A2 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP3A2 protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A2 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP3A2 protein; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP3A11 mRNA; [Mastic Resin co-treated with Diethylnitrosamine] results in increased expression of CYP3A11 mRNA; Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP3A2 protein
Diethylnitrosamine results in decreased expression of CYP3A11 mRNA 		CTD PMID:9744545 PMID:11165752 PMID:15885732 PMID:16246485 PMID:18164116 More... NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions
decreases expression 		EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP3A23-3A1 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP3A23-3A1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP3A23-3A1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA; [Mastic Resin co-treated with Diethylnitrosamine] results in increased expression of CYP3A23-3A1 mRNA; Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP3A23-3A1 protein
Diethylnitrosamine results in decreased expression of CYP3A23-3A1 mRNA 		CTD PMID:14656948 PMID:16158176 PMID:17602206 PMID:18253720 PMID:18977376 More... NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813 		JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP3A62 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CYP3A62 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP3A62 mRNA CTD PMID:18164116 PMID:22129741 PMID:28943392 NCBI chr12:21,511,763...21,547,598
Ensembl chr12:21,471,542...21,547,598 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Diethylnitrosamine results in increased expression of CYP3A13 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A13 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP3A13 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP3A13 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP3A13 mRNA
Diethylnitrosamine results in decreased expression of CYP3A13 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP3A13 mRNA] 		CTD PMID:17602206 PMID:17942915 PMID:18164116 PMID:18253720 PMID:19638242 More... NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp46a1 cytochrome P450, family 46, subfamily a, polypeptide 1 multiple interactions
decreases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CYP46A1 mRNA
Diethylnitrosamine results in decreased expression of CYP46A1 mRNA 		CTD PMID:24535843 NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971 		JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP4A1 protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP4A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA CTD PMID:10550479 PMID:18544905 PMID:18775883 PMID:22129741 NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231 		JBrowse link
G Cyp4a2 cytochrome P450, family 4, subfamily a, polypeptide 2 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP4A2 mRNA CTD PMID:28943392 NCBI chr 5:134,160,356...134,170,908
Ensembl chr 5:134,160,358...134,176,156 		JBrowse link
G Cyp4a3 cytochrome P450, family 4, subfamily a, polypeptide 3 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP4A14 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP4A14 mRNA 		CTD PMID:11323195 PMID:28943392 NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:134,334,701...134,352,236 		JBrowse link
G Cyp4a8 cytochrome P450, family 4, subfamily a, polypeptide 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP4A8 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP4A8 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP4A8 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP4A8 mRNA CTD PMID:18164116 PMID:18253720 PMID:22129741 PMID:28943392 NCBI chr 5:133,938,882...133,970,226
Ensembl chr 5:133,938,883...133,970,226 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions ISO
EXP 		[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA; [Mastic Resin co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA 		CTD PMID:17917374 PMID:18253720 PMID:18544905 PMID:18977376 NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116 		JBrowse link
G Cyp4f1 cytochrome P450, family 4, subfamily f, polypeptide 1 decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of CYP4F14 mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP4F2 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4F2 mRNA
Diethylnitrosamine results in decreased expression of CYP4F2 mRNA 		CTD PMID:12771043 PMID:17602206 PMID:18544905 PMID:19638242 PMID:24535843 NCBI chr 7:12,661,357...12,672,952
Ensembl chr 7:12,661,359...12,672,612 		JBrowse link
G Cyp4f17 cytochrome P450, family 4, subfamily f, polypeptide 17 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP4F17 mRNA CTD PMID:22129741 NCBI chr 7:12,169,366...12,186,731
Ensembl chr 7:12,169,922...12,187,540 		JBrowse link
G Cyp4f4 cytochrome P450, family 4, subfamily f, polypeptide 4 decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of CYP4F4 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP4F4 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 7:12,367,711...12,384,010
Ensembl chr 7:12,367,660...12,384,010 		JBrowse link
G Cyp4f5 cytochrome P450, family 4, subfamily f, polypeptide 5 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP4F5 mRNA CTD PMID:17602206 NCBI chr 7:12,194,567...12,209,495
Ensembl chr 7:12,195,022...12,209,965 		JBrowse link
G Cyp4f6 cytochrome P450, family 4, subfamily f, polypeptide 6 multiple interactions
increases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP4F16 mRNA] CTD PMID:17942915 PMID:24535843 NCBI chr 7:12,680,799...12,708,378
Ensembl chr 7:12,680,806...12,708,402 		JBrowse link
G Cyp51 cytochrome P450, family 51 multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA
Diethylnitrosamine results in increased expression of CYP51 mRNA
Diethylnitrosamine results in decreased expression of CYP51 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:24535843 NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP7A1 mRNA; IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP7A1 mRNA]
Diethylnitrosamine results in decreased expression of CYP7A1 mRNA
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP7A1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA 		CTD PMID:14656948 PMID:16158176 PMID:17917374 PMID:18253720 PMID:18691550 More... NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of CYP7B1 mRNA
[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7B1 mRNA 		CTD PMID:12771043 PMID:18253720 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 multiple interactions
decreases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP8B1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP8B1 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP8B1 mRNA
Diethylnitrosamine results in decreased expression of CYP8B1 mRNA 		CTD PMID:18253720 PMID:18544905 PMID:24535843 PMID:28943392 NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689 		JBrowse link
G Cyth2 cytohesin 2 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of CYTH2 mRNA CTD PMID:20360939 NCBI chr 1:105,419,631...105,427,542
Ensembl chr 1:105,419,631...105,427,542 		JBrowse link
G Dab1 DAB adaptor protein 1 increases expression ISO Diethylnitrosamine results in increased expression of DAB1 mRNA CTD PMID:24535843 NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584 		JBrowse link
G Dab2 DAB adaptor protein 2 increases expression EXP Diethylnitrosamine results in increased expression of DAB2 mRNA CTD PMID:19638242 NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888 		JBrowse link
G Dach2 dachshund family transcription factor 2 decreases expression ISO Diethylnitrosamine results in decreased expression of DACH2 mRNA CTD PMID:24535843 NCBI chr  X:82,644,374...83,210,181
Ensembl chr  X:82,644,128...83,210,000 		JBrowse link
G Dact2 dishevelled-binding antagonist of beta-catenin 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DACT2 mRNA CTD PMID:22129741 NCBI chr 1:63,854,182...63,864,153
Ensembl chr 1:63,854,182...63,864,255 		JBrowse link
G Dad1 defender against cell death 1 decreases expression EXP Diethylnitrosamine results in decreased expression of DAD1 mRNA CTD PMID:11323195 NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287 		JBrowse link
G Dao D-amino-acid oxidase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DAO mRNA CTD PMID:17602206 NCBI chr12:48,252,900...48,275,964
Ensembl chr12:48,252,902...48,273,300 		JBrowse link
G Dap death-associated protein multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of DAP mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of DAP mRNA CTD PMID:14656948 PMID:16158176 NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:83,910,060...83,962,673 		JBrowse link
G Dapk1 death associated protein kinase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of DAPK1 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of DAPK1 promoter CTD PMID:20970405 NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581 		JBrowse link
G Dapk2 death-associated protein kinase 2 increases expression ISO Diethylnitrosamine results in increased expression of DAPK2 mRNA CTD PMID:24535843 NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:75,601,634...75,720,617 		JBrowse link
G Dbi diazepam binding inhibitor multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DBI mRNA CTD PMID:17602206 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dbn1 drebrin 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DBN1 mRNA; [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DBN1 mRNA CTD PMID:18164116 PMID:20360939 NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor decreases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of DBP mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DBP mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DBP mRNA] 		CTD PMID:17942915 PMID:18164116 PMID:19638242 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR21 mRNA CTD PMID:17602206 NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110 		JBrowse link
G Dcakd dephospho-CoA kinase domain containing multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DCAKD mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of DCAKD mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of DCAKD promoter CTD PMID:17602206 PMID:25374375 NCBI chr10:88,457,829...88,489,011
Ensembl chr10:88,457,829...88,480,118 		JBrowse link
G Dck deoxycytidine kinase increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of DCK mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DCK mRNA] 		CTD PMID:17854601 NCBI chr14:19,589,298...19,610,326
Ensembl chr14:19,589,298...19,610,326 		JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DCLK1 mRNA CTD PMID:18164116 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dclk3 doublecortin-like kinase 3 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of DCLK3 mRNA CTD PMID:24535843 NCBI chr 8:120,279,916...120,332,362
Ensembl chr 8:120,279,757...120,332,432 		JBrowse link
G Dcn decorin increases expression
multiple interactions
decreases expression 		EXP
ISO 		Diethylnitrosamine results in increased expression of DCN mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of DCN mRNA
Diethylnitrosamine results in decreased expression of DCN mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of DCN mRNA 		CTD PMID:19638242 PMID:24535843 PMID:28943392 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Dct dopachrome tautomerase increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of DCT mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of DCT mRNA; MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DCT mRNA] 		CTD PMID:17942915 PMID:24535843 NCBI chr15:101,469,159...101,508,029
Ensembl chr15:101,469,159...101,508,029 		JBrowse link
G Dctpp1 dCTP pyrophosphatase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DCTPP1 mRNA CTD PMID:17602206 NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of DCXR mRNA CTD PMID:28943392 NCBI chr10:106,504,730...106,506,619 JBrowse link
G Ddb1 damage-specific DNA binding protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDB1 mRNA CTD PMID:17602206 NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596 		JBrowse link
G Ddc dopa decarboxylase decreases expression ISO Diethylnitrosamine results in decreased expression of DDC mRNA CTD PMID:21527772 NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806 		JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DDHD1 mRNA CTD PMID:22129741 NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression 		ISO
EXP 		Butylated Hydroxyanisole inhibits the reaction [MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DDIT3 mRNA]]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DDIT3 mRNA]
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DDIT3 mRNA 		CTD PMID:18544905 PMID:18691550 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression EXP Diethylnitrosamine results in increased expression of DDIT4 mRNA CTD PMID:19638242 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of DDIT4L mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of DDIT4L mRNA 		CTD PMID:19638242 PMID:21607683 PMID:24535843 PMID:28943392 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225 		JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 increases expression ISO Diethylnitrosamine results in increased expression of DDR1 mRNA CTD PMID:24535843 NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276 		JBrowse link
G Ddx21 DExD-box helicase 21 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX21 mRNA CTD PMID:17602206 NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238 		JBrowse link
G Ddx24 DEAD-box helicase 24 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX24 mRNA CTD PMID:17602206 NCBI chr 6:128,329,554...128,346,818
Ensembl chr 6:128,329,554...128,349,625 		JBrowse link
G Ddx56 DEAD-box helicase 56 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX56 mRNA CTD PMID:17602206 NCBI chr14:85,325,942...85,336,262
Ensembl chr14:85,325,942...85,336,262 		JBrowse link
G Deaf1 DEAF1 transcription factor multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of DEAF1 mRNA CTD PMID:20360939 NCBI chr 1:205,831,428...205,865,106
Ensembl chr 1:205,831,336...205,865,106 		JBrowse link
G Defb1 defensin beta 1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of DEFB1 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of DEFB1 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr16:77,001,326...77,016,068
Ensembl chr16:77,001,326...77,016,068 		JBrowse link
G Defb105a defensin beta 105A multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB12 mRNA CTD PMID:22129741 NCBI chr16:76,838,686...76,841,113
Ensembl chr16:76,838,664...76,841,113 		JBrowse link
G Defb17 defensin beta 17 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of DEFB41 gene CTD PMID:23968726 NCBI chr 9:28,376,792...28,380,421
Ensembl chr 9:28,376,792...28,380,421 		JBrowse link
G Defb18 defensin beta 18 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB18 mRNA CTD PMID:22129741 NCBI chr 9:28,348,776...28,349,793
Ensembl chr 9:28,348,776...28,349,793 		JBrowse link
G Defb49 defensin beta 49 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB49 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA] CTD PMID:22129741 NCBI chr 9:28,329,236...28,333,898
Ensembl chr 9:28,329,236...28,333,999 		JBrowse link
G Degs1 delta(4)-desaturase, sphingolipid 1 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DEGS1 mRNA CTD PMID:20360939 NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302 		JBrowse link
G Dek DEK proto-oncogene multiple interactions
increases expression 		ISO RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DEK mRNA] CTD PMID:17854601 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122 		JBrowse link
G Dennd4a DENN domain containing 4A multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of DENND4A gene CTD PMID:23968726 NCBI chr 8:74,218,131...74,331,543
Ensembl chr 8:74,218,191...74,331,542 		JBrowse link
G Derl3 derlin 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DERL3 mRNA CTD PMID:22129741 NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477 		JBrowse link
G Dgkb diacylglycerol kinase, beta multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DGKB mRNA CTD PMID:20360939 NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:60,368,519...61,124,420 		JBrowse link
G Dgki diacylglycerol kinase, iota multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in decreased methylation of DGKI promoter; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of DGKI mRNA CTD PMID:25374375 NCBI chr 4:66,377,897...66,839,790
Ensembl chr 4:66,387,126...66,990,832 		JBrowse link
G Dguok deoxyguanosine kinase increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of DGUOK mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DGUOK mRNA] 		CTD PMID:17942915 NCBI chr 4:117,544,784...117,572,414
Ensembl chr 4:117,544,773...117,572,414 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase increases expression ISO Diethylnitrosamine results in increased expression of DHCR7 mRNA CTD PMID:24535843 NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382 		JBrowse link
G Dhfr dihydrofolate reductase multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DHFR mRNA CTD PMID:20360939 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Dhh desert hedgehog signaling molecule multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DHH mRNA CTD PMID:22129741 NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352 		JBrowse link
G Dhodh dihydroorotate dehydrogenase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DHODH mRNA CTD PMID:17602206 NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496 		JBrowse link
G Dhrs2 dehydrogenase/reductase 2 decreases expression ISO Diethylnitrosamine results in decreased expression of DHRS2 mRNA CTD PMID:21527772 NCBI chr15:32,658,855...32,673,591
Ensembl chr15:32,659,223...32,673,588 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression ISO Diethylnitrosamine results in decreased expression of DHRS3 mRNA CTD PMID:21527772 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Dhrs7 dehydrogenase/reductase 7 decreases expression EXP Diethylnitrosamine results in decreased expression of DHRS7 mRNA CTD PMID:19638242 NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744 		JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 decreases expression ISO Diethylnitrosamine results in decreased expression of DHTKD1 mRNA CTD PMID:24535843 NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [3,4,5,4'-tetramethoxystilbene co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of DIABLO mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA CTD PMID:17602206 PMID:27048571 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DIAPH3 mRNA CTD PMID:22129741 NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Dio1 iodothyronine deiodinase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIO1 mRNA CTD PMID:17602206 NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771 		JBrowse link
G Dio2 iodothyronine deiodinase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DIO2 mRNA CTD PMID:18164116 NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594 		JBrowse link
G Dipk1a divergent protein kinase domain 1A decreases expression ISO Diethylnitrosamine results in decreased expression of DIPK1A mRNA CTD PMID:24535843 NCBI chr14:1,917,353...1,988,188
Ensembl chr14:1,917,324...1,988,678 		JBrowse link
G Disc1 DISC1 scaffold protein increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of DISC1 mRNA
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of DISC1 mRNA] 		CTD PMID:20360939 NCBI chr19:69,911,548...70,120,970
Ensembl chr19:69,911,976...70,120,970 		JBrowse link
G Dkk4 dickkopf WNT signaling pathway inhibitor 4 decreases expression ISO Diethylnitrosamine results in decreased expression of DKK4 mRNA CTD PMID:24535843 NCBI chr16:76,105,679...76,109,044
Ensembl chr16:76,105,679...76,109,044 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of DMBT1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DMBT1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of DMBT1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:28943392 NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:195,047,713...195,126,704 		JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression
multiple interactions 		EXP
ISO 		Diethylnitrosamine results in decreased expression of DMGDH mRNA
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DMGDH mRNA 		CTD PMID:17602206 PMID:19638242 PMID:24535843 NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071 		JBrowse link
G Dmrt1 doublesex and mab-3 related transcription factor 1 multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DMRT1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DMRT1 mRNA
[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of DMRT1 gene 		CTD PMID:20360939 PMID:22129741 PMID:23968726 NCBI chr 1:232,569,179...232,667,646
Ensembl chr 1:232,569,072...232,668,370 		JBrowse link
G Dmrta1 DMRT-like family A1 decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of DMRTA1 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of DMRTA1 mRNA 		CTD PMID:24535843 NCBI chr 5:109,531,704...109,538,244
Ensembl chr 5:109,531,586...109,538,246 		JBrowse link
G Dnaaf1 dynein, axonemal, assembly factor 1 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of DNAAF1 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of DNAAF1 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr19:64,532,859...64,560,942
Ensembl chr19:64,532,860...64,561,435 		JBrowse link
G Dnah10 dynein, axonemal, heavy chain 10 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DNAH10 mRNA
Diethylnitrosamine results in increased expression of DNAH10 mRNA 		CTD PMID:20360939 NCBI chr12:37,484,444...37,607,810
Ensembl chr12:37,472,813...37,640,860 		JBrowse link
G Dnah3 dynein, axonemal, heavy chain 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA] CTD PMID:22129741 NCBI chr 1:183,738,013...183,910,831
Ensembl chr 1:183,738,013...183,910,432 		JBrowse link
G Dnah5 dynein, axonemal, heavy chain 5 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DNAH5 mRNA CTD PMID:20360939 NCBI chr 2:80,668,182...80,985,918
Ensembl chr 2:80,668,208...80,985,914 		JBrowse link
G Dnah9 dynein, axonemal, heavy chain 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DNAH9 mRNA CTD PMID:18164116 NCBI chr10:50,996,796...51,363,977
Ensembl chr10:50,996,796...51,363,963 		JBrowse link
G Dnai1 dynein, axonemal, intermediate chain 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DNAI1 mRNA CTD PMID:22129741 NCBI chr 5:61,526,079...61,596,806
Ensembl chr 5:61,525,999...61,596,810 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DNAJA1 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA1 mRNA CTD PMID:17602206 PMID:18544905 NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160 		JBrowse link
G Dnaja2 DnaJ heat shock protein family (Hsp40) member A2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DNAJA2 mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of DNAJA2 mRNA CTD PMID:18253720 PMID:18544905 NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions
decreases expression 		ISO
EXP 		IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DNAJB1 mRNA]
[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of DNAJB1 mRNA 		CTD PMID:18253720 PMID:18691550 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of DNAJC9 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNAJC9 mRNA] 		CTD PMID:17854601 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304 		JBrowse link
G Dnase2 deoxyribonuclease 2, lysosomal decreases expression ISO Diethylnitrosamine results in decreased expression of DNASE2A mRNA CTD PMID:24535843 NCBI chr19:40,149,505...40,152,225
Ensembl chr19:40,149,505...40,152,225 		JBrowse link
G Dnm1 dynamin 1 multiple interactions
increases expression 		ISO
EXP 		RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNM1 mRNA]
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DNM1 mRNA 		CTD PMID:17854601 PMID:18164116 NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:36,002,064...36,046,289 		JBrowse link
G Dnm1l dynamin 1-like multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DNM1L mRNA CTD PMID:18164116 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420 		JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions
increases expression
decreases expression 		ISO
EXP 		AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DNMT1 mRNA]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNMT1 mRNA]
[Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT1 protein 		CTD PMID:17854601 PMID:19996281 PMID:21163286 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha multiple interactions EXP [Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT3A protein CTD PMID:21163286 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DNPH1 mRNA CTD PMID:17602206 NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631 		JBrowse link
G Dntt DNA nucleotidylexotransferase increases expression ISO Diethylnitrosamine results in increased expression of DNTT mRNA CTD PMID:24535843 NCBI chr 1:249,805,802...249,837,685
Ensembl chr 1:249,805,802...249,837,684 		JBrowse link
G Dock3 dedicator of cyto-kinesis 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DOCK3 mRNA CTD PMID:22129741 NCBI chr 8:116,431,158...116,782,218
Ensembl chr 8:116,431,159...116,782,195 		JBrowse link
G Dock8 dedicator of cytokinesis 8 decreases expression ISO Diethylnitrosamine results in decreased expression of DOCK8 mRNA CTD PMID:24535843 NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833 		JBrowse link
G Dock9 dedicator of cytokinesis 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DOCK9 mRNA CTD PMID:18164116 NCBI chr15:105,018,341...105,289,799
Ensembl chr15:105,024,912...105,289,799 		JBrowse link
G Dok1 docking protein 1 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of DOK1 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DOK1 mRNA] 		CTD PMID:17854601 NCBI chr 4:117,095,171...117,098,251
Ensembl chr 4:117,095,175...117,097,825 		JBrowse link
G Dpep1 dipeptidase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DPEP1 mRNA CTD PMID:18164116 NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPP4 mRNA
Diethylnitrosamine results in increased expression of DPP4 protein
Vitamin D inhibits the reaction [Diethylnitrosamine results in increased expression of DPP4 protein] 		CTD PMID:17602206 PMID:36442531 NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422 		JBrowse link
G Dpp7 dipeptidylpeptidase 7 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DPP7 mRNA
Diethylnitrosamine results in increased expression of DPP7 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492 		JBrowse link
G Dpt dermatopontin multiple interactions EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPT mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of DPT mRNA 		CTD PMID:17602206 PMID:24535843 NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758 		JBrowse link
G Dpy19l3 dpy-19 like C-mannosyltransferase 3 increases expression ISO Diethylnitrosamine results in increased expression of DPY19L3 mRNA CTD PMID:24535843 NCBI chr 1:97,487,206...97,554,232
Ensembl chr 1:97,487,206...97,554,232 		JBrowse link
G Dpy30 dpy-30 histone methyltransferase complex regulatory subunit multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPY30 mRNA CTD PMID:17602206 NCBI chr 6:26,872,812...26,893,580
Ensembl chr 6:26,872,732...26,894,930 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPYD mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA
Diethylnitrosamine results in decreased expression of DPYD mRNA 		CTD PMID:17602206 PMID:18544905 PMID:19638242 NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778 		JBrowse link
G Dpys dihydropyrimidinase multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of DPYS mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPYS mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of DPYS mRNA
Diethylnitrosamine results in decreased expression of DPYS mRNA 		CTD PMID:17602206 PMID:19638242 PMID:20360939 PMID:28943392 NCBI chr 7:72,707,566...72,814,183
Ensembl chr 7:72,721,048...72,814,142 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 increases expression EXP Diethylnitrosamine results in increased expression of DPYSL2 mRNA CTD PMID:19638242 NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065 		JBrowse link
G Drc1 dynein regulatory complex subunit 1 increases expression ISO Diethylnitrosamine results in increased expression of DRC1 mRNA CTD PMID:24535843 NCBI chr 6:31,744,849...31,779,996
Ensembl chr 6:31,744,850...31,779,256 		JBrowse link
G Dsg1 desmoglein 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DSG1B mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DSG1B mRNA CTD PMID:22129741 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451 		JBrowse link
G Dtnb dystrobrevin, beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DTNB mRNA CTD PMID:18164116 NCBI chr 6:32,286,022...32,483,007
Ensembl chr 6:32,285,941...32,485,872 		JBrowse link
G Dtymk deoxythymidylate kinase increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of DTYMK mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DTYMK mRNA] 		CTD PMID:17854601 NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions
increases expression 		ISO
EXP 		MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DUSP1 mRNA]
[Clofibric Acid co-treated with Diethylnitrosamine] results in decreased expression of DUSP1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of DUSP1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of DUSP1 promoter 		CTD PMID:15833021 PMID:17942915 PMID:25374375 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp13b dual specificity phosphatase 13B multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DUSP13B mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DUSP13B mRNA CTD PMID:18164116 PMID:22129741 NCBI chr15:2,616,761...2,624,434
Ensembl chr15:2,609,049...2,624,887 		JBrowse link
G Dusp3 dual specificity phosphatase 3 multiple interactions
decreases expression 		EXP [Sorafenib co-treated with Methionine] inhibits the reaction [Diethylnitrosamine results in decreased expression of DUSP3 mRNA] CTD PMID:38367245 NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063 		JBrowse link
G Dusp4 dual specificity phosphatase 4 decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of DUSP4 mRNA
IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DUSP4 mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DUSP4 mRNA] 		CTD PMID:18691550 NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700 		JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression ISO Diethylnitrosamine results in increased expression of DUSP5 mRNA CTD PMID:21527772 PMID:24535843 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp6 dual specificity phosphatase 6 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of DUSP6 mRNA
Diethylnitrosamine results in increased expression of DUSP6 mRNA 		CTD PMID:20360939 PMID:24535843 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dvl1 dishevelled segment polarity protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DVL1 mRNA CTD PMID:17602206 NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966 		JBrowse link
G Dxo decapping exoribonuclease multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DXO mRNA CTD PMID:18164116 NCBI chr20:3,997,953...4,000,115
Ensembl chr20:3,997,955...4,000,037 		JBrowse link
G Dync1li2 dynein, cytoplasmic 1 light intermediate chain 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNC1LI2 mRNA CTD PMID:17602206 NCBI chr19:538,207...561,110
Ensembl chr19:538,211...561,107 		JBrowse link
G Dynll1 dynein light chain LC8-type 1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNLL1 mRNA
Diethylnitrosamine results in increased expression of DYNLL1 mRNA 		CTD PMID:17602206 PMID:19041683 PMID:24535843 NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861 		JBrowse link
G Dynll2 dynein light chain LC8-type 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNLL2 mRNA CTD PMID:17602206 NCBI chr10:73,264,260...73,283,042
Ensembl chr10:73,264,261...73,272,285 		JBrowse link
G Dynlt1 dynein light chain Tctex-type 1 multiple interactions
increases expression 		ISO MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DYNLT1 mRNA] CTD PMID:17942915 NCBI chr 1:49,292,093...49,299,051
Ensembl chr 1:49,282,243...49,298,951 		JBrowse link
G Dyrk3 dual specificity tyrosine phosphorylation regulated kinase 3 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of DYRK3 mRNA CTD PMID:24535843 NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249 		JBrowse link
G Dzip1l DAZ interacting zinc finger protein 1-like multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DZIP1L mRNA CTD PMID:18164116 NCBI chr 8:109,067,466...109,108,390
Ensembl chr 8:109,067,775...109,108,393 		JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of E2F1 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of E2F1 mRNA]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of E2F1 protein]
Diethylnitrosamine results in increased expression of E2F1 mRNA; Diethylnitrosamine results in increased expression of E2F1 protein 		CTD PMID:17854601 PMID:19887370 PMID:20101389 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563 		JBrowse link
G E2f6 E2F transcription factor 6 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of E2F6 mRNA CTD PMID:20360939 NCBI chr 6:45,320,993...45,337,437
Ensembl chr 6:45,320,996...45,337,428 		JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EBNA1BP2 mRNA CTD PMID:17602206 NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression
multiple interactions 		EXP Diethylnitrosamine results in decreased expression of EBP mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of EBP mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr  X:16,971,372...16,977,782
Ensembl chr  X:16,971,405...16,977,781 		JBrowse link
G Ebpl EBP like multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter CTD PMID:25374375 NCBI chr15:39,684,140...39,707,537
Ensembl chr15:39,684,140...39,707,537 		JBrowse link
G Echdc2 enoyl CoA hydratase domain containing 2 multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ECHDC2 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ECHDC2 promoter CTD PMID:25374375 NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:128,144,425...128,163,610 		JBrowse link
G Echs1 enoyl-CoA hydratase, short chain 1 multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ECHS1 mRNA CTD PMID:20360939 NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506 		JBrowse link
G Ecm1 extracellular matrix protein 1 decreases expression
multiple interactions 		ISO Diethylnitrosamine results in decreased expression of ECM1 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ECM1 mRNA 		CTD PMID:24535843 NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606 		JBrowse link
G Ect2 epithelial cell transforming 2 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ECT2 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ECT2 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ECT2 mRNA] 		CTD PMID:17854601 PMID:24535843 NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:111,904,522...111,966,626 		JBrowse link
G Eda2r ectodysplasin A2 receptor increases expression ISO Diethylnitrosamine results in increased expression of EDA2R mRNA CTD PMID:21607683 NCBI chr  X:66,225,557...66,280,674
Ensembl chr  X:66,236,111...66,280,663 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression 		EXP [Iron co-treated with Diethylnitrosamine] results in increased expression of EDN1 protein; Copper promotes the reaction [[Iron co-treated with Diethylnitrosamine] results in increased expression of EDN1 protein]; Dahuang Zhechong pill inhibits the reaction [Diethylnitrosamine results in increased expression of EDN1 protein] CTD PMID:20302851 PMID:36731809 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednrb endothelin receptor type B increases expression EXP Diethylnitrosamine results in increased expression of EDNRB mRNA CTD PMID:19638242 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EEF1E1 mRNA CTD PMID:17602206 NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687 		JBrowse link
G Eeig2 EEIG family member 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EEIG2 mRNA CTD PMID:22129741 NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449 		JBrowse link
G Efcab3 EF-hand calcium binding domain 3 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA CTD PMID:22129741 NCBI chr10:90,084,495...90,577,145
Ensembl chr10:90,084,397...90,577,144 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EFEMP1 mRNA CTD PMID:24535843 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Efemp2 EGF containing fibulin extracellular matrix protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EFEMP2 mRNA CTD PMID:18164116 NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739 		JBrowse link
G Efna1 ephrin A1 multiple interactions
increases expression 		ISO
EXP 		MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EFNA1 mRNA]
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA 		CTD PMID:18691550 PMID:22129741 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efna3 ephrin A3 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of EFNA3 gene CTD PMID:23968726 NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843 		JBrowse link
G Egf epidermal growth factor decreases expression EXP Diethylnitrosamine results in decreased expression of EGF mRNA CTD PMID:19638242 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egflam EGF-like, fibronectin type III and laminin G domains multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EGFLAM mRNA CTD PMID:22129741 NCBI chr 2:58,029,934...58,204,010
Ensembl chr 2:58,029,935...58,203,643 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Diethylnitrosamine co-treated with Piperonyl Butoxide] results in decreased expression of EGFR mRNA; Acetylcysteine inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein]; CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of EGFR protein]; Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein; epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of EGFR mRNA]; MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein]; theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of EGFR mRNA]
Diethylnitrosamine results in decreased expression of EGFR mRNA; Diethylnitrosamine results in decreased expression of EGFR protein
[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased phosphorylation of EGFR protein; [Diethylnitrosamine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EGFR protein; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of EGFR mRNA; Curcumin inhibits the reaction [Diethylnitrosamine results in increased expression of EGFR mRNA]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased phosphorylation of EGFR protein]; turmeric extract inhibits the reaction [Diethylnitrosamine results in increased expression of EGFR mRNA] 		CTD PMID:8403215 PMID:15660382 PMID:17942915 PMID:19638242 PMID:20101389 More... NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EGLN3 mRNA
Diethylnitrosamine results in increased expression of EGLN3 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015 		JBrowse link
G Egr1 early growth response 1 increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in increased expression of EGR1 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EGR1 mRNA]
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EGR1 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA 		CTD PMID:17854601 PMID:18164116 PMID:18544905 PMID:19638242 PMID:21527772 More... NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Ehd2 EH-domain containing 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EHD2 mRNA CTD PMID:18164116 NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943 		JBrowse link
G Ehd4 EH-domain containing 4 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EHD4 mRNA CTD PMID:18164116 NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions
decreases expression 		EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EHHADH mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of EHHADH mRNA
Diethylnitrosamine results in decreased expression of EHHADH mRNA 		CTD PMID:17602206 PMID:19638242 PMID:28943392 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662 		JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of EI24 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EI24 mRNA] 		CTD PMID:17854601 NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214 		JBrowse link
G Eif2s2 eukaryotic translation initiation factor 2 subunit beta multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF2S2 mRNA CTD PMID:17602206 NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570 		JBrowse link
G Eif3b eukaryotic translation initiation factor 3, subunit B multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF3B mRNA CTD PMID:17602206 NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939 		JBrowse link
G Eif3c eukaryotic translation initiation factor 3, subunit C multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF3C mRNA CTD PMID:17602206 NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067 		JBrowse link
G Eif3g eukaryotic translation initiation factor 3, subunit G multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF3G mRNA CTD PMID:17602206 NCBI chr 8:27,705,914...27,709,946
Ensembl chr 8:27,705,915...27,709,987 		JBrowse link
G Eif3h eukaryotic translation initiation factor 3, subunit H multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF3H mRNA CTD PMID:17602206 NCBI chr 7:84,980,891...85,064,284
Ensembl chr 7:84,980,891...85,071,546 		JBrowse link
G Eif3k eukaryotic translation initiation factor 3, subunit K multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF3K mRNA CTD PMID:17602206 NCBI chr 1:93,387,628...93,397,551
Ensembl chr 1:93,387,628...93,397,802 		JBrowse link
G Eif3l eukaryotic translation initiation factor 3, subunit L multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF3L mRNA CTD PMID:17602206 NCBI chr 7:112,522,222...112,544,063
Ensembl chr 7:112,507,831...112,544,062 		JBrowse link
G Eif5a eukaryotic translation initiation factor 5A multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EIF5A mRNA CTD PMID:17602206 NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330 		JBrowse link
G Elac2 elaC ribonuclease Z 2 increases expression EXP Diethylnitrosamine results in increased expression of ELAC2 mRNA CTD PMID:20360939 NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069 		JBrowse link
G Elavl1 ELAV like RNA binding protein 1 increases expression EXP Diethylnitrosamine results in increased expression of ELAVL1 protein CTD PMID:37021545 NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631 		JBrowse link
G Elf1 E74 like ETS transcription factor 1 increases expression ISO Diethylnitrosamine results in increased expression of ELF1 mRNA CTD PMID:21527772 NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758 		JBrowse link
G Ell elongation factor for RNA polymerase II multiple interactions EXP [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ELL mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ELL promoter CTD PMID:25374375 NCBI chr16:18,877,751...18,925,449
Ensembl chr16:18,877,751...18,925,076 		JBrowse link
G Eln elastin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ELN mRNA CTD PMID:18164116 NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413 		JBrowse link
G Elob elongin B increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ELOB mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ELOB mRNA] 		CTD PMID:17942915 NCBI chr10:13,353,413...13,358,484
Ensembl chr10:13,353,417...13,358,563 		JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 decreases expression ISO Diethylnitrosamine results in decreased expression of ELOVL3 mRNA CTD PMID:12771043 PMID:24535843 NCBI chr 1:254,938,731...254,942,559
Ensembl chr 1:254,938,731...254,942,559 		JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 increases expression ISO Diethylnitrosamine results in increased expression of ELOVL7 mRNA CTD PMID:24535843 NCBI chr 2:41,522,695...41,592,021
Ensembl chr 2:41,522,738...41,592,020 		JBrowse link
G Emcn endomucin multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of EMCN mRNA
Diethylnitrosamine results in increased expression of EMCN mRNA 		CTD PMID:24535843 NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155 		JBrowse link
G Emilin2 elastin microfibril interfacer 2 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA CTD PMID:22129741 NCBI chr 9:118,607,312...118,667,087
Ensembl chr 9:118,606,891...118,666,957 		JBrowse link
G Emp1 epithelial membrane protein 1 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Diethylnitrosamine results in decreased expression of EMP1 mRNA
Diethylnitrosamine results in increased expression of EMP1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EMP1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:21527772 NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365 		JBrowse link
G Emp2 epithelial membrane protein 2 increases expression ISO Diethylnitrosamine results in increased expression of EMP2 mRNA CTD PMID:21607683 NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532 		JBrowse link
G Enc1 ectodermal-neural cortex 1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENC1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ENC1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ENC1 mRNA
Diethylnitrosamine results in increased expression of ENC1 mRNA 		CTD PMID:18164116 PMID:19638242 PMID:21607683 PMID:22129741 PMID:24535843 More... NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Endod1 endonuclease domain containing 1 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ENDOD1 mRNA CTD PMID:24535843 NCBI chr 8:19,490,615...19,520,007
Ensembl chr 8:19,490,615...19,520,007 		JBrowse link
G Eng endoglin multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ENG mRNA CTD PMID:17602206 NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933 		JBrowse link
G Eno1 enolase 1 multiple interactions EXP [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of ENO1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of ENO1 mRNA CTD PMID:14656948 PMID:16158176 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Enpep glutamyl aminopeptidase multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ENPEP mRNA CTD PMID:17602206 NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218 		JBrowse link
G Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 increases expression EXP
ISO 		Diethylnitrosamine results in increased expression of ENPP1 mRNA CTD PMID:19638242 PMID:24535843 NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression EXP Diethylnitrosamine results in decreased expression of ENPP2 mRNA CTD PMID:19638242 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Enpp5 ectonucleotide pyrophosphatase/phosphodiesterase family member 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENPP5 mRNA CTD PMID:18164116 NCBI chr 9:24,407,574...24,415,029
Ensembl chr 9:24,408,218...24,414,867 		JBrowse link
G Enpp7 ectonucleotide pyrophosphatase/phosphodiesterase 7 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENPP7 mRNA CTD PMID:22129741 NCBI chr10:104,740,763...104,745,760
Ensembl chr10:104,740,763...104,745,760 		JBrowse link
G Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENTPD2 mRNA
Diethylnitrosamine results in increased expression of ENTPD2 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr 3:28,611,722...28,617,237
Ensembl chr 3:28,611,772...28,618,184 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression
multiple interactions 		EXP Diethylnitrosamine results in increased expression of ENTPD5 mRNA
[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ENTPD5 mRNA 		CTD PMID:19638242 PMID:28943392 NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495 		JBrowse link
G Entrep1 endosomal transmembrane epsin interactor 1 multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENTREP1 mRNA CTD PMID:22129741 NCBI chr 1:231,018,987...231,073,474
Ensembl chr 1:231,018,987...231,102,708 		JBrowse link
G Epb41 erythrocyte membrane protein band 4.1 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of EPB41 gene CTD PMID:23968726 NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540 		JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 affects expression EXP Diethylnitrosamine affects the expression of EPB41L3 mRNA CTD PMID:17428255 NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274 		JBrowse link
G Epcam epithelial cell adhesion molecule multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EPCAM mRNA
Diethylnitrosamine results in increased expression of EPCAM mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epdr1 ependymin related 1 multiple interactions
increases expression 		EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EPDR1 mRNA
Diethylnitrosamine results in increased expression of EPDR1 mRNA 		CTD PMID:18164116 PMID:19638242 NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250 		JBrowse link
G Epha8 Eph receptor A8 multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of EPHA8 mRNA CTD PMID:28943392 NCBI chr 5:154,449,566...154,476,966
Ensembl chr 5:154,449,566...154,476,966 		JBrowse link
G Ephb1 Eph receptor B1 multiple interactions
increases phosphorylation 		EXP
ISO 		[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPHB1 mRNA
N-nitrosodiethylamine increases phosphorylation of Ephb1 protein in liver 		CTD
RGD		 PMID:22129741 PMID:28100771 RGD:127285675 NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:111,386,432...111,823,759 		JBrowse link
G Ephb4 EPH receptor B4 multiple interactions EXP 1,2,4-triazole analog inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of EPHB4 protein]; [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of EPHB4 protein CTD PMID:28693887 NCBI chr12:24,963,174...24,988,473
Ensembl chr12:24,963,174...24,988,388 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of EPHX1 mRNA; [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of EPHX1 protein
Diethylnitrosamine results in increased expression of EPHX1 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EPHX1 mRNA] 		CTD PMID:17602206 PMID:17854601 PMID:18544905 PMID:19638242 PMID:20360939 More... NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ephx2 epoxide hydrolase 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA CTD PMID:18544905 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
G Epor erythropoietin receptor increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of EPOR mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of EPOR mRNA] 		CTD PMID:17942915 NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322 		JBrowse link
G Eps15 epidermal growth factor receptor pathway substrate 15 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EPS15 mRNA CTD PMID:18164116 NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856 		JBrowse link
G Eps8 EGFR pathway substrate 8, signaling adaptor multiple interactions EXP [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPS8 mRNA CTD PMID:22129741 NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160 		JBrowse link
G Erc1 ELKS/RAB6-interacting/CAST family member 1 increases expression EXP Diethylnitrosamine results in increased expression of ERC1 mRNA CTD PMID:20360939 NCBI chr 4:154,435,936...154,727,987
Ensembl chr 4:154,435,944...154,727,987 		JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC2 mRNA CTD PMID:17917374 NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:88,160,988...88,175,102 		JBrowse link
G Ercc3 ERCC excision repair 3, TFIIH core complex helicase subunit multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ERCC3 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ERCC3 mRNA CTD PMID:17602206 PMID:18544905 NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA CTD PMID:17917374 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease multiple interactions
increases expression 		ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ERCC5 mRNA] CTD PMID:17854601 PMID:17917374 NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084 		JBrowse link
G Ercc6l ERCC excision repair 6 like, spindle assembly checkpoint helicase increases expression EXP Diethylnitrosamine results in increased expression of ERCC6L mRNA CTD PMID:19041683 NCBI chr  X:71,285,380...71,301,186
Ensembl chr  X:71,285,380...71,301,186 		JBrowse link
G Ero1b endoplasmic reticulum oxidoreductase 1 beta increases expression ISO Diethylnitrosamine results in increased expression of ERO1B mRNA CTD PMID:24535843 NCBI chr17:92,913,696...92,987,401
Ensembl chr17:92,814,368...92,987,555 		JBrowse link
G Erp27 endoplasmic reticulum protein 27 decreases expression ISO Diethylnitrosamine results in decreased expression of ERP27 mRNA CTD PMID:21527772 PMID:24535843 NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072 		JBrowse link
G Erp29 endoplasmic reticulum protein 29 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ERP29 mRNA CTD PMID:17602206 NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010 		JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 multiple interactions ISO [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:24535843 NCBI chr15:44,210,124...44,230,785
Ensembl chr15:44,210,641...44,231,304
Ensembl chr15:44,210,641...44,231,304 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 multiple interactions
increases expression 		EXP
ISO 		[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ESM1 mRNA
Diethylnitrosamine results in increased expression of ESM1 mRNA 		CTD PMID:18164116 PMID:24535843 NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:46,609,204...46,617,990 		JBrowse link
G Espn espin decreases expression ISO Diethylnitrosamine results in decreased expression of ESPN mRNA CTD PMID:21527772 NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
increases expression 		EXP [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylnitrosamine] results in increased expression of ESR1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR1 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein
Diethylnitrosamine results in increased expression of ESR1 protein 		CTD PMID:34186418 PMID:36608567 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
increases expression 		EXP [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [Diethylnitrosamine results in increased expression of ESR2 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [Diethylnitrosamine results in increased expression of ESR2 protein]; [bisphenol A co-treated with Diethylnitrosamine] results in increased expression of ESR2 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR2 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR2 protein; bisphenol A promotes the reaction [[Diethylhexyl Phthalate co-treated with Diethylnitrosamine] results in increased expression of ESR2 protein]; bisphenol A promotes the reaction [Diethylnitrosamine results in increased expression of ESR2 mRNA] CTD PMID:36608567 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Etfbkmt electron transfer flavoprotein subunit beta lysine methyltransferase decreases expression ISO Diethylnitrosamine results in decreased expression of ETFBKMT mRNA CTD PMID:24535843 NCBI chr 4:183,871,819...183,936,843
Ensembl chr 4:183,871,827...183,881,621 		JBrowse link
G Ethe1 ETHE1, persulfide dioxygenase multiple interactions EXP [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ETHE1 mRNA CTD PMID:28943392 NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998 		JBrowse link
G Etnk1 ethanolamine kinase 1 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ETNK1 mRNA CTD PMID:17602206 NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721 		JBrowse link
G Etnppl ethanolamine-phosphate phospho-lyase decreases expression ISO Diethylnitrosamine results in decreased expression of ETNPPL mRNA CTD PMID:24535843 NCBI chr 2:221,847,210...221,868,827
Ensembl chr 2:221,847,250...221,866,357 		JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor multiple interactions EXP [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ETS1 mRNA CTD PMID:20360939 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021 		JBrowse link
G Ets2 ETS proto-oncogene 2, transcription factor increases expression ISO Diethylnitrosamine results in increased expression of ETS2 mRNA CTD PMID:12771043 NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842 		JBrowse link
G Etv4 ETS variant transcription factor 4 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of ETV4 mRNA
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ETV4 mRNA] 		CTD PMID:17854601 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318 		JBrowse link
G Etv5 ETS variant transcription factor 5 increases expression ISO Diethylnitrosamine results in increased expression of ETV5 mRNA CTD PMID:24535843 NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767 		JBrowse link
G Exoc2 exocyst complex component 2 multiple interactions ISO [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of EXOC2 gene CTD PMID:23968726 NCBI chr17:33,714,949...33,906,901
Ensembl chr17:33,715,008...33,901,944 		JBrowse link
G Exoc4 exocyst complex component 4 increases expression ISO Diethylnitrosamine results in increased expression of EXOC4 mRNA CTD PMID:21607683 NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943 		JBrowse link
G Exoc8 exocyst complex component 8 increases expression
multiple interactions 		ISO Diethylnitrosamine results in increased expression of EXOC8 mRNA
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of EXOC8 mRNA] 		CTD PMID:17942915 NCBI chr19:69,752,387...69,754,876
Ensembl chr19:69,727,231...69,804,820 		JBrowse link
G Exosc5 exosome component 5 multiple interactions EXP [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EXOSC5 mRNA CTD PMID:17602206 NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046